Original Article
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
N Engl J Med 1997; 336:973-979April 3, 1997
- Abstract
Background
Inflammation may be important in the pathogenesis of atherothrombosis. We studied whether inflammation increases the risk of a first thrombotic event and whether treatment with aspirin decreases the risk.
Methods
We measured plasma C-reactive protein, a marker for systemic inflammation, in 543 apparently healthy men participating in the Physicians' Health Study in whom myocardial infarction, stroke, or venous thrombosis subsequently developed, and in 543 study participants who did not report vascular disease during a follow-up period exceeding eight years. Subjects were randomly assigned to receive aspirin or placebo at the beginning of the trial.
Results
Base-line plasma C-reactive protein concentrations were higher among men who went on to have myocardial infarction (1.51 vs. 1.13 mg per liter, P<0.001) or ischemic stroke (1.38 vs. 1.13 mg per liter, P = 0.02), but not venous thrombosis (1.26 vs. 1.13 mg per liter, P = 0.34), than among men without vascular events. The men in the quartile with the highest C-reactive protein values had three times the risk of myocardial infarction (relative risk, 2.9; P<0.001) and two times the risk of ischemic stroke (relative risk, 1.9; P = 0.02) of the men in the lowest quartile. Risks were stable over long periods, were not modified by smoking, and were independent of other lipid-related and non–lipid-related risk factors. The use of aspirin was associated with significant reductions in the risk of myocardial infarction (55.7 percent reduction, P = 0.02) among men in the highest quartile but with only small, nonsignificant reductions among those in the lowest quartile (13.9 percent, P = 0.77).
Conclusions
The base-line plasma concentration of C-reactive protein predicts the risk of future myocardial infarction and stroke. Moreover, the reduction associated with the use of aspirin in the risk of a first myocardial infarction appears to be directly related to the level of C-reactive protein, raising the possibility that antiinflammatory agents may have clinical benefits in preventing cardiovascular disease.
Media in This Article
Figure 1
Relative Risk (and 95 Percent Confidence Intervals) of a First Myocardial Infarction Associated with Each Increasing Quartile of Base-Line C-Reactive Protein Values, According to the Year of Study Follow-up.Figure 2
Relative Risk of a First Myocardial Infarction Associated with Base-Line Plasma Concentrations of C-Reactive Protein, Stratified According to Randomized Assignment to Aspirin or Placebo Therapy.Article Activity
- Article
Thrombus formation is the proximate cause of myocardial infarction, but atherosclerosis, the chief underlying cause, is a chronic disease that progresses over decades of life.1 Laboratory and pathological data support the idea that inflammation has a role in both the initiation and the progression of atherosclerosis, and antiinflammatory agents may have a role in the prevention of cardiovascular disease.2-5 However, there are few data to indicate whether inflammation increases the risk of first myocardial infarction, stroke, and venous thrombosis or whether antiinflammatory therapy decreases that risk.
C-reactive protein is an acute-phase reactant that is a marker for underlying systemic inflammation. Elevated plasma concentrations of C-reactive protein have been reported in patients with acute ischemia6 or myocardial infarction7,8 and have been found to predict recurrent ischemia among those hospitalized with unstable angina.9 C-reactive protein is also associated with a risk of myocardial infarction among patients with angina pectoris10 and with a risk of fatal coronary disease among smokers with multiple risk factors for atherosclerosis.11 However, since concentrations of C-reactive protein and other acute-phase reactants increase after acute ischemia6 and are directly related to cigarette smoking,11,12 it has been uncertain whether associations observed in previous studies of acutely ill patients9 or high-risk populations10,11 are causal or are due to short-term inflammatory changes or to interrelations with other risk factors, in particular smoking and hyperlipidemia.
To address these issues, we measured base-line plasma C-reactive protein concentrations in 1086 apparently healthy men participating in the Physicians' Health Study13,14; myocardial infarction, stroke, or venous thrombosis subsequently developed in 543. We hypothesized a priori that levels of C-reactive protein would predict the risk of myocardial infarction and stroke but not of venous thrombosis — an occlusive vascular disease generally not associated with chronic atherosclerosis. After providing base-line blood samples, study participants were randomly assigned to receive aspirin or placebo. Thus, we had the unique opportunity to evaluate directly whether aspirin, an agent with both antiplatelet and antiinflammatory properties, might modify any relation between C-reactive protein and the risk of first myocardial infarction.
Methods
Study Population and Collection of Plasma Samples
The Physicians' Health Study was a randomized, double-blind, placebo-controlled two-by-two factorial trial of aspirin and beta carotene in the primary prevention of cardiovascular disease and cancer. A total of 22,071 U.S. male physicians 40 to 84 years of age in 1982, with no history of myocardial infarction, stroke, transient ischemic attack, or cancer, were assigned to one of four treatments: 325 mg of aspirin on alternate days (Bufferin, provided by Bristol-Myers), 50 mg of beta carotene on alternate days (Lurotin, provided by BASF Corporation), both, or neither. The aspirin component of the study was terminated early, on January 25, 1988, primarily because of a statistically extreme 44 percent reduction in the risk of a first infarction in the aspirin group.13 The beta carotene component continued until the study's scheduled termination on December 31, 1995.14
Before randomization, between August 1982 and December 1984, potential participants were asked to provide base-line blood samples during a 16-week run-in period during which all subjects were given aspirin and none received placebo. Blood-collection kits, including EDTA Vacutainer tubes, were sent to participants with instructions for taking blood. Participants were asked to have their blood drawn into the EDTA tubes, centrifuge the tubes, and return the plasma (accompanied by a cold pack provided to participants) by overnight courier. The specimens were then divided into aliquots and stored at -80°C. Of the 22,071 participants in the Physicians' Health Study, 14,916 (68 percent) provided base-line plasma samples. Over the 14 years of the trial, no specimen inadvertently thawed during storage.
Confirmation of End Points and Selection of Controls
We requested hospital records (and for fatal events, death certificates and autopsy reports) for all reported cases of myocardial infarction, stroke, and venous thrombosis. The records were reviewed by a committee of physicians using standardized criteria to confirm or refute reported events. Reviewers of end points were unaware of treatment assignments.
Reported myocardial infarction was confirmed if its symptoms met World Health Organization (WHO) criteria and it was associated with either elevated plasma concentrations of enzymes or characteristic electrocardiographic changes. Silent myocardial infarctions were not included, since they could not be dated accurately. Deaths due to coronary disease were confirmed on the basis of autopsy reports, symptoms, circumstances of death, and a history of coronary disease. Reported stroke was confirmed on the basis of medical records showing a neurologic deficit of sudden or rapid onset that persisted for more than 24 hours or until death. Strokes were classified as ischemic or hemorrhagic. Computed tomographic scans were available for more than 95 percent of the confirmed strokes. Reported deep venous thrombosis was confirmed by the documentation of a positive venography study or a positive ultrasound study; deep venous thromboses documented only by impedance plethysmography or Doppler examination without ultrasound were not considered confirmed. Reported pulmonary embolism was confirmed by a positive angiogram or a completed ventilation-perfusion scan demonstrating at least two segmental perfusion defects with normal ventilation.
Each participant who provided an adequate base-line plasma sample and had a confirmed myocardial infarction, stroke, or venous thrombosis after randomization was matched with one control. Controls were participating physicians who provided base-line plasma samples and reported no cardiovascular disease at the time the patient reported his event. Controls were selected randomly from among study participants who met the matching criteria of age (±1 year), smoking status (smoking currently, smoked in the past, or never smoked), and length of time since randomization (in 6-month intervals). Using these methods, we evaluated 543 patients and 543 controls in this prospective, nested, case–control study.
Laboratory Analysis
For each patient and control, plasma collected and stored at base line was thawed and assayed for C-reactive protein by enzyme-linked immunosorbent assay (ELISA) based on purified protein and polyclonal anti–C-reactive protein antibodies (Calbiochem).15 Antibodies were used to coat microtiter-plate wells, and biotinylated C-reactive protein, together with the patient's plasma, was diluted 1:700 in assay buffer (phosphate-buffered saline with 0.1 percent Tween 20 and 1 percent bovine serum albumin). The excess was then washed off and the amount of biotinylated protein estimated by the addition of avidin–peroxidase (Vectastain, Vector Laboratories). Purified C-reactive protein was used as the standard, with protein concentrations as determined by the manufacturer. The C-reactive protein assay was standardized according to the WHO First International Reference Standard and had a sensitivity of 0.08 μg per microliter, with a standard reference range of between 0.5 and 2.5 mg per liter. Methods used to measure plasma total and high-density lipoprotein (HDL) cholesterol, triglyceride, lipoprotein(a), total homocysteine, fibrinogen, d-dimer, and endogenous tissue plasminogen activator (t-PA) antigen have been described elsewhere.16-20
Blood specimens were analyzed in blinded pairs, with the position of the patient's specimen varied at random within the pairs to reduce the possibility of systematic bias and decrease interassay variability. The mean coefficient of variation for C-reactive protein across assay runs was 4.2 percent.
Statistical Analysis
Means or proportions for base-line risk factors were calculated for patients and controls. The significance of any difference in means was tested by using Student's t-test, and the significance of any differences in proportions was tested by using the chi-square statistic. Because C-reactive protein values are skewed, median concentrations were computed and the significance of any differences in median values between patients and controls was assessed by using Wilcoxon's rank-sum test. Geometric mean concentrations of C-reactive protein were also computed after log transformation that resulted in nearly normal distribution. We used tests for trend to assess any relation of increasing C-reactive protein values with the risk of future vascular disease after dividing the sample into quartiles defined by the distribution of the control values. We obtained adjusted estimates by using conditional logistic-regression models that accounted for the matching variables and controlled for the random treatment assignment, body-mass index, diabetes, history of hypertension, and parental history of coronary artery disease. Similar models were employed to adjust for measured base-line plasma concentrations of total and HDL cholesterol, triglyceride, lipoprotein(a), t-PA antigen, fibrinogen, d-dimer, and homocysteine. To evaluate whether aspirin affected these relations, analyses were repeated for all cases of myocardial infarction occurring on or before January 25, 1988 — the date when randomized aspirin assignment was terminated. All P values are two-tailed, and confidence intervals were calculated at the 95 percent level.
Results
Table 1Table 1
Base-Line Characteristics of the Study Participants. shows the base-line characteristics of the study participants. As expected, those in whom myocardial infarction subsequently developed were more likely than those who remained free of vascular disease to have a history of hypertension or hyperlipidemia or a parental history of coronary artery disease. Similarly, those in whom stroke subsequently developed were more likely to be hypertensive. Because of the matching, patients and controls were similar in age and history of smoking.Geometric mean and median plasma concentrations of C-reactive protein at base line were significantly higher among those in whom any vascular event subsequently developed than among those who remained free of vascular disease (P<0.001). The difference between patients and controls was greatest for those in whom myocardial infarction subsequently developed (1.51 vs. 1.13 mg per liter, P<0.001), although differences were also significant for stroke (P = 0.03), particularly ischemic stroke (P = 0.02). In contrast, concentrations of C-reactive protein were not significantly higher among those in whom venous thrombosis subsequently developed (P = 0.34) (Table 2Table 2
Base-Line Plasma Concentrations of C-Reactive Protein in Study Participants Who Remained Free of Vascular Disease during Follow-up (Controls) and in Those in Whom Myocardial Infarction, Stroke, or Venous Thrombosis Developed (Patients).).The relative risk of first myocardial infarction increased significantly with each increasing quartile of base-line concentrations of C-reactive protein (P for trend across quartiles, <0.001), in such a way that the men in the highest quartile had a risk of future myocardial infarction almost three times that among those in the lowest quartile (relative risk, 2.9; 95 percent confidence interval, 1.8 to 4.6; P<0.001) (Table 3Table 3
Relative Risk of Future Myocardial Infarction, Stroke, and Venous Thrombosis According to Base-Line Plasma Concentrations of C-Reactive Protein.). Similarly, men with the highest base-line C-reactive protein values had twice the risk of future ischemic stroke (relative risk, 1.9; 95 percent confidence interval, 1.1 to 3.3; P = 0.02). No significant associations were observed for venous thrombosis. The findings were similar in analyses limited to nonfatal events.To evaluate whether increased base-line C-reactive protein values were associated with early rather than late thrombosis, we stratified the analysis of myocardial infarction according to the number of years of follow-up. The relative risk of future myocardial infarction that was associated with the highest quartile of C-reactive protein (as compared with the lowest quartile) ranged from 2.4 for events occurring in the first two years of follow-up to 3.2 for events occurring six or more years into follow-up (Table 4Table 4
Relative Risk of First Myocardial Infarction Associated with the Highest Quartile of Base-Line Plasma C-Reactive Protein Concentrations as Compared with the Lowest Quartile, According to the Year of Study Follow-up.). Similarly, the relative risk of future myocardial infarction that was associated with a one-quartile change in the C-reactive protein concentration was stable over long periods (Figure 1Figure 1Relative Risk (and 95 Percent Confidence Intervals) of a First Myocardial Infarction Associated with Each Increasing Quartile of Base-Line C-Reactive Protein Values, According to the Year of Study Follow-up.).Smokers had significantly higher median concentrations of C-reactive protein than nonsmokers (2.20 vs. 1.19 mg per liter, P<0.001). By matching patients and controls for smoking status, we minimized the potential for confounding by smoking. To assess for effect modification, however, we repeated the analyses, limiting the cohort to nonsmokers. As Table 3 also shows, the relative risk of future myocardial infarction among nonsmokers increased significantly with each increasing quartile of C-reactive protein (P for trend, <0.001). Similarly, the long-term effects of the concentration of C-reactive protein on the risk of myocardial infarction were virtually identical among nonsmokers (Table 4). Moreover, the relation between the concentration of C-reactive protein and myocardial infarction was not significantly altered in analyses that adjusted for body-mass index; the presence or absence of diabetes, hypertension, or a family history of premature coronary artery disease; and the plasma concentrations of total cholesterol, HDL cholesterol, triglycerides, lipoprotein(a), t-PA antigen, d-dimer, fibrinogen, or homocysteine (Table 5Table 5
Relative Risk of Future Myocardial Infarction, According to Base-Line Plasma Concentrations of C-Reactive Protein, Adjusted for Lipid and Nonlipid Variables.).Finally, to assess whether the beneficial effect of aspirin on the risk of myocardial infarction varied according to the base-line level of C-reactive protein, we repeated these analyses for events occurring before January 25, 1988, the date when randomized aspirin treatment was terminated.
The risk of future myocardial infarction increased with each increasing quartile of C-reactive protein values for men randomly assigned to either aspirin or placebo, and the rates of myocardial infarction were lower in the aspirin group for all quartiles of C-reactive protein (Figure 2Figure 2
Relative Risk of a First Myocardial Infarction Associated with Base-Line Plasma Concentrations of C-Reactive Protein, Stratified According to Randomized Assignment to Aspirin or Placebo Therapy.). However, the magnitude of the beneficial effect of aspirin in preventing myocardial infarction was directly related to base-line levels of C-reactive protein. Specifically, randomized aspirin assignment was associated with a large and statistically significant reduction in the risk of myocardial infarction among men with base-line levels of C-reactive protein in the highest quartile (risk reduction, 55.7 percent; P = 0.02). Among those with base-line levels of C-reactive protein in the lowest quartile, however, the reduction in risk associated with aspirin was far smaller and no longer statistically significant (risk reduction, 13.9 percent; P = 0.77). These effects were linear across quartiles, so that the apparent benefit of aspirin diminished in magnitude with each decreasing quartile of inflammatory risk (Figure 2). This finding remained essentially unchanged after further adjustment for other coronary risk factors, and the interaction between assignment to the aspirin group and base-line levels of C-reactive protein (treated as a log-transformed continuous variable) was statistically significant (P = 0.048).Discussion
These prospective data indicate that the base-line plasma concentration of C-reactive protein in apparently healthy men can predict the risk of first myocardial infarction and ischemic stroke. In addition, the risk of arterial thrombosis associated with the level of C-reactive protein was stable over long periods and was not modified by other factors, including smoking status, body-mass index, blood pressure, or the plasma concentration of total or HDL cholesterol, triglyceride, lipoprotein(a), t-PA antigen, d-dimer, fibrinogen, or homocysteine. In contrast, the benefits of aspirin in reducing the risk of a first myocardial infarction diminished significantly with decreasing concentrations of C-reactive protein — an intriguing finding, since this substance has antiinflammatory as well as antiplatelet properties. Finally, there was no significant association for venous thromboembolism, suggesting that the relation of inflammation to vascular risk may be limited to the arterial circulation.
Because blood samples were collected at base line, we can exclude the possibility that acute ischemia affected levels of C-reactive protein. Furthermore, the statistically significant associations observed were present among nonsmokers, indicating that the effect of C-reactive protein on vascular risk is not simply the result of cigarette smoking.11,12 Thus, our prospective data relating base-line levels of C-reactive protein to future risks of myocardial infarction and stroke among apparently healthy men greatly extend previous observations from studies of acutely ill patients,9 patients with symptomatic coronary disease,10 or those at high risk partly because of cigarette smoking.11 Moreover, in these data, the effects of C-reactive protein were independent of a large number of lipid-related and non–lipid-related risk factors.
The mechanism that relates the level of C-reactive protein to atherothrombosis is unclear. Previous infection with Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, or cytomegalovirus may be a source of the chronic inflammation detected by C-reactive protein.21-27 It is also possible that C-reactive protein is a surrogate for interleukin-6,28 a cellular cytokine associated with the recruitment of macrophages and monocytes into atherosclerotic plaques.29 In addition, C-reactive protein can induce monocytes to express tissue factor, a membrane glycoprotein important in initiating coagulation.30 Finally, it had been hypothesized that bronchial inflammation due to smoking was responsible for associations seen in previous studies relating C-reactive protein to vascular risk.11 In this regard, our observation that the effect of C-reactive protein is present among nonsmokers makes bronchial inflammation a less likely mechanism. Furthermore, the finding that the effects are stable over long periods suggests that short-term effects on clotting are unlikely.
Our data regarding the interrelation of C-reactive protein and aspirin merit careful consideration. In the Physicians' Health Study, aspirin reduced the risk of a first myocardial infarction by 44 percent.13 The present findings indicate that the effect of aspirin in preventing a first myocardial infarction was greatest among the men with the highest base-line C-reactive protein concentrations and that the benefit diminished significantly with decreasing concentrations of this inflammatory marker. Thus, although the antiplatelet effects of aspirin may be modified by underlying inflammation, these data also suggest the possibility that the benefit of aspirin may have been due, at least in part, to antiinflammatory effects.31 Alternatively, patients with large inflammatory burdens may have a distinct vascular mechanism leading to thrombosis that is affected differently by aspirin therapy. For example, the protective effect of aspirin may differ in the setting of plaque rupture as compared with focal endothelial erosion.32,33
The potential limitations of these data also merit consideration. First, our analyses are based on a single base-line determination that may not accurately reflect inflammatory status over long periods. Furthermore, although coefficients of variation were low, misclassification due to laboratory error cannot be ruled out. It is important to note, however, that neither of these sources of variability can account for the observed associations, since any random misclassification would bias results toward the null hypothesis. Since our study was limited to measures of C-reactive protein, other prospective studies evaluating specific cytokines, cellular adhesion molecules, and chronic infectious agents will be required to further elucidate the role of inflammation in the initiation and progression of atherosclerosis.
We draw four main conclusions from these data. First, among apparently healthy men, the base-line level of inflammation as assessed by the plasma concentration of C-reactive protein predicts the risk of a first myocardial infarction and ischemic stroke, independently of other risk factors. Second, the base-line concentration of C-reactive protein is not associated with the risk of venous thrombosis, a vascular event generally not associated with atherosclerosis. Third, C-reactive protein is not simply a short-term marker of risk, as has previously been demonstrated in patients with unstable angina,9 but is also a long-term marker of risk, even for events occurring six or more years later. This observation suggests that the effects of inflammation are probably mediated through a chronic process and excludes the possibility that undetected acute illness at base line is responsible for the observed effects. Finally, the benefits of aspirin appear to be modified by underlying inflammation — an observation that raises the possibility of antiinflammatory as well as antiplatelet effects of this agent. The latter observation also suggests the possibility that other antiinflammatory agents may have a role in preventing cardiovascular disease. Moreover, these data suggest that inflammatory markers such as C-reactive protein may provide a method of identifying people for whom aspirin is likely to be more or less effective — a hypothesis requiring direct testing in randomized trials.
Supported by grants (HL-26490, HL-34595, HL-46696, CA-34944, CA-42182, and CA-40360) from the National Institutes of Health. Dr. Ridker is supported by a Clinician Scientist Award from the American Heart Association.
Source Information
From the Divisions of Preventive Medicine (P.M.R., C.H.H.) and Cardiovascular Disease (P.M.R.) and the Channing Laboratory (M.J.S.), Department of Medicine, Brigham and Women's Hospital; the Department of Ambulatory Care and Prevention, Harvard Medical School (C.H.H.); and the Departments of Epidemiology (M.J.S., C.H.H.) and Nutrition (M.J.S.), Harvard School of Public Health — all in Boston; and the Laboratory for Clinical Biochemistry Research, University of Vermont, Burlington (M.C., R.P.T.).
Address reprint requests to Dr. Ridker at the Division of Preventive Medicine, Brigham and Women's Hospital, 900 Commonwealth Ave. E., Boston, MA 02215-1204.
- References
References
1
Fuster V ,Badimon L ,Badimon JJ ,Chesebro JH . The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-250
Full Text | Web of Science | Medline2
Munro JM ,Cotran RS . The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest 1988;58:249-261
Web of Science | Medline3
Ross R . The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809
CrossRef | Web of Science | Medline4
Alexander RW . Inflammation and coronary artery disease. N Engl J Med 1994;331:468-469
Full Text | Web of Science | Medline5
Nieminen MS ,Mattila K ,Valtonen V . Infection and inflammation as risk factors for myocardial infarction. Eur Heart J 1993;14:Suppl K:12-16
Web of Science | Medline6
Berk BC ,Weintraub WS ,Alexander RW . Elevation of C-reactive protein in “active“ coronary artery disease. Am J Cardiol 1990;65:168-172
CrossRef | Web of Science | Medline7
de Beer FC ,Hind CR ,Fox KM ,Allan RM ,Maseri A ,Pepys MB . Measurement of serum C-reactive protein concentration in myocardial ischemia and infarction. Br Heart J 1982;47:239-243
CrossRef | Web of Science | Medline8
Pietila K ,Harmoinen A ,Hermens W ,Simoons ML ,Van de Werf F ,Verstraete M . Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy. Eur Heart J 1993;14:915-919
CrossRef | Web of Science | Medline9
Liuzzo G ,Biasucci LM ,Gallimore JR , et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-424
Full Text | Web of Science | Medline10
Thompson SG ,Kienast J ,Pyke SDM ,Haverkate F ,van de Loo JCW . Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332:635-641
Full Text | Web of Science | Medline11
Kuller LH ,Tracy RP ,Shaten J ,Meilahn EN . Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996;144:537-547
Web of Science | Medline12
Das I . Raised C-reactive protein levels in serum from smokers. Clin Chim Acta 1985;153:9-13
CrossRef | Web of Science | Medline13
Steering Committee of the Physicians' Health Study Research Group
Full Text | Web of Science | Medline14
Hennekens CH ,Buring JE ,Manson JE , et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-1149
Full Text | Web of Science | Medline15
Macy EM ,Hayes TE ,Tracy RP . Variability in the measurement of C-reactive protein in healthy adults: implications for reference interval and epidemiologic methods. Clin Chem 1997;43:52-58
Web of Science | Medline16
Stampfer MJ ,Sacks FM ,Salvini S ,Willett WC ,Hennekens CH . A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1991;325:373-381
Full Text | Web of Science | Medline17
Ridker PM ,Hennekens CH ,Stampfer MJ . A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA 1993;270:2195-2199
CrossRef | Web of Science | Medline18
Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risks of future venous thromboembolism. Circulation (in press).
19
Ridker PM ,Vaughan DE ,Stampfer MJ ,Manson JE ,Hennekens CH . Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993;341:1165-1168
CrossRef | Web of Science | Medline20
Ridker PM ,Hennekens CH ,Cerskus A ,Stampfer MJ . Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation 1994;90:2236-2240
Web of Science | Medline21
Buja LM . Does atherosclerosis have an infectious etiology? Circulation 1996;94:872-873
Web of Science | Medline22
Grayston JT . Chlamydia in atherosclerosis. Circulation 1993;87:1408-1409
Web of Science | Medline23
Saikku P ,Leinonen M ,Tenkanen L , et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992;116:273-278
Web of Science | Medline24
Thom DH ,Grayston JT ,Siscovick DS ,Wang S-P ,Weiss NS ,Daling JR . Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992;268:68-72
CrossRef | Web of Science | Medline25
Melnick JL ,Adam E ,DeBakey ME . Possible role of cytomegalovirus in atherogenesis. JAMA 1990;263:2204-2207
CrossRef | Web of Science | Medline26
Mendall MA ,Goggin PM ,Molineaux N , et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994;71:437-439
CrossRef | Web of Science | Medline27
Patel P ,Mendall MA ,Carrington D , et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995;311:711-714[Erratum, BMJ 1995;311:985.]
CrossRef | Web of Science | Medline28
Bataille R ,Klein B . C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo. Arthritis Rheum 1992;35:982-984
CrossRef | Web of Science | Medline29
Biasucci LM ,Vitelli A ,Liuzzo G , et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996;94:874-877
Web of Science | Medline30
Cermak J ,Key NS ,Bach RR ,Balla J ,Jacob HS ,Vercellotti GM . C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82:513-520
Web of Science | Medline31
Vane J . The evolution of non-steroidal anti-inflammatory drugs and their mechanisms of action. Drugs 1987;33:Suppl 1:18-27
CrossRef | Web of Science | Medline32
van der Wal AC ,Becker AE ,van der Loos CM ,Das PK . Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44
Web of Science | Medline33
Farb A ,Burke AP ,Tang AL , et al. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996;93:1354-1363
Web of Science | Medline
- Citing Articles (1496)
Citing Articles
1
Mónica Acevedo, Ramón Corbalán, Sandra Braun, Jaime Pereira, Ilse González, Carlos Navarrete. (2012) Biochemical predictors of cardiac rhythm at 1 year follow-up in patients with non-valvular atrial fibrillation. Journal of Thrombosis and Thrombolysis
CrossRef2
Benjamin T. Bikman. (2012) A role for sphingolipids in the pathophysiology of obesity-induced inflammation. Cellular and Molecular Life Sciences
CrossRef3
L. M. Biasucci, F. Bellocci, M. Landolina, R. Rordorf, A. Vado, E. Menardi, G. Giubilato, S. Orazi, M. Sassara, A. Castro, R. Massa, A. Kheir, G. Zaccone, C. Klersy, F. Accardi, F. Crea. (2012) Risk stratification of ischaemic patients with implantable cardioverter defibrillators by C-reactive protein and a multi-markers strategy: results of the CAMI-GUIDE study. European Heart Journal
CrossRef4
Nao Fukui, Yoshihiro Shimazaki, Takashi Shinagawa, Yoshihisa Yamashita. (2012) Periodontal Status and Metabolic Syndrome in Middle-Aged Japanese. Journal of Periodontology1-14
CrossRef5
S Masiha, J Sundström, L Lind. (2012) Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women. Journal of Human Hypertension
CrossRef6
Aytekin Guven, Fatma Tolun, Mustafa Caliskan, Ozgur Ciftci, Haldun Muderrisoglu. (2012) C-reactive protein and nitric oxide level in patients with white coat hypertension. Blood Pressure1-5
CrossRef7
Wolfgang Lösche, Janina Boettel, Björn Kabisch, Johannes Winning, Ralf A. Claus, Michael Bauer. (2012) Do Aspirin and Other Antiplatelet Drugs Reduce the Mortality in Critically Ill Patients?. Thrombosis 2012, 1-8
CrossRef8
Yuxiang Dai, Junbo Ge. (2012) Clinical Use of Aspirin in Treatment and Prevention of Cardiovascular Disease. Thrombosis 2012, 1-7
CrossRef9
Sun-Hee Park, Peter Stenvinkel, Bengt Lindholm. (2012) Cardiovascular Biomarkers in Chronic Kidney Disease. Journal of Renal Nutrition 22:1, 120-127
CrossRef10
Mette Rauhe Mouridsen, Theodoros Intzilakis, Zeynep Binici, Olav Wendelboe Nielsen, Ahmad Sajadieh. (2012) Prognostic value of high sensitive C-reactive protein in subjects with silent myocardial ischemia. Journal of Electrocardiology
CrossRef11
Shu Meng, Lin Zhang, Lei Zhao, Yi-ru Fang, Tetsuya Fujimoto, Shun-ichiro Hirano, Hiroshi Inoue, Kenji Uchihashi, Yasuo Nishikawa, Ya-fei Wu. (2012) Effects of C-Reactive Protein on CC Chemokine Receptor 2-Mediated Chemotaxis of Monocytes. DNA and Cell Biology 31:1, 30-35
CrossRef12
Francesco Versaci, Bernhard Reimers, Francesco Prati, Achille Gaspardone, Costantino Del Giudice, Andrea Pacchioni, Alessandro Mauriello, Claudio Cortese, Paolo Nardi, Anna De Fazio, Giovanni Alfonso Chiariello, Igino Proietti, Luigi Chiariello. (2012) Prediction of Cardiovascular Events by Inflammatory Markers in Patients Undergoing Carotid Stenting. Mayo Clinic Proceedings 87:1, 50-58
CrossRef13
Emilio Ortega, Rosa Gilabert, Isabel Nuñez, Montserrat Cofán, Aleix Sala-Vila, Eric de Groot, Emili Ros. (2012) White blood cell count is associated with carotid and femoral atherosclerosis. Atherosclerosis
CrossRef14
Woo-Keun Seo, Hung-Youl Seok, Ji Hyun Kim, Moon-Ho Park, Sung-Wook Yu, Kyungmi Oh, Seong-Beom Koh, Kun-Woo Park. (2012) C-Reactive Protein is a Predictor of Early Neurologic Deterioration in Acute Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases
CrossRef15
Razvan T. Dadu, Vijay Nambi, Christie M. Ballantyne. (2012) Developing and assessing cardiovascular biomarkers. Translational Research
CrossRef16
Mandar S. Joshi, Liyue Tong, Angela C. Cook, Brandon L. Schanbacher, Hong Huang, Bing Han, Leona W. Ayers, John Anthony Bauer. (2012) Increased myocardial prevalence of C-reactive protein in human coronary heart disease: direct effects on microvessel density and endothelial cell survival. Cardiovascular Pathology
CrossRef17
Takeharu Asano, Ikuo Nakamura, Mari Okajima, Kenichi Yamanaka, Shinichi Asabe, Hiroyuki Miyatani, Katsuhiko Matsuura, Yukio Yoshida, Michio Imawari. (2012) A case of pseudoaneurysm formed 10 years after segmental liver resection for hepatocellular carcinoma. Kanzo 53:1, 55-63
CrossRef18
Fernanda G.C. Signoretti, Marcos S. Endo, Brenda P.F.A. Gomes, Francisco Montagner, Fernanda B. Tosello, Rogério C. Jacinto. (2011) Persistent Extraradicular Infection in Root-filled Asymptomatic Human Tooth: Scanning Electron Microscopic Analysis and Microbial Investigation after Apical Microsurgery. Journal of Endodontics 37:12, 1696-1700
CrossRef19
Arnon Blum, Snait Tamir, Keren Mualem, Rotem Shelly Ben-Shushan, Lital Keinan-Boker, Maya Paritsky. (2011) Endothelial Dysfunction Is Reversible in Helicobacter Pylori-Positive Subjects. The American Journal of Medicine 124:12, 1171-1174
CrossRef20
Kamran I Muhammad, Thomas Morledge, Ravish Sachar, Annette Zeldin, Kathy Wolski, Deepak L Bhatt. (2011) Treatment with ω-3 fatty acids reduces serum C-reactive protein concentration. Clinical Lipidology 6:6, 723-729
CrossRef21
Mario Di Napoli, Mitchell SV Elkind, Daniel Agustin Godoy, Puneetpal Singh, Francesca Papa, Aurel Popa-Wagner. (2011) Role of C-reactive protein in cerebrovascular disease: a critical review. Expert Review of Cardiovascular Therapy 9:12, 1565-1584
CrossRef22
DOMINIC A. M. J. THEUNS, TIM SMITH, TAMAS SZILI-TOROK, AGNES MUSKENS-HEEMSKERK R. N., PETTER JANSE, LUC JORDAENS. (2011) Prognostic Role of High-Sensitivity C-Reactive Protein and B-Type Natriuretic Peptide in Implantable Cardioverter-Defibrillator Patients. Pacing and Clinical Electrophysiologyno-no
CrossRef23
Nicole Cristell, Domenico Cianflone, Alessandro Durante, Enrico Ammirati, Diego Vanuzzo, Michela Banfi, Giliola Calori, Azeem Latib, Filippo Crea, Giancarlo Marenzi, Monica De Metrio, Luciano Moretti, Hui Li, Neal G. Uren, Dayi Hu, Attilio Maseri. (2011) High-Sensitivity C-Reactive Protein Is Within Normal Levels at the Very Onset of First ST-Segment Elevation Acute Myocardial Infarction in 41% of Cases. Journal of the American College of Cardiology 58:25, 2654-2661
CrossRef24
Jeannette Y. Wick, Guido R. Zanni. (2011) C-Reactive Protein: The Evolution of a Laboratory Test. The Consultant Pharmacist 26:12, 929-933
CrossRef25
Tanya G. Marsh, Rachel K. Straub, Fatima Villalobos, Mee Young Hong. (2011) Soy protein supports cardiovascular health by downregulating hydroxymethylglutaryl–coenzyme A reductase and sterol regulatory element-binding protein–2 and increasing antioxidant enzyme activity in rats with dextran sodium sulfate–induced mild systemic inflammation. Nutrition Research 31:12, 922-928
CrossRef26
Zhong-Xuan Ye, Po-Hsun Huang, Hsin-Bang Leu, Tao-Cheng Wu, Shing-Jong Lin, Jaw-Wen Chen. (2011) The Role of High Sensitivity C-Reactive Protein and Coronary Artery Calcium as Predictors of the Long-term Prognosis in Men with Coronary Artery Disease. Journal of Experimental & Clinical Medicine
CrossRef27
Eugene Joseph Kucharz. (2011) Chronic inflammation-enhanced atherosclerosis: Can we consider it as a new clinical syndrome?. Medical Hypotheses
CrossRef28
K. Koike, Y. Yamamoto, N. Suzuki, R. Yamazaki, C. Yoshikawa, K. Takuma, K. Sugiura, M. Inoue. (2011) Efficacy of porcine placental extracts with hormone therapy for postmenopausal women with knee pain. Climacteric1-6
CrossRef29
Hua Zhou, Li Cui, GeYa Zhu, YaPing Jiang, XiaoXia Gao, Yun Zou, Min Yang, Hua Liu, Jia Di, Yin Zong, JiaRong Pan. (2011) Survival Advantage of Normal Weight in Peritoneal Dialysis Patients. Renal Failure 33:10, 964-968
CrossRef30
Naoko Takaoka, Kenichi Tsujita, Koichi Kaikita, Shinji Tayama, Seiji Hokimoto, Seigo Sugiyama, Hisao Ogawa. (2011) Subsequent silent plaque rupture of nonculprit lesion in a patient with acute myocardial infarction. International Journal of Cardiology
CrossRef31
Maria Lukasik, Grzegorz Dworacki, Slawomir Michalak, Joanna Kufel-Grabowska, Jacek Golanski, Cezary Watala, Wojciech Kozubski. (2011) Aspirin treatment influences platelet-related inflammatory biomarkers in healthy individuals but not in acute stroke patients. Thrombosis Research 128:5, e73-e80
CrossRef32
Motohiro Shimizu, Joji Ishikawa, Yuichirou Yano, Satoshi Hoshide, Kazuyuki Shimada, Kazuomi Kario. (2011) The relationship between the morning blood pressure surge and low-grade inflammation on silent cerebral infarct and clinical stroke events. Atherosclerosis 219:1, 316-321
CrossRef33
Jennifer G. Robinson, Catherine Rahilly-Tierney, Elizabeth Lawler, J. Michael Gaziano. (2011) Benefits associated with achieving optimal risk factor levels for the primary prevention of cardiovascular disease in older men. Journal of Clinical Lipidology
CrossRef34
Elba Bandeira, Ana Paula Neves, Christiane Costa, Francisco Bandeira. (2011) Association Between Vascular Calcification and Osteoporosis in Men With Type 2 Diabetes. Journal of Clinical Densitometry
CrossRef35
D. O. Dahle, G. Mjoen, B. Oqvist, H. Scharnagl, G. Weihrauch, T. Grammer, W. Marz, S. Abedini, G. E. Norby, I. Holme, B. Fellstrom, A. Jardine, H. Holdaas. (2011) Inflammation-associated graft loss in renal transplant recipients. Nephrology Dialysis Transplantation 26:11, 3756-3761
CrossRef36
Kazutaka Saito, Kazunori Kihara. (2011) C-reactive protein as a biomarker for urological cancers. Nature Reviews Urology
CrossRef37
Georg Aue, Jay Nelson Lozier, Xin Tian, Ann M. Cullinane, Susan Soto, Leigh Samsel, Philip McCoy, Adrian Wiestner. (2011) Inflammation, TNFα and endothelial dysfunction link lenalidomide to venous thrombosis in chronic lymphocytic leukemia. American Journal of Hematology 86:10, 835-840
CrossRef38
Ryo Yoshimoto, Yoshiko Fujita, Akemi Kakino, Shin Iwamoto, Tomohide Takaya, Tatsuya Sawamura. (2011) The Discovery of LOX-1, its Ligands and Clinical Significance. Cardiovascular Drugs and Therapy 25:5, 379-391
CrossRef39
Akira Funayama, Tetsuro Shishido, Shunsuke Netsu, Mitsunori Ishino, Toshiki Sasaki, Shigehiko Katoh, Hiroki Takahashi, Takanori Arimoto, Takuya Miyamoto, Joji Nitobe, Tetsu Watanabe, Isao Kubota. (2011) Serum Pregnancy-Associated Plasma Protein A in Patients With Heart Failure. Journal of Cardiac Failure 17:10, 819-826
CrossRef40
Kanako Shimizu, Kana Shimomura, Yoshiaki Tokuyama, Kenzo Sakurai, Kenji Isahaya, Satoshi Takaishi, Bunta Kato, Noriko Usuki, Takahiro Shimizu, Koji Yamada, Yasuhiro Hasegawa. (2011) Association between Inflammatory Biomarkers and Progression of Intracranial Large Artery Stenosis after Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases
CrossRef41
Ta-Chen Su, Ching-Fen Wu, Chang-Chuan Chan, Ming-Fong Chen. (2011) C-reactive protein and particulate matter predict plasma fibrinogen levels. International Journal of Cardiology
CrossRef42
Anna L. Soares, Rashid S. Kazmi, Michelle A. Borges, Pedro W. Rosário, Ana P. Fernandes, Marinez O. Sousa, Bashir A. Lwaleed, Maria G. Carvalho. (2011) Elevated plasma factor VIII and von Willebrand factor in women with type 2 diabetes. Blood Coagulation & Fibrinolysis 22:7, 600-605
CrossRef43
Paul M Ridker, Tom Thuren, Andrew Zalewski, Peter Libby. (2011) Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). American Heart Journal 162:4, 597-605
CrossRef44
Petrus M. van der Zee, Jan Hein Cornel, Radha Bholasingh, Johan C. Fischer, Jan P. van Straalen, Robbert J. De Winter. (2011) N-Terminal Pro B-Type Natriuretic Peptide Identifies Patients with Chest Pain at High Long-term Cardiovascular Risk. The American Journal of Medicine 124:10, 961-969
CrossRef45
Matthias Hermann, Dieter Fischer, Michael M. Hoffmann, Theo Gasser, Kurt Quitzau, Thomas Meinertz, Thomas Münzel, Thomas F. Lüscher. (2011) CRP and CD14 polymorphisms correlate with coronary plaque volume in patients with coronary artery disease – IVUS substudy of the ENCORE trials. Atherosclerosis
CrossRef46
Tawfiq Almadi, Ian Cathers, Ayman M. Hamdan Mansour, Chin Moi Chow. (2011) The association between work stress and inflammatory biomarkers in Jordanian male workers. Psychophysiologyn/a-n/a
CrossRef47
E. Braunwald. (2011) Creating controversy where none exists: the important role of C-reactive protein in the CARE, AFCAPS/TexCAPS, PROVE IT, REVERSAL, A to Z, JUPITER, HEART PROTECTION, and ASCOT trials. European Heart Journal
CrossRef48
Michael H. Davidson, Christie M. Ballantyne, Terry A. Jacobson, Vera A. Bittner, Lynne T. Braun, Alan S. Brown, W.Virgil Brown, William C. Cromwell, Ronald B. Goldberg, James M. McKenney, Alan T. Remaley, Allan D. Sniderman, Peter P. Toth, Sotirios Tsimikas, Paul E. Ziajka, Kevin C. Maki, Mary R. Dicklin. (2011) Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists. Journal of Clinical Lipidology 5:5, 338-367
CrossRef49
XiaoFei Li, Miranda C. Kramer, Chris M. van der Loos, Karel T. Koch, Onno J. de Boer, José P.S. Henriques, Jan Baan, Marije M. Vis, Jan J. Piek, Jan G.P. Tijssen, Robbert J. de Winter, Allard C. van der Wal. (2011) A pattern of disperse plaque microcalcifications identifies a subset of plaques with high inflammatory burden in patients with acute myocardial infarction. Atherosclerosis 218:1, 83-89
CrossRef50
Toshiki Fukui, Kazuhiro Yamauchi, Mie Maruyama, Tadashi Yasuda, Masakazu Kohno, Youichi Abe. (2011) Significance of measuring oxidative stress in lifestyle-related diseases from the viewpoint of correlation between d-ROMs and BAP in Japanese subjects. Hypertension Research 34:9, 1041-1045
CrossRef51
Marinez F. Matos, Dayse M. Lourenço, Cristina M. Orikaza, João A.H. Bajerl, Maria A.E. Noguti, Vânia M. Morelli. (2011) The role of IL-6, IL-8 and MCP-1 and their promoter polymorphisms IL-6 -174GC, IL-8 -251AT and MCP-1 -2518AG in the risk of venous thromboembolism: A case-control study. Thrombosis Research 128:3, 216-220
CrossRef52
Brian R. Weil, Jared J. Greiner, Christopher A. DeSouza, Brian L. Stauffer. (2011) Relation of C-Reactive Protein to Endothelial Fibrinolytic Function in Healthy Adults. The American Journal of Cardiology
CrossRef53
Nazri Mustaffa, Suhairi Ibrahim, Wan Zaidah Abdullah, Zurkurnai Yusof. (2011) Add-on rosiglitazone therapy improves plasminogen activity and high-density lipoprotein cholesterol in type 2 diabetes mellitus. Blood Coagulation & Fibrinolysis 22:6, 512-520
CrossRef54
V. Vermeeren, L. Grieten, N. Vanden Bon, N. Bijnens, S. Wenmackers, S.D. Janssens, K. Haenen, P. Wagner, L. Michiels. (2011) Impedimetric, diamond-based immmunosensor for the detection of C-reactive protein. Sensors and Actuators B: Chemical 157:1, 130-138
CrossRef55
Kerstyn C. Zalesin, Barry A. Franklin, Wendy M. Miller, Eric D. Peterson, Peter A. McCullough. (2011) Impact of Obesity on Cardiovascular Disease. Medical Clinics of North America 95:5, 919-937
CrossRef56
Thomas Gremmel, Cihan Ay, Daniela Seidinger, Ingrid Pabinger, Simon Panzer, Renate Koppensteiner. (2011) Soluble p-selectin, D-dimer, and high-sensitivity C-reactive protein after acute deep vein thrombosis of the lower limb. Journal of Vascular Surgery
CrossRef57
Qi Yu, Yan Lin, Peigang Yang, Yanli Wang, Sihai Zhao, Penghui Yang, Jianglin Fan, Enqi Liu. (2011) C-reactive protein is associated with the progression of acute embolic stroke in rabbit model. Journal of Thrombosis and Thrombolysis
CrossRef58
Osamu Saiki, Makihiko Kuhara, Nozomi Kikuchi, Sanshirou Shiraishi, Hiroshi Uda. (2011) Evaluation of Lasting High Levels of CRP among the Patients with Metabolic Syndrome. Inflammation
CrossRef59
Emmanuela Quental Callou de Sá, Francisco Carleial Feijó de Sá, Rebeca de Souza e Silva, Kelly Cristina de Oliveira, Alexis Dourado Guedes, Fausto Feres, Ieda Therezinha do Nascimento Verreschi. (2011) Endogenous oestradiol but not testosterone is related to coronary artery disease in men. Clinical Endocrinology 75:2, 177-183
CrossRef60
Regina Rückerl, Alexandra Schneider, Susanne Breitner, Josef Cyrys, Annette Peters. (2011) Health effects of particulate air pollution: A review of epidemiological evidence. Inhalation Toxicology 23:10, 555-592
CrossRef61
S. Yamamoto, Y. Zuo, J. Ma, P. G. Yancey, T. E. Hunley, M. Motojima, A. B. Fogo, M. F. Linton, S. Fazio, I. Ichikawa, V. Kon. (2011) Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice. Nephrology Dialysis Transplantation 26:8, 2491-2497
CrossRef62
H. Kaneko, T. Anzai, T. Nagai, A. Anzai, T. Takahashi, Y. Mano, K. Morimoto, Y. Maekawa, H. Itoh, T. Yoshikawa, S. Ogawa, K. Fukuda. (2011) Human C-reactive protein exacerbates metabolic disorders in association with adipose tissue remodelling. Cardiovascular Research 91:3, 546-555
CrossRef63
Stacy A. Brethauer, Helen M. Heneghan, Shai Eldar, Patrick Gatmaitan, Hazel Huang, Sangeeta Kashyap, Heather L. Gornik, John P. Kirwan, Philip R. Schauer. (2011) Early effects of gastric bypass on endothelial function, inflammation, and cardiovascular risk in obese patients. Surgical Endoscopy 25:8, 2650-2659
CrossRef64
Markus H. Schafer, Kenneth F. Ferraro. (2011) Distal and variably proximal causes: Education, obesity, and health. Social Science & Medicine
CrossRef65
Brice Faraut, Karim Zouaoui Boudjeltia, Luc Vanhamme, Myriam Kerkhofs. (2011) Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery. Sleep Medicine Reviews
CrossRef66
Ya-Ching Chang, Wei-Ming Wu, Lung-An Hsu. (2011) Lack of association between the genetic variations in the C-reactive protein gene and the risk of psoriasis among the Taiwanese. Molecular Biology Reports
CrossRef67
Hanen Belfki, Samir Ben Ali, Souha Bougatef, Decy Ben Ahmed, Najet Haddad, Awatef Jmal, Monia Abdennebi, Habiba Ben Romdhane. (2011) Association Between C-Reactive Protein and Type 2 Diabetes in a Tunisian Population. Inflammation
CrossRef68
Hee-Jin Hwang, Sang-Woo Lee, Sang-Hwan Kim. (2011) Relationship between bilirubin and C-reactive protein. Clinical Chemistry and Laboratory Medicine---
CrossRef69
Meriam Messedi, Makram Frigui, Khaireddine Ben Mahfoudh, Hanen Feki, Salma Triki Ben Mahfoudh, Jameleddine Mnif, Zouhir Bahloul, Fatma Ayadi. (2011) Intima-media Thickness of Carotid Artery in Patients with Behçet’s Disease. Archives of Medical Research 42:5, 398-404
CrossRef70
Xian Li, Michele L. Shaffer, Sol M. Rodríguez-Colón, Fan He, Edward O. Bixler, Alexandros N. Vgontzas, Deborah L. Wolbrette, Chuntao Wu, Richard W. Ball, Duanping Liao. (2011) Systemic inflammation and circadian rhythm of cardiac autonomic modulation. Autonomic Neuroscience 162:1-2, 72-76
CrossRef71
Choy-Lye Chei, Kazumasa Yamagishi, Akihiko Kitamura, Masahiko Kiyama, Hironori Imano, Tetsuya Ohira, Renzhe Cui, Takeshi Tanigawa, Tomoko Sankai, Yoshinori Ishikawa, Shinichi Sato, Hiroyasu Iso. (2011) C-reactive protein levels and risk of stroke and its subtype in Japanese: The Circulatory Risk in Communities Study (CIRCS). Atherosclerosis 217:1, 187-193
CrossRef72
Elsie M. Taveras, Sheryl L. Rifas-Shiman, Janet W. Rich-Edwards, Christos S. Mantzoros. (2011) Maternal short sleep duration is associated with increased levels of inflammatory markers at 3 years postpartum. Metabolism 60:7, 982-986
CrossRef73
Bindu Chamarthi, Gordon H. Williams, Vincent Ricchiuti, Nadarajah Srikumar, Paul N. Hopkins, James M. Luther, Xavier Jeunemaitre, Abraham Thomas. (2011) Inflammation and Hypertension: The Interplay of Interleukin-6, Dietary Sodium, and the Renin–Angiotensin System in Humans. American Journal of Hypertension
CrossRef74
Meng-Yueh Chien, Peilin Lee, Yuan-Feen Tsai, Pan-Chyr Yang, Ying-Tai Wu. (2011) C-reactive protein and heart rate recovery in middle-aged men with severe obstructive sleep apnea. Sleep and Breathing
CrossRef75
Kae-Woei Liang, I-Chen Tsai, Wen-Jane Lee, I-Te Lee, Wen-Lieng Lee, Shih-Yi Lin, Chu-Jen Wan, Chia-Po Fu, Chih-Tai Ting, Wayne H-H Sheu. (2011) MRI Measured Epicardial Adipose Tissue Thickness at the Right AV Groove Differentiates Inflammatory Status in Obese Men With Metabolic Syndrome. Obesity
CrossRef76
Patricia K. Tithof, Sean M. Richards, Mona A. Elgayyar, Fu-Minn Menn, Vijay M. Vulava, Larry McKay, John Sanseverino, Gary Sayler, Dawn E. Tucker, Christina C. Leslie, Kim P. Lu, Kenneth S. Ramos. (2011) Activation of group IVC phospholipase A2 by polycyclic aromatic hydrocarbons induces apoptosis of human coronary artery endothelial cells. Archives of Toxicology 85:6, 623-634
CrossRef77
Hideo Nakarai, Akiko Yamashita, Mikimasa Takagi, Masataka Adachi, Masaharu Sugiyama, Haruhiko Noda, Masafumi Katano, Ryuji Yamakawa, Keiji Nakayama, Hitomi Takumiya, Yoshikatsu Nakai, Ataru Taniguchi, Fusanori Nishimura. (2011) Periodontal disease and hypertriglyceridemia in Japanese subjects: potential association with enhanced lipolysis. Metabolism 60:6, 823-829
CrossRef78
Miraj Mondal, Rathindra Nath Sarkar, Amitava Chakroborty, Ashutosh Dey, Sibaji Phaujdar, Sattik Siddhanta, Siwalik Banerjee. (2011) Atherosclerosis in an Indian cohort of rheumatoid arthritis with low disease activity and its correlation with inflammatory markers. Indian Journal of Rheumatology 6:2, 61-67
CrossRef79
Dong-Hyun Choi, Kyung Woo Park, Han-Mo Yang, Hae-Young Lee, Jin-Shik Park, Hyun-Jai Kang, Yong-Jin Kim, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim. (2011) Renal dysfunction and high levels of hsCRP are additively associated with hard endpoints after percutaneous coronary intervention with drug eluting stents. International Journal of Cardiology 149:2, 174-181
CrossRef80
Kwan Leung Chan, Jean G. Dumesnil, James Tam, Andy Ni, Koon Teo. (2011) Effect of rosuvastatin on C-reactive protein and progression of aortic stenosis. American Heart Journal 161:6, 1133-1139
CrossRef81
Xiang Ying Ouyang, Wen Mei Xiao, Yi Chu, Shuang Ying Zhou. (2011) Influence of periodontal intervention therapy on risk of cardiovascular disease. Periodontology 2000 56:1, 227-257
CrossRef82
M.Y. Hrira, W. Mnif, M. Kerkeni, Z. Jaidane, A. Kasab, S. Ferchichi, S. Laradi, F. Addad, H. Ben Limam, A. Miled. (2011) C-réactive protéine ultrasensible et facteurs de risque cardiovasculaire dans une population tunisienne. IImmuno-analyse & Biologie Spécialisée 26:3, 107-112
CrossRef83
Rae-Chi Huang, Nicholas de Klerk, Trevor A. Mori, John P. Newnham, Fiona J. Stanley, Louis I. Landau, Wendy H. Oddy, Beth Hands, Lawrence J. Beilin. (2011) Differential relationships between anthropometry measures and cardiovascular risk factors in boys and girls. International Journal of Pediatric Obesity 6:2-2, e271-e282
CrossRef84
Yueh-Hsiu Mathilda Chiu, Donna Spiegelman, Douglas W. Dockery, Eric Garshick, S. Katharine Hammond, Thomas J. Smith, Jaime E. Hart, Francine Laden. (2011) Secondhand Smoke Exposure and Inflammatory Markers in Nonsmokers in the Trucking Industry. Environmental Health Perspectives 119:9, 1294-1300
CrossRef85
Wanda Acampa, Maria D. Di Taranto, Alberto Morgante, Barbara Salvatore, Laura Evangelista, Francesca Ricci, Pierluigi Costanzo, Emma de Sisto, Pasquale P. Filardi, Mario Petretta, Giuliana Fortunato, Alberto Cuocolo. (2011) C-reactive protein levels are associated with paraoxonase polymorphism L55M in patients undergoing cardiac SPECT imaging. Scandinavian Journal of Clinical & Laboratory Investigation 71:3, 179-184
CrossRef86
R. Scott Wright, Jeffrey L. Anderson, Cynthia D. Adams, Charles R. Bridges, Donald E. Casey, Steven M. Ettinger, Francis M. Fesmire, Theodore G. Ganiats, Hani Jneid, A. Michael Lincoff, Eric D. Peterson, George J. Philippides, Pierre Theroux, Nanette K. Wenger, James Patrick Zidar. (2011) 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline). Journal of the American College of Cardiology 57:19, 1920-1959
CrossRef87
I. Ouellet-Morin, A. Danese, B. Williams, L. Arseneault. (2011) Validation of a high-sensitivity assay for C-reactive protein in human saliva. Brain, Behavior, and Immunity 25:4, 640-646
CrossRef88
R. Scott Wright, Jeffrey L. Anderson, Cynthia D. Adams, Charles R. Bridges, Donald E. Casey, Steven M. Ettinger, Francis M. Fesmire, Theodore G. Ganiats, Hani Jneid, A. Michael Lincoff, Eric D. Peterson, George J. Philippides, Pierre Theroux, Nanette K. Wenger, James Patrick Zidar. (2011) 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction. Journal of the American College of Cardiology 57:19, e215-e367
CrossRef89
Alan D. Bell, André Roussin, Raymond Cartier, Wee Shian Chan, James D. Douketis, Anil Gupta, Maria E. Kraw, Thomas F. Lindsay, Michael P. Love, Neesh Pannu, Rémi Rabasa-Lhoret, Ashfaq Shuaib, Philip Teal, Pierre Théroux, Alexander G.G. Turpie, Robert C. Welsh, Jean-François Tanguay. (2011) The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines. Canadian Journal of Cardiology 27:3, S1-S59
CrossRef90
Matthew R. Evans, Agustín Escalante, Daniel F. Battafarano, Gregory L. Freeman, Daniel H. O'Leary, Inmaculada del Rincón. (2011) Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis. Arthritis & Rheumatism 63:5, 1211-1220
CrossRef91
Giuseppe Sangiorgi, Alessandro Mauriello, Santi Trimarchi, Elena Bonanno, Luigi Giusto Spagnoli. 2011. Atherogenesis and Inflammation. , 10-29.
CrossRef92
Julianne Holt-Lunstad, Patrick R. Steffen, Jonathan Sandberg, Bryan Jensen. (2011) Understanding the connection between spiritual well-being and physical health: an examination of ambulatory blood pressure, inflammation, blood lipids and fasting glucose. Journal of Behavioral Medicine
CrossRef93
J. V. Baker, J. D. Lundgren. (2011) Cardiovascular implications from untreated human immunodeficiency virus infection. European Heart Journal 32:8, 945-951
CrossRef94
Lung-An Hsu, Yu-Lin Ko, Ming-Sheng Teng, Semon Wu, Hsin-Hua Chou, Pi-Yueh Chang, Hsien-Hsun Chang. (2011) Effect of obesity on the association between common variations in the HNF1A gene region and C-reactive protein level in Taiwanese. Clinica Chimica Acta 412:9-10, 725-729
CrossRef95
Charlotte E. Bolton, Wiebke Schumacher, John R. Cockcroft, Nicholas J. Timpson, George Davey Smith, John Gallacher, Anne Rumley, Gordon D. Lowe, Shah Ebrahim, Dennis J. Shale, Yoav Ben
Shlomo. (2011) The CRP genotype, serum levels and lung function in men: the Caerphilly Prospective Study. Clinical Science 120:8, 347-355
CrossRef96
Giovanni Cimmino, Chiara D’Amico, Valentina Vaccaro, Margherita D’Anna, Paolo Golino. (2011) The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor?. Expert Review of Cardiovascular Therapy 9:4, 517-523
CrossRef97
T. ULRYCH, A. BÖHM, A. POLZIN, G. DAUM, R. M. NÜSING, G. GEISSLINGER, T. HOHLFELD, K. SCHRÖR, B. H. RAUCH. (2011) Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation. Journal of Thrombosis and Haemostasis 9:4, 790-798
CrossRef98
Stefano Volpato, Luigi Ferrucci, Paola Secchiero, Federica Corallini, Giovanni Zuliani, Renato Fellin, Jack M. Guralnik, Stefania Bandinelli, Giorgio Zauli. (2011) Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults. Atherosclerosis 215:2, 452-458
CrossRef99
Jamie A. Bastek, Amy G. Brown, Lauren Anton, Sindhu K. Srinivas, Antonietta D'addio, Michal A. Elovitz. (2011) Biomarkers of inflammation and placental dysfunction are associated with subsequent preterm birth. Journal of Maternal-Fetal and Neonatal Medicine 24:4, 600-605
CrossRef100
Jean-Louis Vincent, Katia Donadello, Xavier Schmit. (2011) Biomarkers in the Critically Ill Patient: C-reactive Protein. Critical Care Clinics 27:2, 241-251
CrossRef101
Zhu-Zhi Wen, Dong-mei Jin, Ya-mei Zhang, Jing-Feng Wang, Deng-Feng Geng. (2011) Glucometabolic state in Chinese patients undergoing elective coronary angiography. Diabetes Research and Clinical Practice 91:3, 300-306
CrossRef102
Hidenori Nishida, Takeshi Horio, Yoshihiko Suzuki, Yoshio Iwashima, Takeshi Tokudome, Fumiki Yoshihara, Satoko Nakamura, Yuhei Kawano. (2011) Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: Comparison with C-reactive protein. Cytokine 53:3, 342-346
CrossRef103
Shujuan Guo, Shu Meng, Bin Chen, Juan Liu, Li Gao, Yafei Wu. (2011) C-Reactive Protein Can Influence the Proliferation, Apoptosis, and Monocyte Chemotactic Protein-1 Production of Human Umbilical Vein Endothelial Cells. DNA and Cell Biology 30:3, 157-162
CrossRef104
Alan D. Bell, André Roussin, Raymond Cartier, Wee Shian Chan, James D. Douketis, Anil Gupta, Maria E. Kraw, Thomas F. Lindsay, Michael P. Love, Neesh Pannu, Rémi Rabasa-Lhoret, Ashfaq Shuaib, Philip Teal, Pierre Théroux, A. Graham Turpie, Robert C. Welsh, Jean-François Tanguay. (2011) The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines Executive Summary. Canadian Journal of Cardiology 27:2, 208-221
CrossRef105
Ako Fukami, Sho-ichi Yamagishi, Hisashi Adachi, Takanori Matsui, Kuniko Yoshikawa, Kinuka Ogata, Akiko Kasahara, Eri Tsukagawa, Kanako Yokoi, Tsutomu Imaizumi. (2011) High White Blood Cell Count and Low Estimated Glomerular Filtration Rate Are Independently Associated With Serum Level of Monocyte Chemoattractant Protein-1 in a General Population. Clinical Cardiology 34:3, 189-194
CrossRef106
A. Pejcic, L. J. Kesic, J. Milasin. (2011) C-reactive protein as a systemic marker of inflammation in periodontitis. European Journal of Clinical Microbiology & Infectious Diseases 30:3, 407-414
CrossRef107
Myung-A Kim, Chee Jeong Kim, Jae-Bin Seo, Woo-Yong Chung, Sang-Hyun Kim, Joo-Hee Zo, Eun Yeon Rho, Sue Shin, Jong Hyun Yoon. (2011) The Effect of Aspirin on C-Reactive Protein in Hypertensive Patients. Clinical and Experimental Hypertension 33:1, 47-52
CrossRef108
Francisco López-Jiménez, Mery Cortés-Bergoderi. (2011) Obesidad y corazón. Revista Española de Cardiología 64:2, 140-149
CrossRef109
Mohsen Moohebati, Shirin Bidmeshgi, Mahmoud R. Azarpazhooh, Mahdi Hassanzadeh Daloee, Majid Ghayour-Mobarhan, Shima Tavallaie, Maral Amini, Akram Momenzadeh, Amirhossein Sahebkar, Roghayeh Paydar. (2011) Simvastatin treatment reduces heat shock protein 60, 65, and 70 antibody titers in dyslipidemic patients: A randomized, double-blind, placebo-controlled, cross-over trial. Clinical Biochemistry 44:2-3, 192-197
CrossRef110
En-Zhi Jia, Zhen-Xia Xu, Zhi-Jian Yang, Tie-Bing Zhu, Lian-Sheng Wang, Ke-Jiang Cao, Wen-Zhu Ma. (2011) Severity of coronary atherosclerosis is an independent predictor of the left ventricular ejection fraction. Clinical and Experimental Pharmacology and Physiology 38:2, 109-112
CrossRef111
Hyun-Jung Kim, Hyun-Syuk Yoo, Pan-Kyeom Kim, Mi-Ryung Kim, Hyup-Woo Lee, Chan-Wha Kim. (2011) Comparative analysis of serum proteomes of patients with cardiovascular disease. Clinical Biochemistry 44:2-3, 178-184
CrossRef112
Marina J. Harutyunyan, Anders B. Mathiasen, Per Winkel, Jens P. Gøtze, Jørgen Fischer Hansen, Per Hildebrandt, Gorm Boje Jensen, Jørgen Hilden, Christian M. Jespersen, Erik Kjøller, Hans J. Kolmos, Christian Gluud, Jens Kastrup. (2011) High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial. Scandinavian Journal of Clinical & Laboratory Investigation 71:1, 52-62
CrossRef113
Adriano Caixeta, Gregg W. Stone, Roxana Mehran, Edwin A. Lee, Brent T. McLaurin, David A. Cox, Michel E. Bertrand, A. Michael Lincoff, Jeffrey W. Moses, Harvey D. White, E. Magnus Ohman, Tullio Palmerini, George Syros, Christos Kittas, Martin Fahy, W. Craig Hooper, Alexandra J. Lansky, George D. Dangas. (2011) Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial. Journal of Thrombosis and Thrombolysis 31:2, 154-164
CrossRef114
Pavel Poredos, Mateja Kaja Jezovnik. (2011) In patients with idiopathic venous thrombosis, interleukin-10 is decreased and related to endothelial dysfunction. Heart and Vessels
CrossRef115
Benjamín Rubio-Jurado, Paulina Iñiguez-Franco, Pedro A. Reyes, Gustavo Robles, Mario Salazar-Páramo, Guadalupe Zavala-Cerna, Carlos Riebeling, Arnulfo Nava. (2011) The Clinical Significance of Coagulation and the Inflammatory Response in Autoimmunity. Clinical Reviews in Allergy & Immunology
CrossRef116
Oh Young Bang. (2011) Biomarkers of Stroke. Korean Journal of Stroke 13:2, 57
CrossRef117
Viviane Zorzanelli Rocha, Eduardo J. Folco. (2011) Inflammatory Concepts of Obesity. International Journal of Inflammation 2011, 1-14
CrossRef118
John R Koethe, Meridith Blevins, Christopher Nyirenda, Edmond K Kabagambe, Bryan E Shepherd, C William Wester, Isaac Zulu, Janelle M Chiasera, Lloyd B Mulenga, Albert Mwango, Douglas C Heimburger. (2011) Nutrition and inflammation serum biomarkers are associated with 12-week mortality among malnourished adults initiating antiretroviral therapy in Zambia. Journal of the International AIDS Society 14:1, 19
CrossRef119
Hem C. Jha, Pragya Srivastava, Jagdish Prasad, Aruna Mittal. (2011) Chlamydia pneumoniae Heat Shock Protein 60 Enhances Expression of ERK, TLR-4 and IL-8 in Atheromatous Plaques of Coronary Artery Disease Patients. Immunological Investigations 40:2, 206-222
CrossRef120
Suthesh Sivapalaratnam, Rosienne Farrugia, Max Nieuwdorp, Cordelia F Langford, Rachel T Van Beem, Stephanie Maiwald, Jaap Jan Zwaginga, Arief Gusnanto, Nicholas A Watkins, Mieke D Trip, Willem H Ouwehand. (2011) Identification of candidate genes linking systemic inflammation to atherosclerosis; results of a human in vivo LPS infusion study.. BMC Medical Genomics 4:1, 64
CrossRef121
Chih-Wei Chen, Chih-Ta Lin, Ying-Lung Lin, Tin-Kwang Lin, Chin-Lon Lin. (2011) Taiwanese Female Vegetarians Have Lower Lipoprotein-Associated Phospholipase A2 Compared with Omnivores. Yonsei Medical Journal 52:1, 13
CrossRef122
L Nibali, S Fedele, F D’Aiuto, N Donos. (2011) Interleukin-6 in oral diseases: a review : IL-6 and oral diseases. Oral Diseasesno
CrossRef123
Carmine Savoia, Lidia Sada, Luigi Zezza, Lorenzo Pucci, Francesco Maria Lauri, Alberto Befani, Alessandro Alonzo, Massimo Volpe. (2011) Vascular Inflammation and Endothelial Dysfunction in Experimental Hypertension. International Journal of Hypertension 2011, 1-8
CrossRef124
Jamal Bamoulid, Cécile Courivaud, Marina Deschamps, Béatrice Gaugler, Pierre Tiberghien, Jean-Marc Chalopin, Philippe Saas, Didier Ducloux. (2011) The Interleukin-6 Gene Promoter Polymorphism -174 and Atherosclerotic Events in Overweight Transplanted Patients. Journal of Transplantation 2011, 1-6
CrossRef125
T.-N. Wang, M.-C. Lin, C.-C. Wu, M.-S. Huang, S. Y. Leung, C.-C. Huang, P.-S. Ho, Y.-C. Ko. (2011) Role of gender disparity of circulating high-sensitivity C-reactive protein concentrations and obesity on asthma in Taiwan. Clinical & Experimental Allergy 41:1, 72-77
CrossRef126
Christopher S. Coffey, Folkert W. Asselbergs, Patricia R. Hebert, Hans L. Hillege, Qing Li, Jason H. Moore, Wiek H. van Gilst. (2011) The Association of the Metabolic Syndrome with PAI-1 and t-PA Levels. Cardiology Research and Practice 2011, 1-8
CrossRef127
John A. Morrison, Charles J. Glueck, Stephen R. Daniels, Ping Wang, Davis M. Stroop, Paul S. Horn. (2011) High-Sensitivity C Reactive Protein: Associations with Cardiovascular Risk Factors and Tracking in Female Adolescents and Young Adults. ISRN Pediatrics 2011, 1-9
CrossRef128
Neil Ruparelia, Janet E Digby, Robin P Choudhury. (2011) Effects of niacin on atherosclerosis and vascular function. Current Opinion in Cardiology 26:1, 66-70
CrossRef129
Emily G. Kurtz, Paul M. Ridker, Lynda M. Rose, Nancy R. Cook, Brendan M. Everett, Julie E. Buring, Kathryn M. Rexrode. (2011) Oral postmenopausal hormone therapy, C-reactive protein, and cardiovascular outcomes. Menopause 18:1, 23-29
CrossRef130
Mark S. Nash, Kevin L. Dalal, Jasmine Martinez-Barrizonte, Diana D. Cardenas. (2011) Suppression of Proatherogenic Inflammatory Cytokines as a Therapeutic Countermeasure to CVD Risks Accompanying SCI. Topics in Spinal Cord Injury Rehabilitation 16:3, 14-32
CrossRef131
Efser Oztas, Gulay Kurtay. (2011) Randomized, controlled study of the effects of raloxifene on high sensitivity C-reactive protein and serum lipids. Archives of Gynecology and Obstetrics 283:1, 71-77
CrossRef132
May A Beydoun, Marie T Fanelli Kuczmarski, Youfa Wang, Marc A Mason, Michele K Evans, Alan B Zonderman. (2011) Receiver-operating characteristics of adiposity for metabolic syndrome: the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) study. Public Health Nutrition 14:01, 77-92
CrossRef133
Juan José Badimón, Carlos G. Santos-Gallego, Francisco Torres, Jesús Castillo, Juan Carlos Kaski. (2011) Nuevas herramientas en la estratificación del riesgo cardiovascular. Revista Española de Cardiología Suplementos 11, 21-28
CrossRef134
K. Stellos, T. Geisler, P. Seizer, M. E. Andia, A. Schuster, A. E. May, A. Melms, M. Gawaz, B. Bigalke, T. Wurster. (2011) Expression of stromal-cell-derived factor-1 (SDF-1): a predictor of ischaemic stroke? : Platelet SDF-1 in patients with TIA and stroke. European Journal of Neurologyno
CrossRef135
Fan He, Michele L Shaffer, Xian Li, Sol Rodriguez-Colon, Deborah L Wolbrette, Ronald Williams, Wayne E Cascio, Duanping Liao. (2011) Individual-level PM2.5 exposure and the time course of impaired heart rate variability: the APACR Study. Journal of Exposure Science and Environmental Epidemiology 21:1, 65-73
CrossRef136
Yongnian Ni, Ruirui Zhu, Serge Kokot. (2011) Competitive binding of small molecules with biopolymers: a fluorescence spectroscopy and chemometrics study of the interaction of aspirin and ibuprofen with BSA. The Analyst
CrossRef137
Kiwoong Yu, Cheolhwan Kim, Eunju Sung, Hocheol Shin, Hyewon Lee. (2011) Association of Serum Total Bilirubin with Serum High Sensitivity C-reactive Protein in Middle-aged Men. Korean Journal of Family Medicine 32:6, 327
CrossRef138
J Van der Heyden, FJ Wolters, N Garin, S Andrejevic Blant, M Inglin, ET Bal, MJ Suttorp. (2011) The role of embolic protection devices during carotid stenting prior to cardiac surgery in asymptomatic patients: Empty filters?. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef139
Tatjana Rundek, Ralph L. Sacco. 2011. Prognosis after Stroke. , 219-241.
CrossRef140
Kathleen Maksimowicz-McKinnon, Susan Manzi. 2011. Heart. , 815-832.
CrossRef141
Zeynep Ozturk, Byambaa Enkhmaa, Neil S. Shachter, Lars Berglund, Erdembileg Anuurad. (2010) Integrated Role of Two Apoliprotein E Polymorphisms on Apolipoprotein B Levels and Coronary Artery Disease in a Biethnic Population. Metabolic Syndrome and Related Disorders 8:6, 531-538
CrossRef142
Sharon M. L. Wallace, Kaisa M. Mäki-Petäjä, Joseph Cheriyan, Edward H. Davidson, Lynne Cherry, Carmel M. McEniery, Naveed Sattar, Ian B. Wilkinson, Rajesh K. Kharbanda. (2010) Simvastatin prevents inflammation-induced aortic stiffening and endothelial dysfunction. British Journal of Clinical Pharmacology 70:6, 799-806
CrossRef143
Kazutaka Saito, Kazunori Kihara. (2010) Role of C-reactive protein as a biomarker for renal cell carcinoma. Expert Review of Anticancer Therapy 10:12, 1979-1989
CrossRef144
Hui Chen, Pei Zheng, Haihua Zhu, Jianhua Zhu, Lili Zhao, Nour Eddine Mokhtari, Jörg Eberhard, Markus Lins, Søren Jepsen. (2010) Platelet-activating factor levels of serum and gingival crevicular fluid in nonsmoking patients with periodontitis and/or coronary heart disease. Clinical Oral Investigations 14:6, 629-636
CrossRef145
Giuseppe Lippi, Emmanuel J. Favaloro, Martina Montagnana, Massimo Franchini. (2010) C-reactive protein and venous thromboembolism: causal or casual association?. Clinical Chemistry and Laboratory Medicine 48:12, 1693-1701
CrossRef146
Rahul Rawat, Jean H. Humphrey, Kuda Mutasa, Robert Ntozini, Rebecca J. Stoltzfus. (2010) Short Communication: Predicting Adverse HIV-Related Outcomes in a Resource-Limited Setting: Use of the Inflammation Marker α 1 -Acid Glycoprotein. AIDS Research and Human Retroviruses 26:11, 1171-1174
CrossRef147
A.R. Pradeep, R.G. Shiva Manjunath, Rahul Kathariya. (2010) Progressive periodontal disease has a simultaneous incremental elevation of gingival crevicular fluid and serum CRP levels. Journal of Investigative and Clinical Dentistry 1:2, 133-138
CrossRef148
Jessica R. Meendering, Britta N. Torgrimson, Nicole P. Miller, Paul F. Kaplan, Christopher T. Minson. (2010) A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation
. Contraception 82:4, 366-372
CrossRef149
Antonio J Vallejo Vaz, María L Miranda Guisado, Pablo Stiefel García-Junco, Encarnación Pamies Andreu, Salvador García Morillo, José Villar Ortiz. (2010) Differences in the prevalence of metabolic syndrome and levels of C-reactive protein after puerperium in women with hypertensive disorders during pregnancy. Hypertension Research 33:10, 1012-1017
CrossRef150
Fumitaka Tanaka, Shinji Makita, Toshiyuki Onoda, Kozo Tanno, Masaki Ohsawa, Kazuyoshi Itai, Kiyomi Sakata, Masayuki Onodera, Yorihiko Koeda, Kazuko Kawarura, Yasuo Terayama, Yuki Yoshida, Akira Ogawa, Akira Okayama, Motoyuki Nakamura. (2010) Prehypertension Subtype With Elevated C-Reactive Protein: Risk of Ischemic Stroke in a General Japanese Population. American Journal of Hypertension 23:10, 1108-1113
CrossRef151
Jiangtao Yan, James K. Liao, Daowen Wang. (2010) Elevated homocysteine and C-reactive protein levels independently predict worsening prognosis after stroke in Chinese patients. Journal of Huazhong University of Science and Technology [Medical Sciences] 30:5, 643-647
CrossRef152
Mitchell S. V. Elkind. (2010) Impact of innate inflammation in population studies. Annals of the New York Academy of Sciences 1207:1, 97-106
CrossRef153
Sandip K. Zalawadiya, Vikas Veeranna, Ashutosh Niraj, Jyotiranjan Pradhan, Luis Afonso. (2010) Red Cell Distribution Width and Risk of Coronary Heart Disease Events. The American Journal of Cardiology 106:7, 988-993
CrossRef154
Duane A. Burnett, Harry R. Davis. 2010. Atherosclerosis I: LDL Cholesterol Lowering. .
CrossRef155
R. J. Bisoendial, S. M. Boekholdt, M. Vergeer, E. S. G. Stroes, J. J. P. Kastelein. (2010) C-reactive protein is a mediator of cardiovascular disease. European Heart Journal 31:17, 2087-2091
CrossRef156
Zhuang Liu, Meng Su, Shi-cheng Yu, Zhi-hua Yin, Bao-sen Zhou. (2010) Association of Chlamydia pneumoniae immunoglobulin G antibodies with the risk of lung cancer among non-smoking women in Liaoning, China. Thoracic Cancer 1:3, 126-129
CrossRef157
Roy Fried. (2010) Zoster Vaccine in Older Adults. Journal of the American Geriatrics Society 58:9, 1799-1800
CrossRef158
John T. Wilkins, Donald M. Lloyd-Jones. (2010) Biomarkers for Coronary Heart Disease Clinical Risk Prediction: A Critical Appraisal. Preventive Cardiology 13:4, 160-165
CrossRef159
Bilgen Balaforlu, Ipek Eskiyoruk, Burcu Kus, Mesut Tozar, Nural Bekiroglu, Mehmet Koc. (2010) Seasonal variation of C-reactive protein and atherosclerotic cardiovascular events in hemodialysis patients. Renal Failure 32:7, 825-831
CrossRef160
J. K. MacLaine, A. B. M. Rabie, R. Wong. (2010) Does orthodontic tooth movement cause an elevation in systemic inflammatory markers?. The European Journal of Orthodontics 32:4, 435-440
CrossRef161
Georgios Tsakos, Wael Sabbah, Aroon D Hingorani, Gopalakrishnan Netuveli, Nikos Donos, Richard G Watt, Francesco DʼAiuto. (2010) Is periodontal inflammation associated with raised blood pressure? Evidence from a National US survey. Journal of Hypertension1
CrossRef162
D. Conen, P. M. Ridker, B. M. Everett, U. B. Tedrow, L. Rose, N. R. Cook, J. E. Buring, C. M. Albert. (2010) A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. European Heart Journal 31:14, 1730-1736
CrossRef163
Filippo Graziani, Silvia Cei, Fabio La Ferla, Michele Vano, Mario Gabriele, Maurizio Tonetti. (2010) Effects of non-surgical periodontal therapy on the glomerular filtration rate of the kidney: an exploratory trial. Journal of Clinical Periodontology 37:7, 638-643
CrossRef164
Zhiqiang Wang, Wendy E. Hoy. (2010) C-reactive protein: an independent predictor of cardiovascular disease in Aboriginal Australians. Australian and New Zealand Journal of Public Health 34, S25-S29
CrossRef165
Carla LoPinto-Khoury, Scott Mintzer. (2010) Antiepileptic Drugs and Markers of Vascular Risk. Current Treatment Options in Neurology 12:4, 300-308
CrossRef166
L. Soares-Miranda, C. E. Negrao, L. M. Antunes-Correa, T. S. Nobre, P. Silva, R. Santos, S. Vale, J. Mota. (2010) High levels of C-reactive protein are associated with reduced vagal modulation and low physical activity in young adults. Scandinavian Journal of Medicine & Science in Sportsno-no
CrossRef167
Petter Quist-Paulsen. (2010) Statins and inflammation: an update. Current Opinion in Cardiology 25:4, 399-405
CrossRef168
Abhimanyu Beri, Tahmeed Contractor, Atul Khasnis, Ranjan Thakur. (2010) Statins and the Reduction of Sudden Cardiac Death. American Journal Cardiovascular Drugs 10:3, 155-164
CrossRef169
Kristen M. Beavers, Tina E. Brinkley, Barbara J. Nicklas. (2010) Effect of exercise training on chronic inflammation. Clinica Chimica Acta 411:11-12, 785-793
CrossRef170
D. Deepak, C. Daousi, M. Javadpour, D. Clark, Y. Perry, J. Pinkney, I.A. MacFarlane. (2010) The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency. Growth Hormone & IGF Research 20:3, 220-225
CrossRef171
Gina Biasillo, Milena Leo, Roberta Della Bona, Luigi Marzio Biasucci. (2010) Inflammatory biomarkers and coronary heart disease: from bench to bedside and back. Internal and Emergency Medicine 5:3, 225-233
CrossRef172
Hongsheng Ren, Ming Li, Lili Feng, Jinjiao Jiang, Yijing Zhang, Yuanchao Zhang, Xinglei Zhu. (2010) Effects of Clopidogrel on Vascular Proliferation and Apoptosis in an Atherosclerotic Rabbit Model. Journal of Cardiovascular Pharmacology 55:6, 617-624
CrossRef173
George S. Abela. (2010) Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation. Journal of Clinical Lipidology 4:3, 156-164
CrossRef174
David Conen, Christine M. Albert. (2010) Sex Differences in Atrial Fibrillation and Its Complications. Current Cardiovascular Risk Reports 4:3, 237-243
CrossRef175
Francesco US Mattace-Raso, Germaine C Verwoert, Albert Hofman, Jacqueline CM Witteman. (2010) Inflammation and incident-isolated systolic hypertension in older adults: the Rotterdam study. Journal of Hypertension 28:5, 892-895
CrossRef176
Willian Cruz, Sonia Fialho, Edelton Morato, Gláucio Castro, Adriana Zimmermann, Giovana Ribeiro, Fabrício Neves, Ivânio Pereira. (2010) Is there a link between inflammation and abnormal lipoprotein profile in Sjögren's syndrome?. Joint Bone Spine 77:3, 229-231
CrossRef177
Tao Zhang, Tomoko Kurita-Ochiai, Tomomi Hashizume, Yuan Du, Sumito Oguchi, Masafumi Yamamoto. (2010) Aggregatibacter actinomycetemcomitans accelerates atherosclerosis with an increase in atherogenic factors in spontaneously hyperlipidemic mice. FEMS Immunology & Medical Microbiologyno-no
CrossRef178
J. Gustav Smith, Christopher Newton-Cheh. (2010) Genetic Loci Associated with C-Reactive Protein Levels and Risk Of Coronary Heart Disease. Current Cardiovascular Risk Reports 4:3, 178-180
CrossRef179
P. M. Ridker. (2010) Psoriasis, inflammation, and vascular risk: a problem more than skin deep?. European Heart Journal 31:8, 902-904
CrossRef180
Peter S. Munk, Tor H. Melberg, Oyvind Skadberg, Jan T. Kvaløy, Alf I. Larsen. (2010) Variations in population-based levels of C-reactive protein, cardiovascular morbidity and all-cause mortality. International Journal of Cardiology 140:2, 247-249
CrossRef181
Grace Casaclang-Verzosa, Marion E. Barnes, Gustavo Blume, James B. Seward, Bernard J. Gersh, Stephen S. Cha, Kent R. Bailey, Teresa S. M. Tsang. (2010) C-Reactive Protein, Left Atrial Volume, and Atrial Fibrillation: A Prospective Study in High-Risk Elderly. Echocardiography 27:4, 394-399
CrossRef182
Rosalind J. Wright. (2010) Perinatal stress and early life programming of lung structure and function. Biological Psychology 84:1, 46-56
CrossRef183
Mi-Ri Kim, Jungil Hong. (2010) Analysis of chemical interactions of (−)-epigallocatechin-3-gallate, a major green tea polyphenol, with commonly-consumed over-thecounter drugs. Food Science and Biotechnology 19:2, 559-564
CrossRef184
Per Torger Skretteberg, Johan Bodegård, Sverre E. Kjeldsen, Gunnar Erikssen, Erik Thaulow, Leif Sandvik, Jan E. Erikssen. (2010) Interaction between inflammation and blood viscosity predicts cardiovascular mortality. Scandinavian Cardiovascular Journal 44:2, 107-112
CrossRef185
Aydin Nazmi, Isabel O. Oliveira, Bernardo L. Horta, Denise P. Gigante, Cesar G. Victora. (2010) Lifecourse socioeconomic trajectories and C-reactive protein levels in young adults: Findings from a Brazilian birth cohort. Social Science & Medicine 70:8, 1229-1236
CrossRef186
R. P. Stowe, M. K. Peek, M. P. Cutchin, J. S. Goodwin. (2010) Plasma Cytokine Levels in a Population-Based Study: Relation to Age and Ethnicity. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 65A:4, 429-433
CrossRef187
Ambareesh Bajpai, Abhinav Goyal, Laurence Sperling. (2010) Should We Measure C-reactive Protein on Earth or Just on JUPITER?. Clinical Cardiology 33:4, 190-198
CrossRef188
Amparo Galán, Antonio Curós, Vicente Valle. (2010) Biomarcadores de detección y predicción de síndrome coronario agudo. Medicina Clínica 134:11, 499-504
CrossRef189
Michael R. Bleavins, Ramin Rahbari. 2010. Anti-Unicorn Principle: Appropriate Biomarkers Don't Need to be Rare or Hard to Find. .
CrossRef190
Rocco Antonio Montone, Giuseppe Ferrante, Marco Bacà, Giampaolo Niccoli. (2010) Predictive value of C-reactive protein after drug-eluting stent implantation. Future Cardiology 6:2, 167-179
CrossRef191
Daisuke Ekuni, Takaaki Tomofuji, Koichiro Irie, Kenta Kasuyama, Michihiro Umakoshi, Tetsuji Azuma, Naofumi Tamaki, Toshihiro Sanbe, Yasumasa Endo, Tatsuo Yamamoto, Takashi Nishida, Manabu Morita. (2010) Effects of periodontitis on aortic insulin resistance in an obese rat model. Laboratory Investigation 90:3, 348-359
CrossRef192
Cedric Delhaye, Gabriel Maluenda, Kohei Wakabayashi, Itsik Ben-Dor, Gilles Lemesle, Sara D. Collins, Asmir I. Syed, Rebecca Torguson, Kimberly Kaneshige, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Joseph Lindsay, Augusto D. Pichard, Ron Waksman. (2010) Long-Term Prognostic Value of Preprocedural C-Reactive Protein After Drug-Eluting Stent Implantation. The American Journal of Cardiology 105:6, 826-832
CrossRef193
Jin Si, Yan Ge, Shougang Zhuang, Rujun Gong. (2010) Inhibiting nonmuscle myosin II impedes inflammatory infiltration and ameliorates progressive renal disease. Laboratory Investigation 90:3, 448-458
CrossRef194
Paolo Calabrò, Enrica Golia, Lucia Riegler, Giuseppe Limongelli, Paolo Golino, Maria Giovanna Russo, Raffaele Calabrò. (2010) Inflammation: The Link Between Obesity and Cardiovascular Risk. Current Cardiovascular Risk Reports 4:2, 101-111
CrossRef195
Miki Sato, Shinichi Kako, Kumi Oshima, Ken Sato, Kiriko Terasako, Shun-Ichi Kimura, Hideki Nakasone, Shinya Okuda, Rie Yamazaki, Takakazu Higuchi, Junji Nishida, Yoshinobu Kanda. (2010) Prediction of infectious events by high-sensitivity C-reactive protein level before undergoing chemotherapy for acute myeloid leukaemia. Scandinavian Journal of Infectious Diseases 42:2, 97-101
CrossRef196
Nithya Sukumar, Ansu Basu. (2010) Treatment of erectile dysfunction in the older diabetic patient. Aging Health 6:1, 9-29
CrossRef197
Umadevi Kandalam, Michelle A. Clark. (2010) Angiotensin II activates JAK2/STAT3 pathway and induces interleukin-6 production in cultured rat brainstem astrocytes. Regulatory Peptides 159:1-3, 110-116
CrossRef198
E. Ramesh, P. Geraldine, P.A. Thomas. (2010) Regulatory effect of epigallocatechin gallate on the expression of C-reactive protein and other inflammatory markers in an experimental model of atherosclerosis. Chemico-Biological Interactions 183:1, 125-132
CrossRef199
Johannes Winning, Jens Neumann, Matthias Kohl, Ralf A. Claus, Konrad Reinhart, Michael Bauer, Wolfgang Lösche. (2010) Antiplatelet drugs and outcome in mixed admissions to an intensive care unit*. Critical Care Medicine 38:1, 32-37
CrossRef200
Shion Imoto, Kosuke Sakurai, Takeshi Sugimoto, Makoto Hashimoto, Katsuyasu Saigo, Shinya Akita, Nobuo Araki, Mariko Yamashita, Kiichiro Namura, Yoshihiro Bouike, Rika Taniguchi, Osamu Mabuchi. (2010) COMPARISON OF ATHEROSCLEROTIC RISK FACTORS BETWEEN DONORS WITH ASSOCIATED ACUTE NON-HEMOLYTIC TRANSFUSION REACTIONS AND DONORS WITHOUT ASSOCIATION. Japanese Journal of Transfusion and Cell Therapy 56:6, 697-701
CrossRef201
Matthias Frick, Herwig Antretter, Otmar Pachinger, Gerhard Pölzl. (2010) Biomarker zur Diagnose der zellulären Abstoßung nach Herztransplantation. Herz 35:1, 11-16
CrossRef202
Charles J. Everett, Dana E. King, Marty S. Player, Eric M. Matheson, Robert E. Post, Arch G. Mainous. (2010) Association of urinary polycyclic aromatic hydrocarbons and serum C-reactive protein. Environmental Research 110:1, 79-82
CrossRef203
L. Takouli, D. Hadjiyannakos, P. Metaxaki, V. Sideris, V. Filiopoulos, A. Anogiati, D. Vlassopoulos. (2010) Vitamin E-coated cellulose acetate dialysis membrane: long-term effect on inflammation and oxidative stress. Renal Failure 32:3, 287-293
CrossRef204
Jung Min Lee, Hyun Woong Lee, Yoon Suk Hong, Eun Soo Kim, Kyung Sik Park, Kwang Bum Cho, Jae Seok Hwang, Hyungseop Kim. (2010) A Case of Acute Myocardial Infarction Occurred Immediately after Endoscopic Submucosal Dissection. The Korean Journal of Gastroenterology 56:4, 249
CrossRef205
Veena S. Rao, Natesha B. Kadarinarasimhiah, Shibu John, Sridhara Hebbagodi, Jayashree Shanker, Vijay V. Kakkar. (2010) Usefulness of C-Reactive Protein as a Marker for Prediction of Future Coronary Events in the Asian Indian Population: Indian Atherosclerosis Research Study. International Journal of Vascular Medicine 2010, 1-8
CrossRef206
Susan M. Ordaz-Medina, Juana González-Plascencia, Fabiola Martín del Campo, Enrique Rojas-Campos, José L Montañez-Fernández, Francisco Espinoza-Gómez, Alfonso M. Cueto-Manzano. (2010) Is Systemic Inflammation of Hemodialysis Patients Improved With the Use of Enalapril? Results of a Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. ASAIO Journal 56:1, 37-41
CrossRef207
Atsushi Tanaka, Guillermo J. Tearney, Brett E. Bouma. (2010) Challenges on the frontier of intracoronary imaging: atherosclerotic plaque macrophage measurement by optical coherence tomography. Journal of Biomedical Optics 15:1, 011104
CrossRef208
(2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. The Lancet 375:9709, 132-140
CrossRef209
Giovanni Guaraldi, Chiara Stentarelli, Stefano Zona, Gabriella Orlando, Federica Carli, Guido Ligabue, Antonella Lattanzi, Giacomo Zaccherini, Rosario Rossi, Maria Grazia Modena, Nikolaos Alexopoulos, Frank Palella, Paolo Raggi. (2010) Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects. Atherosclerosis 208:1, 222-227
CrossRef210
Tomoe KOMORIYA, Maho KIKUCHI, Yutaka TERASHIMA, Mayumi OKAMOTO, Masahiro OGAWA, Mituhiko MORIYAMA, Hideki KOHNO. (2010) Development of a Highly Sensitive Latex Reagent Directed against C-Reactive Protein (CRP) Using Epitope Analysis with Monoclonal Antibodies. Bioscience, Biotechnology, and Biochemistry 74:2, 292-297
CrossRef211
Allison E. Aiello, George A. Kaplan. (2009) Socioeconomic Position and Inflammatory and Immune Biomarkers of Cardiovascular Disease: Applications to the Panel Study of Income Dynamics. Biodemography and Social Biology 55:2, 178-205
CrossRef212
Toshiko Uchida, Stephen D. Persell, David W. Baker. (2009) Update in General Internal Medicine. Journal of General Internal Medicine 24:12, 1327-1332
CrossRef213
Mayuko Akamatsu, Tetsuya Ogawa, Ayuko Fujiu, Nami Matsuda, Kosaku Nitta. (2009) Clinical assessment of atherosclerotic parameters and cardiac function in chronic hemodialysis patients. Clinical and Experimental Nephrology 13:6, 651-658
CrossRef214
Mona Hashem Allam, Azza Farag Said, Ahmed Abd El Samie Omran, Dalia Mohammed Abd El-Reheim, Ahmed Hussein Kasem. (2009) High sensitivity C-reactive protein: Its correlation with sputum cell counts in bronchial asthma. Respiratory Medicine 103:12, 1878-1884
CrossRef215
Vadivel Senthil Kumaran, Karpagavinayagam Arulmathi, Rajaguru Sundarapandiyan, Periandavan Kalaiselvi. (2009) Attenuation of the inflammatory changes and lipid anomalies by epigallocatechin-3-gallate in hypercholesterolemic diet fed aged rats. Experimental Gerontology 44:12, 745-751
CrossRef216
Vicente Bertomeu Martínez, J. Ramón González-Juanatey. (2009) Markers of Inflammation and Cardiovascular Disease. American Journal Cardiovascular Drugs 9:Supplement 1, 3-7
CrossRef217
Yukihiko Momiyama, Akito Kawaguchi, Ichiro Kajiwara, Reiko Ohmori, Katsutoshi Okada, Isao Saito, Masamitsu Konishi, Masakazu Nakamura, Shinichi Sato, Yoshihiro Kokubo, Toshifumi Mannami, Hisashi Adachi, Kazuomi Kario, Hiroyasu Iso, Fumitaka Ohsuzu, Motoo Tsushima. (2009) Prognostic value of plasma high-sensitivity C-reactive protein levels in Japanese patients with stable coronary artery disease: The Japan NCVC-Collaborative Inflammation Cohort (JNIC) Study. Atherosclerosis 207:1, 272-276
CrossRef218
Xiu-ren Gao, Chandar M. Adhikari, Long-yun Peng, Xiao-gang Guo, Yuan-sheng Zhai, Xu-yu He, Li-Yuan Zhang, Jun Lin, Zhi-yi Zuo. (2009) Efficacy of different doses of aspirin in decreasing blood levels of inflammatory markers in patients with cardiovascular metabolic syndrome. Journal of Pharmacy and Pharmacology 61:11, 1505-1510
CrossRef219
S. R. Williams, T. W. McDade. (2009) The Use of Dried Blood Spot Sampling in the National Social Life, Health, and Aging Project. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences 64B:Supplement 1, i131-i136
CrossRef220
Nicoletta Vivona, Giulia Bivona, Davide Noto, Bruna Lo Sasso, Angelo B. Cefalù, Gaia Chiarello, Angelo Falletta, Marcello Ciaccio, Maurizio R. Averna. (2009) C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients. Clinical Biochemistry 42:16-17, 1713-1718
CrossRef221
S. R. Williams, G. Pham-Kanter, S. A. Leitsch. (2009) Measures of Chronic Conditions and Diseases Associated With Aging in the National Social Life, Health, and Aging Project. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences 64B:Supplement 1, i67-i75
CrossRef222
Inmaculada del Rincón. (2009) Atherothrombotic comorbidity in the rheumatic diseases. The evidence becomes clearer. What should clinicians do?. Arthritis & Rheumatism 61:10, 1284-1286
CrossRef223
Steffen U. Eisenhardt, Jonathon Habersberger, Karlheinz Peter. (2009) Monomeric C-Reactive Protein Generation on Activated Platelets: The Missing Link Between Inflammation and Atherothrombotic Risk. Trends in Cardiovascular Medicine 19:7, 232-237
CrossRef224
Laura A. Colangelo, Brian Chiu, Peter Kopp, Kiang Liu, Susan M. Gapstur. (2009) Serum IGF-I and C-reactive protein in healthy black and white young men: The CARDIA male hormone study. Growth Hormone & IGF Research 19:5, 420-425
CrossRef225
Ali A. Rizvi. (2009) Cytokine Biomarkers, Endothelial Inflammation, and Atherosclerosis in the Metabolic Syndrome: Emerging Concepts. The American Journal of the Medical Sciences 338:4, 310-318
CrossRef226
Nitin Mahajan, Namita Malik, Ajay Bahl, Yashpaul Sharma, Veena Dhawan. (2009) Correlation among soluble markers and severity of disease in non-diabetic subjects with pre-mature coronary artery disease. Molecular and Cellular Biochemistry 330:1-2, 201-209
CrossRef227
Giuseppe Marano, Desiree Harnic, Marzia Lotrionte, Giuseppe Biondi-Zoccai, Antonio Abbate, Enrico Romagnoli, Marianna Mazza. (2009) Depression and the cardiovascular system: increasing evidence of a link and therapeutic implications. Expert Review of Cardiovascular Therapy 7:9, 1123-1147
CrossRef228
Shuumarjav Uurtuya, Kazuhiko Kotani, Nobuyuki Taniguchi, Hiroaki Matsunaga, Hiroshi Kanai, Hideyuki Hasegawa, Kazuomi Kario, Shun Ishibashi, Kouichi Itoh. (2009) Relationship between upper limb peripheral artery stiffness using the radial artery and atherosclerotic parameters. Journal of Medical Ultrasonics 36:3, 129-135
CrossRef229
M LINTON, S FAZIO. (2009) Cyclooxygenase products and atherosclerosis. Drug Discovery Today: Therapeutic Strategies 5:1, 25-36
CrossRef230
Francisco AH Fonseca, Maria Cristina O Izar. (2009) Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study. Expert Review of Cardiovascular Therapy 7:9, 1041-1056
CrossRef231
Scott Mintzer, Richard T. Mattson. (2009) Should enzyme-inducing antiepileptic drugs be considered first-line agents?. Epilepsia 50, 42-50
CrossRef232
Gabriel Izbicki, Itsik Ben-Dor, David Shitrit, Danielle Bendayan, Thomas K. Aldrich, Ran Kornowski, Mordechai R. Kramer. (2009) The prevalence of coronary artery disease in end-stage pulmonary disease: Is pulmonary fibrosis a risk factor?. Respiratory Medicine 103:9, 1346-1349
CrossRef233
Sebastián Hernández, Magdalena Vidal, Enric Pedrol. (2009) Evaluación del riesgo cardiovascular e intervención en los pacientes con VIH. Enfermedades Infecciosas y Microbiología Clínica 27, 40-47
CrossRef234
Peter P. Toth. (2009) Statin therapy, inflammation, and risk for cardiovascular events: The light from JUPITER is illuminating. Current Atherosclerosis Reports 11:5, 323-325
CrossRef235
Udaya S. Tantry, Elisabeth Mahla, Paul A. Gurbel. (2009) Aspirin Resistance. Progress in Cardiovascular Diseases 52:2, 141-152
CrossRef236
Abayomi O. Akanji, Jude U. Ohaeri, Suhail Al-Shammri, Hasmukh R. Fatania. (2009) Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients. Psychiatry Research 169:1, 56-61
CrossRef237
Maqsood M. Elahi, Felino R. Cagampang, Dhea Mukhtar, Frederick W. Anthony, Sunil K. Ohri, Mark A. Hanson. (2009) Long-term maternal high-fat feeding from weaning through pregnancy and lactation predisposes offspring to hypertension, raised plasma lipids and fatty liver in mice. British Journal of Nutrition 102:04, 514
CrossRef238
Robin Vos, Bart M. Vanaudenaerde, Stéphanie I. De Vleeschauwer, Anna Willems-Widyastuti, Hans Scheers, Dirk E. Van Raemdonck, Lieven J. Dupont, Geert M. Verleden. (2009) Circulating and Intrapulmonary C-Reactive Protein: A Predictor of Bronchiolitis Obliterans Syndrome and Pulmonary Allograft Outcome. The Journal of Heart and Lung Transplantation 28:8, 799-807
CrossRef239
Louai Razzouk, Paul Muntner, Sameer Bansilal, Annapoorna S. Kini, Ashish Aneja, Joshua Mozes, Oana Ivan, Madhavi Jakkula, Samin Sharma, Michael E. Farkouh. (2009) C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention. American Heart Journal 158:2, 277-283
CrossRef240
Hisao Ogawa, Sunao Kojima. (2009) Modern state of acute myocardial infarction in the interventional era: Observational case–control study—Japanese acute coronary syndrome study (JACSS). Journal of Cardiology 54:1, 1-9
CrossRef241
E. GRAD, M. GOLOMB, N. KOROUKHOV, J. A. LAWSON, C. LOTAN, G. A. FITZGERALD, H. D. DANENBERG. (2009) Aspirin reduces the prothrombotic activity of C-reactive protein. Journal of Thrombosis and Haemostasis 7:8, 1393-1400
CrossRef242
M. Odette Gore, Darren K. McGuire. (2009) Cardiovascular disease and type 2 diabetes mellitus: Regulating glucose and regulating drugs. Current Cardiology Reports 11:4, 258-263
CrossRef243
Nauder Faraday, Lisa R. Yanek, Dhananjay Vaidya, Brian Kral, Rehan Qayyum, J. Enrique Herrera-Galeano, Taryn F. Moy, Diane M. Becker, Lewis C. Becker. (2009) Leukocyte count is associated with increased platelet reactivity and diminished response to aspirin in healthy individuals with a family history of coronary artery disease. Thrombosis Research 124:3, 311-317
CrossRef244
Erdembileg Anuurad, Russell P. Tracy, Thomas A. Pearson, Kyoungmi Kim, Lars Berglund. (2009) Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians. Atherosclerosis 205:1, 290-295
CrossRef245
Xiao-Ming Mao, Hao Liu, Xiao-Jun Tao, Guo-Ping Yin, Qian Li, Shu-Kui Wang. (2009) Independent anti-inflammatory effect of insulin in newly diagnosed type 2 diabetes. Diabetes/Metabolism Research and Reviews 25:5, 435-441
CrossRef246
Jennifer E. Phillips, Anna L. Marsland, Janine D. Flory, Matthew F. Muldoon, Sheldon Cohen, Stephen B. Manuck. (2009) Parental education is related to C-reactive protein among female middle aged community volunteers. Brain, Behavior, and Immunity 23:5, 677-683
CrossRef247
James K. Liao. (2009) Genetically elevated C-reactive protein and ischemic vascular disease. Current Atherosclerosis Reports 11:4, 245-245
CrossRef248
Tibor Fulop, Andrew D. Rule, Darren W. Schmidt, Heather J. Wiste, Kent R. Bailey, Iftikhar J. Kullo, Gary L. Schwartz, Thomas H. Mosley, Eric Boerwinkle, Stephen T. Turner. (2009) C-reactive protein among community-dwelling hypertensives on single-agent antihypertensive treatment. Journal of the American Society of Hypertension 3:4, 260-266
CrossRef249
Paul M. Ridker. (2009) Moving toward new statin guidelines in a post-JUPITER world: Principles to consider. Current Atherosclerosis Reports 11:4, 249-256
CrossRef250
James K. Liao. (2009) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. Current Atherosclerosis Reports 11:4, 243-244
CrossRef251
Guido Lastra, Adam Whaley-Connell. (2009) Diabetes: Aspirin and prevention of diabetes still a topic of debate. Nature Reviews Endocrinology 5:7, 365-366
CrossRef252
Cédric Delhaye, Arnaud Sudre, Gilles Lemesle, Sylvestre Maréchaux, Damien Broucqsault, Bernadette Hennache, Christophe Bauters, Jean-Marc Lablanche. (2009) Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention. Cardiovascular Revascularization Medicine 10:3, 144-150
CrossRef253
Vincent E. Friedewald, Kenneth S. Kornman, James D. Beck, Robert Genco, Allison Goldfine, Peter Libby, Steven Offenbacher, Paul M. Ridker, Thomas E. Van Dyke, William C. Roberts. (2009) The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease ♦. Journal of Periodontology 80:7, 1021-1032
CrossRef254
Jeffrey M Bloom. (2009) Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial. The Lancet 374:9683, 25-26
CrossRef255
Virginia A Triant, James B Meigs, Steven K Grinspoon. (2009) Association of C-Reactive Protein and HIV Infection With Acute Myocardial Infarction. JAIDS Journal of Acquired Immune Deficiency Syndromes 51:3, 268-273
CrossRef256
Takako Nakajima, Kazuhisa Yamazaki. (2009) Periodontal disease and risk of atherosclerotic coronary heart disease. Odontology 97:2, 84-91
CrossRef257
Kai M. Eggers, Bo Lagerqvist, Per Venge, Lars Wallentin, Bertil Lindahl. (2009) Prognostic Value of Biomarkers During and After Non–ST-Segment Elevation Acute Coronary Syndrome. Journal of the American College of Cardiology 54:4, 357-364
CrossRef258
Vincent E. Friedewald, Kenneth S. Kornman, James D. Beck, Robert Genco, Allison Goldfine, Peter Libby, Steven Offenbacher, Paul M. Ridker, Thomas E. Van Dyke, William C. Roberts. (2009) The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease. The American Journal of Cardiology 104:1, 59-68
CrossRef259
Michael A. Zimmerman, Sonia C. Flores. (2009) Autoimmune-Mediated Oxidative Stress and Endothelial Dysfunction: Implications of Accelerated Vascular Injury in Type I Diabetes. Journal of Surgical Research 155:1, 173-178
CrossRef260
PAUL M. RIDKER. (2009) Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT). Journal of Thrombosis and Haemostasis 7, 332-339
CrossRef261
Priscilla Y Hsue, Peter W Hunt, Amanda Schnell, S Craig Kalapus, Rebecca Hoh, Peter Ganz, Jeffrey N Martin, Steven G Deeks. (2009) Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS 23:9, 1059-1067
CrossRef262
Ming-Sheng Teng, Lung-An Hsu, Semon Wu, Hsien-Hsun Chang, Hsin-Hua Chou, Yu-Lin Ko. (2009) Association between C-reactive protein gene haplotypes and C-reactive protein levels in Taiwanese: Interaction with obesity. Atherosclerosis 204:2, e64-e69
CrossRef263
Sunna Snaedal, Olof Heimbürger, Abdul Rashid Qureshi, Anders Danielsson, Björn Wikström, Bengt Fellström, Ingela Fehrman-Ekholm, Juan Jesús Carrero, Anders Alvestrand, Peter Stenvinkel, Peter Bárány. (2009) Comorbidity and Acute Clinical Events as Determinants of C-Reactive Protein Variation in Hemodialysis Patients: Implications for Patient Survival. American Journal of Kidney Diseases 53:6, 1024-1033
CrossRef264
Alberto Dominguez-Rodriguez, Sima Samimi Fard, Pedro Abreu-Gonzalez, Francisco Bosa-Ojeda, Luciano Consuegra-Sanchez, Alejandro Jiménez-Sosa, Alejandro Sánchez Grande, Juan Carlos Kaski. (2009) Randomised, Double-Blind, Placebo-Controlled Trial of Ivabradine in Patients with Acute Coronary Syndrome: Effects of the I f Current Inhibitor Ivabradine on Reduction of Inflammation Markers in Patients with Acute Coronary Syndrome—RIVIERA Trial Study Design and Rationale. Cardiovascular Drugs and Therapy 23:3, 243-247
CrossRef265
Masafumi Koga, Hiroshi Saito, Mikio Mukai, Michio Otsuki, Soji Kasayama. (2009) Serum glycated albumin levels are influenced by smoking status, independent of plasma glucose levels. Acta Diabetologica 46:2, 141-144
CrossRef266
Paolo Calabrò, Enrica Golia, Edward T. H. Yeh. (2009) CRP and the risk of atherosclerotic events. Seminars in Immunopathology 31:1, 79-94
CrossRef267
Stefan Renvert, Christel Lindahl, Ann-Marie Roos-Jansåker, Jan Lessem. (2009) Short-Term Effects of an Anti-Inflammatory Treatment on Clinical Parameters and Serum Levels of C-Reactive Protein and Proinflammatory Cytokines in Subjects With Periodontitis. Journal of Periodontology 80:6, 892-900
CrossRef268
Chen-Chung Fu, Du-An Wu, Ji-hung Wang, Wen-Chin Yang, Chin-Hsiao Tseng. (2009) Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chinese type 2 diabetic patients. Acta Diabetologica 46:2, 127-134
CrossRef269
Viviane Z. Rocha, Peter Libby. (2009) Obesity, inflammation, and atherosclerosis. Nature Reviews Cardiology 6:6, 399-409
CrossRef270
Shinji Makita, Motoyuki Nakamura, Kenyu Satoh, Fumitaka Tanaka, Toshiyuki Onoda, Kazuko Kawamura, Masaki Ohsawa, Kozo Tanno, Kazuyoshi Itai, Kiyomi Sakata, Akira Okayama, Yasuo Terayama, Yuki Yoshida, Akira Ogawa. (2009) Serum C-reactive protein levels can be used to predict future ischemic stroke and mortality in Japanese men from the general population. Atherosclerosis 204:1, 234-238
CrossRef271
Kaoru Matsuura, Mizuho Imamaki, Atsushi Ishida, Hitoshi Shimura, Masaru Miyazaki. (2009) The effect of preoperative aspirin administration on postoperative level of von Willebrand factor in off-pump coronary artery bypass surgery. Heart and Vessels 24:3, 169-174
CrossRef272
Barry McDonnell, Stephen Hearty, Paul Leonard, Richard O'Kennedy. (2009) Cardiac biomarkers and the case for point-of-care testing. Clinical Biochemistry 42:7-8, 549-561
CrossRef273
Henrik Brun, Henrik Holmstrøm, Erik Thaulow, Jan Kristian Damås, Arne Yndestad, Pål Aukrust, Thor Ueland. (2009) Patients with Pulmonary Hypertension Related to Congenital Systemic-to-Pulmonary Shunts are Characterized by Inflammation Involving Endothelial Cell Activation and Platelet-mediated Inflammation. Congenital Heart Disease 4:3, 153-159
CrossRef274
Saori Yoshii, Shinji Tsuboi, Ichizo Morita, Yuko Takami, Keiko Adachi, Junko Inukai, Koji Inagaki, Kinichiro Mizuno, Haruo Nakagaki. (2009) Temporal Association of Elevated C-Reactive Protein and Periodontal Disease in Men. Journal of Periodontology 80:5, 734-739
CrossRef275
Dustin Goei, Sanne E. Hoeks, Eric Boersma, Tamara A. Winkel, Martin Dunkelgrun, Willem-Jan Flu, Olaf Schouten, Jeroen J. Bax, Don Poldermans. (2009) Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients. Coronary Artery Disease 20:3, 219-224
CrossRef276
Adam M. Rogers, Michael G. Shlipak. (2009) C-Reactive Protein, Statins, and Cardiovascular Risk: What Can JUPITER Teach Us?. American Journal of Kidney Diseases 53:5, 737-740
CrossRef277
W. C. Stephen, I. Janssen. (2009) Sarcopenic-obesity and cardiovascular disease risk in the elderly. The Journal of Nutrition, Health and Aging 13:5, 460-466
CrossRef278
Ori Rogowski, Itzhak Shapira, Arie Steinvil, Shlomo Berliner. (2009) Low-grade inflammation in individuals with the hypertriglyceridemic waist phenotype: Another feature of the atherogenic dysmetabolism. Metabolism 58:5, 661-667
CrossRef279
Glynn, Robert J., Danielson, Eleanor, Fonseca, Francisco A.H., Genest, Jacques, Gotto, Antonio M. Jr., Kastelein, John J.P., Koenig, Wolfgang, Libby, Peter, Lorenzatti, Alberto J., MacFadyen, Jean G., Nordestgaard, Børge G., Shepherd, James, Willerson, James T., Ridker, Paul M, . (2009) A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism. New England Journal of Medicine 360:18, 1851-1861
Full Text280
N Goldenberg-Cohen, Y Cohen, Y Monselise, I Eldar, R Axer-Siegel, D Weinberger, M Kramer. (2009) C-reactive protein levels do not correlate with retinal artery occlusion but with atherosclerosis. Eye 23:4, 785-790
CrossRef281
Mariana J. Kaplan. (2009) Management of cardiovascular disease risk in chronic inflammatory disorders. Nature Reviews Rheumatology 5:4, 208-217
CrossRef282
Yasuaki Hayashino, Charles H. Hennekens, Tobias Kurth. (2009) Aspirin Use and Risk of Type 2 Diabetes in Apparently Healthy Men. The American Journal of Medicine 122:4, 374-379
CrossRef283
A Belza, S Toubro, S Stender, A Astrup. (2009) Effect of diet-induced energy deficit and body fat reduction on high-sensitive CRP and other inflammatory markers in obese subjects. International Journal of Obesity 33:4, 456-464
CrossRef284
L. Karlsson, D. Bergqvist, J. Lindbäck, H. Pärsson. (2009) Expansion of Small-diameter Abdominal Aortic Aneurysms is Not Reflected by the Release of Inflammatory Mediators IL-6, MMP-9 and CRP in Plasma. European Journal of Vascular and Endovascular Surgery 37:4, 420-424
CrossRef285
Srinivas Iyengar, LeRoy E. Rabbani. (2009) Beyond platelet inhibition: potential pleiotropic effects of ADP-receptor antagonists. Journal of Thrombosis and Thrombolysis 27:3, 300-306
CrossRef286
Mariann Harangi, Peter Szodoray, György Paragh. (2009) Atherosclerosis: a complex interplay of inflammatory processes. Clinical Lipidology 4:2, 167-187
CrossRef287
Chun-Yan Zhang, Liang-Jing Lu, Feng-Hua Li, Hong-Li Li, Yue-Ying Gu, Shun-le Chen, Chun-De Bao. (2009) Evaluation of Risk Factors That Contribute to High Prevalence of Premature Atherosclerosis in Chinese Premenopausal Systemic Lupus Erythematosus Patients. JCR: Journal of Clinical Rheumatology 15:3, 111-116
CrossRef288
Dean G. Karalis. (2009) Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease. Mayo Clinic Proceedings 84:4, 345-352
CrossRef289
D. G. Karalis. (2009) Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease. Mayo Clinic Proceedings 84:4, 345-352
CrossRef290
Fadi G. Hage, Alexander J. Szalai. (2009) The role of C-reactive protein polymorphisms in inflammation and cardiovascular risk. Current Atherosclerosis Reports 11:2, 124-130
CrossRef291
Jiangtao Yan, Rutai Hui, Daowen Wang. (2009) Elevated C-reactive protein levels predict worsening prognosis in Chinese patients with first-onset stroke. Frontiers of Medicine in China 3:1, 30-35
CrossRef292
Hyun-Chul Kim, Soo-Keun Lee, Seung Woo Lee, Sang Won Jeong. (2009) A reactive polythiophene for protein immobilization. Polymers for Advanced Technologies 20:3, 298-302
CrossRef293
Karina W. Davidson, Joseph E. Schwartz, Susan A. Kirkland, Elizabeth Mostofsky, Daniel Fink, Duane Guernsey, Daichi Shimbo. (2009) Relation of Inflammation to Depression and Incident Coronary Heart Disease (from the Canadian Nova Scotia Health Survey [NSHS95] Prospective Population Study). The American Journal of Cardiology 103:6, 755-761
CrossRef294
C.-Y. Chou, H.-L. Kuo, H.-H. Lin, J. S. Liu, Y.-L. Liu, C.-C. Huang. (2009) C-reactive protein predicts ischaemic stroke in haemodialysis patients. International Journal of Clinical Practice 63:2, 243-248
CrossRef295
Matteo Cesari, Stephen B. Kritchevsky, Hal H. Atkinson, Brenda W. Penninx, Mauro Di Bari, Russell P. Tracy, Marco Pahor. (2009) Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers. American Heart Journal 157:2, 334.e1-334.e8
CrossRef296
Sa Rah Yoon, Oh Young Bang, Ji Man Hong, Wen Yu Li, Phil Hyu Lee, Bruce Ovbiagele. (2009) Non-conventional risk factors were associated with infarct patterns in ischemic stroke. Clinical Neurology and Neurosurgery 111:2, 134-139
CrossRef297
K REIFENBERG, H LEHR, J FAN, T KOIKE, E WIESE, I KUPPER, T SAGBAN, S SCHAEFER, U ZAHRINGER, M TORZEWSKI. (2009) Endotoxin accelerates atherosclerosis independent of complement activation. Thrombosis Research 123:4, 653-658
CrossRef298
JOSEPH E. DONNELLY, STEVEN N. BLAIR, JOHN M. JAKICIC, MELINDA M. MANORE, JANET W. RANKIN, BRYAN K. SMITH. (2009) Appropriate Physical Activity Intervention Strategies for Weight Loss and Prevention of Weight Regain for Adults. Medicine & Science in Sports & Exercise 41:2, 459-471
CrossRef299
Qiu-Li Zhang, Wolfgang Koenig, Elke Raum, Christa Stegmaier, Hermann Brenner, Dietrich Rothenbacher. (2009) Epidemiology of chronic kidney disease: Results from a population of older adults in Germany. Preventive Medicine 48:2, 122-127
CrossRef300
Karen E MacKenzie, Esko J Wiltshire, Alexia S Peña, Roger Gent, Craig Hirte, Lino Piotto, Jennifer J Couper. (2009) Hs-CRP is associated with weight, BMI, and female sex but not with endothelial function in children with type 1 diabetes. Pediatric Diabetes 10:1, 44-51
CrossRef301
Shu-Yuan Yao, Jian-Min Chu, Ke-Ping Chen, Min Tang, Pi-Hua Fang, Fang-Zheng Wang, Shu Zhang. (2009) Inflammation in Lone Atrial Fibrillation. Clinical Cardiology 32:2, 94-98
CrossRef302
S. I. VAN LEUVEN, R. S. BIRJMOHUN, R. FRANSSEN, R. J. BISOENDIAL, H. DE KORT, J. H. M. LEVELS, R. L. BASSER, J. C. M. MEIJERS, J. A. KUIVENHOVEN, J. J. KASTELEIN, E. S. STROES. (2009) ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humans. Journal of Thrombosis and Haemostasis 7:2, 347-354
CrossRef303
Erdembileg Anuurad, Russell P. Tracy, Thomas A. Pearson, Laurel Beckett, Lars Berglund. (2009) Comparison of C-Reactive Protein and Metabolic Syndrome as Cardiovascular Risk Factors in African-Americans and European-Americans. The American Journal of Cardiology 103:4, 523-527
CrossRef304
Milind Y Desai, Paul Schoenhagen. (2009) Emergence of targeted molecular imaging in atherosclerotic cardiovascular disease. Expert Review of Cardiovascular Therapy 7:2, 197-204
CrossRef305
Csaba P. Kovesdy, Kamyar Kalantar-Zadeh. (2009) Why Is Protein–Energy Wasting Associated With Mortality in Chronic Kidney Disease?. Seminars in Nephrology 29:1, 3-14
CrossRef306
Zorica Caparevic, Nada Kostic, Sanja Ilic, Jana Radojkovic, Djordje Marina, Biljana Pencic, Ivan Radojkovic. (2009) Oxidized LDL and C-reactive protein level in relation to carotid intima-media thickness in population with risk factors for atherosclerosis. Srpski arhiv za celokupno lekarstvo 137:3-4, 140-145
CrossRef307
Matthew L. Scherer, Thor Aspelund, Sigurdur Sigurdsson, Robert Detrano, Melissa Garcia, Gary F. Mitchell, Lenore J. Launer, Gudmundur Thorgeirsson, Vilmundur Gudnason, Tamara B. Harris. (2009) Abnormal T-wave axis is associated with coronary artery calcification in older adults. Scandinavian Cardiovascular Journal 43:4, 240-248
CrossRef308
Stephen A. Badger, Chee V. Soong, Mark E. O' Donnell, Caroline Mercer, Ian S. Young, Anne E. Hughes. (2009) C-reactive protein (CRP) elevation in patients with abdominal aortic aneurysm is independent of the most important CRP genetic polymorphism. Journal of Vascular Surgery 49:1, 178-184
CrossRef309
D.G. Federman, M. Shelling, S. Prodanovich, C.G. Gunderson, R.S. Kirsner. (2009) Psoriasis: an opportunity to identify cardiovascular risk. British Journal of Dermatology 160:1, 1-7
CrossRef310
Brendan M. Everett, Sandeep Bansal, Nader Rifai, Julie E. Buring, Paul M. Ridker. (2009) Interleukin-18 and the risk of future cardiovascular disease among initially healthy women. Atherosclerosis 202:1, 282-288
CrossRef311
René Krummenacher, Paul S. Lukas, Franziska Demarmels Biasiutti, Stefan Begré, Hansjörg Znoj, Roland Von Känel. (2009) Independent association of sleep quality, fatigue, and vital exhaustion with platelet count in patients with a previous venous thromboembolic event. Platelets 20:8, 566-574
CrossRef312
R VELANAVARRETE. (2009) Detecting Endothelial Dysfunction in Patients with Erectile Dysfunction: Are There Reliable Laboratory Markers?. European Urology Supplements 8:2, 67-70
CrossRef313
Hyo-Jin Lee, Sung-Ho Her, Yun-Sun Im, Kang-Yeon Won, Sun-Hong Yoo, Dong-Bin Kim, Dong-Il Shin, Pum-Joon Kim, Ki-Bae Seung, Jae-Hyung Kim, Keon-Yeop Kim. (2009) Significance of Inflammatory Markers in Diabetic Patients with Stable Coronary Artery Disease. The Korean Journal of Internal Medicine 24:3, 212
CrossRef314
Mina Suh, Joo Young Lee, Song Vogue Ahn, Hyeon Chang Kim, Il Suh. (2009) C-reactive Protein and Carotid Intima-media Thickness in a Population of Middle-aged Koreans. Journal of Preventive Medicine and Public Health 42:1, 29
CrossRef315
Adel A. Al-Hamdan, Rabba H. Al-Huthail, Mohamed A. Alsaif, Abdulaziz M. Al-Othman, May N. Al-Muammer, Saada M. Al-Orf, Abdallah A. Saeed, Badreldin A. Mohamed. (2009) The Effect of Weight Reduction Diet on C-Reactive Protein Level in Obese-Adult Subjects. Journal of Medical Sciences(Faisalabad) 9:1, 17-23
CrossRef316
S. Charriere, N. Rognant, F. Chiche, A. Cremer, G. Deray, M. Priou. (2009) Insuffisance rénale chronique et maladie cardiovasculaire. Annales de Cardiologie et d Angéiologie 58:1, 40
CrossRef317
Jessica R. Meendering, Britta N. Torgrimson, Nicole P. Miller, Paul F. Kaplan, Christopher T. Minson. (2009) Ethinyl estradiol-to-desogestrel ratio impacts endothelial function in young women. Contraception 79:1, 41-49
CrossRef318
Jens Minnerup, Wolf-Rüdiger Schäbitz. (2009) Multifunctional actions of approved and candidate stroke drugs. Neurotherapeutics 6:1, 43-52
CrossRef319
J. Antonio Aviña-Zubieta, Hyon K. Choi, Mohsen Sadatsafavi, Mahyar Etminan, John M. Esdaile, Diane Lacaille. (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies. Arthritis & Rheumatism 59:12, 1690-1697
CrossRef320
Christopher S. Vaccari, Syed T. Rahman, Qamar A. Khan, Faiz A. Cheema, Bobby V. Khan. (2008) Effects of Angiotensin-Converting Enzyme Inhibitor Therapy on Levels of Inflammatory Markers in Response to Exercise-Induced Stress: Studies in the Metabolic Syndrome. Journal of the CardioMetabolic Syndrome 3:1, 12-17
CrossRef321
E. J. Giltay, A. Haider, F. Saad, L. J. Gooren. (2008) C-reactive protein levels and ageing male symptoms in hypogonadal men treated with testosterone supplementation. Andrologia 40:6, 398-400
CrossRef322
N C Ogston, K Karastergiou, M J Hosseinzadeh-Attar, R Bhome, R Madani, M Stables, D Gilroy, P Flachs, M Hensler, J Kopecky, V Mohamed-Ali. (2008) Low-dose acetylsalicylic acid inhibits the secretion of interleukin-6 from white adipose tissue. International Journal of Obesity 32:12, 1807-1815
CrossRef323
Juey-Jen Hwang, Hung-Yuan Li, Gow-Jen Shieh, Yu-Fen Chien, Cyue-Huei Hua, Jou-Wei Lin. (2008) Illustrating the roles of C-reactive protein in the development of the metabolic syndrome in women – a cross-racial validation. Nutrition, Metabolism and Cardiovascular Diseases 18:10, 671-677
CrossRef324
David Goteiner, Ronald G. Craig, Robert Ashmen, Malvin N. Janal, Barnet Eskin, Neal Lehrman. (2008) Endotoxin Levels Are Associated With High-Density Lipoprotein, Triglycerides, and Troponin in Patients With Acute Coronary Syndrome and Angina: Possible Contributions From Periodontal Sources. Journal of Periodontology 79:12, 2331-2339
CrossRef325
F. Montecucco, F. Mach. (2008) Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology 48:1, 11-22
CrossRef326
Ridker, Paul M, Danielson, Eleanor, Fonseca, Francisco A.H., Genest, Jacques, Gotto, Antonio M. Jr., Kastelein, John J.P., Koenig, Wolfgang, Libby, Peter, Lorenzatti, Alberto J., MacFadyen, Jean G., Nordestgaard, Børge G., Shepherd, James, Willerson, James T., Glynn, Robert J., . (2008) Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. New England Journal of Medicine 359:21, 2195-2207
Full Text327
I LOFTUS, M THOMPSON. (2008) Plaque Biology: Interesting Science or Pharmacological Treasure Trove?. European Journal of Vascular and Endovascular Surgery 36:5, 507-516
CrossRef328
A Yamashita, Y Soga, Y Iwamoto, T Asano, Y Li, Y Abiko, F Nishimura. (2008) DNA microarray analyses of genes expressed differentially in 3T3-L1 adipocytes co-cultured with murine macrophage cell line RAW264.7 in the presence of the toll-like receptor 4 ligand bacterial endotoxin. International Journal of Obesity 32:11, 1725-1729
CrossRef329
Robert Y.L. Zee, Hooman Hennessey, Sherri E. Michaud, Paul M. Ridker. (2008) Genetic variants within the interleukin-1 gene cluster, and risk of incident myocardial infarction, and ischemic stroke: A nested case-control approach. Atherosclerosis 201:1, 124-129
CrossRef330
Yasmin S. Hamirani, Shivda Pandey, Juan J. Rivera, Chiadi Ndumele, Matthew J. Budoff, Roger S. Blumenthal, Khurram Nasir. (2008) Markers of inflammation and coronary artery calcification: A systematic review. Atherosclerosis 201:1, 1-7
CrossRef331
Vivek Sailam, Dean G. Karalis, Ashish Agarwal, Firas Alani, Susan Galardi, Veronica Covalesky, Christian Athanassious. (2008) Prevalence of Emerging Cardiovascular Risk Factors in Younger Individuals with a Family History of Premature Coronary Heart Disease and Low Framingham Risk Score. Clinical Cardiology 31:11, 542-545
CrossRef332
B. Galarraga, F. Khan, P. Kumar, T. Pullar, J. J. F. Belch. (2008) C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis. Rheumatology 47:12, 1780-1784
CrossRef333
K MAKIPETAJA, J CHERIYAN, A BOOTH, F HALL, J BROWN, S WALLACE, M ASHBY, C MCENIERY, I WILKINSON. (2008) Inducible nitric oxide synthase activity is increased in patients with rheumatoid arthritis and contributes to endothelial dysfunction
CrossRef334
Stamatios Lerakis, Andreas Synetos, Konstantinos Toutouzas, Manolis Vavuranakis, Eleftherios Tsiamis, Chistodoulos Stefanadis. (2008) Imaging of the Vulnerable Plaque: Noninvasive and Invasive Techniques. The American Journal of the Medical Sciences 336:4, 342-348
CrossRef335
Salim S. Virani, Christie M. Ballantyne. (2008) How to identify patients with vulnerable plaques. Diabetes, Obesity and Metabolism 10:10, 824-833
CrossRef336
Jessica R. Swoboda, H. Asuman Kiyak, Richard Darveau, G. Rutger Persson. (2008) Correlates of Periodontal Decline and Biologic Markers in Older Adults. Journal of Periodontology 79:10, 1920-1926
CrossRef337
Karin F. Hoth, Andreana P. Haley, John Gunstad, Robert H. Paul, Athena Poppas, Angela L. Jefferson, David F. Tate, Makoto Ono, Beth A. Jerskey, Ronald A. Cohen. (2008) Elevated C-Reactive Protein Is Related to Cognitive Decline in Older Adults with Cardiovascular Disease. Journal of the American Geriatrics Society 56:10, 1898-1903
CrossRef338
Ervin R. Fox, Emelia J. Benjamin, Daniel F. Sarpong, Charles N. Rotimi, James G. Wilson, Michael W. Steffes, Guanjie Chen, Adebowale Adeyemo, Jason K. Taylor, Tandaw E. Samdarshi, Herman A. Taylor. (2008) Epidemiology, Heritability, and Genetic Linkage of C-Reactive Protein in African Americans (from the Jackson Heart Study). The American Journal of Cardiology 102:7, 835-841
CrossRef339
Arman S. Postadzhiyan, Anna V. Tzontcheva, Ivan Kehajov, Stanimir Kyurkchiev, Margarita D. Apostolova, Bojidar Finkov. (2008) Effect of Conventional and More Aggressive Rosuvastatin Treatment on Markers of Endothelial Activation. Journal of Medical Biochemistry 27:4, 432-438
CrossRef340
Kiran Musunuru, Brian G Kral, Roger S Blumenthal, Valentin Fuster, Catherine Y Campbell, Ty J Gluckman, Richard A Lange, Eric J Topol, James T Willerson, Milind Y Desai, Michael H Davidson, Samia Mora. (2008) The use of high-sensitivity assays for C-reactive protein in clinical practice. Nature Clinical Practice Cardiovascular Medicine 5:10, 621-635
CrossRef341
J. P. Casas, T. Shah, A. D. Hingorani, J. Danesh, M. B. Pepys. (2008) C-reactive protein and coronary heart disease: a critical review. Journal of Internal Medicine 264:4, 295-314
CrossRef342
Mohammad Tauseef, Mohd. Shahid, Krishna K. Sharma, Mohammad Fahim. (2008) Antioxidative Action of Aspirin on Endothelial Function in Hypercholesterolaemic Rats. Basic & Clinical Pharmacology & Toxicology 103:4, 314-321
CrossRef343
R LAMPERT, J BREMNER, S SU, A MILLER, F LEE, F CHEEMA, J GOLDBERG, V VACCARINO. (2008) Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. American Heart Journal 156:4, 759.e1-759.e7
CrossRef344
A SABINO, M DEOLIVEIRASOUSA, L LIMA, D RIBEIRO, L DUSSE, M CARVALHO, A FERNANDES. (2008) ApoB/ApoA-I ratio in young patients with ischemic cerebral stroke or peripheral arterial disease. Translational Research 152:3, 113-118
CrossRef345
H KIM, S LEE, W JEON, H LYU, S LEE, S JEONG. (2008) Detection of C-reactive protein on a functional poly(thiophene) self-assembled monolayer using surface plasmon resonance. Ultramicroscopy 108:10, 1379-1383
CrossRef346
Kerstyn C. Zalesin, Barry A. Franklin, Wendy M. Miller, Eric D. Peterson, Peter A. McCullough. (2008) Impact of Obesity on Cardiovascular Disease. Endocrinology & Metabolism Clinics of North America 37:3, 663-684
CrossRef347
Ankur Gupta, Dinesh K. Badyal, Prem P. Khosla, Bharti Uppal, Thannikot M. Jaison, Sandeep Chopra. (2008) Effect of atorvastatin on hs-CRP in acute coronary syndrome. British Journal of Clinical Pharmacology 66:3, 411-413
CrossRef348
Serap Semiz, Simin Rota, Özmert Özdemir, Ayşegül Özdemir, Bünyamin Kaptanoğlu. (2008) Are C-reactive protein and homocysteine cardiovascular risk factors in obese children and adolescents?. Pediatrics International 50:4, 419-423
CrossRef349
Paul M Ridker, Josh D Silvertown. (2008) Inflammation, C-Reactive Protein, and Atherothrombosis. Journal of Periodontology 79:8s, 1544-1551
CrossRef350
M. M. C. Hovens, J. D. Snoep, Y. Groeneveld, M. Frlich, J. T. Tamsma, M. V. Huisman. (2008) Effects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial. Diabetes, Obesity and Metabolism 10:8, 668-674
CrossRef351
(2008) Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by Mendelian randomisation. European Journal of Epidemiology 23:8, 531-540
CrossRef352
Stephen P. Glasser, Mary Cushman, Ronald Prineas, Dawn Kleindorfer, Valerie Prince, Zhiying You, Virginia J. Howard, George Howard. (2008) Does differential prophylactic aspirin use contribute to racial and geographic disparities in stroke and coronary heart disease (CHD)?. Preventive Medicine 47:2, 161-166
CrossRef353
E. Reyna-Villasmil, J. Mejía, N. Reyna-Villasmil, D. Torres, E. Peña, M. Colmenares, O. Delgado, J. Santos. (2008) Efecto de diosgenina sobre la proteína C reactiva y homocisteína en pacientes menopáusicas. Clínica e Investigación en Ginecología y Obstetricia 35:4, 120-125
CrossRef354
Thomas E. Van Dyke, Kenneth S. Kornman. (2008) Inflammation and Factors That May Regulate Inflammatory Response. Journal of Periodontology 79:8s, 1503-1507
CrossRef355
Hedley C. A. Emsley, Craig J. Smith, Pippa J. Tyrrell, Stephen J. Hopkins. (2008) Inflammation in Acute Ischemic Stroke and its Relevance to Stroke Critical Care. Neurocritical Care 9:1, 125-138
CrossRef356
(2008) Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia. New England Journal of Medicine 359:5, 529-533
Full Text357
Wingman Leung, Cangel Puiyee Chan, Timothy H. Rainer, Margaret Ip, George W.H. Cautherley, Reinhard Renneberg. (2008) InfectCheck CRP barcode-style lateral flow assay for semi-quantitative detection of C-reactive protein in distinguishing between bacterial and viral infections. Journal of Immunological Methods 336:1, 30-36
CrossRef358
Barbora de Courten, Melissa N Barber, Renea V Johnston, Danny Liew, Maximilian de Courten, Sharon van Doornum, Christopher Reid, Rachelle Buchbinder, Melissa N Barber. 2008. Hypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritis. .
CrossRef359
Li Wei, Tom Fahey, Thomas M. MacDonald. (2008) Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10-year follow-up of outcome. British Journal of Clinical Pharmacology 66:1, 110-116
CrossRef360
G. Morris-Stiff, D. Gomez, K.R. Prasad. (2008) C-reactive protein in liver cancer surgery. European Journal of Surgical Oncology (EJSO) 34:7, 727-729
CrossRef361
Shun-An Lee, Hsiu-Ting Tsai, Hsiu-Chung Ou, Chih-Ping Han, Yi-Torng Tee, Yi-Chen Chen, Ming-Tsang Wu, Ming-Chin Chou, Po-Hui Wang, Shun-Fa Yang. (2008) Plasma interleukin-1β, -6, -8 and tumor necrosis factor-α as highly informative markers of pelvic inflammatory disease. Clinical Chemistry and Laboratory Medicine 46:7, 997-1003
CrossRef362
Yu Asanuma, Annette Oeser, Eran Stanley, David G. Bailey, Ayumi Shintani, C. Michael Stein. (2008) Effects of C-reactive Protein and Homocysteine on Cytokine Production: Modulation by Pravastatin. Archives of Drug Information 1:1, 14-22
CrossRef363
M FISHER, M CUSHMAN, V KNAPPERTZ, G HOWARD. (2008) An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration
CrossRef364
Kiat Tsong Tan, Gregory Y.H. Lip. (2008) Imaging of the unstable plaque. International Journal of Cardiology 127:2, 157-165
CrossRef365
Efstrathios Karagiannis, Andreas Pfützner, Thomas Forst, Georg Lübben, Werner Roth, Martin Grabellus, Manja Flannery, Thomas Schöndorf. (2008) The IRIS V Study: Pioglitazone Improves Systemic Chronic Inflammation in Patients with Type 2 Diabetes Under Daily Routine Conditions. Diabetes Technology & Therapeutics 10:3, 206-212
CrossRef366
Francesco Cairo, Sergio Castellani, Anna Maria Gori, Michele Nieri, Giorgia Baldelli, Rosanna Abbate, Giovan Paolo Pini-Prato. (2008) Severe periodontitis in young adults is associated with sub-clinical atherosclerosis. Journal of Clinical Periodontology 35:6, 465-472
CrossRef367
Eswar Krishnan. (2008) Gout and coronary artery disease: Epidemiologic clues. Current Rheumatology Reports 10:3, 249-255
CrossRef368
M KOMPOTI, S DRIMIS, A PAPADAKI, K KOTSOMYTIS, C POULOPOULOU, D GIANNELI, D VOUTSINAS. (2008) Serum C-reactive protein at admission predicts in-hospital mortality in medical patients. European Journal of Internal Medicine 19:4, 261-265
CrossRef369
Manuel Rodríguez-Yáñez, José Castillo. (2008) Role of inflammatory markers in brain ischemia. Current Opinion in Neurology 21:3, 353-357
CrossRef370
A. L. EILERTSEN, L. SANDVIK, B. STEINSVIK, P. M. SANDSET. (2008) Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers. Journal of Thrombosis and Haemostasis 6:6, 928-934
CrossRef371
Jordi Ferri, Sergio Martínez-Hervás, Olga Espinosa, Marta Fandos, Teresa Pedro, José Tomás Real, Felipe Javier Chaves, Concha Cerdá, Guillermo Sáez, Juan Francisco Ascaso. (2008) Estudio de los valores de 8-oxo-7,8-dihidro-2’-desoxiguanosina como marcador de estrés oxidativo del ADN en pacientes con hiperlipemia familiar combinada. Medicina Clínica 131:1, 1-4
CrossRef372
S. Le Jeune, M.-A. Pistorius, B. Planchon, P. Pottier. (2008) Risque thromboembolique veineux au cours des affections médicales aiguës. Partie 1 : modèles pathogéniques fondamentaux et cliniques, épidémiologie descriptive et analytique. La Revue de Médecine Interne 29:6, 452-461
CrossRef373
Armen Yuri Gasparyan, Timothy Watson, Gregory Y.H. Lip. (2008) The Role of Aspirin in Cardiovascular Prevention. Journal of the American College of Cardiology 51:19, 1829-1843
CrossRef374
Ko-ichi Kawahara, Kamal Krishna Biswas, Masako Unoshima, Takashi Ito, Kiyoshi Kikuchi, Yoko Morimoto, Masahiro Iwata, Salunya Tancharoen, Yoko Oyama, Kazunori Takenouchi, Yuko Nawa, Noboru Arimura, Meng Xiao Jie, Binita Shrestha, Naoki Miura, Toshiaki Shimizu, Kentaro Mera, Shin-ichiro Arimura, Noboru Taniguchi, Hideo Iwasaka, Sonshin Takao, Teruto Hashiguchi, Ikuro Maruyama. (2008) C-reactive protein induces high-mobility group box-1 protein release through activation of p38MAPK in macrophage RAW264.7 cells. Cardiovascular Pathology 17:3, 129-138
CrossRef375
A JENKINS, M ROTHEN, R KLEIN, K MOLLER, L ELDRIDGE, D ZHENG, R DURAZOARVIZU, D MCGEE, D LACKLAND, S THORPE. (2008) Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort. Journal of Diabetes and its Complications 22:3, 153-163
CrossRef376
Po-Hsun Huang, Tse-Min Lu, Tao-Cheng Wu, Feng-Yen Lin, Yung-Hsiang Chen, Jaw-Wen Chen, Shing-Jong Lin. (2008) Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease. Coronary Artery Disease 19:3, 187-193
CrossRef377
Bernard Abi-Saleh, Said B. Iskandar, Nader Elgharib, Michael V. Cohen. (2008) C-Reactive Protein: The Harbinger of Cardiovascular Diseases. Southern Medical Journal 101:5, 525-533
CrossRef378
Alexandra Schneider, Demosthenes Panagiotakos, Sally Picciotto, Klea Katsouyanni, Hannelore Löwel, Bénédicte Jacquemin, Timo Lanki, Massimo Stafoggia, Tom Bellander, Wolfgang Koenig, Annette Peters. (2008) Air Temperature and Inflammatory Responses in Myocardial Infarction Survivors. Epidemiology 19:3, 391-400
CrossRef379
Paul M. Ridker, Guillaume Pare, Alex Parker, Robert Y.L. Zee, Jacqueline S. Danik, Julie E. Buring, David Kwiatkowski, Nancy R. Cook, Joseph P. Miletich, Daniel I. Chasman. (2008) Loci Related to Metabolic-Syndrome Pathways Including LEPR,HNF1A, IL6R, and GCKR Associate with Plasma C-Reactive Protein: The Women's Genome Health Study. The American Journal of Human Genetics 82:5, 1185-1192
CrossRef380
Bernd Krüger, Carsten A. Böger, Bernd Schröppel, Stefan Farkas, Andreas A. Schnitzbauer, Ute Hoffmann, Aiman Obed, Barbara T. Murphy, Bernhard Banas, Bernhard K. Krämer. (2008) No effect of C-reactive protein (CRP) haplotypes on CRP levels and post-transplant morbidity and mortality in renal transplantation. Transplant International 21:5, 452-458
CrossRef381
Priit Kampus, Jaak Kals, Eve Unt, Kersti Zilmer, Jaan Eha, Rein Teesalu, Aivo Normak, Mihkel Zilmer. (2008) Association between arterial elasticity, C-reactive protein and maximal oxygen consumption in well-trained cadets during three days extreme physical load: a pilot study. Physiological Measurement 29:4, 429-437
CrossRef382
Bernard M.Y. Cheung, Kwok Leung Ong, Roberta V. Cheung, Louisa Y.F. Wong, Nelson M.S. Wat, Sidney Tam, Gabriel M. Leung, Chun Ho Cheng, Jean Woo, Edward D. Janus, Chu Pak Lau, Tai Hing Lam, Karen S.L. Lam. (2008) Association between plasma alkaline phosphatase and C-reactive protein in Hong Kong Chinese. Clinical Chemistry and Laboratory Medicine 46:4, 523-527
CrossRef383
Salim S. Virani, Venkateshwar R. Polsani, Vijay Nambi. (2008) Novel markers of inflammation in atherosclerosis. Current Atherosclerosis Reports 10:2, 164-170
CrossRef384
Kayoung Lee, Yun-Mi Song, Joohon Sung. (2008) Which Obesity Indicators Are Better Predictors of Metabolic Risk?: Healthy Twin Study. Obesity 16:4, 834-840
CrossRef385
Hidenori Nishida, Takeshi Horio, Yoshihiko Suzuki, Yoshio Iwashima, Kei Kamide, Kenji Kangawa, Yuhei Kawano. (2008) Plasma adrenomedullin as an independent predictor of future cardiovascular events in high-risk patients: Comparison with C-reactive protein and adiponectin. Peptides 29:4, 599-605
CrossRef386
Spiros Paraskevas, John D. Huizinga, Bruno G. Loos. (2008) A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. Journal of Clinical Periodontology 35:4, 277-290
CrossRef387
Leslie R. Morse, Kelly Stolzmann, Hiep P. Nguyen, Nitin B. Jain, Cara Zayac, David R. Gagnon, Carlos G. Tun, Eric Garshick. (2008) Association Between Mobility Mode and C-Reactive Protein Levels in Men With Chronic Spinal Cord Injury. Archives of Physical Medicine and Rehabilitation 89:4, 726-731
CrossRef388
J. De Haro, F. Acin, A. Lopez-Quintana, F.J. Medina, E. Martinez-Aguilar, A. Florez, J.R. March. (2008) Direct Association between C-reactive Protein Serum Levels and Endothelial Dysfunction in Patients with Claudication. European Journal of Vascular and Endovascular Surgery 35:4, 480-486
CrossRef389
Robert Y.L. Zee, Sherri E. Michaud, Kirsti A. Diehl, Daniel I. Chasman, Joseph Emmerich, Pascale Gaussem, Martine Aiach, Paul M. Ridker. (2008) Purinergic receptor P2Y, G-protein coupled, 12 gene variants and risk of incident ischemic stroke, myocardial infarction, and venous thromboembolism. Atherosclerosis 197:2, 694-699
CrossRef390
Adriana HUNG, Lara PUPIM, Chang YU, Ayumi SHINTANI, Edward SIEW, Carlos AYUS, Raymond M. HAKIM, Talat Alp IKIZLER. (2008) Determinants of C-reactive protein in chronic hemodialysis patients: Relevance of dialysis catheter utilization. Hemodialysis International 12:2, 236-243
CrossRef391
Lisa M. Mielniczuk, Marc A. Pfeffer, Eldrin F. Lewis, Michael A. Blazing, James A. de Lemos, Amy Shui, Satish Mohanavelu, Robert M. Califf, Eugene Braunwald. (2008) Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome. American Heart Journal 155:4, 725-731
CrossRef392
K. M. Eggers, L. Lind, H. Ahlstrom, T. Bjerner, C. Ebeling Barbier, A. Larsson, P. Venge, B. Lindahl. (2008) Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. European Heart Journal 29:18, 2252-2258
CrossRef393
A. ARCARI, F. ZITO, A. DI CASTELNUOVO, A. DE CURTIS, C. DIRCKX, J. ARNOUT, F. P. CAPPUCCIO, M. C. J. M. VAN DONGEN, M. DE LORGERIL, V. KROGH, A. SIANI, M. B. DONATI, G. DE GAETANO, L. IACOVIELLO, . (2008) C reactive protein and its determinants in healthy men and women from European regions at different risk of coronary disease: the IMMIDIET Project. Journal of Thrombosis and Haemostasis 6:3, 436-443
CrossRef394
William E. Boden, Prediman K. Shah, Vipul Gupta, E. Magnus Ohman. (2008) Contemporary Approach to the Diagnosis and Management of Non–ST-Segment Elevation Acute Coronary Syndromes. Progress in Cardiovascular Diseases 50:5, 311-351
CrossRef395
T. Forst, E. Karagiannis, G. Lübben, C. Hohberg, T. Schöndorf, G. Dikta, M. Drexler, M. Morcos, W. Dänschel, M. Borchert, A. Pfützner. (2008) Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease. Atherosclerosis 197:1, 311-317
CrossRef396
Jin Yang, Junhong Wang, Shushu Zhu, Xiangjian Chen, Hengfang Wu, Di Yang, Jinan Zhang. (2008) C-reactive protein augments hypoxia-induced apoptosis through mitochondrion-dependent pathway in cardiac myocytes. Molecular and Cellular Biochemistry 310:1-2, 215-226
CrossRef397
Kosmas I. Paraskevas. (2008) Statin treatment for rheumatoid arthritis: a promising novel indication. Clinical Rheumatology 27:3, 281-287
CrossRef398
Lisa R Tannock. (2008) Advances in the management of hyperlipidemia-induced atherosclerosis. Expert Review of Cardiovascular Therapy 6:3, 369-383
CrossRef399
Nicholas L. Mills, Simon D. Robinson, Paul H. B. Fokkens, Daan L. A. C. Leseman, Mark R. Miller, David Anderson, Evelyn J. Freney, Mathew R. Heal, Robert J. Donovan, Anders Blomberg, Thomas Sandström, William MacNee, Nicholas A. Boon, Ken Donaldson, David E. Newby, Flemming R. Cassee. (2008) Exposure to Concentrated Ambient Particles Does Not Affect Vascular Function in Patients with Coronary Heart Disease. Environmental Health Perspectives 116:6, 709-715
CrossRef400
Christophe Bauters, Nicolas Lamblin, Pascal de Groote. (2008) High-sensitivity C-reactive protein for risk stratification in patients with heart failure. American Heart Journal 155:2, e7
CrossRef401
José Pablo Werba, Fabrizio Veglia, Mauro Amato, Damiano Baldassarre, Paola Massironi, Pier Luigi Meroni, Piersandro Riboldi, Elena Tremoli, Marina Camera. (2008) Patients with a history of stable or unstable coronary heart disease have different acute phase responses to an inflammatory stimulus. Atherosclerosis 196:2, 835-840
CrossRef402
Altan Onat, Günay Can, Gülay Hergenç. (2008) Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. Metabolism 57:2, 207-214
CrossRef403
Stephen J Carp, Ann E Barr, Mary F Barbe. (2008) Serum biomarkers as signals for risk and severity of work-related musculoskeletal injury. Biomarkers in Medicine 2:1, 67-79
CrossRef404
M.W. Lorenz, C. Stephan, A. Harmjanz, S. Staszewski, A. Buehler, M. Bickel, S. von Kegler, D. Ruhkamp, H. Steinmetz, M. Sitzer. (2008) Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis 196:2, 720-726
CrossRef405
Anna Benrick, Pernilla Jirholt, Ingrid Wernstedt, Maria Gustafsson, Juergen Scheller, Anna-Lena Eriksson, Jan Borén, Thomas Hedner, Claes Ohlsson, Torleif Härd, Stefan Rose-John, John-Olov Jansson. (2008) A non-conservative polymorphism in the IL-6 signal transducer (IL6ST)/gp130 is associated with myocardial infarction in a hypertensive population. Regulatory Peptides 146:1-3, 189-196
CrossRef406
Bruce D. Lindsay. (2008) Are acute phase protein levels the link between atrial arrhythmias and inflammation?. Heart Rhythm 5:2, 222-223
CrossRef407
Tracey M. Farragher, Nicola J. Goodson, Haris Naseem, Alan J. Silman, Wendy Thomson, Deborah Symmons, Anne Barton. (2008) Association of the HLA–DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis & Rheumatism 58:2, 359-369
CrossRef408
Megumi Tsushima, Yuriko Terayama, Akishi Momose, Tomihisa Funyu, Chikara Ohyama, Ryukichi Hada. (2008) Carotid intima media thickness and aortic calcification index closely relate to cerebro- and cardiovascular disorders in hemodialysis patients. International Journal of Urology 15:1, 48-51
CrossRef409
Irfan Moinuddin, David J. Leehey. (2008) A Comparison of Aerobic Exercise and Resistance Training in Patients With and Without Chronic Kidney Disease. Advances in Chronic Kidney Disease 15:1, 83-96
CrossRef410
David Goteiner, Robert Ashmen, Neal Lehrman, Malvin N. Janal, Barnet Eskin. (2008) Presence and Significance of Interleukin-1 Polymorphism in Patients Who Present With Acute Coronary Syndrome, Angina, and Chronic Periodontitis: An Epidemiologic Pilot Study. Journal of Periodontology 79:1, 138-143
CrossRef411
Glenys A. Tennent, Winston L. Hutchinson, Melvyn C. Kahan, Gideon M. Hirschfield, J. Ruth Gallimore, Jackie Lewin, Caroline A. Sabin, Amar P. Dhillon, Mark B. Pepys. (2008) Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE−/− mice. Atherosclerosis 196:1, 248-255
CrossRef412
Tan Xu, Zhong Ju, Weijun Tong, Wei Hu, Yanbin Liu, Li Zhao, Yonghong Zhang. (2008) Relationship of C-Reactive Protein With Hypertension and Interactions Between Increased C-Reactive Protein and Other Risk Factors on Hypertension in Mongolian People, China. Circulation Journal 72:8, 1324-1328
CrossRef413
Vidosava B. Đorđević, Tatjana Ristić, Vladan Ćosić, Predrag Vlahović, Lilika Zvezdanović, Gordana Đorđević. (2008) Inflammatory and Apoptotic Markers in Ischemic Heart Disease Patients. Journal of Medical Biochemistry 27:2, 154-160
CrossRef414
Narbeh Melikian, Bernard De Bruyne, William F. Fearon, Philip A. MacCarthy. (2008) The Pathophysiology and Clinical Course of the Normal Coronary Angina Syndrome (Cardiac Syndrome X). Progress in Cardiovascular Diseases 50:4, 294-310
CrossRef415
Effat Razeghi, Sayeh Parkhideh, Farrokhlagha Ahmadi, Patricia Khashayar. (2008) Serum CRP Levels in Pre-Dialysis Patients. Renal Failure 30:2, 193-198
CrossRef416
Fumiyuki Otsuka, Seigo Sugiyama, Sunao Kojima, Hisao Ogawa. (2008) Reply to Letter Regarding Article, "Hypoadiponectinemia is Associated With Impaired Glucose Tolerance and Coronary Artery Disease in Non-Diabetic Men". Circulation Journal 72:3, 506-507
CrossRef417
Dora Il'yasova, Anastasia Ivanova, Jason D. Morrow, Matteo Cesari, Marco Pahor. (2008) Correlation between two markers of inflammation, serum C-reactive protein and interleukin 6, and indices of oxidative stress in patients with high risk of cardiovascular disease. Biomarkers 13:1, 41-51
CrossRef418
RG Craig. (2008) Interactions between chronic renal disease and periodontal disease. Oral Diseases 14:1, 1-7
CrossRef419
Kosmas I. Paraskevas, George Hamilton, Jenny M. Cross, Dimitri P. Mikhailidis. (2008) Atherosclerotic Renal Artery Stenosis: Association with Emerging Vascular Risk Factors. Nephron Clinical Practice 108:1, c56-c66
CrossRef420
C-W Chen, Y-L Lin, T-K Lin, C-T Lin, B-C Chen, C-L Lin. (2008) Total cardiovascular risk profile of Taiwanese vegetarians. European Journal of Clinical Nutrition 62:1, 138-144
CrossRef421
A C Scheurig, B Thorand, B Fischer, M Heier, W Koenig. (2008) Association between the intake of vitamins and trace elements from supplements and C-reactive protein: results of the MONICA/KORA Augsburg study. European Journal of Clinical Nutrition 62:1, 127-137
CrossRef422
Hideto Ishii, Toyohiro Tsukada, Masayuki Yoshida. (2008) Angiotensin II Type-I Receptor Blocker, Candesartan, Improves Brachial-Ankle Pulse Wave Velocity Independent of Its Blood Pressure Lowering Effects in Type 2 Diabetes Patients. Internal Medicine 47:23, 2013-2018
CrossRef423
Hiromasa Otake, Junya Shite, Toshiro Shinke, Satoshi Watanabe, Yusuke Tanino, Daisuke Ogasawara, Takahiro Sawada, Ken-ichi Hirata, Mitsuhiro Yokoyama. (2008) Relation Between Plasma Adiponectin, High-Sensitivity C-Reactive Protein, and Coronary Plaque Components in Patients With Acute Coronary Syndrome. The American Journal of Cardiology 101:1, 1-7
CrossRef424
Hisashi Makino, Kentaro Doi, Aki Hiuge, Ayako Nagumo, Sadanori Okada, Yoshihiro Miyamoto, Masaaki Suzuki, Yasunao Yoshimasa. (2008) Impaired flow-mediated vasodilatation and insulin resistance in type 2 diabetic patients with albuminuria. Diabetes Research and Clinical Practice 79:1, 177-182
CrossRef425
James D. Beck, David J. Couper, Karen L. Falkner, Susan P. Graham, Sara G. Grossi, John C. Gunsolley, Theresa Madden, Gerardo Maupome, Steven Offenbacher, Dawn D. Stewart, Maurizio Trevisan, Thomas E. Van Dyke, Robert J. Genco. (2008) The Periodontitis and Vascular Events (PAVE) Pilot Study: Adverse Events. Journal of Periodontology 79:1, 90-96
CrossRef426
Prediman K. Shah. 2008. Inflammation and atherothrombosis. , 1013-1021.
CrossRef427
Christiane A. Geluk, Wendy J. Post, Hans L. Hillege, René A. Tio, Jan G.P. Tijssen, René B. van Dijk, W. Arnold Dijk, Stephan J.L. Bakker, Paul E. de Jong, Wiek H. van Gilst, Felix Zijlstra. (2008) C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: Data from the prospective PREVEND cohort. Atherosclerosis 196:1, 372-382
CrossRef428
C ESPINOLAKLEIN, H RUPPRECHT, C BICKEL, K LACKNER, R SCHNABEL, T MUNZEL, S BLANKENBERG. (2007) Inflammation, atherosclerotic burden and cardiovascular prognosis. Atherosclerosis 195:2, e126-e134
CrossRef429
Paul M Ridker. (2007) Inflammatory Biomarkers and Risks of Myocardial Infarction, Stroke, Diabetes, and Total Mortality: Implications for Longevity. Nutrition Reviews 65, S253-S259
CrossRef430
S ELIASSMALE, I KARDYS, M OUDKERK, A HOFMAN, J WITTEMAN. (2007) C-reactive protein is related to extent and progression of coronary and extra-coronary atherosclerosis; results from the Rotterdam study. Atherosclerosis 195:2, e195-e202
CrossRef431
I DELRINCON, D OLEARY, G FREEMAN, A ESCALANTE. (2007) Acceleration of atherosclerosis during the course of rheumatoid arthritis
CrossRef432
OSVALDO P. ALMEIDA, PAUL NORMAN, GRAEME J. HANKEY, KONRAD JAMROZIK, LEON FLICKER. (2007) The association between C-reactive protein concentration and depression in later life is due to poor physical health: results from the Health in Men Study (HIMS). Psychological Medicine 37:12,
CrossRef433
S ABDULLAH, A KHERA, D LEONARD, S DAS, R CANHAM, S KAMATH, G VEGA, S GRUNDY, D MCGUIRE, J DELEMOS. (2007) Sex differences in the association between leptin and CRP: Results from the Dallas Heart Study. Atherosclerosis 195:2, 404-410
CrossRef434
R BISOENDIAL, J KASTELEIN, E STROES. (2007) C-reactive protein and atherogenesis: From fatty streak to clinical event. Atherosclerosis 195:2, e10-e18
CrossRef435
M HARRIS, W DAVIS, N LE, B EGGLESTON, G AUSTIN, M MOUSSA, W BROWN. (2007) Free oxygen radicals in whole blood correlate strongly with high-sensitivity C-reactive protein. Journal of Clinical Lipidology 1:6, 593-598
CrossRef436
Michelle A. Albert. (2007) Inflammatory Biomarkers, Race/Ethnicity and Cardiovascular Disease. Nutrition Reviews 65, S234-S238
CrossRef437
H R Nakhai-Pour, D E Grobbee, M L Bots, M Muller, Y T van der Schouw. (2007) C-reactive protein and aortic stiffness and wave reflection in middle-aged and elderly men from the community. Journal of Human Hypertension 21:12, 949-955
CrossRef438
Mien-Cheng Chen, Chien-Jen Chen, Cheng-Hsu Yang, Chiung-Jen Wu, Chih-Yuan Fang, Yuan-Kai Hsieh, Hsueh-Wen Chang. (2007) Interleukin-18: a strong predictor of the extent of coronary artery disease in patients with unstable angina. Heart and Vessels 22:6, 371-375
CrossRef439
Akiko Yamashita, Yoshihiko Soga, Yoshihiro Iwamoto, Sayuri Yoshizawa, Hirotaka Iwata, Susumu Kokeguchi, Shogo Takashiba, Fusanori Nishimura. (2007) Macrophage-Adipocyte Interaction: Marked Interleukin-6 Production by Lipopolysaccharide**. Obesity 15:11, 2549-2552
CrossRef440
Tim T. Issac, Hisham Dokainish, Nasser M. Lakkis. (2007) Role of Inflammation in Initiation and Perpetuation of Atrial Fibrillation. Journal of the American College of Cardiology 50:21, 2021-2028
CrossRef441
Vittoria Rizzello, Giovanna Liuzzo, Giovanna Di Giannuario, Elisabetta Trabetti, Salvatore Brugaletta, Matteo Santamaria, Maddalena Piro, Pier Franco Pignatti, Attilio Maseri, Luigi M. Biasucci, Filippo Crea. (2007) 1059G/C polymorphism within the exon 2 of the C-reactive protein gene: relationship to C-reactive protein levels and prognosis in unstable angina. Coronary Artery Disease 18:7, 533-538
CrossRef442
Danielle J. Frey, Monika Fleshner, Kenneth P. Wright. (2007) The effects of 40 hours of total sleep deprivation on inflammatory markers in healthy young adults. Brain, Behavior, and Immunity 21:8, 1050-1057
CrossRef443
L Y F Wong, R Y H Leung, K L Ong, B M Y Cheung. (2007) Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene −572C>G polymorphism in subjects with and without hypertension. Journal of Human Hypertension 21:11, 875-882
CrossRef444
Abigail May, Thomas J Wang. (2007) Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin. Expert Review of Molecular Diagnostics 7:6, 793-804
CrossRef445
Hisham Nassar, Ehud Lavi, Sa’ed Akkawi, Khalil Bdeir, Samuel N. Heyman, P.N. Raghunath, John Tomaszewski, Abd Al-Roof Higazi. (2007) α-Defensin: Link between inflammation and atherosclerosis. Atherosclerosis 194:2, 452-457
CrossRef446
Stephan Lindemann, Björn Krämer, Karin Daub, Konstantinos Stellos, Meinrad Gawaz. (2007) Molecular pathways used by platelets to initiate and accelerate atherogenesis. Current Opinion in Lipidology 18:5, 566-573
CrossRef447
Tânia B. Ferraz, Rosa S. Motta, Camila Lousada Ferraz, Diego Moreira Capibaribe, Adriana C. Forti, Antônio R. Chacra. (2007) C-reactive protein and features of metabolic syndrome in Brazilian women with previous gestational diabetes. Diabetes Research and Clinical Practice 78:1, 23-29
CrossRef448
Adam Young, Gouri Koduri. (2007) Extra-articular manifestations and complications of rheumatoid arthritis. Best Practice & Research Clinical Rheumatology 21:5, 907-927
CrossRef449
Rohit Bhatheja, Debabrata Mukherjee. (2007) Acute Coronary Syndromes: Unstable Angina/Non-ST Elevation Myocardial Infarction. Critical Care Clinics 23:4, 709-735
CrossRef450
Ken Donaldson, Nicholas Mills, David E. Newby, William MacNee, Vicki Stone. 2007. Toxicology of Nanoparticles in Environmental Air Pollution. .
CrossRef451
Robert N. Foley. (2007) Infections in Patients with Chronic Kidney Disease. Infectious Disease Clinics of North America 21:3, 659-672
CrossRef452
A TANIGUCHI, M FUKUSHIMA, Y NAKAI, A KUROE, M OHYA, M OHGUSHI, Y SEINO. (2007) Factors responsible for the evolution of insulin resistance in Japanese type 2 diabetic patients: Association with atherosclerosis. Diabetes Research and Clinical Practice 77:3, S213-S219
CrossRef453
Oyku Gulmez, Cagatay Ertan, Aylin Yildirir, Didem Konas, Ugur Bal, Alp Aydinalp, Ozlem Demir, Bulent Ozin, Haldun Muderrisoglu. (2007) C-reactive protein levels increase after exercise testing in patients with increased platelet reactivity. Coronary Artery Disease 18:6, 437-442
CrossRef454
Jianping Liu, Jinquan Cheng, Ji Peng, Shenghong Han, Lei Yu, Shaofa Nie. (2007) Effects of polymorphisms of heat shock protein 70 gene on ischemic stroke, and interaction with smoking in China. Clinica Chimica Acta 384:1-2, 64-68
CrossRef455
Kaushik Bhowmick, A. V. M. Kutty, H. V. Shetty. (2007) Glycemic control modifies the association between microalbuminuria and c-reactive protein in Type 2 Diabetes Mellitus. Indian Journal of Clinical Biochemistry 22:2, 53-59
CrossRef456
Masato Kikuchi, Makoto Nakamura, Kohei Ishikawa, Toshimitsu Suzuki, Hiroaki Nishihara, Tomomi Yamakoshi, Kazuko Nishio, Kentaro Taki, Toshimitsu Niwa, Nobuyuki Hamajima, Hiroko Terasaki. (2007) Elevated C-Reactive Protein Levels in Patients with Polypoidal Choroidal Vasculopathy and Patients with Neovascular Age-Related Macular Degeneration. Ophthalmology 114:9, 1722-1727
CrossRef457
Ruben H. Willemsen, Paul G. H. Mulder, Albert W. van Toorenenbergen, Anita C. S. Hokken-Koelega. (2007) Long-term GH treatment is not associated with disadvantageous changes of inflammatory markers and adipocytokines in children born small for gestational age. Clinical Endocrinology 0:0, 070902090319002-???
CrossRef458
Paola De Pablo, Thomas Dietrich, Elizabeth W. Karlson. (2007) Antioxidants and other novel cardiovascular risk factors in subjects with rheumatoid arthritis in a large population sample. Arthritis & Rheumatism 57:6, 953-962
CrossRef459
Susan G. Lakoski, Mary Cushman, Roger S. Blumenthal, Richard Kronmal, Donna Arnett, Ralph B. D’Agostino, Robert C. Detrano, David M. Herrington. (2007) Implications of C-reactive protein or coronary artery calcium score as an adjunct to global risk assessment for primary prevention of CHD. Atherosclerosis 193:2, 401-407
CrossRef460
David Conen, Paul M Ridker. (2007) Clinical significance of high-sensitivity C-reactive protein in cardiovascular disease. Biomarkers in Medicine 1:2, 229-241
CrossRef461
Omer Guran, Figen Akalin, Canan Ayabakan, Feyza Yagmur Dereli, Goncagul Haklar. (2007) High-sensitivity C-reactive protein in children at risk for coronary artery disease. Acta Paediatrica 96:8, 1214-1219
CrossRef462
Cynthia M. Westerhout, Judy Gnarpe, Wei-Ching Chang, Susan FitzPatrick, Elliot S. Barnathan, Eric Boersma, Robert M. Califf, Lars Wallentin, Maarten L. Simoons, Paul W. Armstrong. (2007) No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: Insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial. American Heart Journal 154:2, 306-312
CrossRef463
Benjamin Z. Leder. (2007) Testosterone, estradiol and aromatase inhibitor therapy in elderly men. The Journal of Steroid Biochemistry and Molecular Biology 106:1-5, 162-167
CrossRef464
Wei Yue, Alexandra Schneider, Matthias Stölzel, Regina Rückerl, Josef Cyrys, Xiaochuan Pan, Wojciech Zareba, Wolfgang Koenig, H.-Erich Wichmann, Annette Peters. (2007) Ambient source-specific particles are associated with prolonged repolarization and increased levels of inflammation in male coronary artery disease patients. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 621:1-2, 50-60
CrossRef465
A. G. Nikitin, D. A. Chudakova, E. V. Spitsina, L. O. Minushkina, D. A. Zateishchikov, V. V. Nosikov, V. G. Debabov. (2007) Association of GNB3 gene C825T polymorphism with coronary heart disease. Russian Journal of Genetics 43:8, 937-941
CrossRef466
Jeffrey L. Anderson, Cynthia D. Adams, Elliott M. Antman, Charles R. Bridges, Robert M. Califf, Donald E. Casey, William E. Chavey, Francis M. Fesmire, Judith S. Hochman, Thomas N. Levin, A. Michael Lincoff, Eric D. Peterson, Pierre Theroux, Nanette Kass Wenger, R. Scott Wright, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Elliott M. Antman, Jonathan L. Halperin, Sharon A. Hunt, Harlan M. Krumholz, Frederick G. Kushner, Bruce W. Lytle, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel. (2007) ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction. Journal of the American College of Cardiology 50:7, e1-e157
CrossRef467
Masato Yoneda, Hironori Mawatari, Koji Fujita, Hiroshi Iida, Kyoko Yonemitsu, Shingo Kato, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Yuichi Nozaki, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Tomoyuki Iwasaki, Yasuo Terauchi, Shinji Togo, Shiro Maeyama, Atsushi Nakajima. (2007) High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. Journal of Gastroenterology 42:7, 573-582
CrossRef468
D. M. Musher, A. M. Rueda, A. S. Kaka, S. M. Mapara. (2007) The Association between Pneumococcal Pneumonia and Acute Cardiac Events. Clinical Infectious Diseases 45:2, 158-165
CrossRef469
Ulrich Broeckel, Christian Hengstenberg, Bjoern Mayer, Karen Maresso, Daniel Gaudet, Ondrej Seda, Johanne Tremblay, Stephan Holmer, Jeanette Erdmann, Christian Glöckner, Michael Harrison, Lisa J. Martin, Jeff T. Williams, Gerd Schmitz, Guenter A. J. Riegger, Howard J. Jacob, Pavel Hamet, Heribert Schunkert. (2007) A locus on chromosome 10 influences C-reactive protein levels in two independent populations. Human Genetics 122:1, 95-102
CrossRef470
A. Abdellaoui, H. Al-Khaffaf. (2007) C-Reactive Protein (CRP) as a Marker in Peripheral Vascular Disease. European Journal of Vascular and Endovascular Surgery 34:1, 18-22
CrossRef471
Samar Basu. (2007) Novel cyclooxygenase-catalyzed bioactive prostaglandin F2α from physiology to new principles in inflammation. Medicinal Research Reviews 27:4, 435-468
CrossRef472
Omer Kozan, Kemalettin Buyukozturk, Baris Ilerigelen, Giray Kabakci, Nevrez Koylan, . (2007) The Impact of Plasma High-Sensitivity C-Reactive Protein Levels on Cardiovascular Risk Stratification of Hypertensive Patients: Results of the ICEBERG Study. The Journal of Clinical Hypertension 9:7, 500-505
CrossRef473
Alena Lorenzová, Vladimír Staněk, Marie Gebauerová, Romana Bohuslavová, Petr Stávek, Jaroslav A. Hubáček, Věra Lánská, Rudolf Poledne. (2007) High-sensitivity C-reactive protein concentration in patients with myocardial infarction-environmental factors, and polymorphisms in interleukin-10 and CD14 genes. Clinical Chemistry and Laboratory Medicine 45:7, 855-861
CrossRef474
Trine Madsen, Jeppe Hagstrup Christensen, Egon Toft, Erik Berg Schmidt. (2007) C-Reactive Protein Is Associated with Heart Rate Variability. Annals of Noninvasive Electrocardiology 12:3, 216-222
CrossRef475
Beom-Jun Kim, Yong Mi Yu, Euy Nyong Kim, Yun-Ey Chung, Jung-Min Koh, Ghi Su Kim. (2007) Relationship between serum hsCRP concentration and biochemical bone turnover markers in healthy pre- and postmenopausal women. Clinical Endocrinology 67:1, 152-158
CrossRef476
Carolyn Katrinchak, Kathryn Fritz. (2007) Clinical implications of C-reactive protein as a predictor of vascular risk. Journal of the American Academy of Nurse Practitioners 19:7, 335-340
CrossRef477
Trine Madsen, Erik B. Schmidt, Jeppe H. Christensen. (2007) The Effect of n-3 Fatty Acids on C-Reactive Protein Levels in Patients With Chronic Renal Failure. Journal of Renal Nutrition 17:4, 258-263
CrossRef478
Christian Madsen, Per Nafstad, Lars Eikvar, Per E. Schwarze, Kjersti S. Rønningen, Lise Lund Haaheim. (2007) Association between tobacco smoke exposure and levels of C-reactive protein in the Oslo II Study. European Journal of Epidemiology 22:5, 311-317
CrossRef479
Sandeep Bansal, Paul M. Ridker. (2007) Comparison of Characteristics of Future Myocardial Infarctions in Women With Baseline High Versus Baseline Low Levels of High-Sensitivity C-Reactive Protein. The American Journal of Cardiology 99:11, 1500-1503
CrossRef480
David W. Paquette, Nadine Brodala, Timothy C. Nichols. (2007) Cardiovascular disease, inflammation, and periodontal infection. Periodontology 2000 44:1, 113-126
CrossRef481
Yun Fang Liu, Hui Ming Yu, Cheng Zhang, Rui Xue Yang, Fang Fang Yan, Yan Liu, Yun Zhang, Yu Xia Zhao. (2007) Effects of Quyu Xiaoban Capsules on Clinical Outcomes and Platelet Activation and Aggregation in Patients with Unstable Angina Pectoris. The Journal of Alternative and Complementary Medicine 13:5, 571-576
CrossRef482
David H. Lee, Theodore E. Warkentin. 2007. Frequency of Heparin-Induced Thrombocytopenia. , 67-116.
CrossRef483
Keith W Muir, Pippa Tyrrell, Naveed Sattar, Elizabeth Warburton. (2007) Inflammation and ischaemic stroke. Current Opinion in Neurology 20:3, 334-342
CrossRef484
Martin K.C. Ng. (2007) New Perspectives on Mars and Venus: Unravelling the Role of Androgens in Gender Differences in Cardiovascular Biology and Disease. Heart, Lung and Circulation 16:3, 185-192
CrossRef485
G ZULIANI, S VOLPATO, A BLE, S BANDINELLI, A CORSI, F LAURETANI, G PAOLISSO, R FELLIN, L FERRUCCI. (2007) High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: The InChianti study. Atherosclerosis 192:2, 384-390
CrossRef486
Maikki K. Heliövaara, Anita Remitz, Sakari Reitamo, Anna-Maija Teppo, Sirkka-Liisa Karonen, Pertti Ebeling. (2007) 13-cis-Retinoic acid therapy induces insulin resistance, regulates inflammatory parameters, and paradoxically increases serum adiponectin concentration. Metabolism 56:6, 786-791
CrossRef487
James R. Sowers. (2007) The Role of C-Reactive Protein in the Metabolic Syndrome and Diabetes Mellitus. The Endocrinologist 17:3, 163-168
CrossRef488
Paul M. Ridker. (2007) C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk. Journal of the American College of Cardiology 49:21, 2129-2138
CrossRef489
Nitsan Maharshak, Yaron Arbel, Natan M. Bornstein, Amir Gal-Oz, Alexander Y. Gur, Itzahk Shapira, Ori Rogowski, Shlomo Berliner, Zamir Halpern, Iris Dotan. (2007) Inflammatory Bowel Disease Is Not Associated With Increased Intimal Media Thickening. The American Journal of Gastroenterology 102:5, 1050-1055
CrossRef490
Jing Qian, Baowu Wang, Norma Dawkins, Alexandria Gray, Ralphenia D. Pace. (2007) Reduction of risk factors for cardiovascular diseases in African Americans with a 12-week nutrition education program. Nutrition Research 27:5, 252-257
CrossRef491
Preethi Yerram, Poorna R. Karuparthi, Laura Hesemann, Jennifer Horst, Adam Whaley-Connell. (2007) Chronic kidney disease and cardiovascular risk. Journal of the American Society of Hypertension 1:3, 178-184
CrossRef492
Bernd Krüger, Carsten A. Böger, Aiman Obed, Stefan Farkas, Ute Hoffmann, Bernhard Banas, Michael Fischereder, Bernhard K. Krämer. (2007) RANTES/CCL5 polymorphisms as a risk factor for recurrent acute rejection. Clinical Transplantation 21:3, 385-390
CrossRef493
Yun Fang Liu, Hui Ming Yu, Cheng Zhang, Rui Xue Yang, Fang Fang Yan, Yan Liu, Yun Zhang, Yu Xia Zhao. (2007) Effects of Quyu Xiaoban Capsules on Clinical Outcomes and Platelet Activation and Aggregation in Patients with Unstable Angina Pectoris. The Journal of Alternative and Complementary Medicine 13:3, 369-374
CrossRef494
Huyn-Chul Kim, Soo-Keun Lee, Young-Soo Sohn, Hong-Kun Ryu, Sang Won Jeong. (2007) Preparation of a Sensing Membrane for C-Reactive Protein. Macromolecular Symposia 249-250:1, 71-75
CrossRef495
Zhiqiang Wang, Wendy E. Hoy. (2007) C-reactive protein and the risk of developing type 2 diabetes in Aboriginal Australians. Diabetes Research and Clinical Practice 76:1, 37-43
CrossRef496
Craig J. McMackin, Michael E. Widlansky, Naomi M. Hamburg, Alex L. Huang, Susan Weller, Monika Holbrook, Noyan Gokce, Tory M. Hagen, John F. Keaney, Joseph A. Vita. (2007) Effect of Combined Treatment With α-Lipoic Acid and Acetyl-L-Carnitine on Vascular Function and Blood Pressure in Patients With Coronary Artery Disease. The Journal of Clinical Hypertension 9:4, 249-255
CrossRef497
Fulvio Bellocci, Luigi M Biasucci, Gian Franco Gensini, Luigi Padeletti, Antonio Raviele, Massimo Santini, Giovanna Giubilato, Maurizio Landolina, Giuseppe Biondi-Zoccai, Giovanni Raciti, Massimo Sassara, Antonello Castro, Antoine Kheir, Filippo Crea. (2007) Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study. Journal of Cardiovascular Medicine 8:4, 293-299
CrossRef498
Vijay Nambi, Christie M. Ballantyne. (2007) Role of Biomarkers in Developing New Therapies for Vascular Disease. World Journal of Surgery 31:4, 676-681
CrossRef499
Jerzy Krupinski, Esther Catena, Marta Miguel, Pere Domenech, Ramon Vila, Sergio Morchon, Francisco Rubio, Marc Cairols, Mark Slevin, Lina Badimon. (2007) D-dimer local expression is increased in symptomatic patients undergoing carotid endarterectomy. International Journal of Cardiology 116:2, 174-179
CrossRef500
Olle Melander. (2007) Are minor gene effects of clinical importance?. Journal of Hypertension 25:3, 505-507
CrossRef501
Antonio M. Gotto. (2007) Role of C-Reactive Protein in Coronary Risk Reduction: Focus on Primary Prevention. The American Journal of Cardiology 99:5, 718-725
CrossRef502
Masafumi Koga, Michio Otsuki, Sueko Matsumoto, Hiroshi Saito, Mikio Mukai, Soji Kasayama. (2007) Negative association of obesity and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels. Clinica Chimica Acta 378:1-2, 48-52
CrossRef503
Hamid Reza Nakhai Pour, Diederick E. Grobbee, Majon Muller, Yvonne T. van der Schouw. (2007) Association of endogenous sex hormone with C-reactive protein levels in middle-aged and elderly men. Clinical Endocrinology 66:3, 394-398
CrossRef504
Walter Stefan Speidl, Mariam Nikfardjam, Alexander Niessner, Nelli Jordanova, Gerlinde Zorn, Gerald Maurer, Wolfgang Schreiber, Johann Wojta, Kurt Huber. (2007) Premature compared with late onset of coronary artery disease: young patients show a severe defect in fibrinolytic response to venous occlusion. Blood Coagulation & Fibrinolysis 18:2, 165-171
CrossRef505
Pia Lundman, Susanna Boquist, Ann Samnegård, Marie Bennermo, Claes Held, Carl-Göran Ericsson, Angela Silveira, Anders Hamsten, Per Tornvall. (2007) A high-fat meal is accompanied by increased plasma interleukin-6 concentrations. Nutrition, Metabolism and Cardiovascular Diseases 17:3, 195-202
CrossRef506
Po-Hsun Huang, Jaw-Wen Chen, Tse-Min Lu, Philip Yu-An Ding, Shing-Jong Lin. (2007) Combined use of endothelial function assessed by brachial ultrasound and high-sensitive C-reactive protein in predicting cardiovascular events. Clinical Cardiology 30:3, 135-140
CrossRef507
A. Picardi, M. G. Valorani, U. Vespasiani Gentilucci, S. Manfrini, O. Ciofini, M. Cappa, C. Guglielmi, P. Pozzilli, . (2007) Raised C-reactive protein levels in patients with recent onset type 1 diabetes. Diabetes/Metabolism Research and Reviews 23:3, 211-214
CrossRef508
S ALBERT, M HAAS, A MOORADIAN. (2007) The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects. Growth Hormone & IGF Research 17:1, 19-25
CrossRef509
T NAGASAKI, M INABA, K SHIRAKAWA, Y HIURA, H TAHARA, Y KUMEDA, T ISHIKAWA, E ISHIMURA, Y NISHIZAWA. (2007) Increased levels of C-reactive protein in hypothyroid patients and its correlation with arterial stiffness in the common carotid artery. Biomedicine & Pharmacotherapy 61:2-3, 167-172
CrossRef510
Gordon D. O. Lowe, Mark B. Pepys. (2007) C-reactive protein and cardiovascular disease: Weighing the evidence. Current Cardiovascular Risk Reports 1:1, 72-79
CrossRef511
Santina Cottone, Giuseppe Mulè, Emilio Nardi, Anna Vadalà, Maria C Lorito, Marco Guarneri, Rosalia Arsena, Alessandro Palermo, Giovanni Cerasola. (2007) C-reactive protein and intercellular adhesion molecule-1 are stronger predictors of oxidant stress than blood pressure in established hypertension. Journal of Hypertension 25:2, 423-428
CrossRef512
Fusanori Nishimura, Yoshihiro Iwamoto, Yoshihiko Soga. (2007) The periodontal host response with diabetes. Periodontology 2000 43:1, 245-253
CrossRef513
Boaz D. Rosen, Mary Cushman, Khurram Nasir, David A. Bluemke, Thor Edvardsen, Verônica Fernandes, Shenghan Lai, Russell P. Tracy, João A.C. Lima. (2007) Relationship Between C-Reactive Protein Levels and Regional Left Ventricular Function in Asymptomatic Individuals. Journal of the American College of Cardiology 49:5, 594-600
CrossRef514
S STEINHUBL. (2007) Platelets as Mediators of Inflammation. Hematology/Oncology Clinics of North America 21:1, 115-121
CrossRef515
M. Caliskan, D. Erdogan, H. Gullu, D. Tok, M. Bilgi, H. Muderrisoglu. (2007) Low serum bilirubin concentrations are associated with impaired aortic elastic properties, but not impaired left ventricular diastolic function. International Journal of Clinical Practice 61:2, 218-224
CrossRef516
B. Müller, N. Morgenthaler, D. Stolz, P. Schuetz, C. Müller, R. Bingisser, A. Bergmann, M. Tamm, M. Christ-Crain. (2007) Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. European Journal of Clinical Investigation 37:2, 145-152
CrossRef517
Mohammad Tauseef, Krishna K. Sharma, Mohammad Fahim. (2007) Aspirin restores normal baroreflex function in hypercholesterolemic rats by its antioxidative action. European Journal of Pharmacology 556:1-3, 136-143
CrossRef518
Daniel I. Steinberg, Alexander Mayer. (2007) Lipoprotein-Associated Phospholipase A2 and Risk Stratification for Cardiovascular Disease: Not Ready for “Prime Time”. Mayo Clinic Proceedings 82:2, 155-157
CrossRef519
Carolina A. Garza, Victor M. Montori, Joseph P. McConnell, Virend K. Somers, Iftikhar J. Kullo, Francisco Lopez-Jimenez. (2007) Association Between Lipoprotein-Associated Phospholipase A2 and Cardiovascular Disease: A Systematic Review. Mayo Clinic Proceedings 82:2, 159-165
CrossRef520
D. I. Steinberg, A. Mayer. (2007) Lipoprotein-Associated Phospholipase A2 and Risk Stratification for Cardiovascular Disease: Not Ready for 'Prime Time'. Mayo Clinic Proceedings 82:2, 155-157
CrossRef521
C. A. Garza, V. M. Montori, J. P. McConnell, V. K. Somers, I. J. Kullo, F. Lopez-Jimenez. (2007) Association Between Lipoprotein-Associated Phospholipase A2 and Cardiovascular Disease: A Systematic Review. Mayo Clinic Proceedings 82:2, 159-165
CrossRef522
Christopher D. Owens, Paul M. Ridker, Michael Belkin, Allen D. Hamdan, Frank Pomposelli, Frank Logerfo, Mark A. Creager, Michael S. Conte. (2007) Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery. Journal of Vascular Surgery 45:1, 2-9
CrossRef523
K. Graf. (2007) CRP ist kein unabhängiger Prädiktor für das Auftreten eines akuten Schlaganfalls. Clinical Research in Cardiology Supplements 2:1, 43-44
CrossRef524
Won-Young Lee, Matthew A. Allison, Dong-Jun Kim, Chan-Hee Song, Elizabeth Barrett-Connor. (2007) Association of Interleukin-6 and C-Reactive Protein With Subclinical Carotid Atherosclerosis (the Rancho Bernardo Study). The American Journal of Cardiology 99:1, 99-102
CrossRef525
Sun Mee Yang, Sung Yong Kim, Ki Young Lee, Yeun Sun Kim, Moon Suk Nam, Ie Byung Park. (2007) Inflammatory Markers are Associated with Microvascular Complications in Type 2 Diabetes. The Journal of Korean Diabetes Association 31:6, 472
CrossRef526
Moo-Yong Rhee, Hyun Kyu Chang, Seong-Kyu Kim. (2007) Intima-media Thickness and Arterial Stiffness of Carotid Artery in Korean Patients with Behçet's Disease. Journal of Korean Medical Science 22:3, 387
CrossRef527
M. John Chapman. (2007) From pathophysiology to targeted therapy for atherothrombosis: A role for the combination of statin and aspirin in secondary prevention. Pharmacology & Therapeutics 113:1, 184-196
CrossRef528
Hsu-Ko Kuo, Chung-Jen Yen, Jen-Hau Chen, Yau-Hua Yu, Jonathan F. Bean. (2007) Association of cardiorespiratory fitness and levels of C-reactive protein: Data from the National Health and Nutrition Examination Survey 1999–2002. International Journal of Cardiology 114:1, 28-33
CrossRef529
Valentin Fuster, Javier Sanz. (2007) Vascular inflammation. Journal of the American Society of Hypertension 1:1, 68-81
CrossRef530
Brian M. Wong, Michael Huang, Jeffrey S. Zaltzman, G V. Ramesh Prasad. (2007) Mycophenolate Mofetil and C-Reactive Protein in Renal Transplant Recipients. Transplantation 83:1, 48-53
CrossRef531
Masami Kosuge, Toshiaki Ebina, Toshiyuki Ishikawa, Kiyoshi Hibi, Kengo Tsukahara, Jyun Okuda, Noriaki Iwahashi, Hiroyuki Ozaki, Hideto Yano, Ikuyoshi Kusama, Tastuya Nakati, Satoshi Umemura, Kazuo Kimura. (2007) Serum Amyloid A is a Better Predictor of Clinical Outcomes than C-Reactive Protein in Non-ST-Segment Elevation Acute Coronary Syndromes. Circulation Journal 71:2, 186-190
CrossRef532
A. Räkel, G. Renier, A. Roussin, J. Buithieu, J.-C. Mamputu, O. Serri. (2007) Beneficial effects of gliclazide modified release compared with glibenclamide on endothelial activation and low-grade inflammation in patients with type 2 diabetes. Diabetes, Obesity and Metabolism 9:1, 127-129
CrossRef533
Thorsten Kälsch, Elif Elmas, Xuan Duc Nguyen, Stefan Kralev, Hans Leweling, Harald Klüter, Carl-Erik Dempfle, Martin Borggrefe. (2007) Effects of alimentary lipemia and inflammation on platelet CD40-ligand. Thrombosis Research 120:5, 703-708
CrossRef534
Gunnar Engström, Bo Hedblad, Lars Janzon, Folke Lindgärde. (2007) Long-Term Change in Cholesterol in Relation to Inflammation-Sensitive Plasma Proteins: A Longitudinal Study. Annals of Epidemiology 17:1, 57-63
CrossRef535
Young Mi Hong, Hee Sun Koo, Jae Young Lee, Jo Won Jung, Nam Su Kim, Chung IL Noh. (2007) Serum Cytokine Levels in Hypertensive Children - Tumor Necrosis Factor-α, Interleukin-6 -. Korean Circulation Journal 37:7, 312
CrossRef536
Frederick Palm, Armin Grau. (2007) Infection as a risk factor for stroke. Future Neurology 2:1, 59-71
CrossRef537
David W. JOHNSON, Ann-Maree CRAVEN, Nicole Maree ISBEL. (2007) Modification of cardiovascular risk in hemodialysis patients: An evidence-based review. Hemodialysis International 11:1,
CrossRef538
Masayo Fukuhara, Kiyoshi Matsumura, Masanori Wakisaka, Yutaka Takata, Kazuo Sonoki, Kiyoshi Fujisawa, Toshihiro Ansai, Sumio Akifusa, Koji Fujii, Mitsuo Iida, Tadamichi Takehara. (2007) Hyperglycemia Promotes Microinflammation as Evaluated by C-Reactive Protein in the Very Elderly. Internal Medicine 46:5, 207-212
CrossRef539
M BONCLER, B LUZAK, M ROZALSKI, J GOLANSKI, B RYCHLIK, C WATALA. (2007) Acetylsalicylic acid is compounding to antiplatelet effect of C-reactive protein. Thrombosis Research 119:2, 209-216
CrossRef540
Markolf Hanefeld, Nikolaus Marx, Andreas Pfützner, Werner Baurecht, Georg Lübben, Efstrathios Karagiannis, Ulf Stier, Thomas Forst. (2007) Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive Protein. Journal of the American College of Cardiology 49:3, 290-297
CrossRef541
Anna Frisinghelli, Antonio Mafrici. (2007) Regression or Reduction in Progression of Atherosclerosis, and Avoidance of Coronary Events, With Lovastatin in Patients With or at High Risk of Cardiovascular Disease. Clinical Drug Investigation 27:9, 591-604
CrossRef542
Vilborg Sigurdardottir, Björn Fagerberg, John Wikstrand, Caroline Schmidt, Johannes Hulthe. (2007) Circulating oxidized low-density lipoprotein is associated with echolucent plaques in the femoral artery independently of hsCRP in 61-year-old men. Atherosclerosis 190:1, 187-193
CrossRef543
Caroline Bulc??o, Fernando Flexa Ribeiro-Filho, Adriana Sa??udo, Sandra G Roberta Ferreira. (2007) Effects of Simvastatin and Metformin on Inflammation and Insulin Resistance in Individuals with Mild Metabolic Syndrome. American Journal of Cardiovascular Drugs 7:3, 219-224
CrossRef544
T YANAGAWA, A TANIGUCHI, M FUKUSHIMA, Y NAKAI, S NAGASAKA, M OHGUSHI, K MATSUMOTO, A KUROE, M OHYA, Y SEINO. (2007) Leptin, triglycerides, and interleukin 6 are independently associated with C-reactive protein in Japanese type 2 diabetic patients. Diabetes Research and Clinical Practice 75:1, 2-6
CrossRef545
Sarah D. de Ferranti, Nader Rifai. (2007) C-reactive protein: a nontraditional serum marker of cardiovascular risk. Cardiovascular Pathology 16:1, 14-21
CrossRef546
Shizukiyo Ishikawa, Kazunori Kayaba, Tadao Gotoh, Yosikazu Nakamura, Eiji Kajii. (2007) Metabolic Syndrome and C-Reactive Protein in the General Population. Circulation Journal 71:1, 26-31
CrossRef547
Banu Aktas Yilmaz, Türkan Mete, Irem Dincer, Sim Kutlay, Sule Sengül, Kenan Keven, Sehsuvar Ertürk. (2007) Predictors of Left Ventricular Hypertrophy in Patients with Chronic Kidney Disease. Renal Failure 29:3, 303-307
CrossRef548
Jaime Gállego, Eduardo Martínez Vila, Roberto Muñoz. (2007) Patients at High Risk for Ischemic Stroke: Identification and Actions. Cerebrovascular Diseases 24:1, 49-63
CrossRef549
F. Purroy, J. Montaner, C. A. Molina, P. Delgado, J. F. Arenillas, P. Chacon, M. Quintana, J. Alvarez-Sabin. (2007) C-reactive protein predicts further ischemic events in transient ischemic attack patients. Acta Neurologica Scandinavica 115:1, 60-66
CrossRef550
Marta Artieda, Ana Cenarro, Alberto Gañán, Antonela Lukic, Eva Moreno, José Puzo, Miguel Pocoví, Fernando Civeira. (2007) Serum Chitotriosidase Activity, a Marker of Activated Macrophages, Predicts New Cardiovascular Events Independently of C-Reactive Protein. Cardiology 108:4, 297-306
CrossRef551
Mary Cushman, Barbara M. Alving. 2007. Risk Factors for Cardiovascular Disease and Arterial Thrombosis. , 371-378.
CrossRef552
Maria L. Canale, Stefano Stroppa, Paolo Caravelli, Anna S. Petronio, Rita Mariotti, Mario Mariani, Alberto Balbarini, Antonio Barsotti. (2006) Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation. Coronary Artery Disease 17:8, 693-698
CrossRef553
Hemendra Basu, Steven Pernecky, Aditi Sengupta, George U. Liepa. (2006) Coronary heart disease: How do the benefits of ω-3 fatty acids compare with those of aspirin, alcohol/red wine, and statin drugs?. Journal of the American Oil Chemists' Society 83:12, 985-997
CrossRef554
Rabih R. Azar, Antoine Sarkis, Elie Salameh, Marie-Hélène Gannagé-Yared, Mireille Amm-Azar, Georges Badaoui, Mirna Germanos, Roland Kassab. (2006) Percutaneous coronary intervention increases leptin and decreases adiponectin levels. Clinical Endocrinology 65:6, 712-716
CrossRef555
Irene M. van der Meer, Hok-Hay S. Oei, Albert Hofman, Huibert A.P. Pols, Frank H. de Jong, Jacqueline C.M. Witteman. (2006) Soluble Fas, a mediator of apoptosis, C-reactive protein, and coronary and extracoronary atherosclerosis. Atherosclerosis 189:2, 464-469
CrossRef556
Rafea Shaaban, Sabine Kony, Fathi Driss, Bénédicte Leynaert, David Soussan, Isabelle Pin, Françoise Neukirch, Mahmoud Zureik. (2006) Change in C-reactive protein levels and FEV1 decline: A longitudinal population-based study. Respiratory Medicine 100:12, 2112-2120
CrossRef557
Brendan M. Everett, Tobias Kurth, Julie E. Buring, Paul M. Ridker. (2006) The Relative Strength of C-Reactive Protein and Lipid Levels as Determinants of Ischemic Stroke Compared With Coronary Heart Disease in Women. Journal of the American College of Cardiology 48:11, 2235-2242
CrossRef558
, G. Breithardt. (2006) Empfehlungen zur Diagnostik und Behandlung von Patienten mit koronarer Herzkrankheit und Niereninsuffizienz. Clinical Research in Cardiology Supplements 1:2, 103-117
CrossRef559
K MATSUMOTO, N FUJITA, M OZAKI, T TOMINAGA, Y UEKI, S MIYAKE. (2006) Coexistence of insulin resistance and inflammation effectively predicts cardiac disease but not stroke in Japanese patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 74:3, 316-321
CrossRef560
Sally Cox, Paul Emery. (2006) Use of prognostic markers in early rheumatoid arthritis to identify patients at risk of destructive disease. Expert Review of Clinical Immunology 2:6, 853-857
CrossRef561
Donald J. Phillips, Stacy C. League, Paula Weinstein, W. Craig Hooper. (2006) Interference in microsphere flow cytometric multiplexed immunoassays for human cytokine estimation. Cytokine 36:3-4, 180-188
CrossRef562
Peter Libby, Paul M. Ridker. (2006) Inflammation and Atherothrombosis. Journal of the American College of Cardiology 48:9, A33-A46
CrossRef563
J. Suk Danik, D. I. Chasman, C. P. Cannon, D. T. Miller, R. Y. L. Zee, P. Kozlowski, D. J. Kwiatkowski, P. M. Ridker. (2006) Influence of Genetic Variation in the C-Reactive Protein Gene on the Inflammatory Response During and After Acute Coronary Ischemia. Annals of Human Genetics 70:6, 705-716
CrossRef564
Sameer Nagamia, Martin Thoenes, Qamar A Khan, Anbu Pandian, Bobby V Khan. (2006) Potential role of statin therapy in heart failure, atrial fibrillation and aortic stenosis. Future Cardiology 2:6, 687-693
CrossRef565
AHMAD SAJADIEH, OLAV WENDELBOE NIELSEN, VERNER RASMUSSEN, HANS OLE HEIN, JØRGEN FISCHER HANSEN. (2006) Increased Ventricular Ectopic Activity in Relation to C-Reactive Protein, and NT-Pro-Brain Natriuretic Peptide in Subjects With No Apparent Heart Disease. Pacing and Clinical Electrophysiology 29:11, 1188-1194
CrossRef566
Leslie A. Lange, Kathryn Burdon, Carl D. Langefeld, Yongmei Liu, Stephanie R. Beck, Stephen S. Rich, Barry I. Freedman, K. Bridget Brosnihan, David M. Herrington, Lynne E. Wagenknecht, Donald W. Bowden. (2006) Heritability and Expression of C-Reactive Protein in Type 2 Diabetes in the Diabetes Heart Study. Annals of Human Genetics 70:6, 717-725
CrossRef567
Panagiota Pietri, Gregory Vyssoulis, Charalambos Vlachopoulos, Alexandra Zervoudaki, Theodoros Gialernios, Konstantinos Aznaouridis, Christodoulos Stefanadis. (2006) Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension. Journal of Hypertension 24:11, 2231-2238
CrossRef568
R. Vormittag, M. Funk, C. Mannhalter, V. Schönauer, T. Vukovich, E. Minar, C. Bialonczyk, M. Hirschl, I. Pabinger. (2006) C-reactive protein 3′ UTR +1444C>T polymorphism in patients with spontaneous venous thromboembolism. Atherosclerosis 188:2, 406-411
CrossRef569
Hasan Güven, Rebecca M. Shepherd, Richard G. Bach, Benjamin J. Capoccia, Daniel C. Link. (2006) The Number of Endothelial Progenitor Cell Colonies in the Blood Is Increased in Patients With Angiographically Significant Coronary Artery Disease. Journal of the American College of Cardiology 48:8, 1579-1587
CrossRef570
Natalie Khuseyinova, Wolfgang Koenig. (2006) Biomarkers of outcome from cardiovascular disease. Current Opinion in Critical Care 12:5, 412-419
CrossRef571
Theodore E. Warkentin, Jo-Ann I. Sheppard. (2006) Testing for Heparin-Induced Thrombocytopenia Antibodies. Transfusion Medicine Reviews 20:4, 259-272
CrossRef572
A. SAJADIEH, O. W. NIELSEN, V. RASMUSSEN, H. O. HEIN, J. F. HANSEN. (2006) C-reactive protein, heart rate variability and prognosis in community subjects with no apparent heart disease. Journal of Internal Medicine 260:4, 377-387
CrossRef573
John A. Farmer. 2006. Inflammatory Mediators and C-Reactive Protein. , 441-462.
CrossRef574
James T. Willerson, Paul W Armstrong. 2006. Acute Myocardial Infarction. , 611-646.
CrossRef575
M A Wörns, A Victor, P R Galle, T Höhler. (2006) Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels – a study in twins. Genes and Immunity 7:7, 600-605
CrossRef576
Shyam Prabhakaran, Bernardo Liberato, Ralph L. Sacco. 2006. Stroke Prevention. , 545-584.
CrossRef577
Adnan K. Chhatriwalla, Deepak L. Bhatt. 2006. Anticoagulation and Antiplatelet Agents. , 501-524.
CrossRef578
Kausik K Ray, Christopher P Cannon. (2006) Intensive statin therapy for treating acute coronary syndromes. Expert Opinion on Investigational Drugs 15:10, 1151-1159
CrossRef579
K MOREAU, P CHAUVEAU, S MARTIN, W ELHAGGAN, N BARTHE, P MERVILLE, M APARICIO. (2006) Long-Term Evolution of Body Composition After Renal Transplantation: 5-Year Survey. Journal of Renal Nutrition 16:4, 291-299
CrossRef580
Hassan M.E. Azzazy, Robert H. Christenson. 2006. Biochemical Markers of Acute Coronary Syndromes. .
CrossRef581
S. R. Salpeter, J. M. E. Walsh, T. M. Ormiston, E. Greyber, N. S. Buckley, E. E. Salpeter. (2006) Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes, Obesity and Metabolism 8:5, 538-554
CrossRef582
Matthew A. Roberts, David L. Hare, Sujiva Ratnaike, Francesco L. Ierino. (2006) Cardiovascular Biomarkers in CKD: Pathophysiology and Implications for Clinical Management of Cardiac Disease. American Journal of Kidney Diseases 48:3, 341-360
CrossRef583
Amber L. Beitelshees, Howard L. McLeod. (2006) Applying pharmacogenomics to enhance the use of biomarkers for drug effect and drug safety. Trends in Pharmacological Sciences 27:9, 498-502
CrossRef584
Paresh Dandona, Ajay Chaudhuri. (2006) Anti-inflammatory and antiatherogenic effects of insulin. Insulin 1, S11-S17
CrossRef585
, G. Breithardt. (2006) Empfehlungen zur Diagnostik und Behandlung von Patienten mit koronarer Herzkrankheit und Niereninsuffizienz. Clinical Research in Cardiology Supplements 1:1, 8-30
CrossRef586
H Hase, T Tsunoda, Y Tanaka, Y Takahashi, Y Imamura, H Ishikawa, Y Inishi, N Joki. (2006) Risk factors for de novo acute cardiac events in patients initiating hemodialysis with no previous cardiac symptom. Kidney International 70:6, 1142-1148
CrossRef587
Gordon D. O. Lowe, Mark B. Pepys. (2006) C-reactive protein and cardiovascular disease: Weighing the evidence. Current Atherosclerosis Reports 8:5, 421-428
CrossRef588
(2006) SIBioC 2006 38th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, Turin, Italy, September 19–22, 2006. Clinical Chemistry and Laboratory Medicine 44:8, A19-A38
CrossRef589
Robert Skinner, Rachel Georgiou, Peter Thornton, Nancy Rothwell. (2006) Psychoneuroimmunology of Stroke. Neurologic Clinics 24:3, 561-583
CrossRef590
Robyn Domsic, Kathleen Maksimowicz-McKinnon, Susan Manzi. (2006) Prevention of cardiovascular disease in patients with rheumatic diseases. Best Practice & Research Clinical Rheumatology 20:4, 741-756
CrossRef591
Andrea Rossi, Lorenzo Franceschini, Massimilano Fusaro, Mariantonietta Cicoira, Alejandra Amado Eleas, Giorgio Golia, Stefano Bonapace, Francesco Santini, Giuseppe Sangiorgi, Piero Zardini, Corrado Vassanelli. (2006) Carotid atherosclerotic plaque instability in patients with acute myocardial infarction. International Journal of Cardiology 111:2, 263-266
CrossRef592
Jessica L. Mega, David A. Morrow, Christopher P. Cannon, Sabina Murphy, Richard Cairns, Paul M. Ridker, Eugene Braunwald. (2006) Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy. Journal of Thrombosis and Thrombolysis 22:1, 71-76
CrossRef593
H. H. HEGENER, K. A. DIEHL, T. KURTH, J. M. GAZIANO, P. M. RIDKER, R. Y. L. ZEE. (2006) Polymorphisms of prostaglandin-endoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherothrombosis: a nested case?control approach. Journal of Thrombosis and Haemostasis 4:8, 1718-1722
CrossRef594
Asim K Duttaroy. (2006) Therapy and clinical trials. Current Opinion in Lipidology 17:4, 492-494
CrossRef595
Raed Osman, Philippe L L'Allier, Nader Elgharib, Jean-Claude Tardif. (2006) Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease. Vascular Health and Risk Management 2:3, 221-237
CrossRef596
Thorsten Kälsch, Xuan Duc Nguyen, Elif Elmas, Nadine Grebert, Tim Süselbeck, Harald Klüter, Martin Borggrefe, Carl Erik Dempfle. (2006) Coagulation activation and expression of CD40 ligand on platelets upon in vitro lipopolysaccharide-challenge in patients with unstable angina. International Journal of Cardiology 111:2, 217-223
CrossRef597
Yin Xu, Kyra Whitmer. (2006) C-REACTIVE PROTEIN AND CARDIOVASCULAR DISEASE IN PEOPLE WITH DIABETES. AJN, American Journal of Nursing 106:8, 66-72
CrossRef598
S. Matthijs Boekholdt, C. Erik Hack, Manjinder S. Sandhu, Robert Luben, Sheila A. Bingham, Nicholas J. Wareham, Ron J.G. Peters, J. Wouter Jukema, Nicholas E. Day, John J.P. Kastelein, Kay-Tee Khaw. (2006) C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: The EPIC-Norfolk prospective population study 1993–2003. Atherosclerosis 187:2, 415-422
CrossRef599
D Conen, A Zeller, T Dieterle, B Martina. (2006) C-reactive protein and echocardiography have little impact on risk stratification in never-treated hypertensive patients. Journal of Human Hypertension 20:8, 587-592
CrossRef600
Thomas D. Giles. (2006) Assessment of Global Risk: A Foundation for a New, Better Definition of Hypertension. The Journal of Clinical Hypertension 8, 5-14
CrossRef601
B FEVE, J BASTARD, H VIDAL. (2006) Les relations entre obésité, inflammation et insulinorésistance : acquisitions récentes. Comptes Rendus Biologies 329:8, 587-597
CrossRef602
Robert N. Foley. (2006) Infections and Cardiovascular Disease in Patients with Chronic Kidney Disease. Advances in Chronic Kidney Disease 13:3, 205-208
CrossRef603
Takanobu Hara, Noboru Takamura, Saori Akashi, Mio Nakazato, Takahiro Maeda, Mitsuhiro Wada, Kenichiro Nakashima, Yasuyo Abe, Yosuke Kusano, Kiyoshi Aoyagi. (2006) Evaluation of clinical markers of atherosclerosis in young and elderly Japanese adults. Clinical Chemistry and Laboratory Medicine 44:7, 824-829
CrossRef604
D. W. Bowden, K. Lohman, F-C. Hsu, C. D. Langefeld, J. J. Carr, L. Lenchik, L. E. Wagenknecht, B. I. Freedman, D. M. Herrington. (2006) Hormone replacement therapy is associated with increased C-reactive protein in women with Type 2 diabetes in the Diabetes Heart Study. Diabetic Medicine 23:7, 763-767
CrossRef605
Matt Fisher, Volker Knappertz. (2006) The dose of aspirin for the prevention of cardiovascular and cerebrovascular events. Current Medical Research and Opinion 22:7, 1239-1248
CrossRef606
Joseph B. Muhlestein, Heidi T. May, Jonathan R. Jensen, Benjamin D. Horne, Richard B. Lanman, Farangis Lavasani, Robert L. Wolfert, Robert R. Pearson, H. Daniel Yannicelli, Jeffrey L. Anderson. (2006) The Reduction of Inflammatory Biomarkers by Statin, Fibrate, and Combination Therapy Among Diabetic Patients With Mixed Dyslipidemia. Journal of the American College of Cardiology 48:2, 396-401
CrossRef607
Sakina B. Naqvi, Allan J. Collins. (2006) Infectious Complications in Chronic Kidney Disease. Advances in Chronic Kidney Disease 13:3, 199-204
CrossRef608
Kathleen L. Wyne. (2006) The metabolic syndrome: evolving evidence that thiazolidinediones provide rational therapy. Diabetes, Obesity and Metabolism 8:4, 365-380
CrossRef609
Gerald Liew, Paul Mitchell, Stephen R Leeder, Wayne Smith, Tien Yin Wong, Jie Jin Wang. (2006) Regular aspirin use and retinal microvascular signs: the Blue Mountains Eye Study. Journal of Hypertension 24:7, 1329-1335
CrossRef610
Charles W. Hogue, Christopher A. Palin, Rajagopal Kailasam, Jennifer S. Lawton, Abdullah Nassief, Victor G. Dávila-Román, Betsy Thomas, Ralph Damiano. (2006) C-Reactive Protein Levels and Atrial Fibrillation After Cardiac Surgery in Women. The Annals of Thoracic Surgery 82:1, 97-102
CrossRef611
Jun Yang, Xiang-Ping Li, Shui-Ping Zhao, Jiang Li, Jing-Dong Li, Xiao-Ming Xie. (2006) The effect of different doses of fluvastatin on inflammatory markers in the early phase of acute coronary syndrome. Clinica Chimica Acta 368:1-2, 183-187
CrossRef612
Noriko Nagi-Miura, Toshie Harada, Hiroyasu Shinohara, Kiyoshi Kurihara, Yoshiyuki Adachi, Akiko Ishida-Okawara, Toshiaki Oharaseki, Kei Takahashi, Shiro Naoe, Kazuo Suzuki, Naohito Ohno. (2006) Lethal and severe coronary arteritis in DBA/2 mice induced by fungal pathogen, CAWS, Candida albicans water-soluble fraction. Atherosclerosis 186:2, 310-320
CrossRef613
Kae-Woei Liang, Wayne Huey-Herng Sheu, Wen-Lieng Lee, Tsun-Jui Liu, Chih-Tai Ting, Ying-Tsung Chen, Wen-Jane Lee. (2006) Coronary artery disease progression is associated with C-reactive protein and conventional risk factors but not soluble CD40 ligand. Canadian Journal of Cardiology 22:8, 691-696
CrossRef614
Anita Schumacher, Kari Peersen, Lisbeth Sommervoll, Ingebj??rg Seljeflot, Harald Arnesen, Jan Erik Otterstad. (2006) Physical performance is associated with markers of vascular inflammation in patients with coronary heart disease. European Journal of Cardiovascular Prevention & Rehabilitation 13:3, 356-362
CrossRef615
A Soto González, D Bellido Guerrero, M Buño Soto, S Pértega Díaz, M Martinez-Olmos, O Vidal. (2006) Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin. European Journal of Clinical Nutrition 60:6, 802-809
CrossRef616
J.A. Gómez-Gerique. (2006) Utilidad de los marcadores de inflamación en el diagnóstico del riesgo cardiovascular. Clínica e Investigación en Arteriosclerosis 18, 56-71
CrossRef617
Mitchell S. V. Elkind. (2006) Inflammation, Atherosclerosis, and Stroke. The Neurologist 12:3, 140-148
CrossRef618
A.-M. Aas, I. Seljeflot, P. A. Torjesen, L. M. Diep, P. M. Thorsby, K. I. Birkeland. (2006) Blood glucose lowering by means of lifestyle intervention has different effects on adipokines as compared with insulin treatment in subjects with type 2 diabetes. Diabetologia 49:5, 872-880
CrossRef619
Charmaine S Tam, Melanie Wong, Rachel McBain, Sherryn Bailey, Karen A Waters. (2006) Inflammatory measures in children with obstructive sleep apnoea. Journal of Paediatrics and Child Health 42:5, 277-282
CrossRef620
Nils H. Thoennissen, Achim Allroggen, Martin Ritter, Ralf Dittrich, Christof Schmid, Hans H. Schmid, E Bernd Ringelstein, Darius G. Nabavi. (2006) Influence of Inflammation and Pump Dynamic on Cerebral Microembolization in Patients with Continuous-Flow DeBakey LVAD. ASAIO Journal 52:3, 243-247
CrossRef621
Carmine Savoia, Ernesto L Schiffrin. (2006) Inflammation in hypertension. Current Opinion in Internal Medicine 5:3, 245-251
CrossRef622
Mònica Tous, Vicent Ribas, Joan Carles Escolà-Gil, Francisco Blanco-Vaca, Laura Calpe-Berdiel, Blai Coll, Natàlia Ferré, Carlos Alonso-Villaverde, Anna Rull, Jordi Camps, Jorge Joven. (2006) Manipulation of inflammation modulates hyperlipidemia in apolipoprotein E-deficient mice: A possible role for interleukin-6. Cytokine 34:3-4, 224-232
CrossRef623
Anna Abou-Raya, Suzan Abou-Raya. (2006) Inflammation: A pivotal link between autoimmune diseases and atherosclerosis. Autoimmunity Reviews 5:5, 331-337
CrossRef624
Devanand Sarkar, Paul B. Fisher. (2006) Molecular mechanisms of aging-associated inflammation. Cancer Letters 236:1, 13-23
CrossRef625
E. Sjögren, P. Leanderson, M. Kristenson, J. Ernerudh. (2006) Interleukin-6 levels in relation to psychosocial factors: Studies on serum, saliva, and in vitro production by blood mononuclear cells. Brain, Behavior, and Immunity 20:3, 270-278
CrossRef626
Udaya S Tantry, Amena Etherington, Kevin P Bliden, Paul A Gurbel. (2006) Antiplatelet therapy: current strategies and future trends. Future Cardiology 2:3, 343-366
CrossRef627
Rainer Hoffmann, Hasna Suliman, Philipp Haager, Philipp Christott, Wolfgang Lepper, Peter W. Radke, Jan Ortlepp, Rüdiger Blindt, Peter Hanrath, Christian Weber. (2006) Association of C-reactive protein and myocardial perfusion in patients with ST-elevation acute myocardial infarction. Atherosclerosis 186:1, 177-183
CrossRef628
M.-K. Wu, P. M. H. Dummer, P. R. Wesselink. (2006) Consequences of and strategies to deal with residual post-treatment root canal infection. International Endodontic Journal 39:5, 343-356
CrossRef629
S SHIESH, T CHOU, X LIN, P KAO. (2006) Determination of C-reactive protein with an ultra-sensitivity immunochemiluminometric assay. Journal of Immunological Methods 311:1-2, 87-95
CrossRef630
Shunroku Baba, Hiroyasu Iso, Toshifumi Mannami, Satoshi Sasaki, Katsutoshi Okada, Masamitsu Konishi. (2006) Cigarette smoking and risk of coronary heart disease incidence among middle-aged Japanese men and women: the JPHC Study Cohort I. European Journal of Cardiovascular Prevention & Rehabilitation 13:2, 207-213
CrossRef631
Peifeng Hu, Gail A. Greendale, Shana L. Palla, Beth A. Reboussin, David M. Herrington, Elizabeth Barrett-Connor, David B. Reuben. (2006) The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: The postmenopausal estrogen progestin intervention (PEPI) trial. Atherosclerosis 185:2, 347-352
CrossRef632
Sotirios Tsimikas, James T. Willerson, Paul M. Ridker. (2006) C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients. Journal of the American College of Cardiology 47:8, C19-C31
CrossRef633
Giuseppe Derosa, Arrigo F.G. Cicero, Angela D??Angelo, Carmine Tinelli, Leonardina Ciccarelli, Mario N. Piccinni, Fabio Pricolo, Sibilla Salvadeo, Lorenza Montagna, Alessia Gravina, Ilaria Ferrari, Simona Galli, Sonia Paniga, Roberto Fogari. (2006) Effect of Doxazosin on C-Reactive Protein Plasma Levels and on Nitric Oxide in Patients With Hypertension. Journal of Cardiovascular Pharmacology 47:4, 508-512
CrossRef634
D I Chasman, P Kozlowski, R Y Zee, D J Kwiatkowski, P M Ridker. (2006) Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein. Genes and Immunity 7:3, 211-219
CrossRef635
P. Ferroni, S. Basili, V. Paoletti, G. Davì. (2006) Endothelial dysfunction and oxidative stress in arterial hypertension. Nutrition, Metabolism and Cardiovascular Diseases 16:3, 222-233
CrossRef636
G MILIO, E CORRADO, D SORRENTINO, I MURATORI, S LACARRUBBA, G MAZZOLA, R TANTILLO, G VITALE, S MANSUETO, S NOVO. (2006) Asymptomatic Carotid Lesions and Aging: Role of Hypertension and Other Traditional and Emerging Risk Factors. Archives of Medical Research 37:3, 342-347
CrossRef637
Merlin G. Butler, Douglas C. Bittel, Nataliya Kibiryeva, Uttam Garg. (2006) C-reactive protein levels in subjects with Prader-Willi syndrome and obesity. Genetics in Medicine 8:4, 243-248
CrossRef638
Eman M. Alissa, Suhad M. Bahjri, Nabeel Al-ama, Waqar H. Ahmed, Gordon A.A. Ferns. (2006) High cardiovascular risk in young Saudi males: Cardiovascular risk factors, diet and inflammatory markers. Clinica Chimica Acta 365:1-2, 288-296
CrossRef639
Alena Dvořáková-Lorenzová, Pavel Suchánek, Peter J. Havel, Petr Stávek, Ludmila Karasová, Zdenĕk Valenta, Jaroslav Tintĕra, Rudolf Poledne. (2006) The decrease in C-reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma lipids, but not interleukin-6 or adiponectin. Metabolism 55:3, 359-365
CrossRef640
Zhiqiang Wang, Wendy E. Hoy. (2006) Population distribution of high sensitivity C-reactive protein values in Aboriginal Australians: A comparison with other populations. Clinical Biochemistry 39:3, 277-281
CrossRef641
Madhumathi Rao, Bertrand L. Jaber, Vaidyanathapuram S. Balakrishnan. (2006) UNRESOLVED ISSUES IN DIALYSIS: Inflammatory Biomarkers and Cardiovascular Risk: Association or Cause and Effect?. Seminars in Dialysis 19:2, 129-135
CrossRef642
Eun Young Choi, Eal Hwan Park, Yoo Seock Cheong, Insoo Rheem, Seouk Gun Park, Sunmi Yoo. (2006) Association of C-reactive protein with the metabolic risk factors among young and middle-aged Koreans. Metabolism 55:3, 415-421
CrossRef643
Pablo Piñón, Juan Carlos Kaski. (2006) Inflamación, aterosclerosis y riesgo cardiovascular: PAPP-A, Lp-PLA2 y cistatina C. ¿Nuevas aportaciones o información redundante?. Revista Española de Cardiología 59:3, 247-258
CrossRef644
Kailash Prasad. (2006) C-Reactive Protein (CRP)-Lowering Agents. Cardiovascular Drug Reviews 24:1, 33-50
CrossRef645
Eszter Vanky, Kjell Åsmund Salvesen, Henrik Hjorth-Hansen, Kristian Bjerve, Sven Magnus Carlsen. (2006) Beneficial effect of metformin on pregnancy outcome in women with polycystic ovary syndrome is not associated with major changes in C-reactive protein levels or indices of coagulation. Fertility and Sterility 85:3, 770-774
CrossRef646
A Bosy-Westphal, C Geisler, S Onur, O Korth, O Selberg, J Schrezenmeir, M J Müller. (2006) Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors. International Journal of Obesity 30:3, 475-483
CrossRef647
T. Ueland, M. N. Vissers, A. Wiegman, J. Rodenburg, B. Hutten, L. Gullestad, L. Ose, N. Rifai, P. M. Ridker, J. J. P. Kastelein, P. Aukrust, A. G. Semb. (2006) Increased inflammatory markers in children with familial hypercholesterolaemia. European Journal of Clinical Investigation 36:3, 147-152
CrossRef648
Charles J. Lowenstein, Munekazu Yamakuchi. 2006. Statins, Inflammation, and Cardiomyopathy: Old Pathways, New Targets. , 155-166.
CrossRef649
Emil Kozarov, Domenica Sweier, Charles Shelburne, Ann Progulske-Fox, Dennis Lopatin. (2006) Detection of bacterial DNA in atheromatous plaques by quantitative PCR. Microbes and Infection 8:3, 687-693
CrossRef650
Frank R. Stassen, Xavier Vega-Córdova, Inge Vliegen, Cathrien A. Bruggeman. (2006) Immune activation following cytomegalovirus infection: More important than direct viral effects in cardiovascular disease?. Journal of Clinical Virology 35:3, 349-353
CrossRef651
K TAKEBAYASHI, S MATSUMOTO, Y ASO, T INUKAI. (2006) Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients. Journal of Diabetes and its Complications 20:2, 98-104
CrossRef652
Caren McHenry Martin, Jina Almond. (2006) New Frontiers for Cardiac Risk Assessment: C-Reactive Protein. The Consultant Pharmacist 21:3, 188-206
CrossRef653
J Sundell, H Laine, P Nuutila, M Luotolahti, J Knuuti. (2006) Short-term changes in inflammatory response protein (hsCRP) do not parallel with changes in coronary vasoreactivity in obese men. International Journal of Obesity 30:3, 460-467
CrossRef654
Mahmoud Suleiman, Rania Khatib, Yoram Agmon, Riad Mahamid, Monther Boulos, Michael Kapeliovich, Yishai Levy, Rafael Beyar, Walter Markiewicz, Haim Hammerman, Doron Aronson. (2006) Early Inflammation and Risk of Long-Term Development of Heart Failure and Mortality in Survivors of Acute Myocardial Infarction. Journal of the American College of Cardiology 47:5, 962-968
CrossRef655
R. Kalani, S. Judge, C. Carter, M. Pahor, C. Leeuwenburgh. (2006) Effects of Caloric Restriction and Exercise on Age-Related, Chronic Inflammation Assessed by C-Reactive Protein and Interleukin-6. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61:3, 211-217
CrossRef656
A. Koster, H. Bosma, B. W. J. H. Penninx, A. B. Newman, T. B. Harris, J. Th. M. van Eijk, G. I. J. M. Kempen, E. M. Simonsick, K. C. Johnson, R. N. Rooks, H. N. Ayonayon, S. M. Rubin, S. B. Kritchevsky, . (2006) Association of Inflammatory Markers With Socioeconomic Status. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61:3, 284-290
CrossRef657
Omar Serri, Ling Li, Jean-Claude Mamputu, Marie-Claude Beauchamp, Fritz Maingrette, Genevieve Renier. (2006) The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy. Clinical Endocrinology 0:0, 060222010233005
CrossRef658
Lucy M. Browning, Susan A. Jebb. (2006) Nutritional Influences on Inflammation and Type 2 Diabetes Risk. Diabetes Technology & Therapeutics 8:1, 45-54
CrossRef659
Eun-Jung Rhee, Young-Choon Kim, Won-Young Lee, Chan-Hee Jung, Ki-Chul Sung, Seung-Ho Ryu, Ki-Won Oh, Sun-Woo Kim. (2006) Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans. Metabolism 55:2, 183-187
CrossRef660
Steve E. Humphries, Aroon Hingorani. (2006) Pharmacogenetics: Progress, pitfalls and clinical potential for coronary heart disease. Vascular Pharmacology 44:2, 119-125
CrossRef661
M. K. Thomas, D. Narang, R. Lakshmy, R. Gupta, N. Naik, S. K. Maulik. (2006) Correlation Between Inflammation and Oxidative Stress in Normocholesterolemic Coronary Artery Disease Patients ‘on’ and ‘off’ Atorvastatin for Short Time Intervals. Cardiovascular Drugs and Therapy 20:1, 37-44
CrossRef662
Nick Newall, Antony D. Grayson, Aung Y. Oo, Nicholas D. Palmer, Walid C. Dihmis, Abbas Rashid, Rodney H. Stables. (2006) Preoperative White Blood Cell Count is Independently Associated With Higher Perioperative Cardiac Enzyme Release and Increased 1-Year Mortality After Coronary Artery Bypass Grafting. The Annals of Thoracic Surgery 81:2, 583-589
CrossRef663
Kimberly P. Liang, Kelly V. Liang, Eric L. Matteson, Robyn L. McClelland, Teresa J. H. Christianson, Carl Turesson. (2006) Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations. Arthritis & Rheumatism 54:2, 642-648
CrossRef664
W.P. Hu, H.-Y. Hsu, A. Chiou, K.Y. Tseng, H.-Y. Lin, G.L. Chang, S.-J. Chen. (2006) Immunodetection of pentamer and modified C-reactive protein using surface plasmon resonance biosensing. Biosensors and Bioelectronics 21:8, 1631-1637
CrossRef665
Susanne B. Schwedler, János G. Filep, Jan Galle, Christoph Wanner, Lawrence A. Potempa. (2006) C-Reactive Protein: A Family of Proteins to Regulate Cardiovascular Function. American Journal of Kidney Diseases 47:2, 212-222
CrossRef666
R. EZZAHIRI, F. R. M. STASSEN, H. R. M. KURVERS, V. DOLMANS, P. J. E. H. M. KITSLAAR, C. A. BRUGGEMAN. (2006) Chlamydia pneumoniae infections augment atherosclerotic lesion formation: a role for serum amyloid P. APMIS 114:2, 117-126
CrossRef667
Andreas Pfützner, Thomas Forst. (2006) High-Sensitivity C-Reactive Protein as Cardiovascular Risk Marker in Patients with Diabetes Mellitus. Diabetes Technology & Therapeutics 8:1, 28-36
CrossRef668
K. M. A. Welch, Avery W. Brandes, Lauren Salerno, Jan Lewis Brandes. (2006) C-Reactive Protein May Be Increased in Migraine Patients Who Present With Complex Clinical Features. Headache: The Journal of Head and Face Pain 46:2, 197-199
CrossRef669
Dogan Erdogan, Hakan Gullu, Erkan Yildirim, Derya Tok, Ismail Kirbas, Ozgur Ciftci, Semra Topcu Baycan, Haldun Muderrisoglu. (2006) Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis 184:2, 431-437
CrossRef670
Cam Patterson, George A Stouffer. 2006. Atherosclerosis. .
CrossRef671
Kang Hyeon Choe. (2006) Complications of Chronic Obstructive Pulmonary Disease. Journal of the Korean Medical Association 49:4, 321
CrossRef672
Satoru Yamada, Tatsuo Yanagawa, Kazuo Sasamoto, Atsushi Araki, Mariko Miyao, Toshikazu Yamanouchi. (2006) Atorvastatin lowers plasma low-density lipoprotein cholesterol and C-reactive protein in Japanese type 2 diabetic patients. Metabolism 55:1, 67-71
CrossRef673
Vincenzo Panichi, Daniele Taccola, Giovanni Manca Rizza, Cristina Consani, Lorenzo Ghiadoni, Cristina Filippi, Renza Cristofani, Erica Panicucci, Massimiliano Migliori, Antonino Sidoti, Marina Biagioli, Donella Boracelli, Giuliano Barsotti, Ciro Tetta. (2006) Interleukin-8 Is a Powerful Prognostic Predictor of All-Cause and Cardiovascular Mortality in Dialytic Patients. Nephron Clinical Practice 102:2, c51-c58
CrossRef674
Cam Patterson, Marschall S. Runge. 2006. Aterosclerosis coronaria. , 18-28.
CrossRef675
Hisashi Kon, Masahide Nagano, Fumitaka Tanaka, Kenyu Satoh, Toshie Segawa, Motoyuki Nakamura. (2006) Association of Decreased Variation of R-R Interval and Elevated Serum C-Reactive Protein Level in a General Population in Japan. International Heart Journal 47:6, 867-876
CrossRef676
Chang Won Won, Sang Won Lee, Hyun Rim Choi, Byung Sung Kim, Hye Soon Park, Michi Yukawa. (2006) Body Mass Index and C-Reactive Protein in the Healthy Korean Aged Men. Journal of Korean Medical Science 21:5, 811
CrossRef677
Jeetesh V Patel, Hoong Sern Lim, Sunil Nadar, Muzahir Tayebjee, Elizabeth A Hughes, Gregory YH Lip. (2006) Abnormal soluble CD40 ligand and C-reactive protein concentrations in hypertension: relationship to indices of angiogenesis. Journal of Hypertension 24:1, 117-121
CrossRef678
Atsushi Satomura, Morito Endo, Takayuki Fujita, Hiroyuki Ohi, Isao Ohsawa, Yoshinobu Fuke, Koichi Matsumoto, Sukemasa Sudo, Misao Matsushita, Teizo Fujita. (2006) Serum Mannose-Binding Lectin Levels in Maintenance Hemodialysis Patients: Impact on All-Cause Mortality. Nephron Clinical Practice 102:3-4, c93-c99
CrossRef679
Eric P Plaisance, Peter W Grandjean. (2006) Physical Activity and High-Sensitivity C-Reactive Protein. Sports Medicine 36:5, 443-458
CrossRef680
Lidija Memon, Vesna Spasojevic-Kalimanovska, Nataša Bogavac-Stanojevic, Dimitra Kalimanovska-Oštric, Zorana Jelic-Ivanovic, Slavica Spasic, Aleksandra Topic. (2006) Association of C-Reactive Protein with the Presence and Extent of Angiographically Verified Coronary Artery Disease. The Tohoku Journal of Experimental Medicine 209:3, 197-206
CrossRef681
Jae-Ho Jeong, Jae-Woo Lim, Eun-Jeong Cheon, Kyong-Og Ko, Young-Hyuk Lee. (2006) Serum high sensitivity C-reactive protein levels in obese middle school boys. Korean Journal of Pediatrics 49:6, 617
CrossRef682
Ciro TETTA, Salvatore DAVID, Daniele MARCELLI, Paolo COGLIATI, Marco FORMICA, Paola INGUAGGIATO, Vincenzo PANICHI. (2006) Clinical effects of online dialysate and infusion fluids. Hemodialysis International 10:s1, S60-S66
CrossRef683
Jose A. DIAZ-BUXO, H. Feidhlim WOODS. (2006) Protecting the endothelium: A new focus for management of chronic kidney disease. Hemodialysis International 10:1, 42-48
CrossRef684
Timo Lenderink, Christopher Heeschen, Stephan Fichtlscherer, Stefanie Dimmeler, Christian W. Hamm, Andreas M. Zeiher, Maarten L. Simoons, Eric Boersma. (2006) Elevated Placental Growth Factor Levels Are Associated With Adverse Outcomes at Four-Year Follow-Up in Patients With Acute Coronary Syndromes. Journal of the American College of Cardiology 47:2, 307-311
CrossRef685
Manuel Feria, Federico Díaz-González. (2006) The CCR2 receptor as a therapeutic target. Expert Opinion on Therapeutic Patents 16:1, 49-57
CrossRef686
Inger Vikholm-Lundin, Willem M. Albers. (2006) Site-directed immobilisation of antibody fragments for detection of C-reactive protein. Biosensors and Bioelectronics 21:7, 1141-1148
CrossRef687
Fabio Monzani, Angela Dardano, Nadia Caraccio. (2006) Does Treating Subclinical Hypothyroidism Improve Markers of Cardiovascular Risk?. Treatments in Endocrinology 5:2, 65-81
CrossRef688
Filiz Kuralay, Emel Altekin, Ayten Sayin Yazlar, Banu Onvural, Ozhan Goldeli. (2006) Suppression of Angioplasty-Related Inflammation by Pre-Procedural Treatment with Trimetazidine. The Tohoku Journal of Experimental Medicine 208:3, 203-212
CrossRef689
Edward C. Suarez. (2006) Sex Differences in the Relation of Depressive Symptoms, Hostility, and Anger Expression to Indices of Glucose Metabolism in Nondiabetic Adults.. Health Psychology 25:4, 484-492
CrossRef690
Konstantinos Tziomalos, Vasilios G Athyros. (2006) Fenofibrate: a novel formulation (Triglide?) in the treatment of lipid disorders: a review. International Journal of Nanomedicine 1:2, 129-147
CrossRef691
Yoshihiro Seo, Shigeyuki Watanabe, Tomoko Ishizu, Naoko Moriyama, Noriyuki Takeyasu, Hiroshi Maeda, Toshiyuki Ishimitsu, Kazutaka Aonuma, Iwao Yamaguchi. (2006) Echolucent Carotid Plaques as a Feature in Patients With Acute Coronary Syndrome. Circulation Journal 70:12, 1629-1634
CrossRef692
M PARK, J MIN, S KOH, B KIM, M PARK, K PARK, D LEE. (2006) Helicobacter pylori infection and the CD14 C(−260)T gene polymorphism in ischemic stroke. Thrombosis Research 118:6, 671-677
CrossRef693
Ljiljana Sevic, Milos Maksimovic, Nebojsa Djurisic, Milan Gajic, Jagoda Jorga. (2006) Relationship between nutritional status and some inflammatory markers. Srpski arhiv za celokupno lekarstvo 134:1-2, 54-59
CrossRef694
Kohzo Takebayashi, Mariko Suetsugu, Rika Matsutomo, Sadao Wakabayashi, Yoshimasa Aso, Toshihiko Inukai. (2006) Correlation of High-sensitivity C-reactive Protein and Plasma Fibrinogen with Individual Complications in Patients with Type 2 Diabetes. Southern Medical Journal 99:1, 23-27
CrossRef695
Frank M. van der Sande, Jeroen P. Kooman, Karel M.L. Leunissen. (2006) The Predictive Value of C-Reactive Protein in End-Stage Renal Disease: Is It Clinically Significant?. Blood Purification 24:4, 335-341
CrossRef696
Kevin D. O’Brien, Alan Chait. (2006) Serum amyloid A: The “other” inflammatory protein. Current Atherosclerosis Reports 8:1, 62-68
CrossRef697
João Egidio Romão Jr., Adlei Rogério Haiashi, Rosilene Mota Elias, Cláudio Luders, Rosiani Ferraboli, Manoel Carlos Martins Castro, Hugo Abensur. (2006) Positive Acute-Phase Inflammatory Markers in Different Stages of Chronic Kidney Disease. American Journal of Nephrology 26:1, 59-66
CrossRef698
Ahmad A. Elesber, Ahmad A. Elesber, Patricia J. Best, Ahmad A. Elesber, Patricia J. Best, Ryan J. Lennon, Ahmad A. Elesber, Patricia J. Best, Ryan J. Lennon, Verghese Mathew, Ahmad A. Elesber, Patricia J. Best, Ryan J. Lennon, Verghese Mathew, Charanjit S. Rihal, Ahmad A. Elesber, Patricia J. Best, Ryan J. Lennon, Verghese Mathew, Charanjit S. Rihal, Lilach O. Lerman, Ahmad A. Elesber, Patricia J. Best, Ryan J. Lennon, Verghese Mathew, Charanjit S. Rihal, Lilach O. Lerman, Amir Lerman, Ahmad A. Elesber, Patricia J. Best, Ryan J. Lennon, Verghese Mathew, Charanjit S. Rihal, Lilach O. Lerman, Amir Lerman. (2006) Plasma 8-iso-prostaglandin F 2α , a marker of oxidative stress, is increased in patients with acute myocardial infarction. Free Radical Research 40:4, 385-391
CrossRef699
Markus Exner, Marianne Raith, Gregor Holzer, Bernhard Gmeiner, Oswald Wagner, Stylianos Kapiotis. (2006) Anti-Inflammatory Mechanisms of the Tibetan Herbal Preparation Padma 28 in the Vessel Wall. Forschende Komplementärmedizin / Research in Complementary Medicine 13:1, 13-17
CrossRef700
Y UNLU, S KARAPOLAT, Y KARACA, A KIZILTUNC. (2006) Comparison of levels of inflammatory markers and hemostatic factors in the patients with and without peripheral arterial disease. Thrombosis Research 117:4, 357-364
CrossRef701
Tiziana Sampietro, Federico Bigazzi, Mariarita Puntoni, Alberto Bionda. (2006) HDL inflammation and atherosclerosis: current and future perspectives. Future Cardiology 2:1, 37-48
CrossRef702
Robert F. Ritchie, Glenn E. Palomaki, Louis M. Neveux, Thomas B. Ledue, Wendy Y. Craig, Santica Marcovina, Olga Navolotskaia. (2006) Reference distributions for apolipoproteins AI and B and the apolipoprotein B/AI ratios: a practical and clinically relevant approach in a large cohort. Journal of Clinical Laboratory Analysis 20:5, 209-217
CrossRef703
Meltem Caglar, Babak Mahmoudian, Kudret Aytemir, Serkan Kahraman, Mustafa Arc, Giray Kabakc, Erdem Karabulut. (2006) Value of 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) gated SPECT for the detection of silent myocardial ischemia in hemodialysis patients: clinical variables associated with abnormal test results. Nuclear Medicine Communications 27:1, 61-69
CrossRef704
Ruba S. Deeb, Hao Shen, Caryn Gamss, Tatyana Gavrilova, Barbara D. Summers, Rosemary Kraemer, Gang Hao, Steven S. Gross, Muriel Lainé, Nobuyo Maeda, David P. Hajjar, Rita K. Upmacis. (2006) Inducible Nitric Oxide Synthase Mediates Prostaglandin H2 Synthase Nitration and Suppresses Eicosanoid Production. The American Journal of Pathology 168:1, 349-362
CrossRef705
Shuntaro FUJIOKA, Kei HAMAZAKI, Miho ITOMURA, Mingming HUAN, Hiroto NISHIZAWA, Shigeki SAWAZAKI, Isao KITAJIMA, Tomohito HAMAZAKI. (2006) The Effects of Eicosapentaenoic Acid-Fortified Food on Inflammatory Markers in Healthy Subjects-A Randomized, Placebo-Controlled, Double-Blind Study. Journal of Nutritional Science and Vitaminology 52:4, 261-265
CrossRef706
Zorica Caparevic, Nada Kostic, Sanja Ilic, Dragos Stojanovic, Ana Ivanovic. (2006) Oxidized LDL and C-reactive protein as markers for detection of accelerated atherosclerosis in type 2 diabetes. Medicinski pregled 59:3-4, 160-164
CrossRef707
Stefan Anker, Stephan von Haehling. 2005. Statins. , 425-450.
CrossRef708
S. Silber, B. M. Richartz. (2005) Stellenwert von Kardio-CT und Kardio-MR zur Bestimmung des koronaren Risikos. Zeitschrift für Kardiologie 94:S4, iv70-iv80
CrossRef709
Mukesh K. Jain, Paul M. Ridker. (2005) Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms. Nature Reviews Drug Discovery 4:12, 977-987
CrossRef710
Gérard Siest, Jean-Brice Marteau, Sandy Maumus, Hind Berrahmoune, Elise Jeannesson, Anastasia Samara, Anne-Marie Batt, Sophie Visvikis-Siest. (2005) Pharmacogenomics and cardiovascular drugs: Need for integrated biological system with phenotypes and proteomic markers. European Journal of Pharmacology 527:1-3, 1-22
CrossRef711
Scott Kinlay. (2005) Potential vascular benefits of statins. The American Journal of Medicine 118:12, 62-67
CrossRef712
Gurushankar Govindarajan, Adam Whaley-Connell, Maryann Mugo, Craig Stump, James R Sowers. (2005) The Cardiometabolic Syndrome as a Cardiovascular Risk Factor. The American Journal of the Medical Sciences 330:6, 311-318
CrossRef713
A-C Santos, C Lopes, J T Guimarães, H Barros. (2005) Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome. International Journal of Obesity 29:12, 1452-1456
CrossRef714
Jorge L Sepulveda, Jawahar L Mehta. (2005) C-reactive protein and cardiovascular disease: a critical appraisal. Current Opinion in Internal Medicine 4:6, 561-570
CrossRef715
Sung Hee Choi, Hyeon Chang Kim, Chul Woo Ahn, Hong Keun Cho, Bong Soo Cha, Yoon-Sok Chung, Kwan Woo Lee, Hyun Chul Lee, Kap Bum Huh, Dae-Jung Kim. (2005) Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?. European Journal of Cardiovascular Prevention & Rehabilitation 12:6, 548-554
CrossRef716
James K Liao. (2005) Clinical implications for statin pleiotropy. Current Opinion in Lipidology 16:6, 624-629
CrossRef717
Patrick A. O??Callaghan, Anthony Fitzgerald, Jane Fogarty, Peter Gaffney, Moira Hanbidge, Gerald Boran, Helen Enright, Jane Murphy, Brendan McCarthy, Ian M. Graham. (2005) New and old cardiovascular risk factors: C-reactive protein, homocysteine, cysteine and von Willebrand factor increase risk, especially in smokers. European Journal of Cardiovascular Prevention & Rehabilitation 12:6, 542-547
CrossRef718
José Carlos Arévalo-Lorido, Juana Carretero-Gómez, José María Calvo- Romero, Jorge Manuel Romero-Requena, Juan Luis Pérez-Alonso, Concepción Gutiérrez-Montaño, Carmen Ortiz-Descane. (2005) Proteína C reactiva en la fase aguda del ictus. Medicina Clínica 125:20, 766-769
CrossRef719
Saad Hafidh, Neelavathi Senkottaiyan, Daniel Villarreal, Martin A. Alpert. (2005) Management of the Metabolic Syndrome. The American Journal of the Medical Sciences 330:6, 343-351
CrossRef720
Jakob Østergaard, Troels Krarup Hansen, Steffen Thiel, Allan Flyvbjerg. (2005) Complement activation and diabetic vascular complications. Clinica Chimica Acta 361:1-2, 10-19
CrossRef721
Ricardo Lauzurica, Cruz Pastor, Beatriz Bay??s, Jose Maria Hern??ndez, Ramon Romero. (2005) Pretransplant Pregnancy-Associated Plasma Protein-A as a Predictor of Chronic Allograft Nephropathy and Posttransplant Cardiovascular Events. Transplantation 80:10, 1441-1446
CrossRef722
M. K. Heliovaara, A.-M. Teppo, S. L. Karonen, J. A. Tuominen, P. Ebeling. (2005) Plasma IL-6 concentration is inversely related to insulin sensitivity, and acute-phase proteins associate with glucose and lipid metabolism in healthy subjects. Diabetes, Obesity and Metabolism 7:6, 729-736
CrossRef723
Liangqi Xie, Lina Chang, Youfei Guan, Xian Wang. (2005) C-Reactive Protein Augments Interleukin-8 Secretion in Human Peripheral Blood Monocytes. Journal of Cardiovascular Pharmacology 46:5, 690-696
CrossRef724
Geoffrey S. Ginsburg, Mark P. Donahue, L. Kristin Newby. (2005) Prospects for Personalized Cardiovascular Medicine. Journal of the American College of Cardiology 46:9, 1615-1627
CrossRef725
Daniel E. Rosenberg, Serge A. Jabbour, Barry J. Goldstein. (2005) Insulin resistance, diabetes and cardiovascular risk: approaches to treatment. Diabetes, Obesity and Metabolism 7:6, 642-653
CrossRef726
Adam Young. (2005) Early Rheumatoid Arthritis. Rheumatic Disease Clinics of North America 31:4, 659-679
CrossRef727
D. T. Miller, R. Y. L. Zee, J. Suk Danik, P. Kozlowski, D. I. Chasman, R. Lazarus, N. R. Cook, P. M. Ridker, D. J. Kwiatkowski. (2005) Association of Common CRP Gene Variants with CRP Levels and Cardiovascular Events. Annals of Human Genetics 69:6, 623-638
CrossRef728
Annika Smedman, Samar Basu, Stefan Jovinge, Gunilla Nordin Fredrikson, Bengt Vessby. (2005) Conjugated linoleic acid increased C-reactive protein in human subjects. British Journal of Nutrition 94:05, 791
CrossRef729
A EILERTSEN, E HOIBRAATEN, I OS, T ANDERSEN, L SANDVIK, P SANDSET. (2005) The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis. Maturitas 52:2, 111-118
CrossRef730
T. Heitzer, T. Meinertz. (2005) Rauchen und koronare Herzkrankheit. Zeitschrift für Kardiologie 94:S3, iii30-iii42
CrossRef731
M. Stagmo, S. Juul-Moller, B. Israelsson. (2005) Fifteen-year risk of major coronary events predicted by Holter ST-monitoring in asymptomatic middle-aged men. European Journal of Cardiovascular Prevention & Rehabilitation 12:5, 478-483
CrossRef732
Emilio Chiurlia, Roberto D’Amico, Carlo Ratti, Antonio R. Granata, Renato Romagnoli, Maria G. Modena. (2005) Subclinical Coronary Artery Atherosclerosis in Patients With Erectile Dysfunction. Journal of the American College of Cardiology 46:8, 1503-1506
CrossRef733
Ian T. Meredith, Julie C. Plunkett, Stephen G. Worthley, Sarah A. Hope, James D. Cameron. (2005) Systemic inflammatory markers in acute coronary syndrome: association with cardiovascular risk factors and effect of early lipid lowering. Coronary Artery Disease 16:7, 415-422
CrossRef734
Sonia Waiczies, Timour Prozorovski, Frauke Zipp. (2005) Modulating T cell signaling cascades by HMG-CoA reductase inhibitors. Signal Transduction 5:5, 231-244
CrossRef735
Pål Aukrust, Arne Yndestad, Camilla Smith, Wiggo J Sandberg, Thor Ueland, Torgun Wæhre, Bente Halvorsen, Lars Gullestad, Jan Kristian Damås. (2005) Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisation. Expert Opinion on Pharmacotherapy 6:13, 2169-2180
CrossRef736
E RODILLA. (2005) Variaciones de la proteína C reactiva inducidas por el tratamiento antihipertensivo e hipolipemiante
CrossRef737
M. Flores-Aldana, O. Peralta-Zaragoza, S. Barquera-Cervera. (2005) El paradigma inmune Th1-Th2: un vínculo entre obesidad, aterosclerosis y diabetes mellitus. Clínica e Investigación en Arteriosclerosis 17:5, 232-248
CrossRef738
Cecilia P. Chung, Annette Oeser, Paolo Raggi, Tebeb Gebretsadik, Ayumi K. Shintani, Tuulikki Sokka, Theodore Pincus, Ingrid Avalos, C. Michael Stein. (2005) Increased coronary-artery atherosclerosis in rheumatoid arthritis: Relationship to disease duration and cardiovascular risk factors. Arthritis & Rheumatism 52:10, 3045-3053
CrossRef739
Kausik K. Ray, Christopher P. Cannon, Richard Cairns, David A. Morrow, Nader Rifai, Ajay J. Kirtane, Carolyn H. McCabe, Allan M. Skene, C. Michael Gibson, Paul M. Ridker, Eugene Braunwald. (2005) Relationship Between Uncontrolled Risk Factors and C-Reactive Protein Levels in Patients Receiving Standard or Intensive Statin Therapy for Acute Coronary Syndromes in the PROVE IT-TIMI 22 Trial. Journal of the American College of Cardiology 46:8, 1417-1424
CrossRef740
L MARQUARDT, A RUF, U MANSMANN, R WINTER, F BUGGLE, K KALLENBERG, A GRAU. (2005) Inflammatory response after acute ischemic stroke. Journal of the Neurological Sciences 236:1-2, 65-71
CrossRef741
E. A. Asbury, P. Collins. (2005) Cardiac syndrome X. International Journal of Clinical Practice 59:9, 1063-1069
CrossRef742
Timur Pırıldar, Canan Tıkız, Sabriye Özkaya, Serdar Tarhan, Ozan Ütük, Hakan Tıkız, Uğur Kemal Tezcan. (2005) Endothelıal dysfunctıon ın patıents wıth prımary Sjögren’s syndrome. Rheumatology International 25:7, 536-539
CrossRef743
M. Serrano–Martinez, M. Palacios, E. Martinez–Losa, R. Lezaun, C. Maravi, M. Prado, J. A. MartÍnez, M. A. Martinez–Gonzalez. (2005) A Mediterranean dietary style influences TNF–alpha and VCAM–1 coronary blood levels in unstable angina patients. European Journal of Nutrition 44:6, 348-354
CrossRef744
Peter J. Mason, Alice K. Jacobs, Jane E. Freedman. (2005) Aspirin Resistance and Atherothrombotic Disease. Journal of the American College of Cardiology 46:6, 986-993
CrossRef745
Charles N. Serhan. (2005) Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins, Leukotrienes and Essential Fatty Acids 73:3-4, 141-162
CrossRef746
Stephan J. L. Bakker, Ron T. Gansevoort, Erik M. Stuveling, Rijk O. B. Gans, Dick Zeeuw. (2005) Microalbuminuria and C-reactive protein: Similar messengers of cardiovascular risk?. Current Hypertension Reports 7:5, 379-384
CrossRef747
Edward T. H. Yeh. (2005) High-sensitivity C-reactive protein as a risk assessment tool for cardiovascular disease. Clinical Cardiology 28:9, 408-412
CrossRef748
Nigel J. Dagenais, Fakhreddin Jamali. (2005) Protective Effects of Angiotensin II Interruption: Evidence for Antiinflammatory Actions. Pharmacotherapy 25:9, 1213-1229
CrossRef749
G. Ravaglia, P. Forti, F. Maioli, N. Brunetti, M. Martelli, L. Servadei, L. Bastagli, M. Bianchin, E. Mariani. (2005) Serum C-Reactive Protein and Cognitive Function in Healthy Elderly Italian Community Dwellers. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60:8, 1017-1021
CrossRef750
G. Targher, L. Bertolini, G. Zoppini, L. Zenari, G. Falezza. (2005) Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy. Diabetic Medicine 22:8, 999-1004
CrossRef751
ALLON N FRIEDMAN, LAWRENCE G HUNSICKER, JACOB SELHUB, ANDREW G BOSTOM. (2005) C-reactive protein as a predictor of total arteriosclerotic outcomes in type 2 diabetic nephropathy. Kidney International 68:2, 773-778
CrossRef752
Marcus H Snow, Ted R Mikuls. (2005) Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention. Current Opinion in Internal Medicine 4:4, 423-430
CrossRef753
J IZQUIERDOALONSO, R ARROYOESPLIGUERO. (2005) EPOC y riesgo cardiovascular. Archivos de Bronconeumología 41:8, 410-412
CrossRef754
Omer Ozcan, Erdinc Cakir, Halil Yaman, Emin Ozgur Akgul, Kivilcim Erturk, Zeynel Beyhan, Cumhur Bilgi, Mehmet Kemal Erbil. (2005) The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism. Clinical Endocrinology 63:2, 203-206
CrossRef755
Tryfon Vainas, Frank R.M. Stassen, Rick de Graaf, Eric L.L. Twiss, Selma B. Herngreen, Rob J. Th.J. Welten, Luc H.J.M. van den Akker, Marja P. van Dieijen-Visser, Cathrien A. Bruggeman, Peter J.E.H.M. Kitslaar. (2005) C-reactive protein in peripheral arterial disease: Relation to severity of the disease and to future cardiovascular events. Journal of Vascular Surgery 42:2, 243-251
CrossRef756
Nicola J. Goodson, Deborah P. M. Symmons, David G. I. Scott, Diane Bunn, Mark Lunt, Alan J. Silman. (2005) Baseline levels of c-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis : A ten-year followup study of a primary care-based inception cohort. Arthritis & Rheumatism 52:8, 2293-2299
CrossRef757
E KANG, H KIM, C AHN, C PARK, B CHA, S LIM, K KIM, H LEE. (2005) Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes. Diabetes Research and Clinical Practice 69:2, 151-159
CrossRef758
Howard S. Weintraub. (2005) Treatment of multiple-risk patients: Using combination therapy to treat beyond LDL lowering. Current Hypertension Reports 7:4, 265-270
CrossRef759
Masaki Ohsawa, Akira Okayama, Motoyuki Nakamura, Toshiyuki Onoda, Karen Kato, Kazuyoshi Itai, Yuki Yoshida, Akira Ogawa, Kazuko Kawamura, Katsuhiko Hiramori. (2005) CRP levels are elevated in smokers but unrelated to the number of cigarettes and are decreased by long-term smoking cessation in male smokers. Preventive Medicine 41:2, 651-656
CrossRef760
Amit Khera, Darren K. McGuire, Sabina A. Murphy, Harold G. Stanek, Sandeep R. Das, Wanpen Vongpatanasin, Frank H. Wians, Scott M. Grundy, James A. de Lemos. (2005) Race and Gender Differences in C-Reactive Protein Levels. Journal of the American College of Cardiology 46:3, 464-469
CrossRef761
Mitchell S.V. Elkind, Robert R. Sciacca, Bernadette Boden-Albala, Maria Lucia C. Tondella, Daniel R. Feikin, Barry S. Fields, Ralph L. Sacco, Marco R. Di Tullio, Shunichi Homma. (2005) Leukocyte count is associated with reduced endothelial reactivity. Atherosclerosis 181:2, 329-338
CrossRef762
(2005) Inflammation, Atherosclerosis, and Coronary Artery Disease. New England Journal of Medicine 353:4, 429-430
Full Text763
P. J. Skerrett, Charles H. Hennekens. 2005. Physicians' Health Study. .
CrossRef764
D A Duprez, P E Somasundaram, G Sigurdsson, L Hoke, N Florea, J N Cohn. (2005) Relationship between C-reactive protein and arterial stiffness in an asymptomatic population. Journal of Human Hypertension 19:7, 515-519
CrossRef765
Wendy M Miller, Katherine E Nori Janosz, Jose Yanez, Peter A McCullough. (2005) Effects of weight loss and pharmacotherapy on inflammatory markers of cardiovascular disease. Expert Review of Cardiovascular Therapy 3:4, 743-759
CrossRef766
M J Hommels, A J A M van der Ven, A A Kroon, A G H Kessels, M P van Dieijen-Visser, J A M van Engelshoven, C A Bruggeman, P W de Leeuw. (2005) C-reactive protein, atherosclerosis and kidney function in hypertensive patients. Journal of Human Hypertension 19:7, 521-526
CrossRef767
Arnold von Eckardstein. (2005) Besteht Bedarf an neuen kardiovaskulären Risikofaktoren? Is there a need for new cardiovascular risk factors?. LaboratoriumsMedizin 29:3, 146-151
CrossRef768
Alfonso M. Cueto-Manzano, Luis E. Morales-Buenrostro, Liliana Gonz??lez-Espinoza, Norma Gonz??lez-Tableros, Fabiola Mart??n-del-Campo, Ricardo Correa-Rotter, Isela Valera, Josefina Alber??. (2005) Markers of Inflammation Before and After Renal Transplantation. Transplantation 80:1, 47-51
CrossRef769
Christopher S. Carlson, Shelley Force Aldred, Philip K. Lee, Russell P. Tracy, Stephen M. Schwartz, Mark Rieder, Kiang Liu, O. Dale Williams, Carlos Iribarren, E. Cora Lewis, Myriam Fornage, Eric Boerwinkle, Myron Gross, Cashell Jaquish, Deborah A. Nickerson, Richard M. Myers, David S. Siscovick, Alexander P. Reiner. (2005) Polymorphisms within the C-Reactive Protein (CRP) Promoter Region Are Associated with Plasma CRP Levels. The American Journal of Human Genetics 77:1, 64-77
CrossRef770
J. Helmersson, A. Larsson, B. Vessby, S. Basu. (2005) Active smoking and a history of smoking are associated with enhanced prostaglandin F2α, interleukin-6 and F2-isoprostane formation in elderly men. Atherosclerosis 181:1, 201-207
CrossRef771
Teruo Inoue, Toru Kato, Toshihiko Uchida, Masashi Sakuma, Atsuko Nakajima, Mitsuei Shibazaki, Yoshitaka Imoto, Masahiko Saito, Shigemasa Hashimoto, Yutaka Hikichi, Koichi Node. (2005) Local Release of C-Reactive Protein From Vulnerable Plaque or Coronary Arterial Wall Injured by Stenting. Journal of the American College of Cardiology 46:2, 239-245
CrossRef772
Yadon Arad, Kenneth J. Goodman, Marguerite Roth, David Newstein, Alan D. Guerci. (2005) Coronary Calcification, Coronary Disease Risk Factors, C-Reactive Protein, and Atherosclerotic Cardiovascular Disease Events. Journal of the American College of Cardiology 46:1, 158-165
CrossRef773
CARSTEN A BÖGER, ANGELA GÖTZ, MIKE STUBANUS, BERNHARD BANAS, MARTINA DEINZER, BERND KRÜGER, STEPHAN R HOLMER, GERD SCHMITZ, GÜNTER A J RIEGGER, BERNHARD K KRÄMER. (2005) C-reactive protein as predictor of death in end-stage diabetic nephropathy: Role of peripheral arterial disease. Kidney International 68:1, 217-227
CrossRef774
C M McEniery, I B Wilkinson. (2005) Large artery stiffness and inflammation. Journal of Human Hypertension 19:7, 507-509
CrossRef775
Duanping Liao, Gerardo Heiss, Vernon M Chinchilli, Yinkang Duan, Aaron R Folsom, Hung-Mo Lin, Veikko Salomaa. (2005) Association of criteria pollutants with plasma hemostatic/inflammatory markers: a population-based study. Journal of Exposure Analysis and Environmental Epidemiology 15:4, 319-328
CrossRef776
Sang Wook Oh, Jung Dae Moon, Sang Yeol Park, Heuk Jae Jang, Jae Hoon Kim, Ki Bong Nahm, Eui Yul Choi. (2005) Evaluation of fluorescence hs-CRP immunoassay for point-of-care testing. Clinica Chimica Acta 356:1-2, 172-177
CrossRef777
J. FROSTEGARD. (2005) SLE, atherosclerosis and cardiovascular disease. Journal of Internal Medicine 257:6, 485-495
CrossRef778
Peter A. McCullough. (2005) Evaluation and treatment of coronary artery disease in patients with end-stage renal disease. Kidney International 67:s95, s51-s58
CrossRef779
Michael J.A. Williams, Barry J. Milne, Robert J. Hancox, Richie Poulton. (2005) C-reactive protein and cardiorespiratory fitness in young adults. European Journal of Cardiovascular Prevention & Rehabilitation 12:3, 216-220
CrossRef780
Stanley S. Levinson. (2005) Brief review and critical examination of the use of hs-CRP for cardiac risk assessment with the conclusion that it is premature to use this test. Clinica Chimica Acta 356:1-2, 1-8
CrossRef781
Hsu-Ko Kuo, Chung-Jen Yen, Chia-Hsuin Chang, Chen-Ko Kuo, Jen-Hau Chen, Farzaneh Sorond. (2005) Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. The Lancet Neurology 4:6, 371-380
CrossRef782
Undurti N. Das. (2005) Pathophysiology of metabolic syndrome X and its links to the perinatal period. Nutrition 21:6, 762-773
CrossRef783
Patricia J. Manns, Jeffrey A. McCubbin, Daniel P. Williams. (2005) Fitness, Inflammation, and the Metabolic Syndrome in Men With Paraplegia. Archives of Physical Medicine and Rehabilitation 86:6, 1176-1181
CrossRef784
Dana E. King. (2005) Dietary fiber, inflammation, and cardiovascular disease. Molecular Nutrition & Food Research 49:6, 594-600
CrossRef785
A. J. Szalai, J. Wu, E. M. Lange, M. A. McCrory, C. D. Langefeld, A. Williams, S. O. Zakharkin, V. George, D. B. Allison, G. S. Cooper, F. Xie, Z. Fan, J. C. Edberg, R. P. Kimberly. (2005) Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. Journal of Molecular Medicine 83:6, 440-447
CrossRef786
Atsushi Tanaka, Kenei Shimada, Toshihiko Sano, Masashi Namba, Tsunemori Sakamoto, Yukio Nishida, Takahiko Kawarabayashi, Daiju Fukuda, Junichi Yoshikawa. (2005) Multiple Plaque Rupture and C-Reactive Protein in Acute Myocardial Infarction. Journal of the American College of Cardiology 45:10, 1594-1599
CrossRef787
Tien Yin Wong, Rachel McIntosh. (2005) Systemic associations of retinal microvascular signs: a review of recent population-based studies. Ophthalmic and Physiological Optics 25:3, 195-204
CrossRef788
Masahide Nagano, Motoyuki Nakamura, Kenyu Sato, Fumitaka Tanaka, Toshie Segawa, Katsuhiko Hiramori. (2005) Association between serum C-reactive protein levels and pulse wave velocity: a population-based cross-sectional study in a general population. Atherosclerosis 180:1, 189-195
CrossRef789
Mandana Nikpour, Murray B. Urowitz, Dafna D. Gladman. (2005) Premature Atherosclerosis in Systemic Lupus Erythematosus. Rheumatic Disease Clinics of North America 31:2, 329-354
CrossRef790
Madhumathi Rao, Bertrand L. Jaber, Vaidyanathapuram S. Balakrishnan, . (2005) Genetics in Dialysis
Series Editors: Bertrand L. Jaber and Vaidyanathapuram S. Balakrishnan: Gene Polymorphism Association Studies in Dialysis: Cardiovascular Disease. Seminars in Dialysis 18:3, 217-225
CrossRef791
A. Due, S. Toubro, S. Stender, A. R. Skov, A. Astrup. (2005) The effect of diets high in protein or carbohydrate on inflammatory markers in overweight subjects. Diabetes, Obesity and Metabolism 7:3, 223-229
CrossRef792
J. R. TIMMER, J. P. OTTERVANGER, J. C. A. HOORNTJE, M.-J. BOER, H. SURYAPRANATA, A. W. J. HOF, F. ZIJLSTRA, . (2005) Prognostic value of erythrocyte sedimentation rate in ST segment elevation myocardial infarction: interaction with hyperglycaemia. Journal of Internal Medicine 257:5, 423-429
CrossRef793
Juan Carlos Ayus, Steven G. Achinger. (2005) Editorial Focus: Transplant Nephrectomy: At the Peril of Dialysis Patients: Ignoring the Failed Transplant. Seminars in Dialysis 18:3, 180-184
CrossRef794
Ilyas Atar, Öykü Gülmez, Asli Atar, Hüseyin Bozbas, Aylin Yildirir, Bülent Özin, Mehmet Emin Korkmaz, Haldun Müderrisoglu. (2005) The effects of prior beta-blocker therapy on serum C-reactive protein levels after percutaneous coronary intervention. Clinical Cardiology 28:5, 243-246
CrossRef795
Karen H. Costenbader, Jonathan S. Coblyn. (2005) Statin Therapy in Rheumatoid Arthritis. Southern Medical Journal 98:5, 534-540
CrossRef796
X. García-Moll, J. Ordóñez-Llanos. (2005) Role of hs-CRP measurements in the current cardiovascular risk assessment. Clinica Chimica Acta 355:1-2, 215-218
CrossRef797
(2005) K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. American Journal of Kidney Diseases 45, 16-153
CrossRef798
J. Helmersson, B. Vessby, A. Larsson, S. Basu. (2005) Cyclooxygenase-mediated prostaglandin F2α is decreased in an elderly population treated with low-dose aspirin. Prostaglandins, Leukotrienes and Essential Fatty Acids 72:4, 227-233
CrossRef799
Edith M. Simmons, Anthony Langone, M Tugrul Sezer, John P. Vella, Peter Recupero, Jason D. Morrow, T Alp Ikizler, Jonathan Himmelfarb. (2005) Effect of Renal Transplantation on Biomarkers of Inflammation and Oxidative Stress in End-Stage Renal Disease Patients. Transplantation 79:8, 914-919
CrossRef800
Paula J. D'Amore. (2005) Evolution of C-Reactive Protein as a Cardiac Risk Factor. Laboratory Medicine 36:4, 234-238
CrossRef801
Francesco D’Aiuto, Juan P. Casas, Tina Shah, Steve E. Humphries, Aroon D. Hingorani, Maurizio S. Tonetti. (2005) C-reactive protein (+1444C>T) polymorphism influences CRP response following a moderate inflammatory stimulus. Atherosclerosis 179:2, 413-417
CrossRef802
Tetsuya Oshima, Ryoji Ozono, Yoko Yano, Yoshihiko Oishi, Hiroki Teragawa, Yukihito Higashi, Masao Yoshizumi, Masayuki Kambe. (2005) Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. Journal of the American College of Cardiology 45:8, 1219-1222
CrossRef803
Kevin J Woollard. (2005) SOLUBLE BIO-MARKERS IN VASCULAR DISEASE: MUCH MORE THAN GAUGES OF DISEASE?. Clinical and Experimental Pharmacology and Physiology 32:4, 233-240
CrossRef804
Chimowitz, Marc I., Lynn, Michael J., Howlett-Smith, Harriet, Stern, Barney J., Hertzberg, Vicki S., Frankel, Michael R., Levine, Steven R., Chaturvedi, Seemant, Kasner, Scott E., Benesch, Curtis G., Sila, Cathy A., Jovin, Tudor G., Romano, Jose G., . (2005) Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis. New England Journal of Medicine 352:13, 1305-1316
Full Text805
Caroline E. Stigant, Ognjenka Djurdjev, Adeera Levin. (2005) C-Reactive Protein Levels in Patients on Maintenance Hemodialysis: Reliability and Reflection on the Utility of Single Measurements. International Urology and Nephrology 37:1, 133-140
CrossRef806
Guilherme H. M. Oliveira. (2005) Novel serologic markers of cardiovascular risk. Current Atherosclerosis Reports 7:2, 148-154
CrossRef807
Kimberly A. Dornbrook-Lavender, Melanie S. Joy, Cynthia J. Denu-Ciocca, Hyunsook Chin, Susan L. Hogan, John A. Pieper. (2005) Effects of Atorvastatin on Low-Density Lipoprotein Cholesterol Phenotype and C-Reactive Protein Levels in Patients Undergoing Long-Term Dialysis. Pharmacotherapy 25:3, 335-344
CrossRef808
Bo Hedblad, Mats Ögren, Gunnar Engström, Per Wollmer, Lars Janzon. (2005) Heterogeneity of cardiovascular risk among smokers is related to degree of carbon monoxide exposure. Atherosclerosis 179:1, 177-183
CrossRef809
Claudia Monaco, Anthony Mathur, John F. Martin. (2005) What causes acute coronary syndromes? Applying Koch's postulates. Atherosclerosis 179:1, 1-15
CrossRef810
A. Helgadottir, S. Gretarsdottir, D. St. Clair, A. Manolescu, J. Cheung, G. Thorleifsson, A. Pasdar, S.F.A. Grant, L.J. Whalley, H. Hakonarson, U. Thorsteinsdottir, A. Kong, J. Gulcher, K. Stefansson, M.J. MacLeod. (2005) Association between the Gene Encoding 5-Lipoxygenase–Activating Protein and Stroke Replicated in a Scottish Population. The American Journal of Human Genetics 76:3, 505-509
CrossRef811
E. Erdmann. (2005) Diabetes and cardiovascular risk markers. Current Medical Research and Opinion 21:s1, S21-S28
CrossRef812
Núria Bertran, Jordi Camps, Joan Fernández-Ballart, Michelle M. Murphy, Victoria Arija, Natàlia Ferré, Mònica Tous, Jorge Joven. (2005) Evaluation of a high-sensitivity turbidimetric immunoassay for serum C-reactive protein: application to the study of longitudinal changes throughout normal pregnancy. Clinical Chemistry and Laboratory Medicine 43:3, 308-313
CrossRef813
Hai-Rong Wang, Jian-Jun Li, Cong-Xin Huang, Hong Jiang. (2005) Fluvastatin inhibits the expression of tumor necrosis factor-+A7E and activation of nuclear factor-+A7o-B in human endothelial cells stimulated by C-reactive protein. Clinica Chimica Acta 353:1-2, 53-60
CrossRef814
KENAN ILTUMUR, AZIZ KARABULUT, GULTEN TOPRAK, NIZAMETTIN TOPRAK. (2005) Complement activation in acute coronary syndromes. APMIS 113:3, 167-174
CrossRef815
G. Rutger Persson, Thomas Pettersson, Ola Ohlsson, Stefan Renvert. (2005) High-sensitivity serum C-reactive protein levels in subjects with or without myocardial infarction or periodontitis. Journal of Clinical Periodontology 32:3, 219-224
CrossRef816
E. M. Stuveling. (2005) Biochemical risk markers: a novel area for better prediction of renal risk?. Nephrology Dialysis Transplantation 20:3, 497-508
CrossRef817
Michael E. Widlansky, Stephen J. Duffy, Naomi M. Hamburg, Noyan Gokce, Beverly A. Warden, Sheila Wiseman, John F. Keaney, Balz Frei, Joseph A. Vita. (2005) Effects of black tea consumption on plasma catechins and markers of oxidative stress and inflammation in patients with coronary artery disease. Free Radical Biology and Medicine 38:4, 499-506
CrossRef818
Jian-Jun Li, Hai-Rong Wang, Cong-Xin Huang, Jia-Lin Xue, Geng-Shan Li. (2005) Enhanced inflammatory response of blood monocytes to C-reactive protein in patients with unstable angina. Clinica Chimica Acta 352:1-2, 127-133
CrossRef819
Paul E. de Jong, Jacobien C. Verhave, Gary C. Curhan. (2005) Reply from the Authors. Kidney International 67:2, 778-779
CrossRef820
Simona Marchesi, Graziana Lupattelli, Rita Lombardini, Alessandra Sensini, Donatella Siepi, Massimo Mannarino, Gaetano Vaudo, Elmo Mannarino. (2005) Acute inflammatory state during influenza infection and endothelial function. Atherosclerosis 178:2, 345-350
CrossRef821
L. Janoskuti, Z. Forhecz, N. Hosszufalusi, M. Kleiber, S. Walentin, O. Balint, J. Duba, S. Rugonfalvi-Kiss, L. Romics, I. Karadi, G. Fust, Z. Prohaszka. (2005) High levels of C-reactive protein with low total cholesterol concentrations additively predict all-cause mortality in patients with coronary artery disease. European Journal of Clinical Investigation 35:2, 104-111
CrossRef822
Brian J. Wells, Arch G. Mainous, Charles J. Everett. (2005) Association between dietary arginine and C-reactive protein. Nutrition 21:2, 125-130
CrossRef823
M. Bas, T. K. Hoffmann, H. Bier, G. Kojda. (2005) Increased C-reactive protein in ACE-inhibitor-induced angioedema. British Journal of Clinical Pharmacology 59:2, 233-238
CrossRef824
James K. Liao, Ulrich Laufs. (2005) PLEIOTROPIC EFFECTS OF STATINS. Annual Review of Pharmacology and Toxicology 45:1, 89-118
CrossRef825
Young-Cheoul Doo, Sang-Jin Han, Sung-Woo Han, Woo-Jung Park, Seung-Hyuk Choi, Goo-Yeong Cho, Kyung-Soon Hong, Kyoo-Rok Han, Nam-Ho Lee, Dong-Jin Oh, Kyu-Hyung Ryu, Chong-Yun Rim, Kwang-Hahk Lee, Yung Lee. (2005) Effect of preexisting statin use on expression of C-reactive protein, adhesion molecules, interleukin-6, and antioxidized low-density lipoprotein antibody in patients with unstable angina undergoing coronary stenting. Clinical Cardiology 28:2, 72-76
CrossRef826
Matthew S Katz. (2005) Therapy Insight: potential of statins for cancer chemoprevention and therapy. Nature Clinical Practice Oncology 2:2, 82-89
CrossRef827
Yong-Hee P. Chun, Kyoung-Ryul J. Chun, De'Avlin Olguin, Hom-Lay Wang. (2005) Biological foundation for periodontitis as a potential risk factor for atherosclerosis. Journal of Periodontal Research 40:1, 87-95
CrossRef828
Didier Ducloux, Amir Kazory, Jean-Marc Chalopin. (2005) Posttransplant Diabetes Mellitus and Atherosclerotic Events in Renal Transplant Recipients: A Prospective Study. Transplantation 79:4, 438-443
CrossRef829
P. M. MANNUCCI, L. BERNARDINELLI, L. FOCO, M. GALLI, F. RIBICHINI, M. TUBARO, F. PEYVANDI. (2005) Tissue plasminogen activator antigen is strongly associated with myocardial infarction in young women. Journal of Thrombosis and Haemostasis 3:2, 280-286
CrossRef830
Jian-Jun Li, Sheng-Shou Hu, Chun-Hong Fang, Rui-Tai Hui, Li-Fu Miao, Yue-Jin Yang, Run-Lin Gao. (2005) Effects of Xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina. Clinica Chimica Acta 352:1-2, 217-224
CrossRef831
Kazuhisa Yamazaki, Tomoyuki Honda, Taro Oda, Kaoru Ueki-Maruyama, Takako Nakajima, Hiromasa Yoshie, Gregory J. Seymour. (2005) Effect of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients. Journal of Periodontal Research 40:1, 53-58
CrossRef832
Ryan H. Dougherty, Jacqueline L. Rohrer, Douglas Hayden, Stephen D. Rubin, Benjamin Z. Leder. (2005) Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels. Clinical Endocrinology 62:2, 228-235
CrossRef833
Wingman Leung, Cangel Puiyee Chan, Manfai Leung, Karin Lehmann, Ilka Renneberg, Matthias Lehmann, Albrecht Hempel, Jan F. C. Glatz, Reinhard Renneberg. (2005) Novel “Digital‐Style” Rapid Test Simultaneously Detecting Heart Attack and Predicting Cardiovascular Disease Risk. Analytical Letters 38:3, 423-439
CrossRef834
I. J. Kullo, C. M. Ballantyne. (2005) Conditional Risk Factors for Atherosclerosis. Mayo Clinic Proceedings 80:2, 219-230
CrossRef835
Ridker, Paul M, Cannon, Christopher P., Morrow, David, Rifai, Nader, Rose, Lynda M., McCabe, Carolyn H., Pfeffer, Marc A., Braunwald, Eugene, . (2005) C-Reactive Protein Levels and Outcomes after Statin Therapy. New England Journal of Medicine 352:1, 20-28
Full Text836
Jian-Jun Li, Chun-Hong Fang, Ming-Zhe Chen, Xin Chen. (2005) Rapid Effects of a Single High Dose of Simvastatin on C-Reactive Protein in Patients with Unstable Angina. Heart Drug 5:3, 140-145
CrossRef837
Walter Stefan Speidl, Andrea Zeiner, Mariam Nikfardjam, Alexander Geppert, Nelli Jordanova, Alexander Niessner, Gerlinde Zorn, Gerald Maurer, Wolfgang Schreiber, Johann Wojta, Kurt Huber. (2005) An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion. Journal of the American College of Cardiology 45:1, 30-34
CrossRef838
W. Palasik, U. Fiszer, W. Lechowicz, B. Czartoryska, M. Krzesiewicz, A. Lugowska. (2005) Assessment of Relations between Clinical Outcome of Ischemic Stroke and Activity of Inflammatory Processes in the Acute Phase Based on Examination of Selected Parameters. European Neurology 53:4, 188-193
CrossRef839
Panagiotis Kougias, Hong Chai, Peter H. Lin, Qizhi Yao, Alan B. Lumsden, Changyi Chen. (2005) Defensins and cathelicidins: Neutrophil peptides with roles in inflammation, hyperlipidemia and atherosclerosis. Journal of Cellular and Molecular Medicine 9:1, 3-10
CrossRef840
So Yeon Ryu, Young Sun Lee, Jong Park, Myeng Geun Kang, Ki Soon Kim. (2005) Relations of Plasma High-Sensitivity C-Reactive Protein to Various Cardiovascular Risk Factors. Journal of Korean Medical Science 20:3, 379
CrossRef841
Alexander Kovacs, Fiona Green, Lars-Olof Hansson, Pia Lundman, Ann Samnegård, Susanna Boquist, Carl-Göran Ericsson, Hugh Watkins, Anders Hamsten, Per Tornvall. (2005) A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis 178:1, 193-198
CrossRef842
Subodh Verma, Paul E Szmitko, Paul M Ridker. (2005) C-reactive protein comes of age. Nature Clinical Practice Cardiovascular Medicine 2:1, 29-36
CrossRef843
Brianna S. Ronnow, Sandra P. Reyna, Joseph B. Muhlestein, Benjamin D. Horne, Chloe A. Allen Maycock, Tami L. Bair, John F. Carlquist, Abdallah G. Kfoury, Jeffrey L. Anderson, Dale G. Renlund. (2005) C-Reactive Protein Predicts Death in Patients with Non-Ischemic Cardiomyopathy. Cardiology 104:4, 196-201
CrossRef844
Justin C Mason. (2005) The statins - therapeutic diversity in renal disease?. Current Opinion in Nephrology and Hypertension 14:1, 17-24
CrossRef845
Barbara Radziszewska, Robert G. Hart, Philip A. Wolf, Ralph B. D’Agostino, Sr., Jeffrey A. Cutler. (2005) Clinical Research in Primary Stroke Prevention: Needs, Opportunities, and Challenges. Neuroepidemiology 25:2, 91-104
CrossRef846
Hiroaki Taniguchi, Yukihiko Momiyama, Reiko Ohmori, Atsushi Yonemura, Takeshi Yamashita, Seiichi Tamai, Haruo Nakamura, Fumitaka Ohsuzu. (2005) Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease. Atherosclerosis 178:1, 173-177
CrossRef847
Meena Bhatia, Peter M. Rothwell. (2005) A Systematic Comparison of the Quality and Volume of Published Data Available on Novel Risk Factors for Stroke versus Coronary Heart Disease. Cerebrovascular Diseases 20:3, 180-186
CrossRef848
José Vivancos-Mora, Antonio C. Gil-Núñez. (2005) Lipids and Stroke: The Opportunity of Lipid-Lowering Treatment. Cerebrovascular Diseases 20:2, 53-67
CrossRef849
Josef Veselka, Sárka Procházková, Radka Duchonová, Ingrid Homolová, David Tesar. (2005) Relationship of C-Reactive Protein to Adverse Cardiovascular Events in Patients Treated by Percutaneous Coronary Intervention for Stable Angina Pectoris. International Heart Journal 46:2, 195-204
CrossRef850
Robert Godefroi, Peter Klementowicz, Catherine Pepler, Barbara Lewis, Kenneth McDonough, Robert J. Goldberg. (2005) Levels of, and Factors Associated with, C-Reactive Protein in Employees Attending a Company-Sponsored Cardiac Screening Program. Cardiology 103:4, 180-184
CrossRef851
Kristina Jackson Behan, Raid W. Amin. (2005) Normoglycemia May Encompass Two Subpopulations With Respect to Vascular Risk in Non-Obese Caucasian Women. Laboratory Medicine 36:1, 35-40
CrossRef852
Stephen P. McDonald, Wendy E. Hoy. (2005) Interfaces between cardiovascular and kidney disease among Aboriginal Australians. Advances in Chronic Kidney Disease 12:1, 39-48
CrossRef853
M. Ghayour‐Mobarhan, D. J. Lamb, D. P. Lovell, C. Livingstone, T. Wang, G. A. A. Ferns. (2005) Plasma antibody titres to heat shock proteins‐60, ‐65 and‐70: Their relationship to coronary risk factors in dyslipidaemic patients and healthy individuals. Scandinavian Journal of Clinical & Laboratory Investigation 65:7, 601-614
CrossRef854
Peter M Rothwell. (2005) Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. The Lancet 365:9454, 176-186
CrossRef855
Teresa M. Seccia, Gian Paolo Rossi. (2005) Clinical Use and Pathogenetic Basis of Laboratory Tests for the Evaluation of Primary Arterial Hypertension. Critical Reviews in Clinical Laboratory Sciences 42:5-6, 393-452
CrossRef856
Eric Ehrensperger, Jeffrey Minuk, Liam Durcan, Ariane Mackey, Christina Wolfson, Anne-Marie Fontaine, Robert Côté. (2005) Predictive Value of Soluble Intercellular Adhesion Molecule-1 for Risk of Ischemic Events in Individuals with Cerebrovascular Disease. Cerebrovascular Diseases 20:6, 456-462
CrossRef857
H. Jacqueline Suk, Paul M. Ridker, Nancy R. Cook, Robert Y.L. Zee. (2005) Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis 178:1, 139-145
CrossRef858
Per Tornvall, Anders Hamsten, Lars-Olof Hansson, Marie-Louise O’Konor, Carl-Göran Ericsson, Lars-Erik Strandberg, Antonio Boavida, Lott Bergstrand. (2005) Plasma C-Reactive Protein and Lipoprotein Levels, and Progression of Coronary Artery Disease after Myocardial Infarction Treated with Thrombolysis. Cardiology 104:2, 65-71
CrossRef859
Jose M. Mostaza, Nuria Camino, Juan Gómez Gerique, Rocío Peña, Margarita Baquero, Carlos Lahoz. (2005) C-reactive protein levels and prevalence of chronic infections in subjects with hypoalphalipoproteinemia. Metabolism 54:1, 33-37
CrossRef860
José L. Teruel, Roberto Marcen, Javier Ocaña, Milagros Fernández-Lucas, Maite Rivera, Guadalupe Tabernero, Joaquín Ortuño. (2005) Clinical Significance of C-Reactive Protein in Patients on Hemodialysis: A Longitudinal Study. Nephron Clinical Practice 100:4, c140-c145
CrossRef861
VANDANA MENON, TOM GREENE, XUELEI WANG, AREMA A PEREIRA, SANTICA M MARCOVINA, GERALD J BECK, JOHN W KUSEK, ALAN J COLLINS, ANDREW S LEVEY, MARK J SARNAK. (2005) C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney International 68:2, 766
CrossRef862
Svetlana Ignjatovic. (2005) Determination of high sensitivity C-reactive protein: Clinical and analytical quality. Jugoslovenska medicinska biohemija 24:2, 85-93
CrossRef863
David Brieger, S Benedict Freedman, Leonard Kritharides, Harry Lowe. 2004. Treatment of Vulnerable Plaques. , 164-202.
CrossRef864
Paul Schoenhagen, Steven Nissen, Richard White. 2004. Imaging of High-Risk Atherosclerotic Plaque by Intravascular Ultrasound. , 67-83.
CrossRef865
Pai, Jennifer K., Pischon, Tobias, Ma, Jing, Manson, JoAnn E., Hankinson, Susan E., Joshipura, Kaumudi, Curhan, Gary C., Rifai, Nader, Cannuscio, Carolyn C., Stampfer, Meir J., Rimm, Eric B., . (2004) Inflammatory Markers and the Risk of Coronary Heart Disease in Men and Women. New England Journal of Medicine 351:25, 2599-2610
Full Text866
E KANG, H KIM, Y KIM, S LEE, B CHA, S LIM, H KIM, H LEE. (2004) Serum high sensitivity C-reactive protein is associated with carotid intima-media thickness in type 2 diabetes. Diabetes Research and Clinical Practice 66, S115-S120
CrossRef867
Sergio M. A. Toloza, Am
rica G. Uribe, Gerald McGwin, Graciela S. Alarc
CrossRef868
Carla Maria Avesani, Sergio Antonio Draibe, Maria Ayako Kamimura, Fernando Antonio Basile Colugnati, Lilian Cuppari. (2004) Resting energy expenditure of chronic kidney disease patients: Influence of renal function and subclinical inflammation. American Journal of Kidney Diseases 44:6, 1008-1016
CrossRef869
Mike J. Peters, Irene E. van der Horst-Bruinsma, Ben A. Dijkmans, Michael T. Nurmohamed. (2004) Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Seminars in Arthritis and Rheumatism 34:3, 585-592
CrossRef870
Nicolas W. Shammas, Eric Dippel. (2004) Inflammation and Cardiovascular Risk: An Overview. International Journal of Angiology 13:4, 161-167
CrossRef871
Eric T. Chou, Robert M. Minutello, Manish Parikh, Geoffrey Bergman, S. Chiu Wong, Mun K. Hong. (2004) Can we identify vulnerable patients at risk for ST-segment elevation myocardial infarction based on their clinical characteristics?. Coronary Artery Disease 15:8, 467-469
CrossRef872
Tracey Phillips, Christiaan Leeuwenburgh. (2004) Lifelong Aspirin Supplementation as a Means to Extending Life Span. Rejuvenation Research 7:4, 243-252
CrossRef873
Rozemarijn Vliegenthart, Hok-Hay S. Oei, Albert Hofman, Matthijs Oudkerk, Jackqueline C. M. Witteman. (2004) Non-invasive assessment of coronary calcification. European Journal of Epidemiology 19:12, 1063-1072
CrossRef874
R ROSSI. (2004) Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women. Maturitas 49:4, 315-320
CrossRef875
Shigeru Kurosawa, Miki Nakamura, Jong-Won Park, Hidenobu Aizawa, Kazunori Yamada, Mitsuo Hirata. (2004) Evaluation of a high-affinity QCM immunosensor using antibody fragmentation and 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer. Biosensors and Bioelectronics 20:6, 1134-1139
CrossRef876
Eduardo Lacson, Nathan W. Levin. (2004) POOR NUTRITIONAL STATUS AND INFLAMMATION: C-Reactive Protein and End-Stage Renal Disease. Seminars in Dialysis 17:6, 438-448
CrossRef877
J. Sundell, T. R
CrossRef878
Meredith A. Hawkins. (2004) Markers of Increased Cardiovascular Risk: Are We Measuring the Most Appropriate Parameters?. Obesity 12, 107S-114S
CrossRef879
Gunilla Nordin Fredrikson, Bo Hedblad, Jan-Åke Nilsson, Ragnar Alm, Göran Berglund, Jan Nilsson. (2004) Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels. Metabolism 53:11, 1436-1442
CrossRef880
Patrizia Ferroni, Stefani Basili, Angela Falco, Giovanni Davì. (2004) Inflammation, insulin resistance, and obesity. Current Atherosclerosis Reports 6:6, 424-431
CrossRef881
P. L. VAN HAELST, J. W. COHEN TERVAERT, J. BIJZET, C. BALJE-VOLKERS, J. F. MAY, B. LANGEVELD, R. O. B. GANS. (2004) Circulating monocytes in patients with acute coronary syndromes lack sufficient interleukin-10 production after lipopolysaccharide stimulation. Clinical and Experimental Immunology 138:2, 364-368
CrossRef882
Burl R. Don, George Kaysen. (2004) POOR NUTRITIONAL STATUS AND INFLAMMATION: Serum Albumin: Relationship to Inflammation and Nutrition. Seminars in Dialysis 17:6, 432-437
CrossRef883
Trevor A. Mori, Lawrence J. Beilin. (2004) Omega-3 fatty acids and inflammation. Current Atherosclerosis Reports 6:6, 461-467
CrossRef884
Mohammad Madjid, Imran Awan, James T. Willerson, S. Ward Casscells. (2004) Leukocyte count and coronary heart disease. Journal of the American College of Cardiology 44:10, 1945-1956
CrossRef885
Alexander Geppert, Kurt Huber. (2004) Inflammation and cardiovascular diseases: lessons that can be learned for the patient with cardiogenic shock in the intensive care unit. Current Opinion in Critical Care 10:5, 347-353
CrossRef886
Dror Harats, Jacob George. (2004) Antigen-tailored therapy based on the inflammatory theory of atherosclerosis. Expert Review of Vaccines 3:5, 605-611
CrossRef887
J. Davignon. (2004) Cardioprotective and other emerging effects of statins. International Journal of Clinical Practice 58, 49-57
CrossRef888
J. K. Liao. (2004) Statins: potent vascular anti-inflammatory agents. International Journal of Clinical Practice 58, 41-48
CrossRef889
Pierluigi Blanc, Anna Maria Corsi, Andrea Gabbuti, Cecilia Peduzzi, Francesca Meacci, Fabiola Olivieri, Fulvio Lauretani, Mazzotta Francesco, Luigi Ferrucci. (2004) Chlamydia Pneumoniae Seropositivity and Cardiovascular Risk Factors: The InCHIANTI Study. Journal of the American Geriatrics Society 52:10, 1626-1631
CrossRef890
Elisabeth Krieger, Bernd van Der Loo, Beatrice R. Amann-Vesti, Valentin Rousson, Renate Koppensteiner. (2004) C-reactive protein and red cell aggregation correlate with late venous function after acute deep venous thrombosis. Journal of Vascular Surgery 40:4, 644-649
CrossRef891
I. Shai, E. B. Rimm, M. B. Schulze, N. Rifai, M. J. Stampfer, F. B. Hu. (2004) Moderate alcohol intake and markers of inflammation and endothelial dysfunction among diabetic men. Diabetologia 47:10, 1760-1767
CrossRef892
K. D. Flemming, R. D. Brown. (2004) Secondary Prevention Strategies in Ischemic Stroke: Identification and Optimal Management of Modifiable Risk Factors. Mayo Clinic Proceedings 79:10, 1330-1340
CrossRef893
Francesco U.S Mattace-Raso, Tischa J.M van der Cammen, Irene M van der Meer, Maarten A.D.H Schalekamp, Roland Asmar, Albert Hofman, Jacqueline C.M Witteman. (2004) C-reactive protein and arterial stiffness in older adults: the Rotterdam Study. Atherosclerosis 176:1, 111-116
CrossRef894
Leonelo E. Bautista, John E. Atwood, Patrick G. O??Malley, Allen J. Taylor. (2004) Association between C-reactive protein and hypertension in healthy middle-aged men and women. Coronary Artery Disease 15:6, 331-336
CrossRef895
Christopher A. Girkin, William B. Kannel, David S. Friedman, Robert N. Weinreb. (2004) Glaucoma risk factor assessment and prevention: Lessons from coronary heart disease. American Journal of Ophthalmology 138:3, 11-18
CrossRef896
Sabine O. Geerts, Victor Legrand, Joseph Charpentier, Adelin Albert, Eric H. Rompen. (2004) Further Evidence of the Association Between Periodontal Conditions and Coronary Artery Disease. Journal of Periodontology 75:9, 1274-1280
CrossRef897
T.Matthew Shields, Charles H Hennekens. (2004) Management of metabolic syndrome: aspirin. Endocrinology & Metabolism Clinics of North America 33:3, 577-593
CrossRef898
Satish Kenchaiah, Jagat Narula, Ramachandran S. Vasan. (2004) Risk factors for heart failure. Medical Clinics of North America 88:5, 1145-1172
CrossRef899
George A. Kaysen. (2004) Inflammation: Cause of vascular disease and malnutrition in dialysis patients. Seminars in Nephrology 24:5, 431-436
CrossRef900
Gen Suzuki, Shizue Izumi, Masayuki Hakoda, Norio Takahashi. (2004) LTA 252G allele containing haplotype block is associated with high serum C-reactive protein levels. Atherosclerosis 176:1, 91-94
CrossRef901
Kathleen L. Wyne. (2004) Management of Type 2 Diabetes Mellitus: Is It Time for a Paradigm Shift?. Metabolic Syndrome and Related Disorders 2:4, 251-262
CrossRef902
Valerie C McWhorter, Lynne C Ford, Anthony W Butch. (2004) Analytical performance of the Synchron LX®20 Pro, BN™II and IMMAGE® high sensitivity C-reactive protein assays and concordance in cardiovascular risk stratification. Clinica Chimica Acta 347:1-2, 71-79
CrossRef903
Eiji Ishimura, Senji Okuno, Kayoko Kitatani, Kiyoshi Maekawa, Tsuyoshi Izumotani, Tomoyuki Yamakawa, Shuichi Jono, Tetsuo Shoji, Atsushi Shioi, Masaaki Inaba, Shaul G. Massry, Yoshiki Nishizawa. (2004) C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries. Seminars in Nephrology 24:5, 408-412
CrossRef904
Nader Rifai, G.Russell Warnick. (2004) Quality specifications and the assessment of the biochemical risk of atherosclerosis. Clinica Chimica Acta 346:1, 55-64
CrossRef905
KIRSTEN DE GROOT, FERDINAND HERMANN BAHLMANN, JOHANNA SOWA, JANA KOENIG, JAN MENNE, HERMANN HALLER, DANILO FLISER. (2004) Uremia causes endothelial progenitor cell deficiency. Kidney International 66:2, 641-646
CrossRef906
Stephen D Wiviott, James A de Lemos, David A Morrow. (2004) Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes. Clinica Chimica Acta 346:2, 119-128
CrossRef907
Mario Bo, Silvio Raspo, Fabio Morra, Maurizio Cassader, Giancarlo Isaia, Leone Poli. (2004) Body fat is the main predictor of fibrinogen levels in healthy non-obese men. Metabolism 53:8, 984-988
CrossRef908
R. Y. L. Zee, H. H. Hegener, N. R. Cook, P. M. Ridker. (2004) C-reactive protein gene polymorphisms and the risk of venous thromboembolism: a haplotype-based analysis. Journal of Thrombosis and Haemostasis 2:8, 1240-1243
CrossRef909
Yoshihiko Suzuki, Takeshi Horio, Hiroshi Nonogi, Tokio Hayashi, Kazuo Kitamura, Tanenao Eto, Kenji Kangawa, Yuhei Kawano. (2004) Adrenomedullin as a sensitive marker for coronary and peripheral arterial complications in patients with atherosclerotic risks. Peptides 25:8, 1321-1326
CrossRef910
VIHANG NARKAR, OKSANA KUNDUZOVA, TAHIR HUSSAIN, CLAUDIE CAMBON, ANGELO PARINI, MUSTAFA LOKHANDWALA. (2004) Dopamine D2-like receptor agonist bromocriptine protects against ischemia/reperfusion injury in rat kidney. Kidney International 66:2, 633-640
CrossRef911
R. Nesto. (2004) C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones. Diabetic Medicine 21:8, 810-817
CrossRef912
Jacques Amar, Jean-Bernard Ruidavets, Claire Baldit Sollier, Vanina Bongard, Henri Boccalon, Bernard Chamontin, Ludovic Drouet, Jean Ferri??res. (2004) CD14 C(???260)T gene polymorphism, circulating soluble CD14 levels and arteriosclerosis. Journal of Hypertension 22:8, 1523-1528
CrossRef913
Jason T Fitzgerald, Jeremy R Johnson, Richard V Perez. (2004) Pre-transplant elevations of interleukin-12 and interleukin-10 are associated with acute rejection after renal transplantation. Clinical Transplantation 18:4, 434-439
CrossRef914
J. Gibney, B. Turner, U. Weis, D. R. Meeking, J. Cansfield, G. F. Watts, K. M. Shaw, M. H. Cummings. (2004) Reduced forearm reactive hyperaemia in normoalbuminuric subjects with Type 1 diabetes and retinopathy. Diabetic Medicine 21:8, 931-935
CrossRef915
Jason T. Fitzgerald, Matthew J. Sena, Kristen Nero Vandewalker, Jeremy R. Johnson, Stephen M. Griffey, Alice F. Tarantal, Peter A. Barry, Michael B. McChesney, Rajendra Ramsamooj, Richard V. Perez. (2004) Occult Pretransplantation Systemic Inflammation and Posttransplantation Vascular Changes in a Primate Arterial Allograft Model. Transplantation 78:3, 367-374
CrossRef916
P. Hu, D. B. Reuben, E. M. Crimmins, T. B. Harris, M.-H. Huang, T. E. Seeman. (2004) The Effects of Serum Beta-Carotene Concentration and Burden of Inflammation on All-Cause Mortality Risk in High-Functioning Older Persons: MacArthur Studies of Successful Aging. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59:8, M849-M854
CrossRef917
Sangeetha Satyan, Leslie L Rocher. (2004) Impact of kidney transplantation on the progression of cardiovascular disease. Advances in Chronic Kidney Disease 11:3, 274-293
CrossRef918
Didier Ducloux, Amir Kazory, Jean-Marc Chalopin. (2004) Predicting coronary heart disease in renal transplant recipients: A prospective study. Kidney International 66:1, 441-447
CrossRef919
Mario Di Napoli, Francesca Papa. (2004) Clinical application of C-reactive protein in stroke prevention: bright and dark sides of the moon. Expert Review of Neurotherapeutics 4:4, 613-622
CrossRef920
Wolfgang C. Winkelmayer, Matthias Lorenz, Reinhard Kramar, Manuela Fodinger, Walter H. Horl, Gere Sunder-Plassmann. (2004) C-Reactive Protein and Body Mass Index Independently Predict Mortality in Kidney Transplant Recipients. American Journal of Transplantation 4:7, 1148-1154
CrossRef921
J.S Yudkin, I Juhan-Vague, E Hawe, S.E Humphries, G di Minno, M Margaglione, E Tremoli, T Kooistra, P.E Morange, P Lundman, V Mohamed-Ali, A Hamsten. (2004) Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism 53:7, 852-857
CrossRef922
Matthias P. Hörl, Walter H. Hörl. (2004) HYPERTENSION IN HEMODIALYSIS PATIENTS: Drug Therapy for Hypertension in Hemodialysis Patients. Seminars in Dialysis 17:4, 288-294
CrossRef923
B BALLA. (2004) Comparative study of cardiovascular markers data by various techniques of multivariate analysis. Chemometrics and Intelligent Laboratory Systems 72:2, 259-267
CrossRef924
Peter A McCullough. (2004) Opportunities for improvement in the cardiovascular care of patients with end-stage renal disease. Advances in Chronic Kidney Disease 11:3, 294-303
CrossRef925
Martin Busch, Sybille Franke, Andreas Muller, Marco Wolf, Jens Gerth, Undine Ott, Toshimitsu Niwa, Gunter Stein. (2004) Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein. Kidney International 66:1, 338-347
CrossRef926
David W Brown, Earl S Ford, Wayne H Giles, Janet B Croft, Lina S Balluz, Ali H Mokdad. (2004) Associations between White Blood Cell Count and Risk for Cerebrovascular Disease Mortality: NHANES II Mortality Study, 1976–1992. Annals of Epidemiology 14:6, 425-430
CrossRef927
Wolf-Peter Schmidt, Andreas Roesler, Konrad Kretzschmar, Karl-Heinz Ladwig, Ralf Junker, Klaus Berger. (2004) Functional and Cognitive Consequences of Silent Stroke Discovered Using Brain Magnetic Resonance Imaging in an Elderly Population. Journal of the American Geriatrics Society 52:7, 1045-1050
CrossRef928
Brenda W. J. H. Penninx, Stephen B. Kritchevsky, Anne B. Newman, Barbara J. Nicklas, Eleanor M. Simonsick, Susan Rubin, Michael Nevitt, Marjolein Visser, Tamara Harris, Marco Pahor. (2004) Inflammatory Markers and Incident Mobility Limitation in the Elderly. Journal of the American Geriatrics Society 52:7, 1105-1113
CrossRef929
Stephan Fichtlscherer, Susanne Breuer, Christopher Heeschen, Stefanie Dimmeler, Andreas M Zeiher. (2004) Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease. Journal of the American College of Cardiology 44:1, 44-49
CrossRef930
Weiss, Ram, Dziura, James, Burgert, Tania S., Tamborlane, William V., Taksali, Sara E., Yeckel, Catherine W., Allen, Karin, Lopes, Melinda, Savoye, Mary, Morrison, John, Sherwin, Robert S., Caprio, Sonia, . (2004) Obesity and the Metabolic Syndrome in Children and Adolescents. New England Journal of Medicine 350:23, 2362-2374
Full Text931
K. Hashimoto, S. Kasayama, H. Yamamoto, S. Kurebayashi, I. Kawase, M. Koga. (2004) Strong association of C-reactive protein with body mass index and 2-h post-challenge glucose in non-diabetic, non-smoker subjects without hypertension. Diabetic Medicine 21:6, 581-585
CrossRef932
Yuko Kimura, Noboru Takamura, Masato Fukunaga, Mitsuo Kanagae, Yasuyo Abe, Kiyoshi Aoyagi. (2004) Evaluation of high sensitive C-reactive protein and 5-10 methylenetetrahydrofolate reductase genotype in Japanese young adults. Biomarkers 9:3, 291-297
CrossRef933
Agha W. Haider, Ronenn Roubenoff, Peter W. F. Wilson, Daniel Levy, Ralph D??Agostino, Halit Silbershatz, Christopher J. O??Donnell. (2004) Monocyte cytokine production, systemic inflammation and cardiovascular disease in very elderly men and women: The Framingham Heart Study. European Journal of Cardiovascular Prevention & Rehabilitation 11:3, 214-215
CrossRef934
Julie P. Sutherland, Benjamin McKinley, Robert H. Eckel. (2004) The Metabolic Syndrome and Inflammation. Metabolic Syndrome and Related Disorders 2:2, 82-104
CrossRef935
Priit Kampus, Jaak Kals, Tiina Ristim??e, Krista Fischer, Mihkel Zilmer, Rein Teesalu. (2004) High-sensitivity C-reactive protein affects central haemodynamics and augmentation index in apparently healthy persons. Journal of Hypertension 22:6, 1133-1139
CrossRef936
Martin A Samuels. (2004) Inflammation and neurological disease. Current Opinion in Neurology 17:3, 307-309
CrossRef937
G LUC. (2004) Marqueurs de l'inflammation et risque vasculaire. La Revue de M
CrossRef938
Kohzo Takebayashi, Yoshimasa Aso, Toshihiko Inukai. (2004) Initiation of insulin therapy reduces serum concentrations of high-sensitivity C-reactive protein in patients with type 2 diabetes. Metabolism 53:6, 693-699
CrossRef939
Ken Ogasawara, Shinichi Mashiba, Youichiro Wada, Makoto Sahara, Kazuo Uchida, Tadanori Aizawa, Tatsuhiko Kodama. (2004) A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease. Atherosclerosis 174:2, 349-356
CrossRef940
Marion Haubitz, Katrin Votsch, Alexander Woywodt, Björn Nashan, Annemarie Groh, Herrmann Haller, Reinhard Brunkhorst. (2004) SEROLOGIC EVIDENCE OF CHLAMYDIA PNEUMONIAE INFECTION AS A LONG-TERM PREDICTOR OF CARDIOVASCULAR DEATH IN RENAL TRANSPLANT RECIPIENTS. Transplantation 77:10, 1517-1521
CrossRef941
Mehdi H. Shishehbor, Stanley L. Hazen. (2004) Inflammatory and oxidative markers in atherosclerosis: Relationship to outcome. Current Atherosclerosis Reports 6:3, 243-250
CrossRef942
Francesco D'Aiuto, Mohammed Parkar, Georgios Andreou, Peter M. Brett, Derren Ready, Maurizio S. Tonetti. (2004) Periodontitis and atherogenesis: causal association or simple coincidence?. A pilot intervention study. Journal of Clinical Periodontology 31:5, 402-411
CrossRef943
Marie Bennermo, Claes Held, Fiona Green, Lars-Erik Strandberg, Carl-Göran Ericsson, Lars-Olof Hansson, Hugh Watkins, Anders Hamsten, Per Tornvall. (2004) Prognostic value of plasma interleukin-6 concentrations and the −174 G > C and −572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis. Atherosclerosis 174:1, 157-163
CrossRef944
M. A. Austin, C. Zhang, S. E. Humphries, W. L. Chandler, P. J. Talmud, K. L. Edwards, D. L. Leonetti, M. J. Mcneely, W. Y. Fujimoto. (2004) Heritability of C-Reactive Protein and Association with Apolipoprotein E Genotypes in Japanese Americans. Annals of Human Genetics 68:3, 179-188
CrossRef945
Carsten Otto, H.Christian Geiss, Klaus Empen, Klaus G. Parhofer. (2004) Long-term reduction of C-reactive protein concentration by regular LDL apheresis. Atherosclerosis 174:1, 151-156
CrossRef946
Bradley J Willcox, Robert D Abbott, Katsuhiko Yano, Beatriz L Rodriguez, D Craig Willcox, J David Curb. (2004) C-reactive protein, cardiovascular disease and stroke: new roles for an old biomarker. Expert Review of Neurotherapeutics 4:3, 507-518
CrossRef947
V. Panichi. (2004) Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients. Nephrology Dialysis Transplantation 19:5, 1154-1160
CrossRef948
Tall, Alan R., . (2004) C-Reactive Protein Reassessed. New England Journal of Medicine 350:14, 1450-1452
Full Text949
Danesh, John, Wheeler, Jeremy G., Hirschfield, Gideon M., Eda, Shinichi, Eiriksdottir, Gudny, Rumley, Ann, Lowe, Gordon D.O., Pepys, Mark B., Gudnason, Vilmundur, . (2004) C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease. New England Journal of Medicine 350:14, 1387-1397
Full Text950
Hakan Kiran, Gurkan Kiran, Hasan C. Ekerbicer, Alanur M. Guven, Metin Kilinc. (2004) Effects of oestrogen replacement therapy on serum C-reactive protein levels in hysterectomised women. The Australian and New Zealand Journal of Obstetrics and Gynaecology 44:2, 131-134
CrossRef951
Shiro Hoshida, Masami Nishino, Toshihiro Takeda, Jun Tanouchi, Yoshio Yamada, Masatsugu Hori. (2004) A persistent increase in C-reactive protein is a risk factor for restenosis in patients with stable angina who are not receiving statins. Atherosclerosis 173:2, 285-290
CrossRef952
M. Bo, S. Raspo, F. Morra, G. Isaia, M. Cassader, F. Fabris, L. Poli. (2004) Body fat and C-reactive protein levels in healthy non-obese men. Nutrition, Metabolism and Cardiovascular Diseases 14:2, 66-72
CrossRef953
Ivan Casserly, Eric J Topol. (2004) Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. The Lancet 363:9415, 1139-1146
CrossRef954
Steve E Humphries, Laleh Morgan. (2004) Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. The Lancet Neurology 3:4, 227-235
CrossRef955
A. von Eckardstein. (2004) Is there a need for novel cardiovascular risk factors?. Nephrology Dialysis Transplantation 19:4, 761-765
CrossRef956
M. Crook. (2004) Type 2 diabetes mellitus: a disease of the innate immune system? An update. Diabetic Medicine 21:3, 203-207
CrossRef957
Luigi Vernaglione, Claudio Cristofano, Pietro Muscogiuri, Stefano Chimienti. (2004) Does atorvastatin influence serum C-reactive protein levels in patients on long-term hemodialysis?. American Journal of Kidney Diseases 43:3, 471-478
CrossRef958
Mehdi H. Shishehbor, Deepak L. Bhatt. (2004) Inflammation and atherosclerosis. Current Atherosclerosis Reports 6:2, 131-139
CrossRef959
Michael Lefevre, Penny M. Kris-Etherton, Guixiang Zhao, Russell P. Tracy. (2004) Dietary fatty acids, hemostasis, and cardiovascular disease risk1 1Continuing Education Questionnaire, page 492 Meets learning need codes 4040, 4050, 5160, and 9020. Journal of the American Dietetic Association 104:3, 410-419
CrossRef960
Mira Varagunam, Hazel Finney, Ray Trevitt, Edward Sharples, Daniel J. McCloskey, Paul J. Sinnott, Martin J. Raftery, Muhammad M. Yaqoob. (2004) Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients. American Journal of Kidney Diseases 43:3, 502-507
CrossRef961
G. Ravaglia, P. Forti, F. Maioli, L. Servadei, M. Martelli, G. Arnone, T. Talerico, M. Zoli, E. Mariani. (2004) Plasma homocysteine and inflammation in elderly patients with cardiovascular disease and dementia. Experimental Gerontology 39:3, 443-450
CrossRef962
Deepak L Bhatt. (2004) Aspirin resistance: more than just a laboratory curiosity. Journal of the American College of Cardiology 43:6, 1127-1129
CrossRef963
Arati Wagh, Neil J Stone. (2004) Treatment of metabolic syndrome. Expert Review of Cardiovascular Therapy 2:2, 213-228
CrossRef964
Richard L Mueller. (2004) First-generation agents: aspirin, heparin and coumarins. Best Practice & Research Clinical Haematology 17:1, 23-53
CrossRef965
Julia K. Wegge, Christian K. Roberts, Tung H. Ngo, R.James Barnard. (2004) Effect of diet and exercise intervention on inflammatory and adhesion molecules in postmenopausal women on hormone replacement therapy and at risk for coronary artery disease. Metabolism 53:3, 377-381
CrossRef966
Richard V Milani, Carl J Lavie, Mandeep R Mehra. (2004) Reduction in C-reactive protein through cardiac rehabilitation and exercise training. Journal of the American College of Cardiology 43:6, 1056-1061
CrossRef967
Hannele Yki-J��rvinen. 2004. Glucose Toxicity. .
CrossRef968
Jacques Amar, Jean-Bernard Ruidavets, Claire BalDit Sollier, Vanina Bongard, Henri Boccalon, Bernard Chamontin, Ludovic Drouet, Jean Ferrières. (2004) Relationship between C reactive protein and pulse pressure is not mediated by atherosclerosis or aortic stiffness. Journal of Hypertension 22:2, 349-355
CrossRef969
Undurti N. Das. (2004) Metabolic syndrome X: An inflammatory condition?. Current Hypertension Reports 6:1, 66-73
CrossRef970
M. Macini, J. Stamler. (2004) Diet for preventing cardiovascular diseases. Nutrition, Metabolism and Cardiovascular Diseases 14:1, 52-57
CrossRef971
Tomonori OKAMURA, Yuri MORIYAMA, Takashi KADOWAKI, Hideyuki KANDA, Hirotsugu UESHIMA. (2004) Non-Invasive Measurement of Brachial-Ankle Pulse Wave Velocity Is Associated with Serum C-Reactive Protein but Not with .ALPHA.-Tocopherol in Japanese Middle-Aged Male Workers. Hypertension Research 27:3, 173-180
CrossRef972
Ori Rogowski, David Zeltser, Itzhak Shapira, Michael Burke, Vera Zakut, Tamar Mardi, Einor Ben-Assayag, Jack Serov, Meirav Rozenblat, Shlomo Berliner. (2004) Gender difference in C-reactive protein concentrations in individuals with atherothrombotic risk factors and apparently healthy ones. Biomarkers 9:1, 85-92
CrossRef973
Faith Selzer, Kim Sutton-Tyrrell, Shirley G. Fitzgerald, Joan E. Pratt, Russell P. Tracy, Lewis H. Kuller, Susan Manzi. (2004) Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus. Arthritis & Rheumatism 50:1, 151-159
CrossRef974
John W Eikelboom, Graeme J Hankey. (2004) Failure of Aspirin to Prevent Atherothrombosis. American Journal of Cardiovascular Drugs 4:1, 57-67
CrossRef975
Michael Hoffman, Arnon Blum, Roni Baruch, Eli Kaplan, Moshe Benjamin. (2004) Leukocytes and coronary heart disease. Atherosclerosis 172:1, 1-6
CrossRef976
Tanja Rundek, Ralph L. Sacco. 2004. Outcome following Stroke. , 35-57.
CrossRef977
Klaus Pethig, Bernd Heublein, Thorsten Wahlers, Olliver Dannenberg, Petra Oppelt, Axel Haverich. (2004) Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: influence on inflammation and progression of intimal hyperplasia. The Journal of Heart and Lung Transplantation 23:1, 61-66
CrossRef978
Adam Williams, Charles H Hennekens. (2004) The role of aspirin in cardiovascular diseases – forgotten benefits?. Expert Opinion on Pharmacotherapy 5:1, 109-115
CrossRef979
Hyunah Choi, Dong Hee Cho, Hyun Ho Shin, Jeong Bae Park. (2004) Association of High Sensitivity C-Reactive Protein With Coronary Heart Disease Prediction, but not With Carotid Atherosclerosis, in Patients With Hypertension. Circulation Journal 68:4, 297-303
CrossRef980
Antonie JHHM van Oostrom, Jeroen PH van Wijk, Manuel Castro Cabezas. (2004) Lipaemia, Inflammation and Atherosclerosis. Drugs 64:Supplement 2, 19-41
CrossRef981
Bruce A Cooper, Erik L Penne, Louise H Bartlett, Carol A Pollock. (2004) Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. American Journal of Kidney Diseases 43:1, 61-66
CrossRef982
David F Kong. (2004) Aspirin in Cardiovascular Disorders. American Journal of Cardiovascular Drugs 4:3, 151-158
CrossRef983
N. Moussavi, G. Renier, A. Roussin, J.-C. Mamputu, J. Buithieu, O. Serri. (2004) Lack of concordance between plasma markers of cardiovascular risk and intima-media thickness in patients with type 2 diabetes. Diabetes, Obesity and Metabolism 6:1, 69-77
CrossRef984
Jason T. Call, Efthymios N. Deliargyris, L Kristin Newby. (2004) Focusing on Inflammation in the Treatment of Atherosclerosis. Cardiology in Review 12:4, 194-200
CrossRef985
Steven M. Kent, Louis C. Coyle, Patrick J. Flaherty, Thor T. Markwood, Allen J. Taylor. (2004) Marked low-density lipoprotein cholesterol reduction below current national cholesterol education program targets provides the greatest reduction in carotid atherosclerosis. Clinical Cardiology 27:1, 17-21
CrossRef986
Kun-Tai Lee, Wen-Ter Lai, Chin-Sheng Chu, Li-Yu Tsai, Hsueh-Wei Yen, Wen-Choi Voon, Sheng-Hsiung Sheu. (2004) Effect of Withdrawal of Statin on C-Reactive Protein. Cardiology 102:3, 166-170
CrossRef987
Allon N. Friedman, Lawrence G. Hunsicker, Jacob Selhub, Andrew G. Bostom. (2004) Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy. Atherosclerosis 172:1, 121-125
CrossRef988
Harish R. Chandra, James A. Goldstein, Nivedita Choudhary, Carol S. O'Neill, Peter B. George, Sreenivasulu R. Gangasani, Lynn Cronin, Pamela A. Marcovitz, Andrew M. Hauser, William W. O'Neill. (2004) Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation. Journal of the American College of Cardiology 43:2, 169-175
CrossRef989
Mitsuru Seishima, Makiko Suzuki, Satoshi Maeda. (2004) Atherosclerosis and biochemical markers.. SEIBUTSU BUTSURI KAGAKU 48:4, 143-146
CrossRef990
Robert F. Ritchie, Glenn E. Palomaki, Louis M. Neveux, Olga Navolotskaia, Thomas B. Ledue, Wendy Y. Craig. (2004) Reference distributions for complement proteins C3 and C4: A practical, simple and clinically relevant approach in a large cohort. Journal of Clinical Laboratory Analysis 18:1, 1-8
CrossRef991
Motoyuki NAKAMURA, Toshiyuki ONODA, Kazuyoshi ITAI, Masaki OHSAWA, Kenyu SATOU, Toshiaki SAKAI, Toshie SEGAWA, Junko SASAKI, Yoko TONARI, Katsuhiko HIRAMORI, Akira OKAYAMA. (2004) Association between Serum C-reactive Protein Levels and Microalbuminuria: A Population-Based Cross-Sectional Study in Northern Iwate, Japan. Internal Medicine 43:10, 919-925
CrossRef992
Panayiotis G. Vlachoyiannopoulos, Michael Samarkos. (2004) Peripheral vascular disease in antiphospholipid syndrome. Thrombosis Research 114:5-6, 509-519
CrossRef993
Stefan James. (2004) Coagulation, inflammation and myocardial dysfunction in unstable coronary artery disease and the influence of glycoprotein IIb/IIIa inhibition and low molecular weight heparin. Upsala Journal of Medical Sciences 109:2, 71-122
CrossRef994
Mitchell S.V. Elkind, J.P. Mohr. 2004. Collagen Vascular and Infectious Diseases. , 575-601.
CrossRef995
M. Bohm. (2004) Alcohol and red wine: impact on cardiovascular risk. Nephrology Dialysis Transplantation 19:1, 11-16
CrossRef996
Gordana Perunicic-Pekovic, Zorica Rasic-Milutinovic, Steva Pljesa. (2004) Predictors of mortality in dialysis patients: Association between malnutrition, inflammation and atherosclerosis (Mia syndrome). Medicinski pregled 57:3-4, 149-152
CrossRef997
Anna Tzontcheva, Arman Postadjian. (2004) Markers of myocardial damage and inflammation in patients with coronary artery disease. Jugoslovenska medicinska biohemija 23:3, 249-253
CrossRef998
Roman, Mary J., Shanker, Beth-Ann, Davis, Adrienne, Lockshin, Michael D., Sammaritano, Lisa, Simantov, Ronit, Crow, Mary K., Schwartz, Joseph E., Paget, Stephen A., Devereux, Richard B., Salmon, Jane E., . (2003) Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus. New England Journal of Medicine 349:25, 2399-2406
Full Text999
T. J. Marrie, E. Michelakis. (2003) Increased Long-Term Mortality after an Episode of Community-Acquired Pneumonia--Time to Move beyond Descriptive Studies. Clinical Infectious Diseases 37:12, 1625-1628
CrossRef1000
H.Vernon Anderson. (2003) Angiotensin-converting enzyme inhibitors: ischemia is not the correct measure of benefit. Journal of the American College of Cardiology 42:12, 2060-2062
CrossRef1001
Toshiyuki Saito, Masatoshi Murakami, Yoshihiro Shimazaki, Kyoko Oobayashi, Sumihisa Matsumoto, Toshihiko Koga. (2003) Association Between Alveolar Bone Loss and Elevated Serum C-Reactive Protein in Japanese Men. Journal of Periodontology 74:12, 1741-1746
CrossRef1002
Subodh Verma, Mitesh V Badiwala, Richard D Weisel, Shu-Hong Li, Chao-Hung Wang, Paul W.M Fedak, Ren-Ke Li, Donald A.G Mickle. (2003) C-reactive protein activates the nuclear factor-κB signal transduction pathway in saphenous vein endothelial cells: implications for atherosclerosis and restenosis. The Journal of Thoracic and Cardiovascular Surgery 126:6, 1886-1891
CrossRef1003
TRACEY PHILLIPS, APRIL C. CHILDS, DARLENE M. DREON, STEPHEN PHINNEY, CHRISTIAAN LEEUWENBURGH. (2003) A Dietary Supplement Attenuates IL-6 and CRP after Eccentric Exercise in Untrained Males. Medicine & Science in Sports & Exercise 35:12, 2032-2037
CrossRef1004
Hani Jneid, Deepak L Bhatt. (2003) Advances in antiplatelet therapy. Expert Opinion on Emerging Drugs 8:2, 349-363
CrossRef1005
Lawrence M Title, Karen Giddens, Michele M McInerney, Matthew J McQueen, Bassam A Nassar. (2003) Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease. Journal of the American College of Cardiology 42:10, 1747-1753
CrossRef1006
Beatriz Alvarez Garcia, Carmen Ruiz, Pilar Chacon, Jose Alvarez Sabin, Manuel Matas. (2003) High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque. Journal of Vascular Surgery 38:5, 1018-1024
CrossRef1007
Jos?? L. Torres, Paul M. Ridker. (2003) Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events. Current Opinion in Cardiology 18:6, 471-478
CrossRef1008
G.M. Hirschfield. (2003) C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM 96:11, 793-807
CrossRef1009
Russell P. Tracy. 2003. Atherogenesis and Coronary Heart Disease. .
CrossRef1010
Jian-Jun Li, Ming-Zhe Chen, Xin Chen, Chun-Hong Fang. (2003) Rapid effects of simvastatin on lipid profile and C-reactive protein in patients with hypercholesterolemia. Clinical Cardiology 26:10, 472-476
CrossRef1011
Jacques Amar, Jean B Ruidavets, Claire Bal Dit Sollier, Vanina Bongard, Henri Boccalon, Bernard Chamontin, Ludovic Drouet, Jean Ferri??res. (2003) Soluble CD14 and aortic stiffness in a population-based study. Journal of Hypertension 21:10, 1869-1877
CrossRef1012
P.L. van Haelst, J.W. Cohen Tervaert, P.P. van Geel, N.J.G.M. Veeger, O. Gurné, R.O.B. Gans, W.H. van Gilst. (2003) Long Term Angiotensin Converting Enzyme-inhibition in Patients after Coronary Artery Bypass Grafting Reduces Levels of Soluble Intercellular Cell Adhesion Molecule-1. European Journal of Vascular and Endovascular Surgery 26:4, 387-391
CrossRef1013
Gavin J. Blake. (2003) Inflammatory biomarkers of the patient with myocardial insufficiency. Current Opinion in Critical Care 9:5, 369-374
CrossRef1014
Jung Sik PARK, Soon Bae KIM. (2003) C-reactive protein as a cardiovascular risk factor and its therapeutic implications in end-stage renal disease patients. Nephrology 8:s2, S40-S44
CrossRef1015
Marcello Rattazzi, Massimo Puato, Elisabetta Faggin, Barbara Bertipaglia, Alberto Zambon, Paolo Pauletto. (2003) C-reactive protein and interleukin-6 in vascular disease. Journal of Hypertension 21:10, 1787-1803
CrossRef1016
Giuseppe Schillaci, Matteo Pirro, Fabio Gemelli, Leonella Pasqualini, Gaetano Vaudo, Simona Marchesi, Donatella Siepi, Francesco Bagaglia, Elmo Mannarino. (2003) Increased C-reactive protein concentrations in never-treated hypertension. Journal of Hypertension 21:10, 1841-1846
CrossRef1017
Yasushi Furuichi, Akihiro Shimotsu, Hiroo Ito, Yukari Namariyama, Yukiharu Yotsumoto, Youichi Hino, Yukie Mishige, Masakazu Inoue, Yuichi Izumi. (2003) Associations of Periodontal Status with General Health Conditions and Serum Antibody Titers for Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans. Journal of Periodontology 74:10, 1491-1497
CrossRef1018
Ted R Mikuls. (2003) Co-morbidity in rheumatoid arthritis. Best Practice & Research Clinical Rheumatology 17:5, 729-752
CrossRef1019
Amy H. Kao, Janice M. Sabatine, Susan Manzi. (2003) Update on vascular disease in systemic lupus erythematosus. Current Opinion in Rheumatology 15:5, 519-527
CrossRef1020
S. A. Hope, I. T. Meredith. (2003) Cellular adhesion molecules and cardiovascular disease. Part II. Their association with conventional and emerging risk factors, acute coronary events and cardiovascular risk prediction. Internal Medicine Journal 33:9-10, 450-462
CrossRef1021
Roland B. Walter, Dietmar Fuchs, Günter Weiss, Thomas R. Walter, Walter H. Reinhart. (2003) HMG-CoA Reductase Inhibitors Are Associated with Decreased Serum Neopterin Levels in Stable Coronary Artery Disease. Clinical Chemistry and Laboratory Medicine 41:10, 1314-1319
CrossRef1022
Lawrence J Dacey, Joseph DeSimone, John H Braxton, Bruce J Leavitt, Stephen J Lahey, John D Klemperer, Benjamin M Westbrook, Elaine M Olmstead, Gerald T O’Connor. (2003) Preoperative white blood cell count and mortality and morbidity after coronary artery bypass grafting. The Annals of Thoracic Surgery 76:3, 760-764
CrossRef1023
David W. Lehman. (2003) Novel Serum Cardiac Risk Biomarkers: Risk Assessment for Primary Prevention. Primary Care Case Reviews 6:3, 121-128
CrossRef1024
Guo Yi, Jiang Xin, Zhou Zhibin, Chen Shi, Zhao Hongwen, Li Fukang. (2003) Relationship between levels of serum C-reactive protein, leucocyte count and carotid plaque in patients with ischemic stroke. Journal of Huazhong University of Science and Technology [Medical Sciences] 23:3, 263-265
CrossRef1025
Paul M. Ridker, Shari S. Bassuk, Peter P. Toth. (2003) C-reactive protein and risk of cardiovascular disease: Evidence and clinical application. Current Atherosclerosis Reports 5:5, 341-349
CrossRef1026
E.Murat Tuzcu, Paul Schoenhagen. (2003) Acute coronary syndromes, plaque vulnerability,and carotid artery disease. Journal of the American College of Cardiology 42:6, 1033-1036
CrossRef1027
M. Bennermo, C. Held, A. Hamsten, L.-E. Strandberg, C.-G. Ericsson, L.-O. Hansson, P. Tornvall. (2003) Prognostic value of plasma C-reactive protein and fibrinogen determinations in patients with acute myocardial infarction treated with thrombolysis. Journal of Internal Medicine 254:3, 244-250
CrossRef1028
Tsutomu Kazumi, Akira Kawaguchi, Tsutomu Hirano, Gen Yoshino. (2003) C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol. Metabolism 52:9, 1113-1116
CrossRef1029
Brenda W.J.H Penninx, Stephen B Kritchevsky, Kristine Yaffe, Anne B Newman, Eleanor M Simonsick, Susan Rubin, Luigi Ferrucci, Tamara Harris, Marco Pahor. (2003) Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biological Psychiatry 54:5, 566-572
CrossRef1030
Kazunari Matsumoto, Yasunori Sera, Yasuyo Abe, Yukitaka Ueki, Tan Tominaga, Seibei Miyake. (2003) Inflammation and insulin resistance are independently related to all-cause of death and cardiovascular events in Japanese patients with type 2 diabetes mellitus. Atherosclerosis 169:2, 317-321
CrossRef1031
T. Kvasnicka, J. Kvasnicka, R. Ceska, M. Vrablik. (2003) Increase of inflammatory state in overweight adults with combined hyperlipidemia. Nutrition, Metabolism and Cardiovascular Diseases 13:4, 227-231
CrossRef1032
Karen E Joynt, David J Whellan, Christopher M O'Connor. (2003) Depression and cardiovascular disease: mechanisms of interaction. Biological Psychiatry 54:3, 248-261
CrossRef1033
Anders Larsson, Lars-Olof Hansson. (2003) Evaluation of a modified hsCRP method for point-of-service testing. Clinica Chimica Acta 334:1-2, 249-252
CrossRef1034
Gregory E. Miller, Kenneth E. Freedland, Robert M. Carney, Cinnamon A. Stetler, William A. Banks. (2003) Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain, Behavior, and Immunity 17:4, 276-285
CrossRef1035
Yoshihiro Iwamoto, Fusanori Nishimura, Yoshihiko Soga, Kazu Takeuchi, Mikinao Kurihara, Shogo Takashiba, Yoji Murayama. (2003) Antimicrobial Periodontal Treatment Decreases Serum C-Reactive Protein, Tumor Necrosis Factor-Alpha, But Not Adiponectin Levels in Patients with Chronic Periodontitis. Journal of Periodontology 74:8, 1231-1236
CrossRef1036
Toshio Ohkuma, Taro Minagawa, Nobuyuki Takada, Michiya Ohno, Hiroshi Oda, Hiroshige Ohashi. (2003) C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients. American Journal of Kidney Diseases 42:2, 355-361
CrossRef1037
Thomas P Erlinger, Michelle E Tarver-Carr, Neil R Powe, Lawrence J Appel, Josef Coresh, Mark S Eberhardt, Frederick L Brancati. (2003) Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in US adults. American Journal of Kidney Diseases 42:2, 256-263
CrossRef1038
Shunichi Kojima, Mikio Shida, Hiroyuki Yokoyama. (2003) Changes in C-reactive Protein Plasma Levels During Low-density Lipoprotein Apheresis. Therapeutic Apheresis and Dialysis 7:4, 431-434
CrossRef1039
S. A. Hope, I. T. Meredith. (2003) Cellular adhesion molecules and cardiovascular disease. Part I. Their expression and role in atherogenesis. Internal Medicine Journal 33:8, 380-386
CrossRef1040
Ibrahim E. Fahdi, Venkat Gaddam, Luis Garza, Francesco Romeo, Jawahar L. Mehta. (2003) Inflammation, infection, and atherosclerosis. Brain, Behavior, and Immunity 17:4, 238-244
CrossRef1041
Anne Klibanski. (2003) Growth hormone and cardiovascular risk markers. Growth Hormone & IGF Research 13, S109-S115
CrossRef1042
Hector O Ventura, Mandeep R Mehra. (2003) C-Reactive protein and cardiac allograft vasculopathy. Journal of the American College of Cardiology 42:3, 483-485
CrossRef1043
M. S. A. Verkerk, F. L. J. Visseren, K. Paul Bouter, R. J. A. Diepersloot. (2003) Acute-phase response of human hepatocytes after infection with Chlamydia pneumoniae and cytomegalovirus. European Journal of Clinical Investigation 33:8, 720-725
CrossRef1044
Ronald G. Craig, Julie K. Yip, Man Ki So, Robert J. Boylan, Sigmund S. Socransky, Anne D. Haffajee. (2003) Relationship of Destructive Periodontal Disease to the Acute-Phase Response. Journal of Periodontology 74:7, 1007-1016
CrossRef1045
SVATI H. SHAH, L. KRISTIN NEWBY. (2003) C-Reactive Protein: A Novel Marker of Cardiovascular Risk. Cardiology in Review 11:4, 169-179
CrossRef1046
José L. Torres, Paul M. Ridker. (2003) High Sensitivity C-Reactive Protein in Clinical Practice. The American Heart Hospital Journal 1:3, 207-211
CrossRef1047
Elizabeth J. Corwin, Laura Cousino Klein. (2003) C-reactive protein and depressed mood in a sub-group of smokers during nicotine abstinence. Human Psychopharmacology: Clinical and Experimental 18:5, 329-337
CrossRef1048
V. Fuster, R. Corti, Z. A. Fayad, J. Schwitter, J. J. Badimon. (2003) Integration of vascular biology and magnetic resonance imaging in the understanding of atherothrombosis and acute coronary syndromes. Journal of Thrombosis and Haemostasis 1:7, 1410-1421
CrossRef1049
Peter K Henke, Pasu Sukheepod, Mary C Proctor, Gilbert R Upchurch, James C Stanley. (2003) Clinical relevance of peripheral vascular occlusive disease in patients with rheumatoid arthritis and systemic lupus erythematosus 11Competition of interest: none.. Journal of Vascular Surgery 38:1, 111-115
CrossRef1050
Toshihiro Takeda, Shiro Hoshida, Masami Nishino, Jun Tanouchi, Kinya Otsu, Masatsugu Hori. (2003) Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levels. Atherosclerosis 169:1, 155-158
CrossRef1051
ERIC S. RAWSON, PATTY S. FREEDSON, STAVROULA K. OSGANIAN, CHARLES E. MATTHEWS, GEORGE REED, IRA S. OCKENE. (2003) Body Mass Index, but Not Physical Activity, Is Associated with C-Reactive Protein. Medicine & Science in Sports & Exercise 35:7, 1160-1166
CrossRef1052
Inmaculada del Rinc
CrossRef1053
Remco Nijmeijer, Wim K. Lagrand, Yvonne T.P. Lubbers, Cees A. Visser, Chris J.L.M. Meijer, Hans W.M. Niessen, C. Erik Hack. (2003) C-Reactive Protein Activates Complement in Infarcted Human Myocardium. The American Journal of Pathology 163:1, 269-275
CrossRef1054
A. Muscari, C. Martignani, L. Bastagli, G. Poggiopollini, V. Tomassetti, L. Baldini, O. Cappelletti, P. Boni, G. Ravaglia, P. Puddu. (2003) A Comparison of Acute Phase Proteins and Traditional Risk Factors as Markers of Combined Plaque and Intima-Media Thickness and Plaque Density in Carotid and Femoral Arteries. European Journal of Vascular and Endovascular Surgery 26:1, 81-87
CrossRef1055
Seth Braunstein. (2003) New developments in type 2 diabetes mellitus: Combination therapy with a thiazolidinedione. Clinical Therapeutics 25:7, 1895-1917
CrossRef1056
Jeffrey T. Kuvin, Richard H. Karas. (2003) The effects of LDL reduction and HDL augmentation on physiologic and inflammatory markers. Current Opinion in Cardiology 18:4, 295-300
CrossRef1057
S HAFFNER. (2003) Pre-diabetes, insulin resistance, inflammation and CVD risk. Diabetes Research and Clinical Practice 61, S9-S18
CrossRef1058
C.J. Malkin. (2003) Testosterone for secondary prevention in men with ischaemic heart disease?. QJM 96:7, 521-529
CrossRef1059
Mark B. Pepys, Gideon M. Hirschfield. (2003) C-reactive protein: a critical update. Journal of Clinical Investigation 111:12, 1805-1812
CrossRef1060
Roberto Pecoits-Filho, Olof Heimbürger, Peter Bárány, Mohamed Suliman, Ingela Fehrman-Ekholm, Bengt Lindholm, Peter Stenvinkel. (2003) Associations between circulating inflammatory markers and residual renal function in CRF patients. American Journal of Kidney Diseases 41:6, 1212-1218
CrossRef1061
Olaf Stüve, Sawsan Youssef, Lawrence Steinman, Scott S. Zamvil. (2003) Statins as potential therapeutic agents in neuroinflammatory disorders. Current Opinion in Neurology 16:3, 393-401
CrossRef1062
Jae Soon Ahn, Sunga Choi, Sang Ho Jang, Hyuk Jae Chang, Jae Hoon Kim, Ki Bong Nahm, Sang Wook Oh, Eui Yul Choi. (2003) Development of a point-of-care assay system for high-sensitivity C-reactive protein in whole blood. Clinica Chimica Acta 332:1-2, 51-59
CrossRef1063
Jian-Jun Li, Xue-Jun Chen. (2003) Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein and lipopolysaccharide. Coronary Artery Disease 14:4, 329-334
CrossRef1064
Carmine Zoccali, Francesca Mallamaci, Giovanni Tripepi. (2003) Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney International 63:s85, 105-110
CrossRef1065
Richard C Pasternak, Jonathan Abrams, Philip Greenland, Lynn A Smaha, Peter W.F Wilson, Nancy Houston-Miller. (2003) Task force #1—identification of coronary heart disease risk: is there a detection gap?. Journal of the American College of Cardiology 41:11, 1863-1874
CrossRef1066
Jian-Jun Li, Xue-Jun Chen. (2003) Coronary Artery Disease 14:4, 329-334
CrossRef1067
Pierre Theuma, Vivian A. Fonseca. (2003) Inflammation and emerging risk factors in diabetes mellitus and atherosclerosis. Current Diabetes Reports 3:3, 248-254
CrossRef1068
Jan Galle, Thomas Quaschning, Stefan Seibold, Christoph Wanner. (2003) Endothelial dysfunction and inflammation: What is the link?. Kidney International 63:s84, 45-49
CrossRef1069
Matthias Girndt, Christof Ulrich, Harald Kaul, Urban Sester, Martina Sester, Hans Kohler. (2003) Uremia-associated immune defect: The IL-10-CRP axis. Kidney International 63:s84, 76-79
CrossRef1070
ARYAN VINK, GERARD PASTERKAMP. (2003) Atherosclerotic Plaques:. Journal of Interventional Cardiology 16:2, 115-122
CrossRef1071
H. Robert Superko. (2003) Sophisticated Tests for Susceptibility to Atherosclerosis:An Added Value for Heart Hospitals. The American Heart Hospital Journal 1:2, 135-140
CrossRef1072
Steven E Lipshultz, Stacy D Fisher, Wyman W Lai, Tracie L Miller. (2003) Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients. AIDS 17, S96-S122
CrossRef1073
N. Rifai. (2003) C-reaktives Protein in der Risikovorhersage und Intervention bei kardiovaskulären Erkrankungen/C-Reactive Protein for Risk Prediction and Intervention in Cardiovascular Disease. LaboratoriumsMedizin 27:3-4, 100-112
CrossRef1074
Paul M. Ridker. (2003) Connecting the role of C-reactive protein and statins in cardiovascular disease. Clinical Cardiology 26:S3, 39-44
CrossRef1075
G. Nordin Fredrikson, B. Hedblad, G. Berglund, J. Nilsson. (2003) Plasma oxidized LDL: a predictor for acute myocardial infarction?. Journal of Internal Medicine 253:4, 425-429
CrossRef1076
R. A. Seymour, P. M. Preshaw, J. M. Thomason, J. S. Ellis, J. G. Steele. (2003) Cardiovascular diseases and periodontology. Journal of Clinical Periodontology 30:4, 279-292
CrossRef1077
M. Ide, D. McPartlin, P.Y. Coward, M. Crook, P. Lumb, R.F. Wilson. (2003) Effect of treatment of chronic periodontitis on levels of serum markers of acute-phase inflammatory and vascular responses. Journal of Clinical Periodontology 30:4, 334-340
CrossRef1078
Giuseppe G.L Biondi-Zoccai, Antonio Abbate, Giovanna Liuzzo, Luigi M Biasucci. (2003) Atherothrombosis, inflammation, and diabetes. Journal of the American College of Cardiology 41:7, 1071-1077
CrossRef1079
L PIERONI, J BASTARD, A PITON, L KHALIL, B HAINQUE, C JARDEL. (2003) Interpretation of circulating C-reactive protein levels in adults: Body Mass Index and gender are a must. Diabetes & Metabolism 29:2, 133-138
CrossRef1080
Trine Madsen, Jeppe H. Christensen, Mogens Blom, Erik B. Schmidt. (2003) The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose–response study. British Journal of Nutrition 89:04, 517
CrossRef1081
F. Zangeneh, Y. C. Kudva, A. Basu. (2003) Insulin Sensitizers. Mayo Clinic Proceedings 78:4, 471-479
CrossRef1082
Stefan K James, Paul Armstrong, Elliott Barnathan, Robert Califf, Bertil Lindahl, Agneta Siegbahn, Maarten L Simoons, Eric J Topol, Per Venge, Lars Wallentin. (2003) Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome. Journal of the American College of Cardiology 41:6, 916-924
CrossRef1083
François Madore. (2003) THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Uremia-Related Metabolic Cardiac Risk Factors in Chronic Kidney Disease. Seminars in Dialysis 16:2, 148-156
CrossRef1084
E. G. J. Vermeulen, J. A. Rauwerda, M. van den Berg, S. C. de Jong, C. Schalkwijk, J. W. R. Twisk, C. D. A. Stehouwer. (2003) Homocysteine-lowering treatment with folic acid plus vitamin B6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-points of a randomized clinical trial. European Journal of Clinical Investigation 33:3, 209-215
CrossRef1085
Heidi L Witherell, Karen L Smith, Gary D Friedman, Catherine Ley, David H Thom, Norman Orentreich, Joseph H Vogelman, Julie Parsonnet. (2003) C-reactive Protein, Helicobacter pylori, Chlamydia pneumoniae, Cytomegalovirus and Risk for Myocardial Infarction. Annals of Epidemiology 13:3, 170-177
CrossRef1086
Edward T. H. Yeh, Robert P. Palusinski. (2003) C-reactive protein: The pawn has been promoted to queen. Current Atherosclerosis Reports 5:2, 101-105
CrossRef1087
Mayumi Saito, Toshihiko Ishimitsu, Junichi Minami, Hidehiko Ono, Masami Ohrui, Hiroaki Matsuoka. (2003) Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 167:1, 73-79
CrossRef1088
J. P. Higgins. (2003) Chlamydia pneumoniae and Coronary Artery Disease: The Antibiotic Trials. Mayo Clinic Proceedings 78:3, 321-332
CrossRef1089
Markus Reiter, Robert A. Bucek, Nihat Koca, Albert Dirisamer, Erich Minar. (2003) Deep vein thrombosis and systemic inflammatory response: A pilot trial. Wiener Klinische Wochenschrift 115:3-4, 111-114
CrossRef1090
Karen E Paisley, Martin Beaman, John E Tooke, Vidya Mohamed-Ali, Gordon DO Lowe, Angela C Shore. (2003) Endothelial dysfunction and inflammation in asymptomatic proteinuria. Kidney International 63:2, 624-633
CrossRef1091
Erik M Stuveling, Hans L Hillege, Stephan JL Bakker, Reinold OB Gans, Paul E de Jong, Dick de Zeeuw. (2003) C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney International 63:2, 654-661
CrossRef1092
C. Lowbeer, P. Stenvinkel, R. Pecoits-Filho, O. Heimburger, B. Lindholm, S. A. Gustafsson, A. Seeberger. (2003) Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. Journal of Internal Medicine 253:2, 153-160
CrossRef1093
A. Myron Johnson, Thomas B. Ledue, Marilyn F. Collins. (2003) Commutability of the CRM 470 C-Reactive Protein Value in the Dade Behring N High Sensitivity CRP Assay. Clinical Chemistry and Laboratory Medicine 41:2, 177-182
CrossRef1094
Frank B. Hu. (2003) Overweight and Obesity in Women: Health Risks and Consequences. Journal of Women's Health 12:2, 163-172
CrossRef1095
F GUERREROROMERO, M RODRIGUEZMORAN. (2003) Relation of C-reactive protein to features of the metabolic syndrome in normal glucose tolerant, impaired glucose tolerant, and newly diagnosed type 2 diabetic subjects. Diabetes & Metabolism 29:1, 65-71
CrossRef1096
Mirjam Christ-Crain, Christian Meier, Merih Guglielmetti, Peter R. Huber, Walter Riesen, Jean-Jacques Staub, Beat Müller. (2003) Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis 166:2, 379-386
CrossRef1097
V. Evangelista, G. Dell'elba, A. Celardo, S. Manarini, C. Cerletti. (2003) TxA2-mediated myocardial ischemia as a consequence of an acute lung inflammatory reaction in the rabbit. Journal of Thrombosis and Haemostasis 1:2, 314-319
CrossRef1098
H. Robert Superko, Nicolas A. Chronos. (2003) Hypercholesterolemia and Dyslipidemia: Issues for the clinician. Current Treatment Options in Cardiovascular Medicine 5:1, 35-50
CrossRef1099
Dianna Magliano, Danny Liew, Emma Ashton, Vijaya Sundararajan, John McNeil. (2003) Journal of Cardiovascular Risk 10:1, 41-55
CrossRef1100
Dominick J Angiolillo, Giovanna Liuzzo, Simona Pelliccioni, Erica De Candia, Raffaele Landolfi, Filippo Crea, Attilio Maseri, Luigi M Biasucci. (2003) Combined role of the Lewis antigenic system, Chlamydia pneumoniae, and C-reactive protein in unstable angina. Journal of the American College of Cardiology 41:4, 546-550
CrossRef1101
M Itoh. (2003) The mechanisms of inhibitory actions of gliclazide on neutrophils–endothelial cells adhesion and surface expression of endothelial adhesion molecules mediated by a high glucose concentration. Journal of Diabetes and its Complications 17:1, 22-26
CrossRef1102
Gavin J Blake, Paul M Ridker. (2003) C-reactive protein and other inflammatory risk markers in acute coronary syndromes. Journal of the American College of Cardiology 41:4, S37-S42
CrossRef1103
Makoto HIURA, Toru KIKUCHI, Keisuke NAGASAKI, Makoto UCHIYAMA. (2003) Elevation of Serum C-Reactive Protein Levels Is Associated with Obesity in Boys. Hypertension Research 26:7, 541-546
CrossRef1104
Okan Erdogan, Armagan Altun, Cetin Gul, Gultac Ozbay. (2003) C-Reactive Protein and Immunoglobulin-E Response to Coronary Artery Stenting in Patients with Stable Angina. Japanese Heart Journal 44:5, 593-600
CrossRef1105
Ilgın Karaca, Erdogan ilkay, Mehmet Akbulut, Mustafa Yavuzkır, Murat Pekdemir, Handan Akbulut, Nadi Arslan. (2003) Atorvastatin affects C-reactive protein levels in patients with coronary artery disease. Current Medical Research and Opinion 19:3, 187-191
CrossRef1106
Robert R. Henry. (2003) Insulin resistance: From predisposing factor to therapeutic target in type 2 diabetes. Clinical Therapeutics 25, B47-B63
CrossRef1107
Stanley Chia, Christopher A Ludlam, Keith A.A Fox, David E Newby. (2003) Acute systemic inflammation enhances endothelium-dependent tissue plasminogen activator release in men. Journal of the American College of Cardiology 41:2, 333-339
CrossRef1108
Isabelle Mah??, Alain Leizorovicz, Charles Caulin, Jean-Fran??ois Bergmann. (2003) Aspirin for the Prevention of Cardiovascular Events in the Elderly. Drugs & Aging 20:13, 999-1010
CrossRef1109
Moira M.B. Mungall, Allan Gaw, James Shepherd. (2003) Statin Therapy in the Elderly. Drugs & Aging 20:4, 263-275
CrossRef1110
Luis Miguel Blanco-Colio, José Tuñón, Jose Luis Martín-Ventura, Jesús Egido. (2003) Anti-inflammatory and immunomodulatory effects of statins. Kidney International 63:1, 12-23
CrossRef1111
M.Jacob Adams, Patricia H. Hardenbergh, Louis S. Constine, Steven E. Lipshultz. (2003) Radiation-associated cardiovascular disease. Critical Reviews in Oncology/Hematology 45:1, 55-75
CrossRef1112
George A Kaysen, Joel A Dubin, Hans-Georg Müller, William E Mitch, Laura Rosales, Nathan W Levin. (2003) Impact of albumin synthesis rate and the acute phase response in the dual regulation of fibrinogen levels in hemodialysis patients1. Kidney International 63:1, 315-322
CrossRef1113
Yasuaki DOHI, Masuo OHASHI, Masaya SUGIYAMA, Hiroyuki TAKASE, Koichi SATO, Ryuzo UEDA. (2003) Candesartan Reduces Oxidative Stress and Inflammation in Patients with Essential Hypertension. Hypertension Research 26:9, 691-697
CrossRef1114
Peifeng Hu, Teresa E. Seeman, Tamara B. Harris, David B. Reuben. (2003) Does Inflammation or Undernutrition Explain the Low CholesterolâMortality Association in High-Functioning Older Persons? MacArthur Studies of Successful Aging. Journal of the American Geriatrics Society 51:1, 80-84
CrossRef1115
Richard Ceska, Tomas Stulc, Tomas Zima, Ivan Malbohan, Lenka Fialova. (2003) PAPP-A, a novel marker of unstable plaque, is not influenced by hypolipidemic treatment in contrast to CRP. Atherosclerosis 166:1, 195-196
CrossRef1116
Patricia J. Manns, Daniel P. Williams, Christine M. Snow, Rosemary C. Wander. (2003) Physical activity, body fat, and serum c-reactive protein in postmenopausal women with and without hormone replacement. American Journal of Human Biology 15:1, 91-100
CrossRef1117
Robert E. Fowles. (2003) Potential Cardiovascular Effects of COX-2 Selective Nonsteroidal Antiinflammatory Drugs. Journal of Pain and Palliative Care Pharmacotherapy 17:2, 27-50
CrossRef1118
Tohru Mezaki, Taku Matsubara, Tomoyuki Hori, Kohtarou Higuchi, Akira Nakamura, Iwao Nakagawa, Shunsuke Imai, Kazuyuki Ozaki, Keiichi Tsuchida, Akimitsu Nasuno, Takayuki Tanaka, Kaname Kubota, Masahiko Nakano, Takashi Miida, Yoshifusa Aizawa. (2003) Plasma Levels of Soluble Thrombomodulin, C-reactive Protein, and Serum Amyloid A Protein in the Atherosclerotic Coronary Circulation. Japanese Heart Journal 44:5, 601-612
CrossRef1119
P. J. Mateos-Careres, A. Garcia-Mendez, J. Farre, L. Sanchez de Miguel, J. Gomez, R. de Andres, L. Rico, J. Romero, A. Lopez-Farre. (2002) Prior aspirin use in unstable angina patients with modified plasma inflammatory markers and endothelial nitric oxide synthase in neutrophils. European Journal of Clinical Investigation 32:12, 895-900
CrossRef1120
Mark J Sarnak, Anthony Poindexter, Shin-Ru Wang, Gerald J Beck, John W Kusek, Santica M Marcovina, Tom Greene, Andrew S Levey. (2002) Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study. Kidney International 62:6, 2208-2215
CrossRef1121
Stefan Störk, Clemens von Schacky, Peter Angerer. (2002) The effect of 17β-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial. Atherosclerosis 165:2, 301-307
CrossRef1122
James D. Beck, Steven Offenbacher. (2002) Relationships Among Clinical Measures of Periodontal Disease and Their Associations With Systemic Markers. Annals of Periodontology 7:1, 79-89
CrossRef1123
Per Ole Iversen, Patricia D. E. Groot, Nils Hjeltnes, Trine Opstad Andersen, Marie Christine Mowinckel, Per Morten Sandset. (2002) Impaired circadian variations of haemostatic and fibrinolytic parameters in tetraplegia. British Journal of Haematology 119:4, 1011-1016
CrossRef1124
Mary Mc Grae McDermott, Elizabeth A. Hahn, Philip Greenland, David Cella, Judith K. Ockene, Donna Brogan, William H. Pearce, Alan T. Hirsch, Kendra Hanley, Linda Odom, Shaheen Khan, Michael H. Criqui, Martin S. Lipsky, Stacie Hudgens. (2002) Atherosclerotic Risk Factor Reduction in Peripheral Arterial Disease. Results of a National Physician Survey. Journal of General Internal Medicine 17:12, 895-904
CrossRef1125
Hedley C. A. Emsley, Pippa J. Tyrrell. (2002) Inflammation and Infection in Clinical Stroke. Journal of Cerebral Blood Flow & Metabolism1399-1419
CrossRef1126
Paul H. Black. (2002) Stress and the inflammatory response: A review of neurogenic inflammation. Brain, Behavior, and Immunity 16:6, 622-653
CrossRef1127
Sanne van Wissen, Mieke D Trip, Tineke J Smilde, Jacqueline de Graaf, Anton F.H Stalenhoef, John J.P Kastelein. (2002) Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy. Atherosclerosis 165:2, 361-366
CrossRef1128
Ridker, Paul M., Rifai, Nader, Rose, Lynda, Buring, Julie E., Cook, Nancy R., . (2002) Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events. New England Journal of Medicine 347:20, 1557-1565
Full Text1129
Robert A. Bucek, Markus Reiter, Peter Quehenberger, Erich Minar. (2002) C-reactive protein in the diagnosis of deep vein thrombosis. British Journal of Haematology 119:2, 385-389
CrossRef1130
Ettore Porreca, Concetta Di Febbo, Augusto di Castelnuovo, Giovanna Baccante, Concetta Amore, Antonio Angelini, Marcello Di Nisio, Maria Benedetta Donati, Franco Cuccurullo, Licia Iacoviello. (2002) Association of factor VII levels with inflammatory parameters in hypercholesterolemic patients. Atherosclerosis 165:1, 159-166
CrossRef1131
Peter Stenvinkel, Christoph Wanner, Thomas Metzger, Olof Heimbürger, Francesca Mallamaci, Giovanni Tripepi, Lorenzo Malatino, Carmine Zoccali. (2002) Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage?. Kidney International 62:5, 1791-1798
CrossRef1132
Marc S Sabatine, David A Morrow, Christopher P Cannon, Sabina A Murphy, Laura A Demopoulos, Peter M DiBattiste, Carolyn H McCabe, Eugene Braunwald, C.Michael Gibson. (2002) Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes. Journal of the American College of Cardiology 40:10, 1761-1768
CrossRef1133
Elisabetta Rossi. (2002) C-reactive protein and progressive atherosclerosis. The Lancet 360:9344, 1436-1437
CrossRef1134
Carlos A Labarrere, Joshua B Lee, David R Nelson, Mohammed Al-Hassani, Steven J Miller, Douglas E Pitts. (2002) C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study. The Lancet 360:9344, 1462-1467
CrossRef1135
Annaswamy Raji, Jorge Plutzky. (2002) Insulin resistance, diabetes, and atherosclerosis: Thiazolidinediones as therapeutic interventions. Current Cardiology Reports 4:6, 514-521
CrossRef1136
MacRae F. Linton, Sergio Fazio. (2002) Cyclooxygenase-2 and atherosclerosis. Current Opinion in Lipidology 13:5, 497-504
CrossRef1137
Filippo Crea, Cmlaudia Monaco, Gaetano A. Lanza, Elena Maggi, Francesca Ginnetti, Domenico Cianflone, Giampaolo Niccoli, Thomas Cook, Giorgio Bellomo, John Kjekshus. (2002) Inflammatory predictors of mortality in the scandinavian simvastatin survival study. Clinical Cardiology 25:10, 461-466
CrossRef1138
P. J. Manning, W. H. F. Sutherland, A. R. Allum, S. A. de Jong, S. D. Jones. (2002) Effect of hormone replacement therapy on inflammation-sensitive proteins in post-menopausal women with Type 2 diabetes. Diabetic Medicine 19:10, 847-852
CrossRef1139
Rasmi Magadle, Paltiel Weiner, Marinella Beckerman, Noa Berar-Yanay. (2002) C-reactive protein as a marker for active coronary artery disease in patients with chest pain in the emergency room. Clinical Cardiology 25:10, 456-460
CrossRef1140
N Okayama. (2002) Mechanisms of inhibitory activity of the aldose reductase inhibitor, epalrestat, on high glucose-mediated endothelial injury Neutrophil–endothelial cell adhesion and surface expression of endothelial adhesion molecules. Journal of Diabetes and its Complications 16:5, 321-326
CrossRef1141
Didier Ducloux, Catherine Bresson-Vautrin, Marc Kribs, Aboubakr Abdelfatah, Jean-Marc Chalopin. (2002) C-reactive protein and cardiovascular disease in peritoneal dialysis patients. Kidney International 62:4, 1417-1422
CrossRef1142
Peter Stenvinkel, Anders Alvestrand. (2002) Review Articles: Inflammation in End-stage Renal Disease: Sources, Consequences, and Therapy. Seminars in Dialysis 15:5, 329-337
CrossRef1143
Matthias Girndt, Harald Kaul, Urban Sester, Christof Ulrich, Martina Sester, Thomas Georg, Hans Kohler. (2002) Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney International 62:3, 949-955
CrossRef1144
Rainer Buchmann, Andrej Hasilik, Thomas E. Van Dyke, Dieter E. Lange. (2002) Resolution of Crevicular Fluid Leukocyte Activity in Patients Treated for Aggressive Periodontal Disease. Journal of Periodontology 73:9, 995-1002
CrossRef1145
Paulette Mehta. (2002) Aspirin in the prophylaxis of coronary artery disease. Current Opinion in Cardiology 17:5, 552-558
CrossRef1146
Vichai Atichartakarn, Pantep Angchaisuksiri, Katcharin Aryurachai, Supornchai Onpun, Suporn Chuncharunee, Ammarin Thakkinstian, Kanlayanee Atamasirikul. (2002) Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/β-thalassaemic patients. British Journal of Haematology 118:3, 893-898
CrossRef1147
Raymond G. Schlienger, Hershel Jick, Christoph R. Meier. (2002) Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction. British Journal of Clinical Pharmacology 54:3, 327-332
CrossRef1148
A Schumacher, I Seljeflot, A.B Lerkerød, L Sommervoll, J.E Otterstad, H Arnesen. (2002) Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease. Atherosclerosis 164:1, 153-160
CrossRef1149
James S. Zebrack, Jeffrey L. Anderson. (2002) Role of Inflammation in Cardiovascular Disease: How to Use C-Reactive Protein in Clinical Practice. Progress in Cardiovascular Nursing 17:4, 174-185
CrossRef1150
Nicola J. Goodson, Nicola J. Wiles, Mark Lunt, Elizabeth M. Barrett, Alan J. Silman, Deborah P. M. Symmons. (2002) Mortality in early inflammatory polyarthritis: Cardiovascular mortality is increased in seropositive patients. Arthritis & Rheumatism 46:8, 2010-2019
CrossRef1151
Monica Acevedo, Dennis L. Sprecher, Leonard Calabrese, Gregory L. Pearce, Denise L. Coyner, Sandra S. Halliburton, Richard D. White, Elizabeth Sykora, George T. Kondos, Julie A. Hoff. (2002) Pilot study of coronary atherosclerotic risk and plaque burden in HIV patients: ‘a call for cardiovascular prevention’. Atherosclerosis 163:2, 349-354
CrossRef1152
Johan Frostegård. (2002) Autoimmunity, oxidized LDL and cardiovascular disease. Autoimmunity Reviews 1:4, 233-237
CrossRef1153
Christopher J Edwards. (2002) Immune-mediated inflammatory disorders. Medicine 30:8, 1-3
CrossRef1154
M VANDERBEEK, L VISSER, M DEMAAT. (2002) Yellow fever vaccination as a model to study the response to stimulation of the inflammation system. Vascular Pharmacology 39:3, 117-121
CrossRef1155
C Kluft. (2002) Pro-inflammatory effects of oestrogens during use of oral contraceptives and hormone replacement treatment. Vascular Pharmacology 39:3, 149-154
CrossRef1156
A Szalai. (2002) The biological functions of C-reactive protein. Vascular Pharmacology 39:3, 105-107
CrossRef1157
Tsu-Lan Wu, Kuo-Chien Tsao, Christine P.-Y Chang, Chia-Ni Li, Chien-Feng Sun, James T Wu. (2002) Development of ELISA on microplate for serum C-reactive protein and establishment of age-dependent normal reference range. Clinica Chimica Acta 322:1-2, 163-168
CrossRef1158
Hyun Ju Sung, Jeong-Ho Kim, Rojin Park, Kyung Ryul Lee, Oh Hun Kwon. (2002) Evaluation of Denka-Seiken Turbidimetric High-Sensitivity C-Reactive Protein Assay. Clinical Chemistry and Laboratory Medicine 40:8, 840-845
CrossRef1159
Víctor Sánchez-Margalet, José M. Cubero, Consuelo Martín-Romero, José Cubero, José M. Cruz-Fernández, Raimundo Goberna. (2002) Inflammatory Response to Coronary Stent Implantation in Patients with Unstable Angina. Clinical Chemistry and Laboratory Medicine 40:8, 769-774
CrossRef1160
Kiechl, Stefan, Lorenz, Eva, Reindl, Markus, Wiedermann, Christian J., Oberhollenzer, Friedrich, Bonora, Enzo, Willeit, Johann, Schwartz, David A., . (2002) Toll-like Receptor 4 Polymorphisms and Atherogenesis. New England Journal of Medicine 347:3, 185-192
Full Text1161
Daisy G.M. Bloemenkamp, Willem P.Th.M. Mali, Bea C. Tanis, Frits R. Rosendaal, Maurice A.A.J. van den Bosch, Jeanet M. Kemmeren, Ale Algra, Jacobus M. Ossewaarde, Frank L.J. Visseren, Anton M. van Loon, Yolanda van der Graaf. (2002) Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease in young women. Atherosclerosis 163:1, 149-156
CrossRef1162
James S. Zebrack, Jeffrey L. Anderson. (2002) The role of inflammation and infection in the pathogenesis and evolution of coronary artery disease. Current Cardiology Reports 4:4, 278-288
CrossRef1163
Robert S. Rosenson, Wolfgang Koenig. (2002) High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease. Current Opinion in Cardiology 17:4, 325-331
CrossRef1164
Susanne B Schwedler, Thomas Metzger, Reinhard Schinzel, Christoph Wanner. (2002) Advanced glycation end products and mortality in hemodialysis patients. Kidney International 62:1, 301-310
CrossRef1165
Adil El Midaoui, Rong Wu, Jacques de Champlain. (2002) Prevention of hypertension, hyperglycemia and vascular oxidative stress by aspirin treatment in chronically glucose-fed rats. Journal of Hypertension 20:7, 1407-1412
CrossRef1166
Gavin J Blake, Paul M Ridker, Karen M Kuntz. (2002) Projected life-expectancy gains with statin therapy for individuals with elevated c-reactive protein levels. Journal of the American College of Cardiology 40:1, 49-55
CrossRef1167
K. Rerkasem, C.P. Shearman, J.A. Williams, G.E. Morris, M.J. Phillips, R.F. Grimble. (2002) C-reactive Protein is Elevated in Symptomatic Compared with Asymptomatic Patients with Carotid Artery Disease. European Journal of Vascular and Endovascular Surgery 23:6, 505-509
CrossRef1168
David A Brown, Samuel N Breit, Julie Buring, W Douglas Fairlie, Asne R Bauskin, Tao Liu, Paul M Ridker. (2002) Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. The Lancet 359:9324, 2159-2163
CrossRef1169
Barbara Dunn, Marietta Anthony, Banu Arun. (2002) The search for the ideal SERM. Expert Opinion on Pharmacotherapy 3:6, 681-691
CrossRef1170
H Omi. (2002) Participation of high glucose concentrations in neutrophil adhesion and surface expression of adhesion molecules on cultured human endothelial cells Effect of antidiabetic medicines. Journal of Diabetes and its Complications 16:3, 201-208
CrossRef1171
Lauer, Michael S., . (2002) Aspirin for Primary Prevention of Coronary Events. New England Journal of Medicine 346:19, 1468-1474
Full Text1172
Christoph Wanner, Josef Zimmermann, Susanne Schwedler, Thomas Metzger. (2002) Inflammation and cardiovascular risk in dialysis patients. Kidney International 61:s80, 99-102
CrossRef1173
Josef Veselka, Šárka Procházková, Radka Duchoňová, Ingrid Bolomová, Tatʼána Urbanová, David Tesař, Tomáš Honěk. (2002) Relationship of C-reactive protein to presence and severity of coronary atherosclerosis in patients with stable angina pectoris or a pathological exercise test. Coronary Artery Disease 13:3, 151-154
CrossRef1174
Robert Y.L. Zee, Paul M. Ridker. (2002) Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 162:1, 217-219
CrossRef1175
Braxton D. Mitchell, Ikhide G. Imumorin. (2002) Genetic determinants of diabetes and atherosclerosis. Current Atherosclerosis Reports 4:3, 193-198
CrossRef1176
Eberhard Wieland, Volker Schettler, Victor William Armstrong. (2002) Highly effective reduction of C-reactive protein in patients with coronary heart disease by extracorporeal low density lipoprotein apheresis. Atherosclerosis 162:1, 187-191
CrossRef1177
Arnaud Chiolero, Michel Burnier, Marc P Maillard. (2002) Cardiovascular hazard of selective COX-2 inhibitors: myth or reality?. Expert Opinion on Drug Safety 1:1, 45-52
CrossRef1178
Pamela Sakkinen, Robert D. Abbott, J.David Curb, Beatriz L. Rodriguez, Katsuhiko Yano, Russell P. Tracy. (2002) C-reactive protein and myocardial infarction. Journal of Clinical Epidemiology 55:5, 445-451
CrossRef1179
Matthias Sitzer, Hugh Markus, Michael Mendall, Rudiger Liehr, Uwe Knorr, Helmuth Steinmetz. (2002) Journal of Cardiovascular Risk 9:2, 97-103
CrossRef1180
Claudia E. Gerber, Gernot Bruchelt, Gerhard Ledinski, Joachim Greilberger, Dietrich Niethammer, Günther Jürgens. (2002) Low-density lipoprotein modification by normal, myeloperoxidase-deficient and NADPH oxidase-deficient granulocytes and the impact of redox active transition metal ions. Redox Report 7:2, 111-119
CrossRef1181
S. Van Doornum, G. McColl, I. P. Wicks. (2002) Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis?. Arthritis & Rheumatism 46:4, 862-873
CrossRef1182
Moti Haim, David Tanne, Valentina Boyko, Tamar Reshef, Uri Goldbourt, Jonathan Leor, Yoseph A Mekori, Solomon Behar. (2002) Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Journal of the American College of Cardiology 39:7, 1133-1138
CrossRef1183
N. Fiotti, A. Di Chiara, N. Altamura, M. Miccio, P. Fioretti, G. Guarnieri, C. Giansante. (2002) Coagulation indicators in chronic stable effort angina and unstable angina: relationship with acute phase reactants and clinical outcome. Blood Coagulation & Fibrinolysis 13:3, 247-255
CrossRef1184
Lewis Wexler. (2002) Ethical Considerations in Image-Based Screening for Coronary Artery Disease. Topics in Magnetic Resonance Imaging 13:2, 95-106
CrossRef1185
E.P.L. Turton, P.A. Coughlin, R.C. Kester, D.J.A. Scott. (2002) Exercise Training Reduces the Acute Inflammatory ResponseAssociated with Claudication. European Journal of Vascular and Endovascular Surgery 23:4, 309-316
CrossRef1186
M Thor. (2002) Markers of inflammation and hypercoagulability in diabetic and nondiabetic patients with lower extremity ischemia. Thrombosis Research 105:5, 379-383
CrossRef1187
Nicola Goodson. (2002) Coronary artery disease and rheumatoid arthritis. Current Opinion in Rheumatology 14:2, 115-120
CrossRef1188
Lung-Ching Chen, Ying-Hwa Chen, Shing-Jong Lin, Wan-Leong Chan, Nai-Wei Hsu, Ju-Pin Pan, Min-Ji Charng, Shi-Pu Wang, Philip Yu-An Ding, Mau-Song Chang. (2002) Clinical and angiographic determinants of adverse cardiac events in patients with stent restenosis. Catheterization and Cardiovascular Interventions 55:3, 331-337
CrossRef1189
Christian Weyer, John S. Yudkin, Coen D.A. Stehouwer, Casper G. Schalkwijk, Richard E. Pratley, P.Antonio Tataranni. (2002) Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis 161:1, 233-242
CrossRef1190
Aram V. Chobanian. (2002) Interaction between blood pressure, lipoproteins, angiotensin, and vascular disease. Current Hypertension Reports 4:2, 93-95
CrossRef1191
Sarah de Ferranti, Nader Rifai. (2002) C-reactive protein and cardiovascular disease: a review of risk prediction and interventions. Clinica Chimica Acta 317:1-2, 1-15
CrossRef1192
F. L. J. Visseren, M. S. A. Verkerk, T. van der Bruggen, J. J. M. Marx, B. S. van Asbeck, R. J. A. Diepersloot. (2002) Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A. European Journal of Clinical Investigation 32:s1, 84-90
CrossRef1193
Luther T. Clark. (2002) Vascular inflammation as a therapeutic target for prevention of cardiovascular disease. Current Atherosclerosis Reports 4:2, 77-81
CrossRef1194
Russell P. Tracy. (2002) Hemostatic and Inflammatory Markers as Risk Factors for Coronary Disease in the Elderly. The American Journal of Geriatric Cardiology 11:2, 93-101
CrossRef1195
Adrian Fine. (2002) Relevance of C-reactive protein levels in peritoneal dialysis patients. Kidney International 61:2, 615-620
CrossRef1196
Joris R. Delanghe, Michel R. Langlois, Dirk De Bacquer, Rudolf Mak, Paul Capel, Lieve Van Renterghem, Guy De Backer. (2002) Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease. Atherosclerosis 160:2, 471-476
CrossRef1197
Helaine E. Resnick, Barbara V. Howard. (2002) D
IABETES AND CARDIOVASCULAR DISEASE . Annual Review of Medicine 53:1, 245-267
CrossRef1198
Michel Accad, Andrew D. Michaels. (2002) Management after myocardial infarction. Current Treatment Options in Cardiovascular Medicine 4:1, 41-54
CrossRef1199
Hugh Markus, Paul Risley, Michael Mendall, Helmuth Steinmetz, Matthias Sitzer. (2002) Journal of Cardiovascular Risk 9:1, 1-6
CrossRef1200
Lars Retterstol, Lars Eikvar, Morten Bohn, Anette Bakken, Jan Erikssen, Kåre Berg. (2002) C-reactive protein predicts death in patients with previous premature myocardial infarction—A 10 year follow-up study. Atherosclerosis 160:2, 433-440
CrossRef1201
J De Backer, R Mak, D De Bacquer, L Van Renterghem, E Verbraekel, M Kornitzer, G De Backer. (2002) Parameters of inflammation and infection in a community based case-control study of coronary heart disease. Atherosclerosis 160:2, 457-463
CrossRef1202
James S Zebrack, Joseph B Muhlestein, Benjamin D Horne, Jeffrey L Anderson. (2002) C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. Journal of the American College of Cardiology 39:4, 632-637
CrossRef1203
Janice K. Kiecolt-Glaser, Lynanne McGuire, Theodore F. Robles, Ronald Glaser. (2002) E
MOTIONS , MORBIDITY ,AND MORTALITY : New Perspectives from Psychoneuroimmunology. Annual Review of Psychology 53:1, 83-107
CrossRef1204
Fusako Maehira, Gloria A. Luyo, Ikuko Miyagi, Masaru Oshiro, Nobuhisa Yamane, Mutsuo Kuba, Yukiyasu Nakazato. (2002) Alterations of serum selenium concentrations in the acute phase of pathological conditions. Clinica Chimica Acta 316:1-2, 137-146
CrossRef1205
Edmund A. Bermudez, Paul M. Ridker. (2002) C-Reactive Protein, Statins, and the Primary Prevention of Atherosclerotic Cardiovascular Disease. Preventive Cardiology 5:1, 42-46
CrossRef1206
P.A. BACON, K. RAZA, M.J. BANKS, J. TOWNEND, G.D. KITAS. (2002) THE ROLE OF ENDOTHELIAL CELL DYSFUNCTION IN THE CARDIOVASCULAR MORTALITY OF RA. International Reviews of Immunology 21:1, 1-17
CrossRef1207
L. Reinares, A. Figueredo, A. Rueda, J.C. Pontes, A. Rodr??guez, M. Ruiz-Yag??e, M.A. Hern??ndez-Presa, C. Pueyo, G. Hern??ndez, A. Fern??ndez-Cruz, R. Pati??o. (2002) Atorvastatin Reduces Expression of the CCR2 and MAC-1 Receptors on Monocytes, and Plasma Levels of Monocyte Chemoattractant Protein-1 and C-Reactive Protein, in Patients with Coronary Heart Disease. Clinical Drug Investigation 22:1, 1-8
CrossRef1208
Ashwani Bedi, Gregory C. Flaker. (2002) How Do HMG-CoA Reductase Inhibitors Prevent Stroke?. American Journal of Cardiovascular Drugs 2:1, 7-14
CrossRef1209
Steven P Schulman, David R Thiemann, Pamela Ouyang, Nisha C Chandra, Douglas S Schulman, Steven E Reis, Michael Terrin, Sandra Forman, Cicero Piva de Albuquerque, Raymond D Bahr, Susan N Townsend, Rosalie Cosgriff, Gary Gerstenblith. (2002) Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina. Journal of the American College of Cardiology 39:2, 231-237
CrossRef1210
S. Mitra, K. Findley, D. Frohnapple, J. L. Mehta. (2002) Trends in long-term management of survivors of acute myocardial infarction by cardiologists in a government university-affiliated teaching hospital. Clinical Cardiology 25:1, 16-18
CrossRef1211
Robert F. Ritchie, Glenn E. Palomaki, Louis M. Neveux, Olga Navolotskaia, Thomas B. Ledue, Wendy Y. Craig. (2002) Reference distributions for serum iron and transferrin saturation: a practical, simple, and clinically relevant approach in a large cohort. Journal of Clinical Laboratory Analysis 16:5, 237-245
CrossRef1212
Miguel Angel Hernández-Presa, José Luis Martı́n-Ventura, Mónica Ortego, Almudena Gómez-Hernández, José Tuñón, Purificación Hernández-Vargas, Luis Miguel Blanco-Colio, Sebastián Mas, César Aparicio, Luis Ortega, Fernando Vivanco, Juan Gómez Gerique, Cristina Dı́az, Gonzalo Hernández, J Egido. (2002) Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells. Atherosclerosis 160:1, 49-58
CrossRef1213
Christopher C. Case, Christie M. Ballantyne. (2002) Statins and inflammatory markers. Current Atherosclerosis Reports 4:1, 42-47
CrossRef1214
William S Shin, Andrzej Szuba, Stanley G Rockson. (2002) The role of chemokines in human cardiovascular pathology: enhanced biological insights. Atherosclerosis 160:1, 91-102
CrossRef1215
Roberto Wayhs, Allan Zelinger, Paolo Raggi. (2002) High coronary artery calcium scores pose an extremely elevated risk for hard events. Journal of the American College of Cardiology 39:2, 225-230
CrossRef1216
Darko Cerne, Günther Jürgens, Gerhard Ledinski, Gerd Kager, Joachim Greilberger, Jana Lukac-Bajalo. (2002) Relationship between the Sialic Acid Content of Low-Density Lipoprotein (LDL) and Autoantibodies to Oxidized LDL in the Plasma of Healthy Subjects and Patients with Atherosclerosis. Clinical Chemistry and Laboratory Medicine 40:1, 15-20
CrossRef1217
Johann Auer, Robert Berent, Elisabeth Lassnig, Bernd Eber. (2002) C-reactive Protein and Coronary Artery Disease.. Japanese Heart Journal 43:6, 607-619
CrossRef1218
Joseph P. McConnell, Earl L. Branum, Karla V. Ballman, Susan A. Lagerstedt, Jerry A. Katzmann, Allan S. Jaffe. (2002) Gender Differences in C-Reactive Protein Concentrations - Confirmation with Two Sensitive Methods. Clinical Chemistry and Laboratory Medicine 40:1, 56-59
CrossRef1219
George A Kaysen, Joel A Dubin, Hans G Müller, William E Mitch, Nathan W Levin. (2001) Levels of α1 acid glycoprotein and ceruloplasmin predict future albumin levels in hemodialysis patients. Kidney International 60:6, 2360-2366
CrossRef1220
James Shepherd. (2001) Issues surrounding age: vascular disease in the elderly. Current Opinion in Lipidology 12:6, 601-609
CrossRef1221
Dirk H Walter, Stephan Fichtlscherer, Martina B Britten, Patrick Rosin, Wolfgang Auch-Schwelk, Volker Schächinger, Andreas M Zeiher. (2001) Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation. Journal of the American College of Cardiology 38:7, 2006-2012
CrossRef1222
DAVID M. HERRINGTON, KAREN POTVIN KLEIN. (2001) Cardiovascular Trials of Estrogen Replacement Therapy. Annals of the New York Academy of Sciences 949:1, 153-162
CrossRef1223
Richard P. Donahue, Tiejian Wu. (2001) Insulin Resistance and Periodontal Disease: An Epidemiologic Overview of Research Needs and Future Directions. Annals of Periodontology 6:1, 119-124
CrossRef1224
Jørgen Slots, Joanna J. Kamma. (2001) General health risk of periodontal disease. International Dental Journal 51:6, 417-427
CrossRef1225
MARIETTA ANTHONY, J. KOUDY WILLIAMS, BARBARA K. DUNN. (2001) What Would Be the Properties of an Ideal SERM?. Annals of the New York Academy of Sciences 949:1, 261-278
CrossRef1226
Inmaculada Del Rinc
CrossRef1227
Peifeng Hu, Teresa E. Seeman, Tamara B. Harris, David B. Reuben. (2001) Is Serum Uric Acid Level Associated with All-Cause Mortality in High-Functioning Older Persons: MacArthur Studies of Successful Aging?. Journal of the American Geriatrics Society 49:12, 1679-1684
CrossRef1228
Ernesto De Nardin. (2001) The Role of Inflammatory and Immunological Mediators in Periodontitis and Cardiovascular Disease. Annals of Periodontology 6:1, 30-40
CrossRef1229
H Tohgi. (2001) Ischemic Stroke Among Inpatients with Preceding Inflammatory Response. Thrombosis Research 104:5, 375-377
CrossRef1230
E Teiger. (2001) Physiopathologie de l'angor instablePathogenesis of instable angina. Annales de Cardiologie et d'Angéiologie 50:7-8, 359-365
CrossRef1231
Serge Masson, Aldo Pietro Maggioni, Pietro Ghezzi, Riccardo Bertini, Roberto Latini, Laura Calvillo. (2001) Cardiac protection by pharmacological modulation of inflammation. Expert Opinion on Investigational Drugs 10:11, 1913-1924
CrossRef1232
Stephen R. Daniels. (2001) Cardiovascular disease risk factors and atherosclerosis in children and adolescents. Current Atherosclerosis Reports 3:6, 479-485
CrossRef1233
Kenneth Boockvar, Mark Lachs. (2001) Development of Definitions for Acute Illness in Nursing Home Residents Based on Chart-Recorded Physical Exam Findings. Journal of the American Medical Directors Association 2:6, 279-284
CrossRef1234
STEVEN E. LIPSHULTZ, STACY D. FISHER, WYMAN W. LAI, TRACIE L. MILLER. (2001) Cardiovascular Monitoring and Therapy for HIV-Infected Patients. Annals of the New York Academy of Sciences 946:1, 236-273
CrossRef1235
Gavin J Blake, Nisha Dada, Jonathan C Fox, JoAnn E Manson, Paul M Ridker. (2001) A prospective evaluation of lipoprotein-associated phospholipase A2 levels and the risk of future cardiovascular events in women. Journal of the American College of Cardiology 38:5, 1302-1306
CrossRef1236
Uichi Ikeda, Takayuki Ito, Kazuyuki Shimada. (2001) Interleukin-6 and acute coronary syndrome. Clinical Cardiology 24:11, 701-704
CrossRef1237
John Whicher, Nader Rifai, Luigi M. Biasucci. (2001) Markers of the Acute Phase Response in Cardiovascular Disease: An Update. Clinical Chemistry and Laboratory Medicine 39:11, 1054-1064
CrossRef1238
Thomas B. Ledue, Nader Rifai. (2001) High Sensitivity Immunoassays for C-Reactive Protein: Promises and Pitfalls. Clinical Chemistry and Laboratory Medicine 39:11, 1171-1176
CrossRef1239
Giuseppe Bellelli, Renzo Rozzini, G. Battista Frisoni, Marco Trabucchi. (2001) Is C-reactive protein an independent risk factor for essential hypertension?. Journal of Hypertension 19:11, 2107
CrossRef1240
U.N. Das. (2001) Is obesity an inflammatory condition?. Nutrition 17:11-12, 953-966
CrossRef1241
(2001) The Antiinflammatory Effects of Statins. New England Journal of Medicine 345:16, 1209-1211
Full Text1242
Bayes-Genis, Antoni, Conover, Cheryl A., Overgaard, Michael T., Bailey, Kent R., Christiansen, Michael, Holmes, David R. Jr., Virmani, Renu, Oxvig, Claus, Schwartz, Robert S., . (2001) Pregnancy-Associated Plasma Protein A as a Marker of Acute Coronary Syndromes. New England Journal of Medicine 345:14, 1022-1029
Full Text1243
Anna Yu, Ulla Pira. (2001) False Increase in Serum C-Reactive Protein Caused by Monoclonal IgM-λ: a Case Report. Clinical Chemistry and Laboratory Medicine 39:10, 983-987
CrossRef1244
Ron Kerr, David Stirling, Christopher A. Ludlam. (2001) Interleukin 6 and Haemostasis. British Journal of Haematology 115:1, 3-12
CrossRef1245
R. Michael BENITEZ, Robert A. Vogel. (2001) Assessment of subclinical atherosclerosis and cardiovascular risk. Clinical Cardiology 24:10, 642-650
CrossRef1246
Alberto Galante, Antonio Pietroiusti, Marina Vellini, Paola Piccolo, Gianfederico Possati, Michele De Bonis, Rita L Grillo, Carla Fontana, Cartesio Favalli. (2001) C-reactive protein is increased in patients with degenerative aortic valvular stenosis. Journal of the American College of Cardiology 38:4, 1078-1082
CrossRef1247
Marek H. Dominiczak. (2001) Risk Factors for Coronary Disease: the Time for a Paradigm Shift?. Clinical Chemistry and Laboratory Medicine 39:10, 907-919
CrossRef1248
Aryan Vink, Arjan H Schoneveld, Wietske Richard, Dominique P.V de Kleijn, Erling Falk, Cornelius Borst, Gerard Pasterkamp. (2001) Plaque burden, arterial remodeling and plaque vulnerability: determined by systemic factors?. Journal of the American College of Cardiology 38:3, 718-723
CrossRef1249
M.V Ciarla, A Bocciarelli, S Di Gregorio, A Tordi, P Cotroneo, G Marra, G Ghirlanda, R Strom. (2001) Autoantibodies and endothelial dysfunction in well-controlled, uncomplicated insulin-dependent diabetes mellitus patients. Atherosclerosis 158:1, 241-246
CrossRef1250
Jane E. Salmon, Mary J. Roman. (2001) Accelerated atherosclerosis in systemic lupus erythematosus: implications for patient management. Current Opinion in Rheumatology 13:5, 341-344
CrossRef1251
Antonino Mazzone, Chiara Cusa, Iolanda Mazzucchelli, Monia Vezzoli, Elena Ottini, Stefano Ghio, Gianna Tossini, Roberta Pacifici, Piergiorgio Zuccaro. (2001) Cigarette Smoking and Hypertension Influence Nitric Oxide Release and Plasma Levels of Adhesion Molecules. Clinical Chemistry and Laboratory Medicine 39:9, 822-826
CrossRef1252
Sheila A Doggrell. (2001) Statins in the 21st century: end of the simple story?. Expert Opinion on Investigational Drugs 10:9, 1755-1766
CrossRef1253
Julian P.J. Halcox, Arshed A. Quyyumi. (2001) Coronary vascular endothelial function and myocardial ischemia: why should we worry about endothelial dysfunction?. Coronary Artery Disease 12:6, 475-484
CrossRef1254
Volker Schächinger, Andreas M. Zeiher. (2001) Prognostic implications of endothelial dysfunction: does it mean anything?. Coronary Artery Disease 12:6, 435-443
CrossRef1255
Giovanna Liuzzo, Vittoria Rizzello. (2001) C-reactive protein and primary prevention of ischemic heart disease. Clinica Chimica Acta 311:1, 45-48
CrossRef1256
Barbara Noack, Robert J. Genco, Maurizio Trevisan, Sara Grossi, Joseph J. Zambon, Ernesto De Nardin. (2001) Periodontal Infections Contribute to Elevated Systemic C-Reactive Protein Level. Journal of Periodontology 72:9, 1221-1227
CrossRef1257
Simin Liu, JoAnn E. Manson. (2001) Dietary carbohydrates, physical inactivity, obesity, and the ‘metabolic syndrome’ as predictors of coronary heart disease. Current Opinion in Lipidology 12:4, 395-404
CrossRef1258
George A Kaysen, Glenn M Chertow, Rohini Adhikarla, Belinda Young, Claudio Ronco, Nathan W Levin. (2001) Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney International 60:1, 333-340
CrossRef1259
J De Sutter. (2001) Fibrinogen and C-reactive protein on admission as markers of final infarct size after primary angioplasty for acute myocardial infarction. Atherosclerosis 157:1, 189-196
CrossRef1260
Juan J. Guardiola, Eugene C. Fletcher, H. Alhariri, Nuzhat Hasan. (2001) Hypercoagulability in Obstructive Sleep Apnea. Clinical Pulmonary Medicine 8:4, 238-241
CrossRef1261
George V. Moukarbel, M. Samir A. Arnaout, Samir E. Alam. (2001) C-Reactive protein is a marker for a complex culprit lesion anatomy in unstable angina. Clinical Cardiology 24:7, 506-510
CrossRef1262
Ridker, Paul M., Rifai, Nader, Clearfield, Michael, Downs, John R., Weis, Stephen E., Miles, J. Shawn, Gotto, Antonio M. Jr., . (2001) Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events. New England Journal of Medicine 344:26, 1959-1965
Full Text1263
Charles N. Serhan, Ernst Oliw. (2001) Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. Journal of Clinical Investigation 107:12, 1481-1489
CrossRef1264
Fatma Nurhan Ozdemir, Galip Guz, Siren Sezer, Zubeyde Arat, Munire Turan, Mehmet Haberal. (2001) Atherosclerosis Risk Is Higher in Continuous Ambulatory Peritoneal Dialysis Patients Than in Hemodialysis Patients. Artificial Organs 25:6, 448-452
CrossRef1265
Masahiro Akishita, Gotaro Shirakami, Masaru Iwai, Lan Wu, Motokuni Aoki, Lunan Zhang, Kenji Toba, Masatsugu Horiuchi. (2001) Angiotensin converting enzyme inhibitor restrains inflammation-induced vascular injury in mice. Journal of Hypertension 19:6, 1083-1088
CrossRef1266
Naveed Sattar, Donald McMillan. (2001) Plasma ascorbic acid and risk of heart disease and cancer. The Lancet 357:9274, 2134
CrossRef1267
Kyra J. Becker. (2001) Targeting the central nervous system inflammatory response in ischemic stroke. Current Opinion in Neurology 14:3, 349-353
CrossRef1268
Mark Feldman, Ishwarlal Jialal, Sridevi Devaraj, Byron Cryer. (2001) Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay. Journal of the American College of Cardiology 37:8, 2036-2041
CrossRef1269
Ted R. Mikuls, Kenneth G. Saag. (2001) COMORBIDITY IN RHEUMATOID ARTHRITIS. Rheumatic Disease Clinics of North America 27:2, 283-303
CrossRef1270
Frederick G.P. Welt, Daniel I. Simon. (2001) Atherosclerosis and plaque rupture. Catheterization and Cardiovascular Interventions 53:1, 56-63
CrossRef1271
Lennart T. H. Jacobsson, Carl Turesson, Robert L. Hanson, Stanley Pillemer, Maurice L. Sievers, David J. Pettitt, Peter H. Bennett, William C. Knowler. (2001) Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians. Arthritis & Rheumatism 44:5, 1170-1176
CrossRef1272
John W. Eikelboom, Graeme J. Hankey. (2001) Associations of homocysteine, C-reactive protein and cardiovascular disease in patients with renal disease. Current Opinion in Nephrology and Hypertension 10:3, 377-383
CrossRef1273
Garry J. Handelman, Mary F. Walter, Rohini Adhikarla, Jonathan Gross, Gerard E. Dallal, Nathan W. Levin, Jeffrey B. Blumberg. (2001) Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney International 59:5, 1960-1966
CrossRef1274
Simon Kennon, Christopher P Price, Peter G Mills, Kulasegaram Ranjadayalan, Jackie Cooper, Heather Clarke, Adam D Timmis. (2001) The effect of aspirin on C-reactive protein as a marker of risk in unstable angina. Journal of the American College of Cardiology 37:5, 1266-1270
CrossRef1275
Luqi Chi, Yuai Li, Lisa Stehno-Bittel, Jianjun Gao, David C. Morrison, Daniel J. Stechschulte, Kottarappat N. Dileepan. (2001) Interleukin-6 Production by Endothelial Cells via Stimulation of Protease-Activated Receptors Is Amplified by Endotoxin and Tumor Necrosis Factor-α. Journal of Interferon & Cytokine Research 21:4, 231-240
CrossRef1276
Christodoulos Stefanadis, Konstantinos Toutouzas, Eleftherios Tsiamis, Costas Stratos, Manolis Vavuranakis, Ioannis Kallikazaros, Dimosthenis Panagiotakos, Pavlos Toutouzas. (2001) Increased local temperature in human coronary atherosclerotic plaques: an independent predictor of clinical outcome in patients undergoing a percutaneous coronary intervention. Journal of the American College of Cardiology 37:5, 1277-1283
CrossRef1277
R Nijmeijer. (2001) CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction?. International Immunopharmacology 1:3, 403-414
CrossRef1278
M.-L.M. Grønholdt, H. Sillesen, B.M. Wiebe, H. Laursen, B.G. Nordestgaard. (2001) Increased Acute Phase Reactants are Associated with Levels of Lipoproteins and Increased Carotid Plaque Volume. European Journal of Vascular and Endovascular Surgery 21:3, 227-234
CrossRef1279
Dirk H Walter, Stephan Fichtlscherer, Marc Sellwig, Wolfgang Auch-Schwelk, Volker Schächinger, Andreas M Zeiher. (2001) Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. Journal of the American College of Cardiology 37:3, 839-846
CrossRef1280
A. B. Newman, J. S. Gottdiener, M. A. McBurnie, C. H. Hirsch, W. J. Kop, R. Tracy, J. D. Walston, L. P. Fried. (2001) Associations of Subclinical Cardiovascular Disease With Frailty. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 56:3, M158-M166
CrossRef1281
Carlos Guijarro, Jesus Egido. (2001) Transcription factor-kappaB (NF-kappaB) and renal disease. Kidney International 59:2, 415-424
CrossRef1282
Mustafa Arici, John Walls. (2001) End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?. Kidney International 59:2, 407-414
CrossRef1283
Robert Y.L Zee, Klaus Lindpaintner, Berthold Struk, Charles H Hennekens, Paul M Ridker. (2001) A prospective evaluation of the CD14 C(-260)T gene polymorphism and the risk of myocardial infarction. Atherosclerosis 154:3, 699-702
CrossRef1284
James S Pankow, Aaron R Folsom, Mary Cushman, Ingrid B Borecki, Paul N Hopkins, John H Eckfeldt, Russell P Tracy. (2001) Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 154:3, 681-689
CrossRef1285
Kristin M. Kolltveit, Harald M. Eriksen. (2001) Is the observed association between periodontitis and atherosclerosis causal?. European Journal of Oral Sciences 109:1, 2-7
CrossRef1286
D. Hamerman, J. Zeleznik. (2001) Translating basic aging research into geriatric health care. Experimental Gerontology 36:2, 193-203
CrossRef1287
Wolfgang Koenig. (2001) Inflammation and Coronary Heart Disease: An Overview. Cardiology in Review 9:1, 31-35
CrossRef1288
Gaye Cunnane. (2001) Amyloid precursors and amyloidosis in inflammatory arthritis. Current Opinion in Rheumatology 13:1, 67-73
CrossRef1289
A. Tedgui, Z. Mallat. (2001) Interleukin-10: an anti-atherogenic cytokine?. European Journal of Clinical Investigation 31:1, 1-2
CrossRef1290
Jean-Pierre Després. (2001) Health consequences of visceral obesity. Annals of Medicine 33:8, 534-541
CrossRef1291
G. R. de Freitas, J. Bogousslavsky. (2001) Primary stroke prevention. European Journal of Neurology 8:1, 1-15
CrossRef1292
WOO TEAK CHUNG, SEO HO LEE, JONG DAI KIM, YOUNG SIK PARK, BAIK HWANG, SHIN YOUNG LEE, HYEON YONG LEE. (2001) Effect of Mycelial Culture Broth of Ganoderma lucidum on the Growth Characteristics of Human Cell Lines. Journal of Bioscience and Bioengineering 92:6, 550-555
CrossRef1293
Emmanuel Oger, Martine Alhenc-Gelas, Geneviève Plu-Bureau, Louise Mennen, Michèle Cambillau, Louis Guize, Yamilée Pujol, Pierre-Yves Scarabin. (2001) Association of Circulating Cellular Adhesion Molecules with Menopausal Status and Hormone Replacement Therapy. Thrombosis Research 101:2, 35-43
CrossRef1294
Masami Kosuge, Kazuo Kimura, Toshiyuki Ishikawa, Tsutomu Endo, Makoto Shimizu, Yoichiro Hongo, Osamu Tochikubo, Satoshi Umemura. (2001) Differences in Inflammatory Activity at the Onset of Acute Myocardial Infarction According to the Clinical Presentation of Preinfarction Angina. Japanese Circulation Journal 65:8, 707-710
CrossRef1295
Heli Koukkunen, Karri Penttilä, Art Kemppainen, Matti Halinen, Ilkka Penttilä, Tapio Rantanen, Kalevi Pyörälä. (2001) C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-α in the prognostic classification of unstable angina pectoris. Annals of Medicine 33:1, 37-47
CrossRef1296
Vincenzo Panichi, Massimiliano Migliori, Stefano De Pietro, Daniele Taccola, Anna Maria Bianchi, Maria Norpoth, Maria Rita Metelli, Luca Giovannini, Ciro Tetta, Roberto Palla. (2001) C REACTIVE PROTEIN IN PATIENTS WITH CHRONIC RENAL DISEASES. Renal Failure 23:3-4, 551-562
CrossRef1297
Moses Elisaf. (2001) The Treatment of Coronary Heart Disease: An Update. Current Medical Research and Opinion 17:1, 18-26
CrossRef1298
James R. Sowers. (2001) Update on the cardiometabolic syndrome. Clinical Cornerstone 4:2, 17-23
CrossRef1299
Woo Teak Chung, Seo Ho Lee, Jong Dai Kim, Young Sik Park, Baik Hwang, Shin Young Lee, Hyeon Yong Lee. (2001) Effect of mycelial culture broth of Ganoderma lucidum on the growth characteristics of human cell lines. Journal of Bioscience and Bioengineering 92:6, 550-555
CrossRef1300
Moniek P.M. de Maat, Jacobus M. Ossewaarde, Peter W.H.M. Verheggen, Cornelis Kluft, Volkert Manger Cats, Frits Haverkate. (2000) Antibodies to Chlamydia pneumoniae and clinical course in patients with unstable angina pectoris. Atherosclerosis 153:2, 499-504
CrossRef1301
Dan Sunnemark, Robert A Harris, Johan Frostegård, Anders Örn. (2000) Induction of early atherosclerosis in CBA/J mice by combination of Trypanosoma cruzi infection and a high cholesterol diet. Atherosclerosis 153:2, 273-282
CrossRef1302
Gavin J. Blake, Paul M. Ridker. (2000) Albumin, fibrinogen, von Willebrand factor, factor VIII activity, and leukocyte count are significant nontraditional risk factors for CHD in patients with diabetes. Evidence-based Cardiovascular Medicine 4:4, 89-91
CrossRef1303
D. R. Taaffe, T. B. Harris, L. Ferrucci, J. Rowe, T. E. Seeman. (2000) Cross-sectional and Prospective Relationships of Interleukin-6 and C-Reactive Protein With Physical Performance in Elderly Persons: MacArthur Studies of Successful Aging. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 55:12, M709-M715
CrossRef1304
Toshihiro Onohara, Kimihiro Komori, Masazumi Kume, Masaru Ishida, Shinji Ohta, Kensuke Takeuchi, Takuya Matsumoto, Keizo Sugimachi. (2000) Increased plasma fibrinogen level and future risk of coronary artery disease after repair of abdominal aortic aneurysm11No competing interests declared.. Journal of the American College of Surgeons 191:6, 619-625
CrossRef1305
Hideo Tohgi, Shu Konno, Satoshi Takahashi, Daizo Koizumi, Ryushi Kondo, Hiroaki Takahashi. (2000) Activated coagulation/fibrinolysis system and platelet function in acute thrombotic stroke patients with increased C-reactive protein levels. Thrombosis Research 100:5, 373-379
CrossRef1306
Martin W Lunnon. (2000) Report on the Royal Society of Medicine one day meeting on coronary artery disease - ‘Bench to Bedside’.. Expert Opinion on Pharmacotherapy 1:7, 1469-1473
CrossRef1307
D YAMADA. (2000) Importance of microembolization and inflammation in atherosclerotic heart disease. American Heart Journal 140:6, s90-s102
CrossRef1308
Lewis H. Kuller, Karen A. Matthews, Elaine N. Meilahn. (2000) Estrogens and women's health: interrelation of coronary heart disease, breast cancer and osteoporosis. The Journal of Steroid Biochemistry and Molecular Biology 74:5, 297-309
CrossRef1309
H Yu. (2000) High-Sensitivity C-Reactive Protein and Atherosclerosis: From Theory to Therapy. Clinical Biochemistry 33:8, 601-610
CrossRef1310
Benjamin D Horne, Joseph B Muhlestein, John F Carlquist, Tami L Bair, Troy E Madsen, Noal I Hart, Jeffrey L Anderson. (2000) Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease. Journal of the American College of Cardiology 36:6, 1774-1780
CrossRef1311
Rader, Daniel J., . (2000) Inflammatory Markers of Coronary Risk. New England Journal of Medicine 343:16, 1179-1182
Full Text1312
Lindahl, Bertil, Toss, Henrik, Siegbahn, Agneta, Venge, Per, Wallentin, Lars, . (2000) Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease. New England Journal of Medicine 343:16, 1139-1147
Full Text1313
Packard, Chris J., O'Reilly, Denis S.J., Caslake, Muriel J., McMahon, Alex D., Ford, Ian, Cooney, JosephineMacphee, Colin H., Suckling, Keith E., Krishna, Mala, Wilkinson, Francis E., Rumley, Ann, Docherty, Gillian, Burczak, John D., Lowe, Gordon D.O., . (2000) Lipoprotein-Associated Phospholipase A2 as an Independent Predictor of Coronary Heart Disease. New England Journal of Medicine 343:16, 1148-1155
Full Text1314
C. N. Serhan, C. B. Clish, J. Brannon, S. P. Colgan, N. Chiang, K. Gronert. (2000) Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2-Nonsteroidal Antiinflammatory Drugs and Transcellular Processing. Journal of Experimental Medicine 192:8, 1197-1204
CrossRef1315
Frits Haverkate. (2000) C-Reactive Protein as Cardiovascular Risk Factor A Discovery by ECAT. Clinical Chemistry and Laboratory Medicine 38:10, 1055-1055
CrossRef1316
Andreas Festa, Ralph D'agostino, George Howard, Leena Mykkanen, Russell P. Tracy, Steven M. Haffner. (2000) Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney International 58:4, 1703-1710
CrossRef1317
Bruno G. Loos, Jeroen Craandijk, Frans J. Hoek, Paulien M.E. Wertheim-van Dillen, Ubele Van Der Velden. (2000) Elevation of Systemic Markers Related to Cardiovascular Diseases in the Peripheral Blood of Periodontitis Patients. Journal of Periodontology 71:10, 1528-1534
CrossRef1318
Goldstein, James A., Demetriou, Demetris, Grines, Cindy L., Pica, Mark, Shoukfeh, Mazen, O'Neill, William W., . (2000) Multiple Complex Coronary Plaques in Patients with Acute Myocardial Infarction. New England Journal of Medicine 343:13, 915-922
Full Text1319
Caitlin M. Nass, Stephen D. Wiviott, Jerilyn K. Allen, Wendy S. Post, Roger S. Blumenthal. (2000) Global risk assessment for lipid therapy to prevent coronary heart disease. Current Cardiology Reports 2:5, 424-432
CrossRef1320
Eugene Braunwald, Elliott M Antman, John W Beasley, Robert M Califf, Melvin D Cheitlin, Judith S Hochman, Robert H Jones, Dean Kereiakes, Joel Kupersmith, Thomas N Levin, Carl J Pepine, John W Schaeffer, Earl E Smith, David E Steward, Pierre Theroux, Raymond J Gibbons, Joseph S Alpert, Kim A Eagle, David P Faxon, Valentin Fuster, Timothy J Gardner, Gabriel Gregoratos, Richard O Russell, Sidney C Smith. (2000) ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction. Journal of the American College of Cardiology 36:3, 970-1062
CrossRef1321
Becker, van Hinsbergh, Kostense, Jager, Dekker, Nijpels, Heine, Bouter, Stehouwer. (2000) Serum homocysteine is weakly associated with von Willebrand factor and soluble vascular cell adhesion molecule 1, but not with C-reactive protein in type 2 diabetic and non-diabetic subjects - The Hoorn Study. European Journal of Clinical Investigation 30:9, 763-770
CrossRef1322
L. Kristin Newby, Darren K. McGuire. (2000) Oral platelet glycoprotein IIb/IIIa inhibition. Current Cardiology Reports 2:5, 372-377
CrossRef1323
(2000) C-Reactive Protein in the Prediction of Cardiovascular Disease. New England Journal of Medicine 343:7, 512-513
Full Text1324
Vincenzo Panichi, Massimiliano Migliori, Stefano De Pietro, Daniele Taccola, Brunella Andreini, Maria Rita Metelli, Luca Giovannini, Roberto Palla. (2000) The link of biocompatibility to cytokine production. Kidney International 58:Suppl. 76, 96-103
CrossRef1325
James A de Lemos, Charles H Hennekens, Paul M Ridker. (2000) Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk. Journal of the American College of Cardiology 36:2, 423-426
CrossRef1326
H. Bruunsgaard, P. Skinhoj, A. N. Pedersen, M. Schroll, B. K. Pedersen. (2000) Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clinical and Experimental Immunology 121:2, 255-260
CrossRef1327
V Stemme, J Swedenborg, H -E Claesson, GK Hansson. (2000) Expression of Cyclo-oxygenase-2 in Human Atherosclerotic Carotid Arteries. European Journal of Vascular and Endovascular Surgery 20:2, 146-152
CrossRef1328
Christopher J. O'Donnell, Daniel Levy. (2000) Weighing the evidence for infection as a risk factor for coronary heart disease. Current Cardiology Reports 2:4, 280-287
CrossRef1329
George A. Kaysen, Joel A. Dubin, Hans G. Muller, Laura M. Rosales, Nathan W. Levin, The Hemo Study Group. (2000) The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. Kidney International 58:1, 346-352
CrossRef1330
Giovanni Cammarota, Natale Figura, Rossella Cianci, Vincenzo Pasceri, Paolo Fedeli, Giusto Cristina Lenzi, Giovanni Gasbarrini. (2000) Is there an antigenic mimicry between arteriosclerotic lesions and H. pylori antigens?. Clinical Biochemistry 33:5, 419-421
CrossRef1331
Gerard Pasterkamp, Erling Falk, Hein Woutman, Cornelius Borst. (2000) Techniques characterizing the coronary atherosclerotic plaque: influence on clinical decision making?. Journal of the American College of Cardiology 36:1, 13-21
CrossRef1332
Paul M. Ridker. (2000) Are statins anti-inflammatory? Issues in the design and conduct of the pravastatin inflammation C-reactive protein evaluation. Current Cardiology Reports 2:4, 269-273
CrossRef1333
Michelle A. Albert. (2000) The role of C-reactive protein in cardiovascular disease risk. Current Cardiology Reports 2:4, 274-279
CrossRef1334
Luis A García Rodríguez, Cristina Varas, Carlo Patrono. (2000) Differential Effects of Aspirin and Non-Aspirin Nonsteroidal Antiinflammatory Drugs in the Primary Prevention of Myocardial Infarction in Postmenopausal Women. Epidemiology 11:4, 382-387
CrossRef1335
Pang H. Chong, Bob Kezele. (2000) Periodontal Disease and Atherosclerotic Cardiovascular Disease: Confounding Effects or Epiphenomenon?. Pharmacotherapy 20:7, 805-818
CrossRef1336
Rita F Redberg, Nader Rifai, Lauren Gee, Paul M Ridker. (2000) Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening. Journal of the American College of Cardiology 36:1, 39-43
CrossRef1337
Bruce B. Duncan, Maria Ines Schmidt, Lloyd E. Chambless, Aaron R. Folsom, Myra Carpenter, Gerardo Heiss. (2000) Fibrinogen, Other Putative Markers of Inflammation, and Weight Gain in Middle-aged Adults—The ARIC Study. Obesity 8:4, 279-286
CrossRef1338
William A Pryor. (2000) FORUM: oxidation and atherosclerosis. Free Radical Biology and Medicine 28:12, 1681-1682
CrossRef1339
Darko Cerne, Gerhard Ledinski, Gerd Kager, Joachim Greilberger, Xiasong Wang, Günther Jürgens. (2000) Comparison of Laboratory Parameters as Risk Factors for the Presence and the Extent of Coronary or Carotid Atherosclerosis: the Significance of Apolipoprotein B to Apolipoprotein AII Ratio. Clinical Chemistry and Laboratory Medicine 38:6, 529-538
CrossRef1340
Michael W. Dunne. (2000) Rationale and Design of a Secondary Prevention Trial of Antibiotic Use in Patients after Myocardial Infarction: The WIZARD (Weekly Intervention with Zithromax [Azithromycin] for Atherosclerosis and Its Related Disorders) Trial. The Journal of Infectious Diseases 181:s3, S572-S578
CrossRef1341
Jeffrey L. Anderson, Joseph B. Muhlestein. (2000) The ACADEMIC Study in Perspective (Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia). The Journal of Infectious Diseases 181:s3, S569-S571
CrossRef1342
Jacob George, Yair Levy, Boris Gilburd, Yehuda Shoenfeld, Alaa Ahmed, Madhumita Patnaik, Jeff Terrybery, Guo Qui Shen, James Peter, Yehuda Adler, Alex Sagie, Itzhak Herz, Dror Harats, Peter Snow, Jeff Brandt. (2000) The prediction of coronary atherosclerosis employing artificial neural networks. Clinical Cardiology 23:6, 453-456
CrossRef1343
Paul L Fox, Barsanjit Mazumder, Eduardo Ehrenwald, Chinmay K Mukhopadhyay. (2000) Ceruloplasmin and cardiovascular disease. Free Radical Biology and Medicine 28:12, 1735-1744
CrossRef1344
H. Grasemann, C.N. Yandava, K. Storm van's Gravesande, A. Deykin, A. Pillari, J. Ma, L.A. Sonna, C. Lilly, M.J. Stampfer, E. Israel, E.K. Silverman, J.M. Drazen. (2000) A Neuronal NO Synthase (NOS1) Gene Polymorphism Is Associated with Asthma. Biochemical and Biophysical Research Communications 272:2, 391-394
CrossRef1345
Lisa A. Jackson. (2000) Description and Status of the Azithromycin and Coronary Events Study (ACES). The Journal of Infectious Diseases 181:s3, S579-S581
CrossRef1346
James J. Nawarskas, Sarah A. Spinler. (2000) Update on the Interaction Between Aspirin and Angiotensin-Converting Enzyme Inhibitors. Pharmacotherapy 20:6, 698-710
CrossRef1347
Christoph Wanner, Josef Zimmermann. (2000) What Are the Causes and Consequences of the Chronic Inflammatory State in Chronic Dialysis Patients?. Seminars in Dialysis 13:3, 174-175
CrossRef1348
Christopher Heeschen, Christian W Hamm, Jens Bruemmer, Maarten L Simoons. (2000) Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. Journal of the American College of Cardiology 35:6, 1535-1542
CrossRef1349
Ian N. Bruce, Dafna D. Gladman, Murray B. Urowitz. (2000) PREMATURE ATHEROSCLEROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS. Rheumatic Disease Clinics of North America 26:2, 257-278
CrossRef1350
Dong-Keun Song, Yeong-Bin Im, Jun-Sub Jung, Ji-Jing Yan, Sung-Oh Huh, Hong-Won Suh, Yung-Hi Kim. (2000) Central injection of nitric oxide synthase inhibitors increases peripheral interleukin-6 and serum amyloid A: involvement of adrenaline from adrenal medulla. British Journal of Pharmacology 130:1, 41-48
CrossRef1351
E.Bernd Ringelstein, Darius Nabavi. (2000) Long-Term Prevention of Ischaemic Stroke and Stroke Recurrence. Thrombosis Research 98:3, 83-96
CrossRef1352
Richard J. Glassock. (2000) What Are the Causes and Consequences of the Chronic Inflammatory State in Chronic Dialysis Patients?. Seminars in Dialysis 13:3, 167-169
CrossRef1353
John D. Rutherford. (2000) Chlamydia pneumoniae and atherosclerosis. Current Atherosclerosis Reports 2:3, 218-225
CrossRef1354
John S Gottdiener, Alice M Arnold, Gerard P Aurigemma, Joseph F Polak, Russell P Tracy, Dalane W Kitzman, Julius M Gardin, John E Rutledge, Robin C Boineau. (2000) Predictors of congestive heart failure in the elderly: the cardiovascular health study. Journal of the American College of Cardiology 35:6, 1628-1637
CrossRef1355
George A. Kaysen. (2000) C-Reactive Protein: A Story Half Told. Seminars in Dialysis 13:3, 143-146
CrossRef1356
John A. Farmer. (2000) Renin angiotensin system and ASCVD. Current Opinion in Cardiology 15:3, 141-150
CrossRef1357
J Sinisalo, J Paronen, K.J Mattila, M Syrjälä, G Alfthan, T Palosuo, M.S Nieminen, O Vaarala. (2000) Relation of inflammation to vascular function in patients with coronary heart disease. Atherosclerosis 149:2, 403-411
CrossRef1358
A.G Zaman, G Helft, S.G Worthley, J.J Badimon. (2000) The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis 149:2, 251-266
CrossRef1359
CLARY B. CLISH, KARSTEN GRONERT, CHARLES N. SERHAN. (2000) Local and Systemic Delivery of an Aspirin-Triggered Lipoxin Stable Analog Inhibits Neutrophil Trafficking. Annals of the New York Academy of Sciences 905:1, 274-278
CrossRef1360
Mark J. Sarnak, Andrew S. Levey. (2000) Cardiovascular disease and chronic renal disease: A new paradigm. American Journal of Kidney Diseases 35:4, S117-S131
CrossRef1361
I J Kullo, G T Gau, A J Tajik. (2000) Novel risk factors for atherosclerosis.. Mayo Clinic Proceedings 75:4, 369-380
CrossRef1362
Ridker, Paul M., Hennekens, Charles H., Buring, Julie E., Rifai, Nader, . (2000) C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women. New England Journal of Medicine 342:12, 836-843
Full Text1363
Derek G Cook, Mike A Mendall, Peter H Whincup, Iain M Carey, Lydia Ballam, Julia E Morris, George J Miller, David P Strachan. (2000) C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 149:1, 139-150
CrossRef1364
Frederick Van Lente. (2000) Markers of inflammation as predictors in cardiovascular disease. Clinica Chimica Acta 293:1-2, 31-52
CrossRef1365
Larry B. Goldstein. (2000) Novel risk factors for stroke: Homocysteine, inflammation, and infection. Current Atherosclerosis Reports 2:2, 110-114
CrossRef1366
Robert S. Rosenson. (2000) Basic mechanisms of stroke prevention with lipid-lowering therapy. Current Atherosclerosis Reports 2:2, 120-125
CrossRef1367
M. Nikfardjam, M. Mullner, W. Schreiber, E. Oschatz, M. Exner, H. Domanovits, A. N. Laggner, K. Huber. (2000) The association between C-reactive protein on admission and mortality in patients with acute myocardial infarction. Journal of Internal Medicine 247:3, 341-345
CrossRef1368
Richard V. Perez, David J. Brown, Steven A. Katznelson, Joel A. Dubin. (2000) PRETRANSPLANT SYSTEMIC INFLAMMATION AND ACUTE REJECTION AFTER RENAL TRANSPLANTATION1. Transplantation869-874
CrossRef1369
Donald F. Sellitti, David Dennison, Takashi Akamizu, Sonia Q. Doi, Leonard D. Kohn, Hiroyuki Koshiyama. (2000) Thyrotropin Regulation of Cyclic Adenosine Monophosphate Production in Human Coronary Artery Smooth Muscle Cells. Thyroid 10:3, 219-225
CrossRef1370
H.Richard Hellstrom. (2000) Mechanism of protection against vascular smoking-induced changes by hormone replacement therapy. Journal of the American College of Cardiology 35:3, 815
CrossRef1371
Jawahar L. Mehta, Francesco Romeo. (2000) Inflammation, Infection and Atherosclerosis. Drugs 59:2, 159-170
CrossRef1372
John S Yudkin, Meena Kumari, Steve E Humphries, Vidya Mohamed-Ali. (2000) Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 148:2, 209-214
CrossRef1373
Robert S. Rosenson. (2000) Biological basis for statin therapy in stroke prevention. Current Opinion in Neurology 13:1, 57-62
CrossRef1374
J. Gram, E.-M. Bladbjerg, L. Moller, A. Sjol, J. Jespersen. (2000) Tissue-type plasminogen activator and C-reactive protein in acute coronary heart disease. A nested case-control study. Journal of Internal Medicine 247:2, 205-212
CrossRef1375
David A Morrow, Nader Rifai, Elliott M Antman, Debra L Weiner, Carolyn H McCabe, Christopher P Cannon, Eugene Braunwald. (2000) Serum amyloid A predicts early mortality in acute coronary syndromes: a TIMI 11A substudy. Journal of the American College of Cardiology 35:2, 358-362
CrossRef1376
Georg Wick, Pidder Jansen-Dürr, Peter Berger, Imrich Blasko, Beatrix Grubeck-Loebenstein. (2000) Diseases of aging. Vaccine 18:16, 1567-1583
CrossRef1377
W. Barbara Wierzbicki, Kathleen O. Hagmeyer. (2000) Helicobacter pylori, Chlamydia pneumoniae , and Cytomegalovirus: Chronic Infections and Coronary Heart Disease. Pharmacotherapy 20:1, 52-63
CrossRef1378
Deepak L. Bhatt, Eric J. Topol. (2000) ANTIPLATELET AND ANTICOAGULANT THERAPY IN THE SECONDARY PREVENTION OF ISCHEMIC HEART DISEASE. Medical Clinics of North America 84:1, 163-179
CrossRef1379
Stephan Fichtlscherer, Andreas M Zeiher. (2000) Endothelial dysfunction in acute coronary syndromes: association with elevated C-reactive protein levels. Annals of Medicine 32:8, 515-518
CrossRef1380
Robert F. Ritchie, Glenn E. Palomaki, Louis M. Neveux, Olga Navolotskaia, Thomas B. Ledue, Wendy Y. Craig. (2000) Reference distributions for the positive acute phase serum proteins, ?1-acid glycoprotein (orosomucoid), ?1-antitrypsin, and haptoglobin: A practical, simple, and clinically relevant approach in a large cohort. Journal of Clinical Laboratory Analysis 14:6, 284-292
CrossRef1381
Claes Held, Paul Hjemdahl, N. Håkan Wallén, Inge Björkander, Lennart Forslund, Björn Wiman, Nina Rehnqvist. (2000) Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Atherosclerosis 148:1, 179-188
CrossRef1382
D MORROW, P RIDKER. (2000) C-REACTIVE PROTEIN, INFLAMMATION, AND CORONARY RISK. Medical Clinics of North America 84:1, 149-161
CrossRef1383
Earl S Ford, Wayne H Giles. (2000) Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction. Journal of Clinical Epidemiology 53:1, 95-102
CrossRef1384
William A Pryor. (2000) Vitamin E and heart disease:. Free Radical Biology and Medicine 28:1, 141-164
CrossRef1385
Matthias Girndt, Sascha Lengler, Harald Kaul, Urban Sester, Martina Sester, Hans Köhler. (2000) Prospective crossover trial of the influence of vitamin E–coated dialyzer membranes on T-cell activation and cytokine induction. American Journal of Kidney Diseases 35:1, 95-104
CrossRef1386
(2000) Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial. The Lancet 355:9201, 337-345
CrossRef1387
Ulf Janssen, Ferdinand Bahlmann, Jörg Köhl, Jörg Zwirner, Marion Haubitz, Jürgen Floege. (2000) Activation of the acute phase response and complement C3 in patients with IgA nephropathy. American Journal of Kidney Diseases 35:1, 21-28
CrossRef1388
Joseph B. Muhlestein. (2000) CHRONIC INFECTION AND CORONARY ARTERY DISEASE. Medical Clinics of North America 84:1, 123-148
CrossRef1389
G. Cammarota, V. Pasceri, A. Gasbarrini, G. Gasbarrini. (2000) Helicobacter pylori is an aetiological factor for ischaemic heart disease: the case against. Digestive and Liver Disease 32:1, 65-68
CrossRef1390
S. S. Levinson. (2000) Opinion: Oxidized Lipoproteins, Inflammation, and Acute Phase Reactants as Markers for Coronary Artery Disease. Oxidierte Lipoproteine, Entzündung und Akute Phase-Reaktanden als Marker für Koronararterienerkrankung: Persönlicher Standpunkt. LaboratoriumsMedizin 24:1, 5-13
CrossRef1391
Mustafa Porsch-Oezçueruemez, Dagmar Kunz, Hans-Ulrich Kloer, Claus Luley. (1999) Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease. Journal of the American College of Cardiology 34:7, 1995-2001
CrossRef1392
John F Carlquist. (1999) Endotoxin: another phantom menace?. Journal of the American College of Cardiology 34:7, 1982-1984
CrossRef1393
N. Turgan, S. Habif, C. Gülter, B. Şenol, I. Mutaf, D. Özmen, O. Bayindir, B. Boydak, N. Turgan. (1999) Urinary hypoxanthine and xanthine levels in acute coronary syndromes. International Journal of Clinical & Laboratory Research 29:4, 162-165
CrossRef1394
Christian J Wiedermann, Stefan Kiechl, Stefan Dunzendorfer, Peter Schratzberger, Georg Egger, Friedrich Oberhollenzer, Johann Willeit. (1999) Association of endotoxemia with carotid atherosclerosis and cardiovascular disease. Journal of the American College of Cardiology 34:7, 1975-1981
CrossRef1395
K Johansen. (1999) The Effect of Red Wine on the Fibrinolytic System and the Cellular Activation Reactions before and after Exercise. Thrombosis Research 96:5, 355-363
CrossRef1396
H.R. Hellstrom. (1999) Occlusions of epicardial arteries might not directly induce symptoms in ischemic heart disease. Medical Hypotheses 53:6, 533-542
CrossRef1397
Arsalan Kharazmi, Kaj Winther. (1999) Rose hip inhibits chemotaxis and chemiluminescence of human peripheral blood neutrophils in vitro and reduces certain inflammatory parameters in vivo. Inflammopharmacology 7:4, 377-386
CrossRef1398
Giovanna Liuzzo, Luigi M Biasucci, J.Ruth Gallimore, Giuseppina Caligiuri, Antonino Buffon, Antonio G Rebuzzi, Mark B Pepys, Attilio Maseri. (1999) Enhanced inflammatory response in patients with preinfarction unstable angina. Journal of the American College of Cardiology 34:6, 1696-1703
CrossRef1399
Jianhui Zhu, Arshed A Quyyumi, James E Norman, Gyorgy Csako, Stephen E Epstein. (1999) Cytomegalovirus in the pathogenesis of atherosclerosis. Journal of the American College of Cardiology 34:6, 1738-1743
CrossRef1400
C.R. Canova, C. Courtin, W.H. Reinhart. (1999) C-reactive protein (CRP) in cerebro-vascular events. Atherosclerosis 147:1, 49-53
CrossRef1401
Russell P. Tracy. (1999) Inflammation markers and coronary heart disease. Current Opinion in Lipidology 10:5, 435-442
CrossRef1402
Russell P. Tracy. (1999) Diet and hemostatic factors. Current Atherosclerosis Reports 1:3, 243-248
CrossRef1403
C.R. Meier. (1999) The possible role of infections in acute myocardial infarction. Biomedicine & Pharmacotherapy 53:9, 397-404
CrossRef1404
Elina Ikonen. (1999) Genetics and molecular biology. Current Opinion in Lipidology 10:5, 471-474
CrossRef1405
Peter Weissberg. (1999) Mechanisms modifying atherosclerotic disease — from lipids to vascular biology. Atherosclerosis 147, S3-S10
CrossRef1406
P.K MacCallum, T.W Meade. (1999) Haemostatic function, arterial disease and the prevention of arterial thrombosis. Best Practice & Research Clinical Haematology 12:3, 577-599
CrossRef1407
E.B Wu, P Lumb, J.B Chambers, M.A Crook. (1999) Plasma sialic acid and coronary artery atheromatous load in patients with stable chest pain. Atherosclerosis 145:2, 261-266
CrossRef1408
Emanuel R. Christ, Michael H. Cummings, Peter J. Lumb, Martin A. Crook, Peter H. Sonksen, David L. Russell-Jones. (1999) Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled study. Clinical Endocrinology 51:2, 173-179
CrossRef1409
James T. Willerson, Pierre Zoldhelyi. (1999) Future directions in thrombolysis. Clinical Cardiology 22:S4, 44-53
CrossRef1410
A Mazzone. (1999) Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease. Atherosclerosis 145:2, 369-374
CrossRef1411
M HOLMES, B SOBEL, D HOWARD, D SCHNEIDER. (1999) Differences between Activation Thresholds for Platelet P-Selectin and Glycoprotein IIb-IIIa Expression and Their Clinical Implications. Thrombosis Research 95:2, 75-82
CrossRef1412
Michelle A. Albert, Paul M. Ridker. (1999) The role of C-reactive protein in cardiovascular disease risk. Current Cardiology Reports 1:2, 99-104
CrossRef1413
Klaus Pethig, Bernd Heublein, Rolf R Meliss, Axel Haverich. (1999) Volumetric remodeling of the proximal left coronary artery. Journal of the American College of Cardiology 34:1, 197-203
CrossRef1414
Nicola Fiotti, Carlo Giansante, Euro Ponte, Claudia Delbello, Salvatore Calabrese, Tiberio Zacchi, Aldo Dobrina, Gianfranco Guarnieri. (1999) Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis 145:1, 51-60
CrossRef1415
Tsung O. Cheng. (1999) Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects. Clinical Cardiology 22:6, A27-A27
CrossRef1416
Raymond J. Gibbons, Kanu Chatterjee, Jennifer Daley, John S. Douglas, Stephan D. Fihn, Julius M. Gardin, Mark A. Grunwald, Daniel Levy, Bruce W. Lytle, Robert A. O’Rourke, William P. Schafer, Sankey V. Williams, James L. Ritchie, Raymond J. Gibbons, Melvin D. Cheitlin, Kim A. Eagle, Timothy J. Gardner, Arthur Garson, Richard O. Russell, Thomas J. Ryan, Sidney C. Smith. (1999) ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina. Journal of the American College of Cardiology 33:7, 2092-2197
CrossRef1417
M. Plebani, M. Zaninotto. (1999) Cardiac markers: present and future. International Journal of Clinical & Laboratory Research 29:2, 56-63
CrossRef1418
John Whicher, Luigi Biasucci, Nader Rifai. (1999) Inflammation, the Acute Phase Response and Atherosclerosis. Clinical Chemistry and Laboratory Medicine 37:5, 495-503
CrossRef1419
Carsten Ranke, Hans-Joachim Trappe. (1999) Update Angiologie. Medizinische Klinik 94:5, 251-263
CrossRef1420
Peter Stenvinkel, Olof Heimburger, Furcy Paultre, Ulf Diczfalusy, Tao Wang, Lars Berglund, Tomas Jogestrand. (1999) Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney International 55:5, 1899-1911
CrossRef1421
T. Alp Ikizler, Rebecca L. Wingard, Janice Harvell, Yu Shyr, Raymond M. Hakim. (1999) Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study. Kidney International 55:5, 1945-1951
CrossRef1422
Eduardo K. Lacson Jr., William F. Owen Jr.. (1999) CARDIAC DISEASE IN DIALYSIS PATIENTS: Interactions Between Hemodialysis Adequacy and Nutrition in Dialysis Patients. Seminars in Dialysis 12:2, 112-116
CrossRef1423
Bruce F. Culleton, Peter W. F. Wilson. (1999) CARDIAC DISEASE IN DIALYSIS PATIENTS: Thrombogenic Risk Factors for Cardiovascular Disease in Dialysis Patients. Seminars in Dialysis 12:2, 117-125
CrossRef1424
Debra A. Schaumberg, Paul M. Ridker, Robert J. Glynn, William G. Christen, M.Reza Dana, Charles H. Hennekens. (1999) High Levels of Plasma C-Reactive Protein and Future Risk of Age-Related Cataract. Annals of Epidemiology 9:3, 166-171
CrossRef1425
L Braeckman, D De Bacquer, J Delanghe, L Claeys, G De Backer. (1999) Associations between haptoglobin polymorphism, lipids, lipoproteins and inflammatory variables. Atherosclerosis 143:2, 383-388
CrossRef1426
W.Marchien van Baal, Peter Kenemans, Jef J Emeis, Casper G Schalkwijk, Velja Mijatovic, Marius J van der Mooren, Ulrich M Vischer, Coen D.A Stehouwer. (1999) Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women. Fertility and Sterility 71:4, 663-670
CrossRef1427
K. Winther, E. Rein, A. Kharazmi. (1999) The anti-inflammatory properties of rose-hip. Inflammopharmacology 7:1, 63-68
CrossRef1428
Bruce R. Bistrian. (1999) Acute phase proteins and the systemic inflammatory response. Critical Care Medicine 27:3, 452-453
CrossRef1429
SUZANNE OPARIL, ALBERT OBERMAN. (1999) Nontraditional Cardiovascular Risk Factors. The American Journal of the Medical Sciences 317:3, 193-207
CrossRef1430
David J. Lamb, Lesley-Jane Eales, Gordon A. Ferns. (1999) Immunization with bacillus Calmette–Guerin vaccine increases aortic atherosclerosis in the cholesterol-fed rabbit. Atherosclerosis 143:1, 105-113
CrossRef1431
Peter W. F. Wilson. (1999) Metabolic risk factors for coronary heart disease: current and future prospects. Current Opinion in Cardiology 14:2, 176
CrossRef1432
Amir Kol, Todd Bourcier, Andrew H. Lichtman, Peter Libby. (1999) Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. Journal of Clinical Investigation 103:4, 571-577
CrossRef1433
Epstein, Franklin H., , Gabay, Cem, Kushner, Irving, . (1999) Acute-Phase Proteins and Other Systemic Responses to Inflammation. New England Journal of Medicine 340:6, 448-454
Full Text1434
Frank M. Sacks, Paul M. Ridker. (1999) Lipid lowering and beyond: Results from the CARE study on lipoproteins and inflammation. Herz 24:1, 51-56
CrossRef1435
Walter J. Loesche. (1999) Anaerobic periodontal infections as risk factors for medical diseases. Current Infectious Disease Reports 1:1, 33-38
CrossRef1436
Darren Thompson, Mark B Pepys, Steve P Wood. (1999) The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 7:2, 169-177
CrossRef1437
D.J. Lamb, G.A.A. Ferns. (1999) Infection, immunisation and atherosclerosis: is there a link?. Vaccine 17:6, 559-564
CrossRef1438
Kenneth R. Feingold, Riaz A. Memon, Arthur H. Moser, Judy K. Shigenaga, Carl Grunfeld. (1999) Endotoxin and interleukin-1 decrease hepatic lipase mRNA levels. Atherosclerosis 142:2, 379-387
CrossRef1439
JOSEF ZIMMERMANN, SILKE HERRLINGER, ANTJE PRUY, THOMAS METZGER, CHRISTOPH WANNER. (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney International 55:2, 648-658
CrossRef1440
Christopher P. Price, Jacqui Calvin, Susan A. Walker, Andrew Trull, David J. Newman, Eileen G. Gorman. (1999) A Rapid and Sensitive Automated Light Scattering Immunoassay for Serum C-Reactive Protein and the Definition of a Reference Range in Healthy Blood Donors. Clinical Chemistry and Laboratory Medicine 37:2, 109-113
CrossRef1441
James F. Benenati. (1999) Risk Assessment and Physical Examination in Vascular Disease. Journal of Vascular and Interventional Radiology 10:2, 311-316
CrossRef1442
Epstein, Franklin H., , Ross, Russell, . (1999) Atherosclerosis — An Inflammatory Disease. New England Journal of Medicine 340:2, 115-126
Full Text1443
R Wergeland, O Øyen, Ø Bentdal, O S. (1999) MicroCRP: a highly sensitive CRP method applied in the monitoring of renal allograft recipients. Scandinavian Journal of Clinical & Laboratory Investigation 59:6, 405-416
CrossRef1444
Takeshi Soeki, Yoshiyuki Tamura, Hisanori Shinohara, Hideji Tanaka, Kanji Bando, Yasuko Yui, Nobuo Fukuda. (1999) Fibrinolytic Factors, Serum Lipid and C-reactive Protein Predicting Cardiac Events in Japanese Patients With Coronary Atherosclerotic Lesions. Japanese Circulation Journal 63:12, 976-980
CrossRef1445
Toshiyuki Ishibashi, Mikihiro Kijima, Keiko Yokoyama, Joji Shindo, Kenji Nagata, Akira Hirosaka, Masaaki Techigawara, Yukihiko Abe, Eiichi Sato, Nozomi Yamaguchi, Naohiko Watanabe, Tomiyoshi Saito, Kazuhira Maehara, Yasukazu Ohmoto, Yukio Maruyama. (1999) Expression of Cytokine and Adhesion Molecule mRNA in Atherectomy Specimens From Patients With Coronary Artery Disease. Japanese Circulation Journal 63:4, 249-254
CrossRef1446
Robert F. Ritchie, Glenn E. Palomaki, Louis M. Neveux, Olga Navolotskaia, Thomas B. Ledue, Wendy Y. Craig. (1999) Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: A practical, simple and clinically relevant approach in a large cohort. Journal of Clinical Laboratory Analysis 13:6, 273-279
CrossRef1447
David J Schneider, Douglas J Taatjes, Diantha B Howard, Burton E Sobel. (1999) Increased reactivity of platelets induced by fibrinogen independent of its binding to the IIb-IIIa surface glycoprotein:. Journal of the American College of Cardiology 33:1, 261-266
CrossRef1448
Tatu Juvonen, Jukka Juvonen, Markku J. Savolainen. (1999) Is vasculitis a significant component of atherosclerosis?. Current Opinion in Rheumatology 11:1, 3-10
CrossRef1449
H. Asuman KAFTAN, Osman KAFTAN, Mustafa KILIÇ. (1999) Markers of Chronic Infection and Inflammation Are They Important in Cases with Chronic Coronary Heart Disease.. Japanese Heart Journal 40:3, 275-280
CrossRef1450
Susan Manzi, Faith Selzer, Kim Sutton-Tyrrell, Shirley G. Fitzgerald, Joan E. Rairie, Russell P. Tracy, Lewis H. Kuller. (1999) Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis & Rheumatism 42:1, 51-60
CrossRef1451
William D. McMillan, William H. Pearce. (1999) Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. Journal of Vascular Surgery 29:1, 122-129
CrossRef1452
J. L. Mehta. (1998) Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects. Clinical Cardiology 21:12, 879-884
CrossRef1453
DavidA Halon, MosheY Flugelman, Amnon Merdler, Hedy Rennert, Johnny Shahla, BasilS Lewis. (1998) Long-term (10-year) outcome in patients with unstable angina pectoris treated by coronary balloon angioplasty. Journal of the American College of Cardiology 32:6, 1603-1609
CrossRef1454
R. P. Steeds, K. S. Channer. (1998) Recent advances in the management of unstable angina and non-Q-wave myocardial infarction. British Journal of Clinical Pharmacology 46:4, 335-341
CrossRef1455
Karin B. Nelson, James M. Dambrosia, Judith K. Grether, Terry M. Phillips. (1998) Neonatal cytokines and coagulation factors in children with cerebral palsy. Annals of Neurology 44:4, 665-675
CrossRef1456
Cho-chou Kuo, Lee Ann Campbell. (1998) Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis?. Molecular Medicine Today 4:10, 426-430
CrossRef1457
Luigi M Biasucci, Giovanna Liuzzo, Christian Colizzi, Attilio Maseri. (1998) The role of cytokines in unstable angina. Expert Opinion on Investigational Drugs 7:10, 1667-1672
CrossRef1458
David Wood, Guy De Backer, Ole Faergeman, Ian Graham, Giuseppe Mancia, Kalevi Pyörälä. (1998) Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2. Atherosclerosis 140:2, 199-270
CrossRef1459
Gerard Pasterkamp, Arjan H Schoneveld, Allard C van der Wal, Christian C Haudenschild, Ruud J.G Clarijs, Anton E Becker, Berend Hillen, Cornelius Borst. (1998) Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: the remodeling paradox. Journal of the American College of Cardiology 32:3, 655-662
CrossRef1460
Kenneth R Feingold, Riaz A Memon, Arthur H Moser, Carl Grunfeld. (1998) Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis 139:2, 307-315
CrossRef1461
Harvey D. White, John K. French, Christopher J. Ellis. (1998) New antiplatelet agents. Australian and New Zealand Journal of Medicine 28:4, 558-564
CrossRef1462
G. Hornstra, C. A. Barth, C. Galli, R. P. Mensink, M. Mutanen, R. A. Riemersma, M. Roberfroid, K. Salminen, G. Vansant, P. M. Verschuren. (1998) Functional food science and the cardiovascular system. British Journal of Nutrition 80:S1, S113
CrossRef1463
A.Maziar Zafari, Nanette K. Wenger. (1998) Secondary prevention of coronary heart disease. Archives of Physical Medicine and Rehabilitation 79:8, 1006-1017
CrossRef1464
G Ristori, F Laurenti, P Stacchini, C Gasperini, C Buttinelli, C Pozzilli, M Salvetti. (1998) Serum amyloid A protein is elevated in relapsing–remitting multiple sclerosis. Journal of Neuroimmunology 88:1-2, 9-12
CrossRef1465
Raul I. Garcia, Elizabeth A. Krall, Pantel S. Vokonas. (1998) Periodontal Disease and Mortality From All Causes in the VA Dental Longitudinal Study. Annals of Periodontology 3:1, 339-349
CrossRef1466
Mark C. Herzberg, Maurice W. Meyer. (1998) Dental Plaque, Platelets, and Cardiovascular Diseases*. Annals of Periodontology 3:1, 151-160
CrossRef1467
Jeffrey L Anderson, John F Carlquist, Joseph B Muhlestein, Benjamin D Horne, Sidney P Elmer. (1998) Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. Journal of the American College of Cardiology 32:1, 35-41
CrossRef1468
Dirk O. Stichtenoth, Henning Zeidler, Jürgen C. Frölich. (1998) Neue nichtsteroidale Antirheumatika: Selektive Hemmstoffe der induzierbaren Cyclooxygenase. Medizinische Klinik 93:7, 407-415
CrossRef1469
David A Morrow, Nader Rifai, Elliott M Antman, Debra L Weiner, Carolyn H McCabe, Christopher P Cannon, Eugene Braunwald. (1998) C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy. Journal of the American College of Cardiology 31:7, 1460-1465
CrossRef1470
Bruce Watkins, Bernhard Hennig. 1998. Dietary Lipid Guidelines for Infants and Children. .
CrossRef1471
R. W. F. Campbell, L. Wallentin, F. W. A. Verheugt, A. G. G. Turpie, A. Maseri, W. Klein, J. G. F. Cleland, C. Bode, R. Becker, J. Anderson, M. E. Bertrand, C. R. Conti. (1998) Management Strategies for a Better Outcome in Unstable Coronary Artery Disease. Clinical Cardiology 21:5, 314-322
CrossRef1472
John Danesh, Paul Appleby. (1998) Persistent infection and vascular disease: a systematic review. Expert Opinion on Investigational Drugs 7:5, 691-713
CrossRef1473
Jawahar L Mehta, Tom G.P Saldeen, Kenneth Rand. (1998) Interactive Role of Infection, Inflammation and Traditional Risk Factors in Atherosclerosis and Coronary Artery Disease. Journal of the American College of Cardiology 31:6, 1217-1225
CrossRef1474
Christoph R Meier, Susan S Jick, Laura E Derby, Catherine Vasilakis, Hershel Jick, CR Meier, SS Jick, LE Derby, C Vasilakis, H Jick. (1998) Acute respiratory-tract infections and risk of first-time acute myocardial infarction. The Lancet 351:9114, 1467-1471
CrossRef1475
Gerd Schmitz, Alexandra S. Herr, Gregor Rothe. (1998) T-lymphocytes and monocytes in atherogenesis. Herz 23:3, 168-177
CrossRef1476
Wolfgang Stille, Rike Dittmann. (1998) Arteriosklerose als Folge einer chronischen Infektion durch Chlamydia pneumoniae. Herz 23:3, 185-192
CrossRef1477
Philip D Henry, Antonio Pacifico. (1998) Altering molecular mechanisms to prevent sudden arrhythmic death. The Lancet 351:9111, 1276-1278
CrossRef1478
Frazier T. Stevenson. (1998) Inflammation and End-Stage Renal Disease: Recent Insights. Seminars in Dialysis 11:2, 119-123
CrossRef1479
K Sadegh-Zadeh. (1998) Fundamentals of clinical methodology: 2. Etiology. Artificial Intelligence in Medicine 12:3, 227-270
CrossRef1480
Kyra J. Becker. (1998) Inflammation and acute stroke. Current Opinion in Neurology45-49
CrossRef1481
John M. Porter. (1998) Vascular Surgery. Journal of the American College of Surgeons 186:2, 247-262
CrossRef1482
Walter J. Loesche, Dennis E. Lopatin. (1998) Interactions between periodontal disease, medical diseases and immunity in the older individual. Periodontology 2000 16:1, 80-105
CrossRef1483
Paul M Ridker, Charles H Hennekens, Beatrice Roitman-Johnson, Meir J Stampfer, Jean Allen. (1998) Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. The Lancet 351:9096, 88-92
CrossRef1484
K. Fred Gey. (1998) Vitamins E plus C and interacting conutrients required for optimal health. BioFactors 7:1-2, 113-174
CrossRef1485
Nils Gunnar Arvidsson, Björn Gudbjörnsson, Roger Hällgren, Anders Larsson. (1998) Concordant Message of Different Inflammatory Markers in Patients with Rheumatoid Arthritis. Upsala Journal of Medical Sciences 103:1, 35-42
CrossRef1486
James F. Benenati. (1998) Risk Assessment and Physical Examination in Vascular Disease. Journal of Vascular and Interventional Radiology 9:1, 264-269
CrossRef1487
Karen E. Weck, Albert J. Dal Canto, James D. Gould, Andrew K. O'Guin, Kevin A. Roth, Jeffrey E. Saffitz, Samuel H. Speck, Herbert W. Virgin. (1997) Murine γ-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-γ responsiveness: A new model for virus-induced vascular disease. Nature Medicine 3:12, 1346-1353
CrossRef1488
Eyal Leibovitz, Yizhak Hertz, Eliezer Liberman, Samuel Sclarovsky, A.S. Berliner. (1997) Increased adhesiveness of white blood cells in patients with unstable angina: Additional evidence for an involvement of the immune-inflammatory system. Clinical Cardiology 20:12, 1017-1020
CrossRef1489
Braunwald, Eugene, . (1997) Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities. New England Journal of Medicine 337:19, 1360-1369
Full Text1490
Helge Stormorken, Kjell S. Sakariassen. (1997) HEMOSTATIC RISK FACTORS IN ARTERIAL THROMBOSIS AND ATHEROSCLEROSIS: THE THROMBIN-FIBRIN AND PLATELET-VWF AXIS. Thrombosis Research 88:1, 1-25
CrossRef1491
Harri Vainio, Gareth Morgan. (1997) Aspirin for the Second Hundred Years: New Uses for an Old Drug. Pharmacology & Toxicology 81:4, 151-152
CrossRef1492
A. Chamorro, N. Vila, R. Blanc, A. Saiz, C. Ascaso, R. Deulofeu. (1997) The prognostic value of the acute-phase response in stroke recurrence. European Journal of Neurology 4:5, 491-497
CrossRef1493
Marco A. Cimmino, Silvano Accardo, Marco Scudeletti, Francesco Indiveri, Simon M. Helfgott, Raphael I. Kieval. (1997) The diagnosis of polymyalgia rheumatica in patients with a low erythrocyte sedimentation rate: Comment on the article by Helfgott and Kieval. Arthritis & Rheumatism 40:9, 1726-1728
CrossRef1494
(1997) Inflammation, Aspirin, and the Risk of Cardiovascular Disease. New England Journal of Medicine 337:6, 422-424
Full Text1495
John Danesh, Rory Collins, Richard Peto. (1997) Chronic infections and coronary heart disease: is there a link?. The Lancet 350:9075, 430-436
CrossRef1496
Maseri, Attilio, . (1997) Inflammation, Atherosclerosis, and Ischemic Events — Exploring the Hidden Side of the Moon. New England Journal of Medicine 336:14, 1014-1016
Full Text
- Letters
